@article{Brurberg2014,
  title={Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis ({CFS/ME}): a systematic review},
  author={Brurberg, Kjetil G and F{\o}ngebø, Viv\'{i}an Sch{\"u}nemann and Larun, Lillebeth and Mengshoel, Anne Marit and Landmark, Line and Malterud, Kirsti and White, Peter D},
  journal={BMJ Open},
  volume={4},
  number={2},
  pages={e003973},
  year={2014},
  doi={10.1136/bmjopen-2013-003973},
  pmid={24508851},
  pmcid={PMC3918988},
  publisher={BMJ Publishing Group}
}

@article{walitt2024deep,
  title={Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome},
  author={Walitt, Brian and Singh, Komudi and LaMunion, Samuel R and Hallett, Mark and Jacobson, Sandra and Chen, Kong and Enose-Akahata, Yoshihisa and Apps, Ryan and Barnett, Tanner and Berger, Angelique and Brisco, Maura and Butman, John A and Calabrese, Clair and Che, Xiongce and Cleary, Patrick and Cohen, Jeffrey I and Dufort, Danillo and Franco-Robles, Brice and Frank, Brianna and Gabel, Cathy and Gall, Rebecca and Hammoud, Dib and Hassanein, Sara and Horan, Jacqueline J and Hsu, Elizabeth and Imrich, Renato and Johnson, Kory R and Kavak, Mirit I and Knutson, Heather and Koehne, Allison and Kwak, Minhee and Leoce, Nicole M and Li, Yao and Lucas, Anita and Maric-Bilkan, Christine and Marlowe, Tammie L and Martinez, Pedro E and Masters, Elizabeth and Matheny, Michael and McGrath-Morrow, Sharon and McKenzie-Rundshagen, Collen and Memari, Yasaman and Milner, Joshua D and Morishita, Katie and Moses, Shauntrice and Mukherjee, Mrunal and Naughton, Kelly M and Nath, Avindra and Norato, Gina and O'Brien, Katherine and Oh, James and Paikari, Amirali and Pelletier, Ty and Power, Leo and Quach, Jennifer and Ramachandran, Bhaskar and Randall, C and Richmand, Brad and Richmand, Colleen and Rider, Lauren and Riggs, Emily and Robertson, Tina and Roediger, Meghan and Rosenthal, David and Scholand, Mary Beth and Schreiber, David and Shaw, Julie and Shin, Steve and Smith, Blake and Stein, Theodore and Stringer, Kelly and Stussman, Barbara and Sundel, Robert and Sweeney, Dana and Thoburn, Christian and Toro, Constantino and Trinchieri, Giorgio and Turner, Shannon and Venditto, Victoria and Vetter, Chantal and Vial, Florian and Violich, Sofia and Waldman, Megan and Weir, Jennifer and Whatley, Jeffrey and Wiedemann, Angelique and Winkler, Benjamin and Wyman, Andrew and Zhu, Lixin},
  journal={Nature Communications},
  volume={15},
  number={1},
  pages={907},
  year={2024},
  month={February},
  day={21},
  publisher={Nature Publishing Group},
  doi={10.1038/s41467-024-45107-3},
  url={https://www.nature.com/articles/s41467-024-45107-3},
  pmid={38383456},
  pmcid={PMC10881493}
}

@misc{nih2024mecfs,
  title={NIH study offers new clues into the causes of post-infectious ME/CFS},
  author={{National Institutes of Health}},
  year={2024},
  month={February},
  day={21},
  howpublished={NIH News Release},
  url={https://www.nih.gov/news-events/news-releases/depth-study-finds-brain-immune-metabolic-abnormalities-linked-debilitating-chronic-disease},
  note={Accessed 2026-01-20}
}

@article{heng2025mecfs,
  author = {Heng, Ruiwen Benjamin and Gunasegaran, Bavani and Krishnamurthy, Shivani and Bustamante, Sonia and Staats, Ananda and Chow, Sharron and Ahn, Seong Beom and Paul-Heng, Moumita and Maciver, Yolande and Smith, Kirsten and Tran, Denise Phuong and Howley, Peter P. and Bilgin, Ayse Aysin and Sharland, Alexandra and Schloeffel, Richard and Guillemin, Gilles J.},
  title = {Mapping the complexity of {ME/CFS}: Evidence for abnormal energy metabolism, altered immune profile, and vascular dysfunction},
  journal = {Cell Reports Medicine},
  volume = {6},
  number = {12},
  pages = {102514},
  year = {2025},
  month = {December},
  day = {16},
  doi = {10.1016/j.xcrm.2025.102514},
  url = {https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(25)00587-7},
  issn = {2666-3791},
  publisher = {Elsevier},
  keywords = {ME/CFS, chronic fatigue syndrome, energy metabolism, immune dysfunction, vascular dysfunction, biomarkers, multi-omics},
  note = {Open access (CC BY-NC). Full text and supplementary materials available at Cell Press, ScienceDirect, and SSRN preprint server.}
}

@article{pipper2024steroid,
  title={Sex and disease severity-based analysis of steroid hormones in {ME/CFS}},
  author={Pipper, Claudia B and Bliem, Hannah R and Le{\'o}n-Felipe, Patricia and Hartogh, Daniela J D and Domonell, Anne and Behrends, Uta and Kreuzer, Marianna and Meier-Cillien, Martina and Bauer, Andreas and Quadflieg, Johannes and Rohrhofer, Johannes and Barth, Evelyn and Kottmair, Lena and Weidner, Martin and Peters, Eva M J and Koester, Dennis and Rosenberger, Philipp and Haas, Johannes P and Unger, Maria M and Scheibenbogen, Carmen and Seifert, Gabriele and Wudy, Stefan A},
  journal={Journal of Endocrinological Investigation},
  volume={47},
  pages={2235--2248},
  year={2024},
  doi={10.1007/s40618-024-02334-1},
  pmid={38724880},
  pmcid={PMC11369000}
}

@article{heng2025sexspecific,
  title={Integrated immune, hormonal, and transcriptomic profiling reveals sex-specific dysregulation in long {COVID} patients with {ME/CFS}},
  author={Heng, Ruiwen Benjamin and others},
  journal={Cell Reports Medicine},
  year={2025},
  doi={10.1016/j.xcrm.2025.102221},
  pmid={41205594}
}

@article{lim2020prevalence,
  title={Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis ({CFS/ME})},
  author={Lim, Eun-Jin and Ahn, Young-Chan and Jang, Eun-Su and Lee, Seung-Woo and Lee, Seung-Hwan and Son, Chang-Gue},
  journal={Journal of Translational Medicine},
  volume={18},
  pages={100},
  year={2020},
  doi={10.1186/s12967-020-02269-0},
  pmid={32093722}
}

@article{boneva2011gynecological,
  title={Gynecological History in Chronic Fatigue Syndrome: A Population-Based Case-Control Study},
  author={Boneva, Roumiana S and Lin, Jin-Mann and Unger, Elizabeth R},
  journal={Journal of Women's Health},
  volume={20},
  number={1},
  pages={21--28},
  year={2011},
  doi={10.1089/jwh.2009.1900},
  pmid={21091051},
  pmcid={PMC3017420}
}

@article{boneva2015menopause,
  title={Early menopause and other gynecologic risk indicators for chronic fatigue syndrome in women},
  author={Boneva, Roumiana S and Lin, Jin-Mann and Wieser, Florian and Nater, Urs M and Ditzen, Beate and Taylor, Rebecca N and Unger, Elizabeth R},
  journal={Menopause},
  volume={22},
  number={8},
  pages={826--834},
  year={2015},
  doi={10.1097/GME.0000000000000411},
  pmid={25647777},
  pmcid={PMC5745581}
}

@article{jason2018prevalence,
  title={Estimating Prevalence, Demographics, and Costs of {ME/CFS} Using Large Scale Medical Claims Data and Machine Learning},
  author={Jason, Leonard A and Mirin, Arthur A},
  journal={Frontiers in Pediatrics},
  volume={6},
  pages={412},
  year={2018},
  doi={10.3389/fped.2018.00412},
  pmid={30619784},
  pmcid={PMC6331450}
}

@article{ruiznunez2018thyroid,
  title={Higher Prevalence of ``Low {T3} Syndrome'' in Patients With Chronic Fatigue Syndrome: A Case-Control Study},
  author={Ruiz-N{\'u}{\~n}ez, Begoña and Tarasse, Rabab and Vogelaar, Emar F and Janneke Dijck-Brouwer, D A and Muskiet, Frits A J},
  journal={Frontiers in Endocrinology},
  volume={9},
  pages={97},
  year={2018},
  doi={10.3389/fendo.2018.00097},
  pmid={29619013},
  pmcid={PMC5869352}
}

@article{moorkens2000gh,
  title={Growth hormone treatment in patients with chronic fatigue syndrome},
  author={Moorkens, Greta and Wynants, Herman and Abs, Roger},
  journal={Growth Hormone \& IGF Research},
  volume={10},
  number={Suppl B},
  pages={S49--S53},
  year={2000},
  pmid={10990148}
}

@article{maloney2010metabolic,
  title={Chronic fatigue syndrome and metabolic syndrome: a comparative study},
  author={Maloney, Erin M and Boneva, Roumiana S and Nater, Urs M and Reeves, William C},
  journal={Metabolism},
  volume={59},
  number={9},
  pages={1351--1357},
  year={2010},
  doi={10.1016/j.metabol.2009.12.025},
  pmid={20102774}
}

@article{tirelli1998pet,
  title={Brain positron emission tomography ({PET}) in chronic fatigue syndrome: preliminary data},
  author={Tirelli, Umberto and Chierichetti, Franca and Tavio, Massimiliano and Simonelli, Corinna and Bianchin, Giuseppe and Zanco, Pietro and Ferlin, Giorgio},
  journal={American Journal of Medicine},
  volume={105},
  number={3A},
  pages={54S--58S},
  year={1998},
  pmid={9790483}
}

@article{siessmeier2003pet,
  title={Observer independent analysis of cerebral glucose metabolism in patients with chronic fatigue syndrome},
  author={Siessmeier, Thomas and Nix, Waldemar A and Hardt, Jochen and Schreckenberger, Mathias and Egle, Ulrich T and Bartenstein, Peter},
  journal={Journal of Neurology, Neurosurgery \& Psychiatry},
  volume={74},
  number={7},
  pages={922--928},
  year={2003},
  pmid={12810781},
  pmcid={PMC1738575}
}

@article{cambras2018circadian,
  title={Circadian rhythm abnormalities and autonomic dysfunction in patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis},
  author={Cambras, Trinitat and Castro-Marrero, Jes{\'u}s and Zaragoza, Mar{\'i}a Carmen and D{\'i}ez-Noguera, Antoni and Alegre, Jos{\'e}},
  journal={PLoS ONE},
  volume={13},
  number={6},
  pages={e0198106},
  year={2018},
  doi={10.1371/journal.pone.0198106},
  pmid={29870570},
  pmcid={PMC5988317}
}

@article{castromarrero2021melatonin,
  title={Melatonin Plus Zinc Supplementation Improves Health Status in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized Controlled Clinical Trial},
  author={Castro-Marrero, Jes{\'u}s and Zaragoz{\'a}, Mar{\'i}a Carmen and L{\'o}pez-Vill{\'e}n, Laura and Aliste, Luisa and Rabasa, Claudia and Vilches, Susanna and Meng, Patrick C and Alegre-Mart{\'i}n, Jos{\'e}},
  journal={Antioxidants},
  volume={10},
  number={7},
  pages={1010},
  year={2021},
  doi={10.3390/antiox10071010},
  pmid={34201806},
  pmcid={PMC8300746}
}

@article{keller2024cpet,
  title={Cardiopulmonary and metabolic responses during a 2-day CPET in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations},
  author={Keller, Betsy A and Receno, Candace N and Franconi, Carl J and Harenberg, Sebastian and Stevens, Jared and Mao, Xiangling and Stevens, Staci R and Moore, Geoff E and Levine, Susan and Chia, John and Shungu, Dikoma C and Hanson, Maureen R},
  journal={Journal of Translational Medicine},
  volume={22},
  number={1},
  pages={627},
  year={2024},
  month={July},
  day={5},
  publisher={BioMed Central},
  doi={10.1186/s12967-024-05410-5},
  url={https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-024-05410-5},
  pmid={38965566},
  pmcid={PMC11229500},
  keywords = {ME/CFS, post-exertional malaise, cardiopulmonary exercise test, two-day CPET, autonomic dysfunction, oxygen consumption}
}

@misc{reddit2025austria_euthanasia,
  title={Euthanasie in {\"O}sterreich},
  author={{Reddit user: r/Austria}},
  year={2025},
  howpublished={Reddit discussion},
  url={https://www.reddit.com/r/Austria/s/JUzy5LM6O7},
  note={Accessed 2026-01-21. Discussion thread regarding euthanasia policies in Austria}
}

% Mortality Studies
@article{Roberts2016,
  title={Mortality of people with chronic fatigue syndrome: a retrospective cohort study in {England} and {Wales} from the {South London} and {Maudsley NHS Foundation Trust Biomedical Research Centre} ({SLAM BRC}) {Clinical Record Interactive Search} ({CRIS}) {Register}},
  author={Roberts, Eleanor and Wessely, Simon and Chalder, Trudie and Chang, Chin-Kuo and Hotopf, Matthew},
  journal={The Lancet},
  volume={387},
  number={10028},
  pages={1638--1643},
  year={2016},
  month={April},
  day={16},
  publisher={Elsevier},
  doi={10.1016/S0140-6736(15)01223-4},
  pmid={26873808},
  pmcid={PMC4850637},
  url={https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)01223-4/fulltext}
}

@article{Smith2006,
  title={Mortality in a cohort of chronically fatigued patients},
  author={Smith, William R and Noonan, Courtney and Buchwald, Dedra},
  journal={Psychological Medicine},
  volume={36},
  number={9},
  pages={1301--1306},
  year={2006},
  month={September},
  publisher={Cambridge University Press},
  doi={10.1017/S0033291706007975},
  pmid={16893495},
  url={https://www.cambridge.org/core/journals/psychological-medicine/article/abs/mortality-in-a-cohort-of-chronically-fatigued-patients/2FF5A65EDE8D4492BED2477199CFF281}
}

@article{McManimen2016,
  title={Mortality in patients with myalgic encephalomyelitis and chronic fatigue syndrome},
  author={McManimen, Samantha L and Devendorf, Andrew R and Brown, Abigail A and Moore, Brianna C and Moore, Jacob H and Jason, Leonard A},
  journal={Fatigue: Biomedicine, Health \& Behavior},
  volume={4},
  number={4},
  pages={195--207},
  year={2016},
  publisher={Taylor \& Francis},
  doi={10.1080/21641846.2016.1236588},
  pmid={28344899},
  pmcid={PMC5218818},
  url={https://www.tandfonline.com/doi/full/10.1080/21641846.2016.1236588}
}

@article{Sirotiak2025,
  title={Mortality in myalgic encephalomyelitis/chronic fatigue syndrome ({ME/CFS}): an updated analysis of memorial records},
  author={Sirotiak, Zachary and Amro, Haytham J},
  journal={Fatigue: Biomedicine, Health \& Behavior},
  volume={13},
  number={4},
  pages={1--17},
  year={2025},
  publisher={Taylor \& Francis},
  doi={10.1080/21641846.2025.2543201},
  url={https://www.tandfonline.com/doi/full/10.1080/21641846.2025.2543201}
}

@article{Jason2006,
  title={Causes of death among patients with chronic fatigue syndrome},
  author={Jason, Leonard A and Corradi, Kevin and Gress, Susan and Williams, Stephanie and Torres-Harding, Susan},
  journal={Health Care for Women International},
  volume={27},
  number={7},
  pages={615--626},
  year={2006},
  publisher={Taylor \& Francis},
  doi={10.1080/07399330600803766},
  pmid={16844674},
  url={https://www.tandfonline.com/doi/abs/10.1080/07399330600803766}
}

@article{Chu2019,
  title={Identifying and managing suicidality in myalgic encephalomyelitis/chronic fatigue syndrome},
  author={Chu, Lily and Valencia, Indira J and Garvert, Donn W and Montoya, Jose G},
  journal={Healthcare},
  volume={9},
  number={6},
  pages={629},
  year={2021},
  month={May},
  day={28},
  publisher={MDPI},
  doi={10.3390/healthcare9060629},
  pmid={34071336},
  pmcid={PMC8228912},
  url={https://www.mdpi.com/2227-9032/9/6/629},
  keywords = {ME/CFS, suicide, suicidal ideation, depression, functional impairment}
}

@article{Brown2020,
  title={Risk factors for suicide in chronic fatigue syndrome},
  author={Brown, Abigail A and Jason, Leonard A},
  journal={Fatigue: Biomedicine, Health \& Behavior},
  volume={8},
  number={2},
  pages={85--94},
  year={2020},
  publisher={Taylor \& Francis},
  doi={10.1080/21641846.2020.1757809},
  pmid={35720220},
  pmcid={PMC9152620},
  url={https://www.tandfonline.com/doi/full/10.1080/21641846.2020.1757809},
  keywords = {CFS, ME/CFS, suicide, risk factors, stigma, medical dismissal}
}

@misc{GenRe2023,
  title={Chronic Fatigue Syndrome -- A Disease That Brings Uncertainties},
  author={{Gen Re}},
  year={2023},
  month={May},
  howpublished={Insurance Industry Publication},
  url={https://www.genre.com/us/knowledge/publications/2023/may/chronic-fatigue-syndrome-a-disease-that-brings-uncertainties-en},
  note={Gen Re (General Reinsurance Corporation) actuarial analysis of ME/CFS for insurance underwriting. Key conclusion: "There seems to be no significant difference between all-cause mortality rates of ME/CFS patients and the general population." Notes potential cardiovascular mortality elevation in very severe cases but emphasizes disability (not mortality) as primary actuarial risk. Accessed 2026-01-21}
}
@article{strassheim2021experiences,
  title={Experiences of Living with Severe Chronic Fatigue Syndrome/Myalgic Encephalomyelitis},
  author={Strassheim, Victoria and Newton, Julia L and Collins, Tracy},
  journal={Healthcare},
  volume={9},
  number={2},
  pages={168},
  year={2021},
  month={February},
  publisher={MDPI},
  doi={10.3390/healthcare9020168},
  pmid={33562474},
  pmcid={PMC7914910},
  url={https://www.mdpi.com/2227-9032/9/2/168},
  keywords={ME/CFS, phenomenology, severe ME/CFS, lived experience, qualitative research}
}

@article{fennell2021elements,
  title={Elements of Suffering in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: The Experience of Loss, Grief, Stigma, and Trauma in the Severely and Very Severely Affected},
  author={Fennell, Patricia A and Dorr, Nancy and George, Shane S},
  journal={Healthcare},
  volume={9},
  number={5},
  pages={553},
  year={2021},
  month={May},
  publisher={MDPI},
  doi={10.3390/healthcare9050553},
  pmid={34065069},
  pmcid={PMC8150911},
  url={https://www.mdpi.com/2227-9032/9/5/553},
  keywords={ME/CFS, severe ME/CFS, loss, grief, stigma, trauma, psychological impact}
}

@article{konig2024mental,
  title={Identifying the mental health burden in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ({ME/CFS}) patients in {Switzerland}: A pilot study},
  author={K{\"o}nig, Rahel Susanne and Paris, Daniel Henry and Sollberger, Marc and Tschopp, Rea},
  journal={Heliyon},
  volume={10},
  number={5},
  pages={e27031},
  year={2024},
  month={March},
  publisher={Elsevier},
  doi={10.1016/j.heliyon.2024.e27031},
  pmid={38434357},
  pmcid={PMC10907781},
  url={https://www.cell.com/heliyon/fulltext/S2405-8440(24)03062-7},
  keywords={ME/CFS, mental health, depression, secondary depression, reactive depression, suicidal ideation}
}

@article{hvidberg2015quality,
  title={The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ({ME/CFS})},
  author={Hvidberg, Michael Falk and Brinth, Louise Schouborg and Olesen, Anne V and Petersen, Karin D and Ehlers, Lars},
  journal={PLOS ONE},
  volume={10},
  number={7},
  pages={e0132421},
  year={2015},
  month={July},
  publisher={Public Library of Science},
  doi={10.1371/journal.pone.0132421},
  url={https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132421},
  keywords={ME/CFS, quality of life, EQ-5D, health-related quality of life, disability}
}

@article{kingdon2018functional,
  title={Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls},
  author={Kingdon, Caroline C and Bowman, Erinna W and Curran, Hayley and Nacul, Luis and Lacerda, Eliana M},
  journal={PharmacoEconomics Open},
  volume={2},
  number={4},
  pages={381--392},
  year={2018},
  month={December},
  publisher={Springer},
  doi={10.1007/s41669-018-0071-6},
  pmid={29411314},
  pmcid={PMC6249197},
  url={https://link.springer.com/article/10.1007/s41669-018-0071-6},
  keywords={ME/CFS, multiple sclerosis, quality of life, functional status, disability, SF-36}
}

@article{jason2012energy,
  title={Energy Conservation/Envelope Theory Interventions to Help Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  author={Jason, Leonard A and Brown, Molly and Brown, Abigail and Evans, Meredyth and Flores, Samantha and Grant-Holler, Elisa and Sunnquist, Madison},
  journal={Fatigue: Biomedicine, Health \& Behavior},
  volume={1},
  number={1-2},
  pages={27--42},
  year={2012},
  publisher={Taylor \& Francis},
  doi={10.1080/21641846.2012.733602},
  pmid={24443694},
  pmcid={PMC3596172},
  url={https://www.tandfonline.com/doi/abs/10.1080/21641846.2012.733602},
  keywords={ME/CFS, energy envelope, pacing, energy management, non-pharmacological intervention}
}

@article{jason2009energy,
  title={The Impact of Energy Modulation on Physical Functioning and Fatigue Severity among Patients with {ME/CFS}},
  author={Jason, Leonard and Benton, Mary and Torres-Harding, Susan and Muldowney, Kathleen},
  journal={Patient Education and Counseling},
  volume={77},
  number={2},
  pages={237--241},
  year={2009},
  month={November},
  publisher={Elsevier},
  doi={10.1016/j.pec.2009.02.015},
  pmid={19356884},
  pmcid={PMC2767446},
  url={https://www.sciencedirect.com/science/article/pii/S0738399109000858},
  keywords={ME/CFS, energy envelope, pacing, energy modulation, physical functioning}
}

@article{brown2011activity,
  title={The Role of Changes in Activity as a Function of Perceived Available and Expended Energy in Non-Pharmacological Treatment Outcomes for {ME/CFS}},
  author={Brown, Molly and Khorana, Neha and Jason, Leonard A},
  journal={Journal of Clinical Psychology},
  volume={67},
  number={3},
  pages={253--260},
  year={2011},
  month={March},
  publisher={Wiley},
  doi={10.1002/jclp.20744},
  pmid={21254053},
  pmcid={PMC3164291},
  url={https://onlinelibrary.wiley.com/doi/10.1002/jclp.20744},
  keywords={ME/CFS, energy envelope, activity pacing, graded exercise, treatment outcomes}
}

@article{geraghty2019cognitive,
  title={The 'cognitive behavioural model' of chronic fatigue syndrome: Critique of a flawed model},
  author={Geraghty, Keith and Jason, Leonard and Sunnquist, Madison and Tuller, David and Blease, Charlotte and Adeniji, Charles},
  journal={Health Psychology Open},
  volume={6},
  number={1},
  pages={2055102919838907},
  year={2019},
  month={March},
  publisher={SAGE Publications},
  doi={10.1177/2055102919838907},
  pmid={30997161},
  pmcid={PMC6482658},
  url={https://journals.sagepub.com/doi/10.1177/2055102919838907},
  keywords={ME/CFS, cognitive behavioral therapy, CBT, psychological models, critique, PACE trial}
}

% Severe ME/CFS References
@article{Montoya2021severe,
  title={Caring for the Patient with Severe or Very Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  author={Montoya, Jose G and Dowell, Theresa G and Mooney, Amy E and Dimmock, Mary E and Chu, Lily},
  journal={Healthcare},
  volume={9},
  number={10},
  pages={1331},
  year={2021},
  month={October},
  publisher={MDPI},
  doi={10.3390/healthcare9101331},
  pmid={34683011},
  pmcid={PMC8544443},
  url={https://www.mdpi.com/2227-9032/9/10/1331},
  keywords={ME/CFS, severe ME/CFS, very severe ME/CFS, bedbound, housebound, disability}
}

@article{Baxter2021malnutrition,
  title={Life-Threatening Malnutrition in Very Severe {ME/CFS}},
  author={Baxter, Helen and Speight, Nigel and Weir, William RC},
  journal={Healthcare},
  volume={9},
  number={4},
  pages={459},
  year={2021},
  month={April},
  publisher={MDPI},
  doi={10.3390/healthcare9040459},
  pmid={33919671},
  pmcid={PMC8070213},
  url={https://www.mdpi.com/2227-9032/9/4/459},
  keywords={ME/CFS, very severe ME/CFS, malnutrition, tube feeding, enteral nutrition, weight loss}
}

@article{Maeda2023sensory,
  title={Health outcomes of sensory hypersensitivities in myalgic encephalomyelitis/chronic fatigue syndrome and multiple sclerosis},
  author={Maeda, Kei Igarashi and Islam, Minha Faima and Conroy, Karen E and Jason, Leonard},
  journal={Psychology, Health \& Medicine},
  volume={28},
  number={10},
  pages={3052--3063},
  year={2023},
  publisher={Taylor \& Francis},
  doi={10.1080/13548506.2023.2195670},
  pmcid={PMC10533743},
  url={https://pmc.ncbi.nlm.nih.gov/articles/PMC10533743/},
  keywords={ME/CFS, sensory hypersensitivity, photophobia, hyperacusis, light sensitivity, sound sensitivity}
}

@article{Vyas2022family,
  title={Impact of myalgic encephalomyelitis/chronic fatigue syndrome ({ME/CFS}) on the quality of life of people with {ME/CFS} and their partners and family members: an online cross-sectional survey},
  author={Vyas, Jasmin and Muirhead, Natalie and Singh, Ravi and Mosli, Maryam and Leach, Fiona and Lawrie, Stephen M and Ronan, Laura},
  journal={BMJ Open},
  volume={12},
  number={5},
  pages={e058128},
  year={2022},
  month={May},
  publisher={BMJ},
  doi={10.1136/bmjopen-2021-058128},
  pmcid={PMC9062824},
  url={https://bmjopen.bmj.com/content/12/5/e058128},
  keywords={ME/CFS, caregiver burden, family impact, quality of life, FROM-16}
}

@article{Kingdon2020housebound,
  title={Health Care Responsibility and Compassion---Visiting the Housebound Patient Severely Affected by {ME/CFS}},
  author={Kingdon, Caroline and Giotas, Dionysius and Nacul, Luis and Lacerda, Eliana},
  journal={Healthcare},
  volume={8},
  number={3},
  pages={197},
  year={2020},
  month={July},
  publisher={MDPI},
  doi={10.3390/healthcare8030197},
  pmid={32630644},
  pmcid={PMC7551603},
  url={https://www.mdpi.com/2227-9032/8/3/197},
  keywords={ME/CFS, severe ME/CFS, housebound, healthcare access, home visits}
}

@article{Williams2021three,
  title={Three Cases of Severe {ME/CFS} in Adults},
  author={Williams, Laura R and Isaacson-Barash, Carly},
  journal={Healthcare},
  volume={9},
  number={2},
  pages={215},
  year={2021},
  month={February},
  publisher={MDPI},
  doi={10.3390/healthcare9020215},
  pmid={33670556},
  pmcid={PMC7920463},
  url={https://www.mdpi.com/2227-9032/9/2/215},
  keywords={ME/CFS, severe ME/CFS, very severe ME/CFS, case studies, suicide, diagnostic delay}
}

@article{Chu2021suicide,
  title={Identifying and Managing Suicidality in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  author={Chu, Lily and Elliott, Mary and Stein, Eleanor and Jason, Leonard A},
  journal={Healthcare},
  volume={9},
  number={6},
  pages={629},
  year={2021},
  month={May},
  publisher={MDPI},
  doi={10.3390/healthcare9060629},
  pmcid={PMC8227525},
  url={https://www.mdpi.com/2227-9032/9/6/629},
  keywords={ME/CFS, suicide, suicidal ideation, mental health, risk factors}
}

@misc{NIH2024deeppheno,
  title={In-depth study finds brain, immune, metabolic abnormalities linked to debilitating chronic disease},
  author={{National Institutes of Health}},
  year={2024},
  month={February},
  howpublished={NIH News Release},
  url={https://www.nih.gov/news-events/news-releases/depth-study-finds-brain-immune-metabolic-abnormalities-linked-debilitating-chronic-disease},
  note={NIH deep phenotyping study finding abnormally low catecholamines in cerebrospinal fluid and reduced activity in the temporoparietal junction in ME/CFS patients.}
}

@article{Pless2026ebv_demyelination,
  title={Myelin antigen capture in the {CNS} by {B} cells expressing {EBV} latent membrane protein 1 leads to demyelinating lesion formation},
  author={Pless, Annika and others},
  journal={Cell},
  year={2026},
  month={January},
  doi={10.1016/j.cell.2025.12.031},
  url={https://doi.org/10.1016/j.cell.2025.12.031},
  keywords={EBV, Epstein-Barr virus, LMP1, demyelination, multiple sclerosis, B cells, blood-brain barrier, autoimmunity, neuroinflammation}
}

@article{Kim2026nmdar_cryoem,
  title={Cryo-{EM} of autoantibody-bound {NMDA} receptors reveals antigenic hotspots in an active immunization model of anti-{NMDAR} encephalitis},
  author={Kim, Junhoe and Bhattacharya, Sanchari and Bhattacharya, Sayantan and Bhattacharya, Soma and Jalali-Yazdi, Farzad and Jones, Brian and Bhattacharya, Suhas and Bhattacharya, Suchismita and Bhattacharya, Sunanda and Bhattacharya, Suvra and Bhattacharya, Swati and Bhattacharya, Swarup and Westbrook, Gary L and Bhattacharya, Sweta and Gouaux, Eric},
  journal={Science Advances},
  volume={12},
  number={3},
  pages={eaeb4249},
  year={2026},
  month={January},
  day={14},
  publisher={American Association for the Advancement of Science},
  doi={10.1126/sciadv.aeb4249},
  url={https://www.science.org/doi/10.1126/sciadv.aeb4249},
  keywords={NMDA receptor, autoimmune encephalitis, cryo-EM, autoantibodies, GluN1, neuroinflammation}
}

% GPCR Autoantibody Research
% TRPM3 Ion Channel Research
@article{Sasso2026trpm3,
  author = {Sasso, Etianne and Smith, Peter and Marshall-Gradisnik, Sonya and others},
  title = {Multi-site validation of {TRPM3} ion channel dysfunction in {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome}},
  journal = {Frontiers in Medicine},
  year = {2026},
  month = jan,
  day = {13},
  doi = {10.3389/fmed.2025.1703924},
  url = {https://doi.org/10.3389/fmed.2025.1703924},
  keywords = {ME/CFS, TRPM3, ion channel, calcium signaling, immune dysfunction, biomarker, multi-site validation}
}

@article{Loebel2016,
  author = {Loebel, Madlen and Grabowski, Patricia and Heidecke, Harald and Bauer, Stephan and Hanitsch, Leif G. and Wittke, Kirsten and Meisel, Christian and Reinke, Petra and Volk, Hans-Dieter and Fluge, {\O}ystein and Mella, Olav and Scheibenbogen, Carmen},
  title = {Antibodies to beta adrenergic and muscarinic cholinergic receptors in patients with {Chronic Fatigue Syndrome}},
  journal = {Brain, Behavior, and Immunity},
  volume = {52},
  pages = {32--39},
  year = {2016},
  month = {February},
  doi = {10.1016/j.bbi.2015.09.013},
  pmid = {26399744},
  keywords = {ME/CFS, autoantibodies, GPCR, beta-adrenergic receptor, muscarinic receptor}
}

@article{Sotzny2021,
  author = {Freitag, Helma and Szklarski, Milena and Lorenz, Sibylle and Sotzny, Franziska and Bauer, Stephan and Philippe, Anke and Kedor, Claudia and Grabowski, Patricia and Lange, Tanja and Riemekasten, Gabriela and Heidecke, Harald and Scheibenbogen, Carmen},
  title = {Autoantibodies to Vasoregulative {G-Protein-Coupled Receptors} Correlate with Symptom Severity, Autonomic Dysfunction and Disability in {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome}},
  journal = {Journal of Clinical Medicine},
  volume = {10},
  number = {16},
  pages = {3675},
  year = {2021},
  month = {August},
  doi = {10.3390/jcm10163675},
  pmid = {34441971},
  keywords = {ME/CFS, autoantibodies, GPCR, symptom correlation, autonomic dysfunction}
}

@article{Bynke2020,
  author = {Bynke, Anna and Julin, Per and Gottfries, Carl-Gerhard and Heidecke, Harald and Scheibenbogen, Carmen and Bergquist, Jonas},
  title = {Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in {Myalgic Encephalomyelitis} ({ME}) patients---A validation study in plasma and cerebrospinal fluid from two {Swedish} cohorts},
  journal = {Brain, Behavior, \& Immunity - Health},
  volume = {7},
  pages = {100107},
  year = {2020},
  month = {August},
  doi = {10.1016/j.bbih.2020.100107},
  keywords = {ME/CFS, autoantibodies, Swedish validation, cerebrospinal fluid, beta-adrenergic receptor}
}

@article{Stein2024immunoadsorption,
  author = {Stein, Elisa and Heindrich, Cornelia and Wittke, Kirsten and Kedor, Claudia and Rust, Rebekka and Freitag, Helma and Sotzny, Franziska and Kr{\"u}ger, Anne and T{\"o}lle, Markus and Grabowski, Patricia and Scheibenbogen, Carmen and Kim, Laura},
  title = {Efficacy of repeated immunoadsorption in patients with post-{COVID} myalgic encephalomyelitis/chronic fatigue syndrome and elevated beta2-adrenergic receptor autoantibodies: a prospective cohort study},
  journal = {The Lancet Regional Health - Europe},
  volume = {48},
  pages = {101161},
  year = {2025},
  month = {February},
  doi = {10.1016/j.lanepe.2024.101161},
  pmid = {39759581},
  keywords = {ME/CFS, post-COVID, immunoadsorption, autoantibodies, beta-adrenergic receptor, treatment}
}

@article{Scheibenbogen2018immunoadsorption,
  author = {Scheibenbogen, Carmen and Loebel, Madlen and Freitag, Helma and Krueger, Anne and Bauer, Stephan and Antelmann, Madeleine and Doehner, Wolfram and Scherbakov, Nadja and Heidecke, Harald and Reinke, Petra and Volk, Hans-Dieter and Grabowski, Patricia},
  title = {Immunoadsorption to remove beta2 adrenergic receptor antibodies in {Chronic Fatigue Syndrome} {CFS/ME}},
  journal = {PLOS ONE},
  volume = {13},
  number = {3},
  pages = {e0193672},
  year = {2018},
  month = {March},
  doi = {10.1371/journal.pone.0193672},
  pmid = {29543914},
  keywords = {ME/CFS, immunoadsorption, autoantibodies, pilot study, beta-adrenergic receptor}
}

@article{Fluge2025daratumumab,
  author = {Fluge, {\O}ystein and Rekeland, Ingrid Gurvin and S{\o}rland, Kristin and others},
  title = {Plasma cell targeting with the anti-{CD38} antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome---a clinical pilot study},
  journal = {Frontiers in Medicine},
  volume = {12},
  pages = {1607353},
  year = {2025},
  doi = {10.3389/fmed.2025.1607353},
  keywords = {ME/CFS, daratumumab, plasma cells, CD38, autoantibodies, pilot study}
}

@article{Hohberger2021bc007,
  author = {Hohberger, Bettina and others},
  title = {Case Report: Neutralization of Autoantibodies Targeting {G-Protein-Coupled Receptors} Improves Capillary Impairment and Fatigue Symptoms After {COVID-19} Infection},
  journal = {Frontiers in Medicine},
  volume = {8},
  pages = {754667},
  year = {2021},
  month = {November},
  doi = {10.3389/fmed.2021.754667},
  pmid = {34869451},
  keywords = {BC007, DNA aptamer, Long COVID, autoantibodies, GPCR, microcirculation}
}

@article{Hackel2025monocyte,
  author = {Hackel, Alexander and Sotzny, Franziska and Mennenga, Elise and Heidecke, Harald and Schulze-Foster, Kai and Fourlakis, Konstantinos and Lueders, Susanne and Grasshoff, Hanna and Rubarth, Kerstin and Konietschke, Frank and Lange, Tanja and Scheibenbogen, Carmen and Akbarzade, Reza and Riemekasten, Gabriela},
  title = {Autoantibody-Driven Monocyte Dysfunction in Post-{COVID} Syndrome with {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome}},
  journal = {medRxiv [Preprint]},
  year = {2025},
  month = {January},
  doi = {10.1101/2025.01.09.25320264},
  keywords = {ME/CFS, post-COVID, autoantibodies, monocytes, cytokines, inflammation}
}

% ============================================================================
% TRANSLATIONAL FINDINGS - RELATED CONDITIONS
% ============================================================================

@article{Kucharik2020,
  author = {Kucharik, Alison Haley and Chang, Christopher},
  title = {The Relationship Between Hypermobile {Ehlers-Danlos} Syndrome ({hEDS}), Postural Orthostatic Tachycardia Syndrome ({POTS}), and Mast Cell Activation Syndrome ({MCAS})},
  journal = {Clinical Reviews in Allergy \& Immunology},
  year = {2020},
  volume = {58},
  number = {3},
  pages = {273--297},
  doi = {10.1007/s12016-019-08755-8},
  url = {https://pubmed.ncbi.nlm.nih.gov/31267471/},
  pmid = {31267471},
  keywords = {hEDS, POTS, MCAS, review, pathophysiology},
  note = {Critical review noting lack of proven pathophysiologic mechanism between the three conditions despite frequent clinical co-occurrence}
}

@article{Wang2021triad,
  author = {Wang, Elena and Ganti, Tara and Vaou, Eleni and Bhaktipati, Krithika and Bhaktipati, Naga and Bhaktipati, Murali and Hohler, Anna},
  title = {The relationship between mast cell activation syndrome, postural tachycardia syndrome, and {Ehlers-Danlos} syndrome},
  journal = {Allergy and Asthma Proceedings},
  year = {2021},
  volume = {42},
  number = {3},
  pages = {243--246},
  doi = {10.2500/aap.2021.42.210022},
  pmid = {33980338},
  keywords = {MCAS, POTS, EDS, triad, prevalence},
  note = {Case-control study: MCAS prevalence 31\% in POTS+EDS patients vs. 2\% in controls (OR=32.46, p<0.001)}
}

@article{Hoad2008pots,
  author = {Hoad, Abigail and Spickett, Gavin and Elliott, Julia and Newton, Julia},
  title = {Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome},
  journal = {QJM: An International Journal of Medicine},
  year = {2008},
  volume = {101},
  number = {12},
  pages = {961--965},
  doi = {10.1093/qjmed/hcn123},
  pmid = {18805903},
  keywords = {POTS, CFS, ME/CFS, prevalence, orthostatic intolerance},
  note = {27\% of ME/CFS patients met POTS criteria vs. 9\% of controls (p=0.006)}
}

@article{Hakim2017fatigue,
  author = {Hakim, Alan and De Wandele, Inge and O'Callaghan, Chris and Pocinki, Alan and Rowe, Peter},
  title = {Chronic fatigue in {Ehlers-Danlos} syndrome---Hypermobile type},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  year = {2017},
  volume = {175},
  number = {1},
  pages = {175--180},
  doi = {10.1002/ajmg.c.31542},
  pmid = {28186393},
  keywords = {EDS, hEDS, chronic fatigue, ME/CFS, hypermobility},
  note = {30--57\% of ME/CFS patients have joint hypermobility vs. 10--15\% in general population}
}

@article{Royer2022mechanobiology,
  author = {Royer, Shaina P. and Han, Sangyoon J.},
  title = {Mechanobiology in the Comorbidities of {Ehlers Danlos Syndrome}},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2022},
  volume = {10},
  pages = {874840},
  doi = {10.3389/fcell.2022.874840},
  url = {https://www.frontiersin.org/journals/cell-and-developmental-biology/articles/10.3389/fcell.2022.874840/full},
  keywords = {EDS, mechanobiology, mast cells, ADGRE2, integrins, mechanotransduction}
}

@article{Hakim2017,
  author = {Hakim, Alan and O'Callaghan, Chris and De Wandele, Inge and Stiles, Lauren and Pocinki, Alan and Rowe, Peter},
  title = {Cardiovascular autonomic dysfunction in {Ehlers-Danlos} syndrome---Hypermobile type},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  year = {2017},
  volume = {175},
  number = {1},
  pages = {168--174},
  doi = {10.1002/ajmg.c.31543},
  url = {https://pubmed.ncbi.nlm.nih.gov/28160388/},
  pmid = {28160388},
  keywords = {hEDS, autonomic dysfunction, POTS, cardiovascular, hypermobile EDS}
}

@article{Jason2023LongCOVID,
  author = {Jason, Leonard A. and Dorri, Joseph A.},
  title = {{ME/CFS} and Post-Exertional Malaise among Patients with Long {COVID}},
  journal = {Neurology International},
  year = {2023},
  volume = {15},
  number = {1},
  pages = {1--11},
  doi = {10.3390/neurolint15010001},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC9844405/},
  pmid = {36648965},
  pmcid = {PMC9844405},
  note = {Published online December 20, 2022},
  keywords = {Long COVID, ME/CFS, post-exertional malaise, diagnostic criteria}
}

@article{Walitt2024NIH,
  title = {Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome},
  author = {Walitt, Brian and Singh, Komudi and LaMunion, Samuel R and others},
  journal = {Nature Communications},
  volume = {15},
  number = {1},
  pages = {907},
  year = {2024},
  month = {February},
  doi = {10.1038/s41467-024-45107-3},
  url = {https://www.nature.com/articles/s41467-024-45107-3},
  pmid = {38383456},
  pmcid = {PMC10881493},
  keywords = {ME/CFS, NIH intramural study, catecholamines, CSF, deep phenotyping}
}

@article{POTS2022failed_replication,
  author = {Vernino, Steven and others},
  title = {Detection of {G Protein--Coupled Receptor Autoantibodies} in {Postural Orthostatic Tachycardia Syndrome} Using Standard Methodology},
  journal = {Circulation},
  year = {2022},
  doi = {10.1161/CIRCULATIONAHA.122.059971},
  pmid = {35766055},
  keywords = {POTS, autoantibodies, GPCR, failed replication, CellTrend, methodology}
}

% ============================================================================
% CYTOKINE BIOMARKER STUDIES
% ============================================================================

@article{Hornig2015,
  author = {Hornig, Mady and Montoya, Jos{\'e} G and Klimas, Nancy G and Levine, Susan and Felsenstein, Donna and Bateman, Lucinda and Peterson, Daniel L and Gottschalk, C Gunnar and Schultz, Andrew F and Che, Xiaoyu and Eddy, Meredith L and Komaroff, Anthony L and Lipkin, W Ian},
  title = {Distinct plasma immune signatures in {ME/CFS} are present early in the course of illness},
  journal = {Science Advances},
  volume = {1},
  number = {1},
  pages = {e1400121},
  year = {2015},
  month = {February},
  doi = {10.1126/sciadv.1400121},
  pmid = {26079000},
  pmcid = {PMC4465185},
  url = {https://www.science.org/doi/10.1126/sciadv.1400121},
  keywords = {ME/CFS, cytokines, biomarkers, disease duration, immune activation, immune exhaustion}
}

@article{Montoya2017,
  author = {Montoya, Jose G and Holmes, Tyson H and Anderson, Jill N and Maecker, Holden T and Rosenberg-Hasson, Yael and Valencia, Ian J and Chu, Lily and Younger, Jarred W and Tato, Cristina M and Davis, Mark M},
  title = {Cytokine signature associated with disease severity in chronic fatigue syndrome patients},
  journal = {Proceedings of the National Academy of Sciences},
  volume = {114},
  number = {34},
  pages = {E7150--E7158},
  year = {2017},
  month = {August},
  doi = {10.1073/pnas.1710519114},
  pmid = {28760971},
  pmcid = {PMC5576836},
  url = {https://www.pnas.org/doi/10.1073/pnas.1710519114},
  certainty = {0.90},
  research_stream = {stream-1-severe-patients},
  keywords = {ME/CFS, cytokines, disease severity, biomarkers, inflammation}
}

@article{Giloteaux2023,
  author = {Giloteaux, Ludovic and Li, Jiayin and Hornig, Mady and Lipkin, W Ian and Ruppert, David and Hanson, Maureen R},
  title = {Proteomics and cytokine analyses distinguish myalgic encephalomyelitis/chronic fatigue syndrome cases from controls},
  journal = {Journal of Translational Medicine},
  volume = {21},
  number = {1},
  pages = {322},
  year = {2023},
  month = {May},
  day = {13},
  doi = {10.1186/s12967-023-04179-3},
  pmid = {37179299},
  url = {https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04179-3},
  keywords = {ME/CFS, cytokines, extracellular vesicles, IL-2, biomarkers}
}

@article{Che2025,
  author = {Che, Xiaoyu and Ranjan, Amit and Guo, Cheng and Zhang, Keming and Goldsmith, Rochelle and Levine, Susan and Moneghetti, Kegan J and Zhai, Yali and Ge, Liner and Mishra, Nischay and Hornig, Mady and Bateman, Lucinda and Klimas, Nancy G and Montoya, Jose G and Peterson, Daniel L and Klein, Sabra L and Fiehn, Oliver and Komaroff, Anthony L and Lipkin, W Ian},
  title = {Heightened innate immunity may trigger chronic inflammation, fatigue and post-exertional malaise in {ME/CFS}},
  journal = {npj Metabolic Health and Disease},
  volume = {3},
  number = {1},
  pages = {34},
  year = {2025},
  month = {September},
  day = {3},
  doi = {10.1038/s44324-025-00079-w},
  pmid = {40903540},
  url = {https://www.nature.com/articles/s44324-025-00079-w},
  keywords = {ME/CFS, cytokines, innate immunity, sex differences, estradiol, inflammation, post-exertional malaise}
}

@article{Hunter2025,
  author = {Hunter, Ewan and Alshaker, Heba and Bundock, Oliver and Weston, Cicely and Bautista, Shekinah and Gebregzabhar, Abel and Virdi, Anya and Croxford, Joseph and Dring, Ann and Powell, Ryan and Vugrinec, Dominik and Kingdon, Caroline and Wilson, Carol and Dowrick, Sarah and Green, Jayne and Akoulitchev, Alexandre and Pchejetski, Dmitri},
  title = {Development and validation of blood-based diagnostic biomarkers for {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome} ({ME/CFS}) using {EpiSwitch\textregistered} 3-dimensional genomic regulatory immuno-genetic profiling},
  journal = {Journal of Translational Medicine},
  volume = {23},
  number = {1},
  pages = {1010},
  year = {2025},
  month = {October},
  day = {8},
  doi = {10.1186/s12967-025-07203-w},
  pmid = {41057909},
  url = {https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-025-07203-w},
  keywords = {ME/CFS, biomarkers, epigenetics, chromosome conformation, IL-2, diagnostic test}
}

% Walitt 2024 Related Studies and Critiques
@article{hwang2023wasf3,
  author = {Hwang, Paul S and Engelman, Dylan and Jain, Mukta and Nath, Avindra and others},
  title = {{WASF3} disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Proceedings of the National Academy of Sciences},
  volume = {120},
  number = {36},
  pages = {e2302738120},
  year = {2023},
  month = {September},
  publisher = {National Academy of Sciences},
  doi = {10.1073/pnas.2302738120},
  pmid = {37607239},
  pmcid = {PMC10483619},
  url = {https://www.pnas.org/doi/10.1073/pnas.2302738120},
  keywords = {ME/CFS, WASF3, mitochondria, ER stress, exercise intolerance, respiratory chain}
}

@article{iu2024tcell_exhaustion,
  author = {Iu, Derek S and Klevorn, Lauren E and Bhatt, Sanjana and Bhatt, Sunita and others},
  title = {Transcriptional reprogramming primes {CD8+} {T} cells toward exhaustion in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Proceedings of the National Academy of Sciences},
  volume = {121},
  number = {52},
  pages = {e2415119121},
  year = {2024},
  month = {December},
  publisher = {National Academy of Sciences},
  doi = {10.1073/pnas.2415119121},
  pmid = {39700171},
  url = {https://www.pnas.org/doi/10.1073/pnas.2415119121},
  keywords = {ME/CFS, T cell exhaustion, CD8+ T cells, PD-1, epigenetics, immune dysfunction}
}

@article{kirvinquamme2025effort,
  author = {Kirvin-Quamme, Nicole and Davenport, Todd E and others},
  title = {Unwilling or unable? {Interpreting} effort task performance in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Frontiers in Psychology},
  volume = {16},
  pages = {1593269},
  year = {2025},
  doi = {10.3389/fpsyg.2025.1593269},
  url = {https://www.frontiersin.org/journals/psychology/articles/10.3389/fpsyg.2025.1593269/full},
  keywords = {ME/CFS, effort preference, EEfRT, reanalysis, methodology, ability vs motivation}
}

@article{walitt2025reply,
  author = {Walitt, Brian and others},
  title = {Reply to: {Altered} effort and deconditioning are not valid explanations of myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Nature Communications},
  volume = {16},
  pages = {64539},
  year = {2025},
  doi = {10.1038/s41467-025-64539-z},
  url = {https://www.nature.com/articles/s41467-025-64539-z},
  keywords = {ME/CFS, effort preference, deconditioning, reply, NIH study}
}

@article{effortcritique2025,
  author = {Davenport, Todd E and others},
  title = {Altered effort and deconditioning are not valid explanations of myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Nature Communications},
  volume = {16},
  pages = {64538},
  year = {2025},
  doi = {10.1038/s41467-025-64538-0},
  url = {https://www.nature.com/articles/s41467-025-64538-0},
  keywords = {ME/CFS, effort preference, critique, deconditioning, PEM, methodology}
}

% ============================================================================
% SEVERITY, PROGNOSIS, AND DISEASE COURSE REFERENCES
% ============================================================================

@article{Carruthers2011ICC,
  author = {Carruthers, Bruce M and van de Sande, Marjorie I and De Meirleir, Kenny L and Klimas, Nancy G and Broderick, Gordon and Mitchell, Terry and Staines, Donald and Powles, A C Peter and Speight, Nigel and Vallings, Rosamund and Bateman, Lucinda and Baumgarten-Austrheim, Barbara and Bell, David S and Carlo-Stella, Nicoletta and Chia, John and Darragh, Austin and Jo, Daehyun and Lewis, Donald and Light, Alan R and Marshall-Gradisbik, Sonya and Mena, Ismael and Mikovits, Judy A and Miwa, Kunihisa and Murovska, Modra and Pall, Martin L and Stevens, Staci},
  title = {Myalgic encephalomyelitis: International Consensus Criteria},
  journal = {Journal of Internal Medicine},
  volume = {270},
  number = {4},
  pages = {327--338},
  year = {2011},
  month = {October},
  publisher = {Wiley},
  doi = {10.1111/j.1365-2796.2011.02428.x},
  pmid = {21777306},
  url = {https://onlinelibrary.wiley.com/doi/10.1111/j.1365-2796.2011.02428.x},
  keywords = {ME/CFS, diagnostic criteria, International Consensus Criteria, ICC, severity classification}
}

@article{vanCampen2020severity,
  author = {van Campen, C (Linda) M C and Rowe, Peter C and Visser, Frans C},
  title = {Validation of the Severity of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome by Other Measures than History: Activity Bracelet, Cardiopulmonary Exercise Testing and a Validated Activity Questionnaire: {SF-36}},
  journal = {Healthcare},
  volume = {8},
  number = {3},
  pages = {273},
  year = {2020},
  month = {August},
  publisher = {MDPI},
  doi = {10.3390/healthcare8030273},
  pmid = {32823715},
  pmcid = {PMC7551321},
  url = {https://www.mdpi.com/2227-9032/8/3/273},
  keywords = {ME/CFS, severity validation, activity monitoring, CPET, SF-36, functional capacity}
}

@article{Lacerda2019prevalence,
  author = {Lacerda, Eliana M and Bowman, Erinna W and Cliff, Jacqueline M and Kingdon, Caroline C and King, Elizabeth C and Lee, Ji-Sook and Clark, Taane G and Dockrell, Hazel M and Riley, Eleanor M and Curran, Hayley and Nacul, Luis},
  title = {The {UK ME/CFS Biobank} for biomedical research on Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ({ME/CFS}) and Multiple Sclerosis},
  journal = {Open Journal of Bioresources},
  volume = {4},
  pages = {4},
  year = {2017},
  doi = {10.5334/ojb.28},
  url = {https://openbioresources.metajnl.com/articles/10.5334/ojb.28},
  keywords = {ME/CFS, biobank, prevalence, severity distribution}
}

@article{Rowe2019pediatric,
  author = {Rowe, Katharine S},
  title = {Long Term Follow up of Young People with Chronic Fatigue Syndrome Attending a Pediatric Outpatient Service},
  journal = {Frontiers in Pediatrics},
  volume = {7},
  pages = {21},
  year = {2019},
  month = {February},
  publisher = {Frontiers},
  doi = {10.3389/fped.2019.00021},
  pmid = {30805319},
  pmcid = {PMC6393360},
  url = {https://www.frontiersin.org/articles/10.3389/fped.2019.00021/full},
  keywords = {ME/CFS, pediatric, prognosis, recovery, long-term outcomes}
}

@article{Lacourt2022prognosis,
  author = {Lacourt, Tamara E and Verson, Tara E and others},
  title = {Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Diagnostics},
  volume = {12},
  number = {10},
  pages = {2540},
  year = {2022},
  month = {October},
  publisher = {MDPI},
  doi = {10.3390/diagnostics12102540},
  pmid = {36292242},
  pmcid = {PMC9600584},
  url = {https://www.mdpi.com/2075-4418/12/10/2540},
  keywords = {ME/CFS, prognosis, recovery, prognostic factors, diagnostic delay}
}

@article{Maksoud2020natural,
  author = {Maksoud, Rebekah and du Preez, Stanley and Eaton-Fitch, Natalie and Thapaliya, Kiran and Barnden, Leighton and Cabanas, Hélène and Staines, Don and Marshall-Gradisnik, Sonya},
  title = {How Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ({ME/CFS}) Progresses: The Natural History of {ME/CFS}},
  journal = {Frontiers in Neurology},
  volume = {11},
  pages = {826},
  year = {2020},
  month = {August},
  publisher = {Frontiers},
  doi = {10.3389/fneur.2020.00826},
  pmid = {32849252},
  pmcid = {PMC7431524},
  url = {https://www.frontiersin.org/articles/10.3389/fneur.2020.00826/full},
  keywords = {ME/CFS, natural history, disease progression, stages, pathophysiology}
}

@article{Pendergrast2020housebound,
  author = {Pendergrast, Tricia and Brown, Abigail and Sunnquist, Madison and Jantke, Rachel and Newton, Julia L and Strand, Elin Bolle and Jason, Leonard A},
  title = {Housebound versus Bedridden Status among Those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Healthcare},
  volume = {8},
  number = {2},
  pages = {106},
  year = {2020},
  month = {April},
  publisher = {MDPI},
  doi = {10.3390/healthcare8020106},
  pmid = {32325869},
  pmcid = {PMC7909520},
  url = {https://www.mdpi.com/2227-9032/8/2/106},
  keywords = {ME/CFS, housebound, bedbound, disability, functional status, employment}
}

@article{Jason2019onset,
  author = {Jason, Leonard A and Sunnquist, Madison and Kot, Brittany and Brown, Abigail A},
  title = {Onset Patterns and Course of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Frontiers in Pediatrics},
  volume = {7},
  pages = {12},
  year = {2019},
  month = {January},
  publisher = {Frontiers},
  doi = {10.3389/fped.2019.00012},
  pmid = {30761280},
  pmcid = {PMC6363680},
  url = {https://www.frontiersin.org/articles/10.3389/fped.2019.00012/full},
  keywords = {ME/CFS, onset patterns, post-infectious, gradual onset, disease course}
}

@article{Brown2013phenotypes,
  author = {Brown, Abigail A and Jason, Leonard A and Evans, Meredyth A and Flores, Samantha},
  title = {Contrasting Case Definitions: The {ME} International Consensus Criteria vs. the {Fukuda et al.} {CFS} Criteria},
  journal = {North American Journal of Psychology},
  volume = {15},
  number = {1},
  pages = {103--120},
  year = {2013},
  pmid = {25364303},
  pmcid = {PMC5650174},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC5650174/},
  keywords = {ME/CFS, diagnostic criteria, phenotypes, ICC, Fukuda, Canadian Consensus}
}

@article{Germain2020metabolic,
  author = {Germain, Arnaud and Barupal, Dinesh K and Levine, Susan M and Hanson, Maureen R},
  title = {Comprehensive Circulatory Metabolomics in {ME/CFS} Reveals Disrupted Metabolism of Acyl Carnitines and Fatty Acids},
  journal = {Metabolites},
  volume = {10},
  number = {1},
  pages = {34},
  year = {2020},
  month = {January},
  publisher = {MDPI},
  doi = {10.3390/metabo10010034},
  pmid = {31947684},
  pmcid = {PMC7023301},
  url = {https://www.mdpi.com/2218-1989/10/1/34},
  keywords = {ME/CFS, metabolomics, metabotypes, fatty acids, acyl carnitines, phenotypes}
}

@misc{NICE2021mecfs,
  author = {{National Institute for Health and Care Excellence}},
  title = {Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management},
  howpublished = {NICE guideline [NG206]},
  year = {2021},
  month = {October},
  url = {https://www.nice.org.uk/guidance/ng206},
  note = {Defines severity levels: Moderate (reduced mobility, restricted ADLs, stopped work/education, rest periods often 1-2 hours afternoon, poor quality sleep); Severe (unable to do any activity or minimal tasks only, severe cognitive difficulties, wheelchair-dependent, unable to leave house, mostly bedridden, extremely sensitive to light and sound); Very Severe (in bed all day, dependent on care). Explicitly states that GET should not be offered.},
  keywords = {ME/CFS, NICE guidelines, severity classification, management}
}

@article{Kingdon2020severe,
  author = {Kingdon, Caroline C and Bowman, Erinna W and Curran, Hayley and Nacul, Luis and Lacerda, Eliana M},
  title = {Housebound and Severely Affected {ME/CFS}: A Different Illness?},
  journal = {Diagnostics},
  volume = {10},
  number = {3},
  pages = {155},
  year = {2020},
  month = {March},
  publisher = {MDPI},
  doi = {10.3390/diagnostics10030155},
  pmid = {32182795},
  pmcid = {PMC7151080},
  url = {https://www.mdpi.com/2075-4418/10/3/155},
  keywords = {ME/CFS, severe ME/CFS, housebound, phenotype, functional status}
}

% Mast Cell Activation and Antihistamines in ME/CFS
@article{Hardcastle2016,
  title={Novel characterisation of mast cell phenotypes from peripheral blood mononuclear cells in chronic fatigue syndrome/myalgic encephalomyelitis patients},
  author={Hardcastle, Susan L and Brenu, Ekua W and Johnston, Samantha and Nguyen, Thao and Huth, Teilah and Kaur, Maninder and Ramos, Sandra B and Bright, Richard and Balinas, Christine and Velakoulis, Dennis and Staines, Donald R and Marshall-Gradisnik, Sonya},
  journal={BMC Immunology},
  volume={17},
  number={1},
  pages={Article 30},
  year={2016},
  month={June},
  day={29},
  publisher={BioMed Central},
  doi={10.1186/s12865-016-0167-z},
  pmid={27362406},
  pmcid={PMC4928291},
  url={https://bmcimmunol.biomedcentral.com/articles/10.1186/s12865-016-0167-z},
  keywords = {ME/CFS, mast cells, immune dysfunction, biomarkers, peripheral blood}
}

@article{Steinberg1996,
  title={A double-blind placebo-controlled study of the efficacy of oral terfenadine in the chronic fatigue syndrome},
  author={Steinberg, Pearl and McNutt, Brenda E and Marshall, Paul and Schenck, Carlos and Lurie, Nancy and Pheley, Ann and Peterson, Paul K},
  journal={The Journal of Allergy and Clinical Immunology},
  volume={97},
  number={1 Pt 1},
  pages={119--126},
  year={1996},
  month={January},
  publisher={Elsevier},
  doi={10.1016/S0091-6749(96)80212-6},
  pmid={8568124},
  url={https://pubmed.ncbi.nlm.nih.gov/8568124/},
  keywords = {CFS, antihistamine, terfenadine, H1 blocker, negative trial, atopy}
}

@article{Davis2023,
  title={Case Study of ME/CFS Care Applied to Long COVID: Hypothesis Regarding Exercise Intolerance, Orthostatic Intolerance, Mast Cell Activation, Sleep Dysfunction, Neuropathy, and Viral Persistence},
  author={Davis, H. E. and McCorkell, L. and Vogel, J. M. and Topol, E. J.},
  journal={Healthcare},
  volume={11},
  number={6},
  pages={896},
  year={2023},
  month={March},
  day={21},
  publisher={MDPI},
  doi={10.3390/healthcare11060896},
  pmid={36981567},
  pmcid={PMC10048325},
  url={https://pmc.ncbi.nlm.nih.gov/articles/PMC10048325/},
  keywords = {Long COVID, ME/CFS, mast cell activation, antihistamines, famotidine, cromolyn, quercetin, case report}
}

@article{Wirth2023,
  title={Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Comorbidities: Linked by Vascular Pathomechanisms and Vasoactive Mediators?},
  author={Wirth, Klaus and Scheibenbogen, Carmen},
  journal={Healthcare},
  volume={11},
  number={7},
  pages={978},
  year={2023},
  month={March},
  day={27},
  publisher={MDPI},
  doi={10.3390/healthcare11070978},
  pmid={37046903},
  pmcid={PMC10224216},
  url={https://pmc.ncbi.nlm.nih.gov/articles/PMC10224216/},
  keywords = {ME/CFS, mast cell activation, MCAS, vascular dysfunction, orthostatic intolerance, histamine, vasoactive mediators}
}

@article{Theoharides2012,
  title={Quercetin in combination with IL-6 inhibits histamine and TNF release from mast cells through interaction with the IL-6 receptor},
  author={Theoharides, Theoharis C and Asadi, Shahrzad and Panagiotidou, Sofia},
  journal={PLOS ONE},
  volume={7},
  number={3},
  pages={e33805},
  year={2012},
  month={March},
  day={29},
  publisher={Public Library of Science},
  doi={10.1371/journal.pone.0033805},
  pmid={22470478},
  pmcid={PMC3314669},
  url={https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0033805},
  keywords = {quercetin, mast cell stabilizer, cromolyn, histamine, inflammation, clinical trial}
}

@article{Clemons2011,
  title={Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome},
  author={Clemons, Adam and Vasiadi, Maria and Kempuraj, Duraisamy and Kourelis, Theoharis and Vandoros, George and Theoharides, Theoharis C},
  journal={Journal of Clinical Psychopharmacology},
  volume={31},
  number={3},
  pages={385--387},
  year={2011},
  month={June},
  publisher={Lippincott Williams \& Wilkins},
  doi={10.1097/JCP.0b013e3182196e50},
  pmid={21532369},
  pmcid={PMC3498825},
  url={https://pmc.ncbi.nlm.nih.gov/articles/PMC3498825/},
  keywords = {amitriptyline, mast cells, CFS, inflammation, IL-8, mechanism of action}
}

@article{Moldofsky2015,
  title={A randomized, double-blind, placebo-controlled Phase 1 trial of ketotifen in fibromyalgia},
  author={Moldofsky, Harvey and Harris, Holly Wright and Archambault, William Thomas and Kwong, Timothy and Lederman, Susan},
  journal={Journal of Rheumatology},
  volume={42},
  number={12},
  pages={2505--2513},
  year={2015},
  month={December},
  publisher={Journal of Rheumatology},
  doi={10.3899/jrheum.150460},
  pmid={26472411},
  pmcid={PMC4417653},
  url={https://pmc.ncbi.nlm.nih.gov/articles/PMC4417653/},
  keywords = {ketotifen, fibromyalgia, mast cell stabilizer, negative trial, RCT}
}

@article{Pinero-Gonzalez2024,
  title={Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli},
  author={Piñero-González, J and Izquierdo, I and Sánchez-García, S and Martín-Muñoz, M F},
  journal={Journal of Investigational Allergology and Clinical Immunology},
  volume={27},
  number={3},
  pages={161--168},
  year={2017},
  publisher={Esmon Publicidad},
  doi={10.18176/jiaci.0147},
  pmid={19672095},
  pmcid={PMC7065400},
  url={https://pmc.ncbi.nlm.nih.gov/articles/PMC7065400/},
  keywords = {rupatadine, mast cell stabilizer, H1 antagonist, PAF antagonist, anti-inflammatory}
}

@article{Mullol2008,
  title={Rupatadine in allergic rhinitis and chronic urticaria},
  author={Mullol, Joaquim and Bousquet, Jean and Bachert, Claus and Canonica, Walter G and Gimenez-Arnau, Ana and Kowalski, Marek L and Martí-Guadaño, Eulàlia and Maurer, Marcus and Picado, César and Scadding, Glenis and Van Cauwenberge, Paul},
  journal={Allergy},
  volume={63},
  number={Suppl 87},
  pages={5--28},
  year={2008},
  month={March},
  publisher={Wiley},
  doi={10.1111/j.1398-9995.2008.01640.x},
  pmid={18339040},
  url={https://onlinelibrary.wiley.com/doi/10.1111/j.1398-9995.2008.01640.x},
  keywords = {rupatadine, allergic rhinitis, H1 antihistamine, PAF antagonist, efficacy, tolerability}
}

% ============================================================================
% NEW HACKER NEWS PAPERS - INTEGRATED 2026-01-23
% ============================================================================

@article{wang2023wasf3,
  title={{WASF3} disrupts mitochondrial respiration and may mediate exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome},
  author={Wang, Ping-yuan and Ma, Jin and Kim, Young-Chae and others},
  journal={Proceedings of the National Academy of Sciences},
  volume={120},
  number={34},
  pages={e2302738120},
  year={2023},
  month={August},
  day={22},
  publisher={National Academy of Sciences},
  doi={10.1073/pnas.2302738120},
  pmid={37579159},
  pmcid={PMC10450651},
  url={https://www.pnas.org/doi/10.1073/pnas.2302738120},
  keywords={ME/CFS, WASF3, mitochondrial dysfunction, ER stress, exercise intolerance, post-exertional malaise, respiratory supercomplex, PNAS}
}

@article{phair2019ido,
  title={The {IDO} Metabolic Trap Hypothesis for the Etiology of {ME/CFS}},
  author={Phair, Robert D. and Davis, Ronald W. and Kashi, Alex A.},
  journal={Diagnostics},
  volume={9},
  number={3},
  pages={82},
  year={2019},
  month={July},
  day={26},
  publisher={MDPI},
  doi={10.3390/diagnostics9030082},
  pmid={31357483},
  pmcid={PMC6787624},
  url={https://www.mdpi.com/2075-4418/9/3/82},
  keywords={ME/CFS, IDO-2, IDO-1, metabolic trap, tryptophan, kynurenine pathway, bistability, mathematical model}
}

@article{hwang2023viral,
  title={Evaluation of viral infection as an etiology of {ME/CFS}: a systematic review and meta-analysis},
  author={Hwang, Jae-Hyun and Lee, Jae-Seung and Oh, Hyun-Mi and others},
  journal={Journal of Translational Medicine},
  volume={21},
  number={1},
  pages={763},
  year={2023},
  month={October},
  day={29},
  publisher={BioMed Central},
  doi={10.1186/s12967-023-04635-0},
  pmid={37898798},
  pmcid={PMC10612276},
  url={https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04635-0},
  keywords={ME/CFS, viral etiology, systematic review, meta-analysis, EBV, HHV-7, enterovirus, parvovirus B19, Borna disease virus}
}

@article{lim2020cpet,
  author={Lim, Eun-Jin and Kang, Eun-Bum and Jang, Eun-Su and Son, Chang-Gue},
  title={The Prospects of the Two-Day Cardiopulmonary Exercise Test (CPET) in ME/CFS Patients: A Meta-Analysis},
  journal={Journal of Clinical Medicine},
  year={2020},
  volume={9},
  number={12},
  pages={4040},
  month={December},
  day={14},
  publisher={MDPI},
  doi={10.3390/jcm9124040},
  pmid={33327624},
  pmcid={PMC7765094},
  url={https://doi.org/10.3390/jcm9124040},
  keywords={ME/CFS, two-day CPET, post-exertional malaise, cardiopulmonary exercise testing, meta-analysis, biomarker}
}

@article{Fluge2019,
  author = {Fluge, Øystein and Rekeland, Ingrid G. and Lien, Kristin and Thürmer, Hilde and Borchgrevink, Petter C. and Schäfer, Christoph and Sørland, Kari and Aßmus, Jörg and Ktoridou-Valen, Irini and Herder, Inger and Gotaas, Marte Ekeland and Kvammen, Øystein and Baranowska, Katarzyna A. and Bohnen, Lisette M. L. J. and Martinsen, Sissel S. and Lonar, Anne Elin and Solvang, Anne Haukland and Gya, Aud E. S. and Bruland, Olav and Risa, Kristin and Alme, Kari and Dahl, Olav and Mella, Olav},
  title = {B-Lymphocyte Depletion in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial},
  journal = {Annals of Internal Medicine},
  year = {2019},
  month = {May},
  volume = {170},
  number = {9},
  pages = {585--593},
  doi = {10.7326/M18-1451},
  pmid = {30934066},
  url = {https://pubmed.ncbi.nlm.nih.gov/30934066/},
  keywords = {ME/CFS, rituximab, B-cell depletion, autoimmune, randomized controlled trial, negative trial, placebo response}
}

@article{Rekeland2024,
  author = {Rekeland, Ingrid G. and Sørland, Kari and Neteland, Linn L. and Fosså, Alexander and Alme, Kari and Risa, Kristin and Dahl, Olav and Tronstad, Karl J. and Mella, Olav and Fluge, Øystein},
  title = {Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {PLoS One},
  year = {2024},
  month = {July},
  day = {23},
  volume = {19},
  number = {7},
  pages = {e0307484},
  doi = {10.1371/journal.pone.0307484},
  pmid = {39042627},
  pmcid = {PMC11265720},
  url = {https://pubmed.ncbi.nlm.nih.gov/39042627/},
  keywords = {ME/CFS, rituximab, cyclophosphamide, long-term follow-up, immune modulation, natural history, prognosis},
  note = {Open access}
}

@article{Chia2005,
  author = {Chia, John K. S.},
  title = {The role of enterovirus in chronic fatigue syndrome},
  journal = {Journal of Clinical Pathology},
  year = {2005},
  month = {November},
  volume = {58},
  number = {11},
  pages = {1126--1132},
  doi = {10.1136/jcp.2004.020255},
  pmid = {16254097},
  pmcid = {PMC1770761},
  url = {https://pubmed.ncbi.nlm.nih.gov/16254097/},
  keywords = {enterovirus, chronic fatigue syndrome, double stranded RNA, viral persistence, post-viral ME/CFS, dsRNA, RT-PCR},
  note = {Review article. Open access}
}

@article{Polo2019,
  author = {Polo, Olli and Pesonen, Pia and Tuominen, Essi},
  title = {Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome ({ME/CFS})},
  journal = {Fatigue: Biomedicine, Health \& Behavior},
  year = {2019},
  month = {November},
  day = {19},
  volume = {7},
  number = {4},
  pages = {207--217},
  doi = {10.1080/21641846.2019.1692770},
  url = {https://www.tandfonline.com/doi/full/10.1080/21641846.2019.1692770},
  keywords = {low-dose naltrexone, LDN, ME/CFS, chronic fatigue syndrome, treatment, retrospective study, off-label},
  note = {Retrospective chart review. No placebo control. Authors acknowledge need for RCT validation.}
}

@article{Gottschalk2023,
  author = {Gottschalk, Carl Gunnar and Whelan, Ryan and Peterson, Daniel and Roy, Avik},
  title = {Detection of Elevated Level of Tetrahydrobiopterin in Serum Samples of {ME/CFS} Patients with Orthostatic Intolerance: A Pilot Study},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  month = {May},
  day = {12},
  volume = {24},
  number = {10},
  pages = {8713},
  doi = {10.3390/ijms24108713},
  pmid = {37240059},
  url = {https://www.mdpi.com/1422-0067/24/10/8713},
  keywords = {tetrahydrobiopterin, BH4, ME/CFS, orthostatic intolerance, biomarker, oxidative stress, nitric oxide},
  note = {Pilot study. n=32 CFS, n=10 CFS+OI, n=12 CFS+OI+SFN. Open access.}
}

@article{Bulbule2024,
  author = {Bulbule, Sarojini and Gottschalk, Carl Gunnar and Drosen, Molly E. and Peterson, Daniel and Arnold, Leggy A. and Roy, Avik},
  title = {Dysregulation of tetrahydrobiopterin metabolism in myalgic encephalomyelitis/chronic fatigue syndrome by pentose phosphate pathway},
  journal = {Journal of Central Nervous System Disease},
  year = {2024},
  month = {August},
  day = {19},
  volume = {16},
  pages = {11795735241271675},
  doi = {10.1177/11795735241271675},
  pmid = {39161795},
  pmcid = {PMC11331476},
  url = {https://pubmed.ncbi.nlm.nih.gov/39161795/},
  keywords = {tetrahydrobiopterin, BH4, ME/CFS, orthostatic intolerance, pentose phosphate pathway, GCH1, iNOS, neuroinflammation, biomarker},
  note = {Pilot mechanistic study. n=10 ME+OI. Companion to Gottschalk 2023. Open access.}
}

% ============================================================================
% TIER 1 ESSENTIAL PAPERS - INTEGRATED 2026-01-24
% ============================================================================

@article{Lim2020,
  author = {Lim, Eun-Jin and Kang, Eun-Bum and Jang, Eun-Su and Son, Chang-Gue},
  title = {Systematic Review of the Two-Day Cardiopulmonary Exercise Test as an Objective Assessment Tool for Post-Exertional Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Journal of Clinical Medicine},
  year = {2020},
  month = {December},
  day = {14},
  volume = {9},
  number = {12},
  pages = {4040},
  doi = {10.3390/jcm9124040},
  pmcid = {PMC7765094},
  url = {https://www.mdpi.com/2077-0383/9/12/4040},
  keywords = {ME/CFS, post-exertional malaise, PEM, cardiopulmonary exercise testing, CPET, 2-day CPET, workload, ventilatory threshold, meta-analysis},
  note = {Meta-analysis of 5 studies. n=98 ME/CFS, n=51 controls. Open access.}
}

@article{Cabanas2021,
  author = {Cabanas, Helene and Muraki, Katsuhiko and Eaton-Fitch, Natalie and Staines, Donald R and Marshall-Gradisnik, Sonya},
  title = {Low Dose Naltrexone Restores {TRPM3} Ion Channel Function in Natural Killer Cells from Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients},
  journal = {Frontiers in Immunology},
  year = {2021},
  month = {July},
  day = {13},
  volume = {12},
  pages = {687806},
  doi = {10.3389/fimmu.2021.687806},
  pmid = {34305918},
  pmcid = {PMC8313851},
  url = {https://www.frontiersin.org/articles/10.3389/fimmu.2021.687806/full},
  keywords = {low-dose naltrexone, LDN, TRPM3, ion channels, natural killer cells, ME/CFS, immune dysfunction, calcium signaling},
  note = {Pilot study. n=9 ME/CFS on LDN, n=9 healthy controls. Open access.}
}

@article{Syed2025,
  author = {Syed, Abu Mohammad and Karius, Alexander K and Ma, Jin and Wang, Ping-yuan and Hwang, Paul M},
  title = {Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Physiology},
  year = {2025},
  month = {February},
  day = {17},
  volume = {40},
  number = {4},
  doi = {10.1152/physiol.00056.2024},
  pmid = {39960432},
  pmcid = {PMC12151296},
  url = {https://journals.physiology.org/doi/full/10.1152/physiol.00056.2024},
  keywords = {mitochondrial dysfunction, ME/CFS, WASF3, ER stress, respiratory complexes, cytochrome c oxidase, ATP, energy metabolism, post-exertional malaise},
  note = {Comprehensive review from NIH authors. Published in Physiology (American Physiological Society). Available in PMC.}
}

@article{Natelson2022,
  author = {Natelson, Benjamin H and Lin, Jin-Mann S and Blate, Michelle and Khan, Sarah and Chen, Yang and Unger, Elizabeth R},
  title = {Physiological assessment of orthostatic intolerance in chronic fatigue syndrome},
  journal = {Journal of Translational Medicine},
  year = {2022},
  month = {February},
  day = {16},
  volume = {20},
  number = {1},
  pages = {95},
  doi = {10.1186/s12967-022-03289-8},
  pmid = {35172863},
  pmcid = {PMC8849016},
  url = {https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-022-03289-8},
  keywords = {orthostatic intolerance, ME/CFS, hypocapnia, POTS, end-tidal CO2, capnography, autonomic dysfunction, lean test},
  note = {Prospective study. n=63 ME/CFS patients. Open access.}
}

@article{Joseph2023,
  author = {Joseph, Phillip and Singh, Inderjit and Oliveira, Raquel and Capone, Catherine A and Mullen, Mary P and Cook, Dane B and Stovall, Megan C and Squires, Jeffrey and Madsen, Kathryn and Waxman, Aaron B and Systrom, David M},
  title = {Exercise Pathophysiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Postacute Sequelae of {SARS-CoV-2}: More in Common Than Not?},
  journal = {CHEST},
  year = {2023},
  month = {September},
  volume = {164},
  number = {3},
  pages = {717--726},
  doi = {10.1016/j.chest.2023.03.049},
  pmid = {37054777},
  pmcid = {PMC10088277},
  url = {https://journal.chestnet.org/article/S0012-3692(23)00502-0/fulltext},
  keywords = {ME/CFS, Long COVID, PASC, exercise physiology, cardiopulmonary exercise testing, CPET, post-exertional malaise, deconditioning},
  note = {Review article. Harvard Medical School and Yale authors. Published in CHEST.}
}

% ============================================================================
% TIER 2 SUPPORTING PAPERS - INTEGRATED 2026-01-24
% ============================================================================

@article{Komaroff2023,
  author = {Komaroff, Anthony L and Lipkin, W Ian},
  title = {{ME/CFS} and Long {COVID} share similar symptoms and biological abnormalities: road map to the literature},
  journal = {Frontiers in Medicine},
  year = {2023},
  month = {June},
  day = {2},
  volume = {10},
  pages = {1187163},
  doi = {10.3389/fmed.2023.1187163},
  pmid = {37293396},
  pmcid = {PMC10278546},
  url = {https://www.frontiersin.org/articles/10.3389/fmed.2023.1187163/full},
  keywords = {ME/CFS, Long COVID, PASC, post-viral syndrome, mitochondrial dysfunction, immune dysfunction, neurological dysfunction, endothelial dysfunction},
  note = {Comprehensive review. Leading ME/CFS researcher (Komaroff) and virologist (Lipkin). Open access.}
}

% ============================================================================
% SLEEP AND AUTONOMIC DYSFUNCTION REFERENCES - ADDED 2026-01-25
% ============================================================================

@article{Jason2010sleepMECFS,
  author = {Jason, Leonard A and Sunnquist, Madison and Brown, Abigail and Evans, Meredyth and Vernon, Suzanne D and Furst, Jacob and Simonis, Vincent},
  title = {Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis},
  journal = {Fatigue: Biomedicine, Health \& Behavior},
  volume = {2},
  number = {1},
  pages = {40--56},
  year = {2014},
  month = {January},
  publisher = {Taylor \& Francis},
  doi = {10.1080/21641846.2013.862993},
  pmid = {24511456},
  pmcid = {PMC3912876},
  url = {https://www.tandfonline.com/doi/full/10.1080/21641846.2013.862993},
  keywords = {ME/CFS, unrefreshing sleep, diagnostic criteria, DePaul Symptom Questionnaire, prevalence},
  note = {Cites unrefreshing sleep prevalence from Jason et al. studies using DePaul Symptom Questionnaire data showing 95-100\% prevalence in ME/CFS patients.}
}

@article{Unger2016sleepPrevalence,
  author = {Unger, Elizabeth R and Lin, Jin-Mann S and Brimmer, Dana J and Lapp, Charles W and Komaroff, Anthony L and Nath, Avindra and Jones, James F and Reeves, William C},
  title = {{CDC} Grand Rounds: Chronic Fatigue Syndrome --- Advancing Research and Clinical Education},
  journal = {Morbidity and Mortality Weekly Report},
  volume = {65},
  number = {50--51},
  pages = {1434--1438},
  year = {2016},
  month = {December},
  day = {30},
  publisher = {Centers for Disease Control and Prevention},
  doi = {10.15585/mmwr.mm655051a4},
  pmid = {28033311},
  url = {https://www.cdc.gov/mmwr/volumes/65/wr/mm655051a4.htm},
  keywords = {ME/CFS, CDC, unrefreshing sleep, diagnostic criteria, prevalence, clinical education},
  note = {CDC publication identifying unrefreshing sleep as a core diagnostic feature of ME/CFS.}
}

@article{Reeves2006sleepCharacteristics,
  author = {Reeves, William C and Heim, Christine and Maloney, Elizabeth M and Youngblood, Laura Solomon and Unger, Elizabeth R and Decker, Michael J and Jones, James F and Rye, David B},
  title = {Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study},
  journal = {BMC Neurology},
  volume = {6},
  pages = {41},
  year = {2006},
  month = {November},
  day = {16},
  publisher = {BioMed Central},
  doi = {10.1186/1471-2377-6-41},
  pmid = {17109739},
  pmcid = {PMC1660569},
  url = {https://bmcneurol.biomedcentral.com/articles/10.1186/1471-2377-6-41},
  keywords = {ME/CFS, sleep, polysomnography, unrefreshing sleep, population-based study},
  note = {Population-based study examining sleep characteristics in CFS patients vs. controls.}
}

@article{Moldofsky1975alphaDeltaSleep,
  author = {Moldofsky, H and Scarisbrick, P and England, R and Smythe, H},
  title = {Musculoskeletal symptoms and non-{REM} sleep disturbance in patients with ``fibrositis syndrome'' and healthy subjects},
  journal = {Psychosomatic Medicine},
  volume = {37},
  number = {4},
  pages = {341--351},
  year = {1975},
  month = {July},
  publisher = {American Psychosomatic Society},
  doi = {10.1097/00006842-197507000-00008},
  pmid = {169541},
  url = {https://journals.lww.com/psychosomaticmedicine/abstract/1975/07000/musculoskeletal_symptoms_and_non_rem_sleep.8.aspx},
  keywords = {alpha-delta sleep, fibromyalgia, slow-wave sleep, sleep architecture, musculoskeletal pain},
  note = {Landmark study describing alpha-delta sleep pattern in fibromyalgia patients.}
}

@article{Jackson2012sleepAbnormalities,
  author = {Jackson, Melinda L and Bruck, Dorothy},
  title = {Sleep abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a review},
  journal = {Journal of Clinical Sleep Medicine},
  volume = {8},
  number = {6},
  pages = {719--728},
  year = {2012},
  month = {December},
  day = {15},
  publisher = {American Academy of Sleep Medicine},
  doi = {10.5664/jcsm.2276},
  pmid = {23243408},
  pmcid = {PMC3501671},
  url = {https://jcsm.aasm.org/doi/10.5664/jcsm.2276},
  keywords = {ME/CFS, sleep fragmentation, sleep architecture, polysomnography, unrefreshing sleep},
  note = {Comprehensive review of sleep abnormalities in ME/CFS including fragmentation patterns.}
}

@article{Peppard2013OSAprevalence,
  author = {Peppard, Paul E and Young, Terry and Barnet, Jodi H and Palta, Mari and Hagen, Erika W and Hla, Khin Mae},
  title = {Increased Prevalence of Sleep-Disordered Breathing in Adults},
  journal = {American Journal of Epidemiology},
  volume = {177},
  number = {9},
  pages = {1006--1014},
  year = {2013},
  month = {May},
  day = {1},
  publisher = {Oxford University Press},
  doi = {10.1093/aje/kws342},
  pmid = {23589584},
  pmcid = {PMC3639722},
  url = {https://academic.oup.com/aje/article/177/9/1006/103691},
  keywords = {obstructive sleep apnea, OSA, prevalence, sleep-disordered breathing, epidemiology},
  note = {Wisconsin Sleep Cohort Study documenting OSA prevalence of 10-30\% in general population.}
}

@article{Senaratna2017OSAmeta,
  author = {Senaratna, Chamara V and Perret, Jennifer L and Lodge, Caroline J and Lowe, Adrian J and Campbell, Brittany E and Matheson, Melanie C and Hamilton, Garun S and Dharmage, Shyamali C},
  title = {Prevalence of obstructive sleep apnea in the general population: A systematic review},
  journal = {Sleep Medicine Reviews},
  volume = {34},
  pages = {70--81},
  year = {2017},
  month = {August},
  publisher = {Elsevier},
  doi = {10.1016/j.smrv.2016.07.002},
  pmid = {27568340},
  url = {https://www.sciencedirect.com/science/article/abs/pii/S1087079216300648},
  keywords = {obstructive sleep apnea, OSA, systematic review, meta-analysis, prevalence},
  note = {Systematic review finding OSA prevalence of 9-38\% at AHI $\geq$5 and 6-17\% at AHI $\geq$15.}
}

@article{Bagai2011sleepPOTS,
  author = {Bagai, Kanika and Song, Yanna and Ling, John F and Malow, Beth and Black, Bonnie K and Biaggioni, Italo and Robertson, David and Raj, Satish R},
  title = {Sleep disturbances and diminished quality of life in postural tachycardia syndrome},
  journal = {Journal of Clinical Sleep Medicine},
  volume = {7},
  number = {2},
  pages = {204--210},
  year = {2011},
  month = {April},
  day = {15},
  publisher = {American Academy of Sleep Medicine},
  doi = {10.5664/jcsm.28110},
  pmid = {21509337},
  pmcid = {PMC3077350},
  url = {https://jcsm.aasm.org/doi/10.5664/jcsm.28110},
  keywords = {POTS, postural tachycardia syndrome, sleep disturbances, quality of life, autonomic dysfunction},
  note = {Study from Vanderbilt Autonomic Dysfunction Center on sleep issues in POTS patients.}
}

@article{Allen2018RLSironThreshold,
  author = {Allen, Richard P and Picchietti, Daniel L and Auerbach, Michael and Cho, Yong Won and Connor, James R and Earley, Christopher J and Garcia-Borreguero, Diego and Kotagal, Suresh and Manconi, Mauro and Ondo, William and Ulfberg, Jan and Winkelman, John W},
  title = {Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome/{Willis-Ekbom} disease in adults and children: an {IRLSSG} task force report},
  journal = {Sleep Medicine},
  volume = {41},
  pages = {27--44},
  year = {2018},
  month = {January},
  publisher = {Elsevier},
  doi = {10.1016/j.sleep.2017.11.1126},
  pmid = {29425576},
  url = {https://www.sciencedirect.com/science/article/abs/pii/S1389945717315599},
  keywords = {restless legs syndrome, RLS, Willis-Ekbom disease, iron supplementation, ferritin threshold, treatment guidelines},
  note = {IRLSSG consensus guidelines recommending oral iron for ferritin ≤75 μg/L and IV iron for ferritin ≤100 μg/L.}
}

@article{Newton2007autonomicDysfunction,
  author = {Newton, J L and Okonkwo, O and Sutcliffe, K and Seth, A and Shin, J and Jones, D E J},
  title = {Symptoms of autonomic dysfunction in chronic fatigue syndrome},
  journal = {QJM: An International Journal of Medicine},
  volume = {100},
  number = {8},
  pages = {519--526},
  year = {2007},
  month = {August},
  publisher = {Oxford University Press},
  doi = {10.1093/qjmed/hcm057},
  pmid = {17617647},
  url = {https://academic.oup.com/qjmed/article/100/8/519/1521818},
  keywords = {ME/CFS, autonomic dysfunction, COMPASS, dysautonomia, prevalence},
  note = {Study identifying high prevalence of autonomic symptoms in ME/CFS using Composite Autonomic Symptom Scale (COMPASS).}
}

@article{Newton2008POTSprevalence,
  author = {Hoad, A and Spickett, G and Elliott, J and Newton, J},
  title = {Postural orthostatic tachycardia syndrome is an under-recognized condition in chronic fatigue syndrome},
  journal = {QJM: An International Journal of Medicine},
  volume = {101},
  number = {12},
  pages = {961--965},
  year = {2008},
  month = {December},
  publisher = {Oxford University Press},
  doi = {10.1093/qjmed/hcn123},
  pmid = {18805903},
  url = {https://academic.oup.com/qjmed/article/101/12/961/1564413},
  keywords = {POTS, postural orthostatic tachycardia syndrome, ME/CFS, prevalence, autonomic dysfunction},
  note = {UK study from Northern CFS/ME Clinical Network finding 27\% POTS prevalence in ME/CFS patients vs. 9\% in controls.}
}

@article{Sheldon2015POTScriteria,
  author = {Sheldon, Robert S and Grubb, Blair P and Olshansky, Brian and Shen, Win-Kuang and Calkins, Hugh and Brignole, Massimo and Raj, Satish R and Krahn, Andrew D and Morillo, Carlos A and Stewart, Julian M and Sutton, Richard and Sandroni, Paola and Friday, Kenneth J and Hachul, Denise T and Cohen, Mitchell I and Lau, Dennis H and Mayuga, Kristine A and Moak, Jeffrey P and Sandhu, Roopinder K and Kanjwal, Khalil},
  title = {2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope},
  journal = {Heart Rhythm},
  volume = {12},
  number = {6},
  pages = {e41--e63},
  year = {2015},
  month = {June},
  publisher = {Elsevier},
  doi = {10.1016/j.hrthm.2015.03.029},
  pmid = {25980576},
  pmcid = {PMC5267948},
  url = {https://www.heartrhythmjournal.com/article/S1547-5271(15)00328-8/fulltext},
  keywords = {POTS, postural orthostatic tachycardia syndrome, diagnostic criteria, heart rate increase, consensus statement},
  note = {Heart Rhythm Society consensus defining POTS as $\geq$30 bpm HR increase (or $\geq$40 bpm in ages 12-19) upon standing.}
}

@article{Young2002OSAepidemiology,
  author = {Young, Terry and Peppard, Paul E and Gottlieb, Daniel J},
  title = {Epidemiology of obstructive sleep apnea: a population health perspective},
  journal = {American Journal of Respiratory and Critical Care Medicine},
  volume = {165},
  number = {9},
  pages = {1217--1239},
  year = {2002},
  month = {May},
  day = {1},
  publisher = {American Thoracic Society},
  doi = {10.1164/rccm.2109080},
  pmid = {11991871},
  url = {https://www.atsjournals.org/doi/10.1164/rccm.2109080},
  keywords = {obstructive sleep apnea, OSA, epidemiology, population health, sleep-disordered breathing},
  note = {Seminal review on OSA epidemiology documenting high prevalence and wide severity spectrum.}
}

@article{Lerner2002valacyclovir,
  author = {Lerner, A Martin and Beqaj, Safedin H and Deeter, Robert G and Dworkin, Howard J and Zervos, Marcos and Chang, Chung-Ho and Fitzgerald, James T and Goldstein, James and O'Neill, William},
  title = {A six-month trial of valacyclovir in the {Epstein-Barr} virus subset of chronic fatigue syndrome: improvement in left ventricular function},
  journal = {Drugs of Today},
  volume = {38},
  number = {8},
  pages = {549--561},
  year = {2002},
  month = {August},
  doi = {10.1358/dot.2002.38.8.820095},
  pmid = {12582420},
  url = {https://pubmed.ncbi.nlm.nih.gov/12582420/},
  keywords = {ME/CFS, chronic fatigue syndrome, valacyclovir, Epstein-Barr virus, EBV, antiviral, herpesvirus},
  note = {Six-month open-label trial showing improvement in left ventricular function and clinical status in EBV-subset CFS patients treated with valacyclovir.}
}

@article{Lerner2007valacyclovir,
  author = {Lerner, A Martin and Beqaj, Safedin H and Deeter, Robert G and Fitzgerald, James T},
  title = {Valacyclovir treatment in {Epstein-Barr} virus subset chronic fatigue syndrome: thirty-six months follow-up},
  journal = {In Vivo},
  volume = {21},
  number = {5},
  pages = {707--713},
  year = {2007},
  month = {September},
  pmid = {18019402},
  url = {https://pubmed.ncbi.nlm.nih.gov/18019402/},
  keywords = {ME/CFS, chronic fatigue syndrome, valacyclovir, Epstein-Barr virus, EBV, antiviral, herpesvirus, long-term follow-up},
  note = {36-month blinded randomized placebo-controlled follow-up study confirming sustained benefit of valacyclovir in EBV-subset CFS.}
}

@article{Lerner2010antivirals,
  author = {Lerner, A Martin and Beqaj, Safedin H and Fitzgerald, James T and Gill, Kristine and Gill, Curtis and Edington, Jennifer},
  title = {Subset-directed antiviral treatment of 142 herpesvirus patients with chronic fatigue syndrome},
  journal = {Virus Adaptation and Treatment},
  volume = {2},
  pages = {47--57},
  year = {2010},
  month = {December},
  doi = {10.2147/VAAT.S10695},
  url = {https://www.dovepress.com/subset-directed-antiviral-treatment-of-142-herpesvirus-patients-with-c-peer-reviewed-fulltext-article-VAAT},
  keywords = {ME/CFS, chronic fatigue syndrome, valacyclovir, valganciclovir, Epstein-Barr virus, EBV, cytomegalovirus, CMV, HHV-6, herpesvirus, antiviral},
  note = {Large cohort study (n=142) from 2001-2007 showing 30-40\% response rate to subset-directed long-term antiviral therapy in herpesvirus-associated CFS. Group A (no coinfections) showed significantly better outcomes than coinfection groups.}
}

@article{Montoya2013valganciclovir,
  author = {Montoya, Jose G and Kogelnik, Andreas M and Bhangoo, Munveer and Lunn, Mitchell R and Flamand, Louis and Merrihew, Lindsey E and Watt, Tessa and Kubo, Jessica T and Paik, Jane and Desai, Manisha},
  title = {Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome},
  journal = {Journal of Medical Virology},
  volume = {85},
  number = {12},
  pages = {2101--2109},
  year = {2013},
  month = {December},
  doi = {10.1002/jmv.23713},
  pmid = {23959519},
  url = {https://onlinelibrary.wiley.com/doi/10.1002/jmv.23713},
  keywords = {ME/CFS, chronic fatigue syndrome, valganciclovir, HHV-6, Epstein-Barr virus, EBV, herpesvirus, antiviral, randomized controlled trial, EVOLVE study},
  note = {Landmark Stanford double-blind RCT (n=30) showing valganciclovir 900mg BID for 6 months resulted in 50-60\% response rate with significant improvements in mental fatigue (p=0.039), fatigue severity (p=0.006), and cognitive function (p=0.025) in CFS patients with elevated HHV-6/EBV titers. Patients in VGCV arm 7.4 times more likely to be responders (p=0.029).}
}

@article{Forsyth1999NADH,
  author = {Forsyth, L M and Preuss, H G and MacDowell, A L and Chiazze, L and Birkmayer, G D and Bellanti, J A},
  title = {Therapeutic effects of oral {NADH} on the symptoms of patients with chronic fatigue syndrome},
  journal = {Annals of Allergy, Asthma \& Immunology},
  volume = {82},
  number = {2},
  pages = {185--191},
  year = {1999},
  month = {February},
  doi = {10.1016/S1081-1206(10)62595-1},
  pmid = {10071523},
  url = {https://pubmed.ncbi.nlm.nih.gov/10071523/},
  keywords = {ME/CFS, chronic fatigue syndrome, NADH, nicotinamide adenine dinucleotide, mitochondrial support, energy metabolism, randomized controlled trial},
  note = {Randomized, double-blind, placebo-controlled crossover study (n=26) showing 31\% of patients responded favorably to 10mg NADH daily for 4 weeks compared to 8\% placebo response. Suggests NADH may be valuable adjunctive therapy for CFS.}
}

@article{Santaella2004NADH,
  author = {Santaella, María L and Font, Ivonne and Disdier, Orville M},
  title = {Comparison of oral nicotinamide adenine dinucleotide ({NADH}) versus conventional therapy for chronic fatigue syndrome},
  journal = {Puerto Rico Health Sciences Journal},
  volume = {23},
  number = {2},
  pages = {89--93},
  year = {2004},
  month = {June},
  pmid = {15377055},
  url = {https://pubmed.ncbi.nlm.nih.gov/15377055/},
  keywords = {ME/CFS, chronic fatigue syndrome, NADH, nicotinamide adenine dinucleotide, mitochondrial support, conventional therapy, negative study},
  note = {Randomized trial (n=31) comparing NADH to conventional therapy (nutritional supplements and psychological therapy) over 24 months. NADH showed significant improvement in first trimester (p < 0.001), but subsequent trimesters showed similar outcomes between groups. Mixed results compared to conventional treatment.}
}

@article{Teitelbaum2006ribose,
  author = {Teitelbaum, Jacob E and Johnson, Clarence and St Cyr, John},
  title = {The use of {D-ribose} in chronic fatigue syndrome and fibromyalgia: a pilot study},
  journal = {Journal of Alternative and Complementary Medicine},
  volume = {12},
  number = {9},
  pages = {857--862},
  year = {2006},
  month = {November},
  doi = {10.1089/acm.2006.12.857},
  pmid = {17109576},
  url = {https://pubmed.ncbi.nlm.nih.gov/17109576/},
  keywords = {ME/CFS, chronic fatigue syndrome, fibromyalgia, D-ribose, ribose, mitochondrial support, energy metabolism, pentose carbohydrate, open-label study},
  note = {Open-label pilot study (n=41) of 5g D-ribose three times daily showing significant improvement in all five VAS categories: energy, sleep, mental clarity, pain intensity, and well-being. Well-tolerated with clinically significant symptom reduction.}
}

@article{Vermeulen2004carnitine,
  author = {Vermeulen, Ruud C W and Scholte, Hans R},
  title = {Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome},
  journal = {Psychosomatic Medicine},
  volume = {66},
  number = {2},
  pages = {276--282},
  year = {2004},
  month = {March},
  doi = {10.1097/01.psy.0000116249.60477.e9},
  pmid = {15039515},
  url = {https://pubmed.ncbi.nlm.nih.gov/15039515/},
  keywords = {ME/CFS, chronic fatigue syndrome, acetyl-L-carnitine, propionyl-L-carnitine, carnitine, acylcarnitine, mitochondrial support, energy metabolism, fatigue, mental fatigue},
  note = {Open-label randomized study (n=90, 3 groups of 30) comparing 2g/d acetyl-L-carnitine, 2g/d propionyl-L-carnitine, and combination over 24 weeks. Considerable improvement in 59\% acetyl-L-carnitine group and 63\% propionyl-L-carnitine group. Acetyl-L-carnitine significantly improved mental fatigue (p=0.015); propionyl-L-carnitine improved general fatigue (p=0.004). Demonstrated reduced acylcarnitine levels in CFS patients.}
}

@article{Plioplys1995carnitine,
  author = {Plioplys, A V and Plioplys, S},
  title = {Serum levels of carnitine in chronic fatigue syndrome: clinical correlates},
  journal = {Neuropsychobiology},
  volume = {32},
  number = {3},
  pages = {132--138},
  year = {1995},
  doi = {10.1159/000119226},
  pmid = {8544970},
  url = {https://pubmed.ncbi.nlm.nih.gov/8544970/},
  keywords = {ME/CFS, chronic fatigue syndrome, carnitine, acylcarnitine, mitochondrial dysfunction, biomarkers, serum levels},
  note = {Study of 35 CFS patients showing significantly lower serum total carnitine, free carnitine, and acylcarnitine levels compared to controls. Statistically significant correlation between higher serum carnitine levels and better functional capacity. Findings suggest mitochondrial dysfunction contributing to fatigue symptoms.}
}

@article{Plioplys1997carnitineTreatment,
  author = {Plioplys, A V and Plioplys, S},
  title = {Amantadine and {L-carnitine} treatment of {Chronic} {Fatigue} {Syndrome}},
  journal = {Neuropsychobiology},
  volume = {35},
  number = {1},
  pages = {16--23},
  year = {1997},
  doi = {10.1159/000119325},
  pmid = {9018019},
  url = {https://pubmed.ncbi.nlm.nih.gov/9018019/},
  keywords = {ME/CFS, chronic fatigue syndrome, L-carnitine, amantadine, treatment, clinical improvement, mitochondrial support},
  note = {Follow-up treatment study showing statistically significant clinical improvement in 12 of 18 studied parameters after 8 weeks of L-carnitine treatment (3g/day). L-carnitine found to be safe, well-tolerated, and improved clinical status of CFS patients.}
}

@article{Malaguarnera2011ALCAR,
  author = {Malaguarnera, Michele and Vacante, Marco and Giordano, Maria and Pennisi, Giovanni and Bella, Rita and Rampello, Liborio and Malaguarnera, Mariano and Li Volti, Giovanni and Galvano, Fabio},
  title = {Oral acetyl-{L-carnitine} therapy reduces fatigue in overt hepatic encephalopathy: a randomized, double-blind, placebo-controlled study},
  journal = {American Journal of Clinical Nutrition},
  volume = {93},
  number = {4},
  pages = {799--808},
  year = {2011},
  month = {April},
  doi = {10.3945/ajcn.110.007393},
  pmid = {21310833},
  url = {https://pubmed.ncbi.nlm.nih.gov/21310833/},
  keywords = {acetyl-L-carnitine, ALCAR, carnitine, fatigue, cognitive function, hepatic encephalopathy, mitochondrial support, neuroprotection, randomized controlled trial},
  note = {Double-blind RCT in hepatic encephalopathy patients showing acetyl-L-carnitine reduced fatigue and improved cognitive function. Demonstrates neuroprotective benefits and improved mitochondrial energetics. Note: not specific to ME/CFS but relevant for understanding acetyl-L-carnitine's effects on fatigue and cognition.}
}

% Translational findings citations - Chapter 25

@article{MyersEtAl2022,
  author = {Tate, Warren and Walker, Max and Sweetman, Eiren and Helliwell, Amber and Peppercorn, Katie and Edgar, Christina and Blair, Anna and Chatterjee, Aniruddha},
  title = {Molecular Mechanisms of Neuroinflammation in {ME/CFS} and Long {COVID} to Sustain Disease and Promote Relapses},
  journal = {Frontiers in Neurology},
  year = {2022},
  volume = {13},
  pages = {877772},
  doi = {10.3389/fneur.2022.877772},
  pmid = {35693009},
  pmcid = {PMC9174654},
  url = {https://pubmed.ncbi.nlm.nih.gov/35693009/},
  note = {Comprehensive review of neuroinflammation mechanisms in ME/CFS and Long COVID. Note: Actual authors are Tate et al., not Myers et al.}
}

@article{VisserEtAl2023,
  author = {Wang, Ping-Yuan and Ma, Jin and Kim, Young-Chae and Son, Annie Y and Syed, Abu Mohammad and Liu, Chengyu and Mori, Mateus P and Huffstutler, Rebecca D and Stolinski, JoEllyn L and Talagala, S Lalith and Kang, Ju-Gyeong and Walitt, Brian T and Nath, Avindra and Hwang, Paul M},
  title = {{WASF3} Disrupts Mitochondrial Respiration and May Mediate Exercise Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Proceedings of the National Academy of Sciences U.S.A.},
  year = {2023},
  volume = {120},
  number = {34},
  pages = {e2302738120},
  doi = {10.1073/pnas.2302738120},
  pmid = {37579159},
  pmcid = {PMC10450651},
  url = {https://pubmed.ncbi.nlm.nih.gov/37579159/},
  note = {NIH study identifying WASF3-mediated mitochondrial dysfunction in ME/CFS. Note: Actual authors are Wang et al., not Visser et al.}
}

@article{AllenEtAl2024,
  author = {Syed, Abu Mohammad and Karius, Alexander K and Ma, Jin and Wang, Ping-Yuan and Hwang, Paul M},
  title = {Mitochondrial Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Physiology},
  year = {2025},
  volume = {40},
  number = {4},
  pages = {0},
  doi = {10.1152/physiol.00056.2024},
  pmid = {39960432},
  pmcid = {PMC12151296},
  url = {https://pubmed.ncbi.nlm.nih.gov/39960432/},
  note = {Comprehensive review of mitochondrial dysfunction in ME/CFS published 2025. Note: Actual authors are Syed et al., not Allen et al.}
}

@article{CastroMarrero2015,
  author = {Castro-Marrero, Jesús and Cordero, Mario D and Segundo, María José and Sáez-Francàs, Naia and Calvo, Natalia and Román-Malo, Lourdes and Aliste, Luisa and Fernández de Sevilla, Tomás and Alegre, José},
  title = {Does Oral Coenzyme {Q10} Plus {NADH} Supplementation Improve Fatigue and Biochemical Parameters in Chronic Fatigue Syndrome?},
  journal = {Antioxidants \& Redox Signaling},
  year = {2015},
  volume = {22},
  number = {8},
  pages = {679--685},
  doi = {10.1089/ars.2014.6181},
  pmid = {25386668},
  pmcid = {PMC4346380},
  url = {https://pubmed.ncbi.nlm.nih.gov/25386668/}
}

@article{Saunders2024,
  author = {Wu, Chao-Yi and Guzmán-Vélez, Edmarie and others},
  title = {Effects of Nicotinamide Riboside on {NAD+} Levels, Cognition, and Symptom Recovery in Long-{COVID}: A Randomized Controlled Trial},
  journal = {eClinicalMedicine},
  year = {2025},
  pmid = {41357333},
  pmcid = {PMC12675013},
  url = {https://pubmed.ncbi.nlm.nih.gov/41357333/},
  note = {Study used n=58, 2000mg/day NR (parameters differ from text citation). Note: Actual authors are Wu et al., published 2025, not Saunders 2024}
}

@article{Cordero2013,
  author = {Cordero, Mario D and Alcocer-Gómez, Elísabet and de Miguel, Manuel and Culic, Ognjen and Carrión, Angel M and Alvarez-Suarez, José Miguel and Bullón, Pedro and Battino, Maurizio and Fernández-Rodríguez, Ana and Sánchez-Alcazar, José Antonio},
  title = {Can Coenzyme {Q10} Improve Clinical and Molecular Parameters in Fibromyalgia?},
  journal = {Antioxidants \& Redox Signaling},
  year = {2013},
  volume = {19},
  number = {12},
  pages = {1356--1361},
  doi = {10.1089/ars.2013.5260},
  pmid = {23458405},
  url = {https://pubmed.ncbi.nlm.nih.gov/23458405/},
  note = {Study used 300mg/day CoQ10, not 200mg as cited in text}
}

@article{Parikh2009,
  author = {Parikh, Sumit and Saneto, Russell and Falk, Marni J and Anselm, Irina and Cohen, Bruce H and Haas, Richard and {The Mitochondrial Medicine Society}},
  title = {A Modern Approach to the Treatment of Mitochondrial Disease},
  journal = {Current Treatment Options in Neurology},
  year = {2009},
  volume = {11},
  number = {6},
  pages = {414--430},
  doi = {10.1007/s11940-009-0046-0},
  pmid = {19891905},
  pmcid = {PMC3561461},
  url = {https://pubmed.ncbi.nlm.nih.gov/19891905/}
}

@article{VanCampenEtAl2020,
  author = {van Campen, C Linda M C and Verheugt, Freek W A and Rowe, Peter C and Visser, Frans C},
  title = {Cerebral Blood Flow Is Reduced in {ME/CFS} During Head-Up Tilt Testing Even in the Absence of Hypotension or Tachycardia: A Quantitative, Controlled Study Using Doppler Echography},
  journal = {Clinical Neurophysiology Practice},
  year = {2020},
  volume = {5},
  pages = {50--58},
  doi = {10.1016/j.cnp.2020.01.003},
  pmid = {32140630},
  pmcid = {PMC7044650},
  url = {https://pubmed.ncbi.nlm.nih.gov/32140630/},
  keywords = {ME/CFS, cerebral blood flow, orthostatic intolerance, tilt testing, transcranial Doppler},
  note = {Landmark study: 82\% of patients with normal HR/BP, 98\% with delayed orthostatic hypotension, and 100\% with POTS showed abnormal CBF reduction. End-tilt CBF reduction 7\% controls vs 26\% ME/CFS (3.7-fold greater)}
}

@article{VanCampenEtAl2021,
  author = {van Campen, C Linda M C and Rowe, Peter C and Visser, Frans C},
  title = {Cerebral Blood Flow Remains Reduced After Tilt Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients},
  journal = {Clinical Neurophysiology Practice},
  year = {2021},
  volume = {6},
  pages = {245--255},
  doi = {10.1016/j.cnp.2021.09.001},
  pmid = {34667909},
  pmcid = {PMC8505270},
  url = {https://pubmed.ncbi.nlm.nih.gov/34667909/},
  keywords = {ME/CFS, cerebral blood flow, orthostatic intolerance, post-tilt recovery},
  note = {CBF reduction -29\% at end-tilt, improving to only -16\% post-tilt. Recovery correlates with disease severity}
}

@article{VanCampenEtAl2023,
  author = {van Campen, C Linda M C and Rowe, Peter C and Visser, Frans C},
  title = {Worsening Symptoms Is Associated with Larger Cerebral Blood Flow Abnormalities During Tilt-Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ({ME/CFS})},
  journal = {Medicina},
  year = {2023},
  volume = {59},
  number = {12},
  pages = {2153},
  doi = {10.3390/medicina59122153},
  pmid = {38138257},
  url = {https://pubmed.ncbi.nlm.nih.gov/38138257/},
  keywords = {ME/CFS, cerebral blood flow, disease severity, orthostatic intolerance, tilt testing},
  note = {ME/CFS severity directly related to degree of CBF reduction during tilt testing}
}

@article{VanCampenEtAl2024,
  author = {van Campen, C Linda M C and Verheugt, Freek W A and Rowe, Peter C and Visser, Frans C},
  title = {The Cardiac Output--Cerebral Blood Flow Relationship Is Abnormal in Most Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients with a Normal Heart Rate and Blood Pressure Response During a Tilt Test},
  journal = {Healthcare},
  year = {2024},
  volume = {12},
  number = {24},
  pages = {2566},
  doi = {10.3390/healthcare12242566},
  pmid = {39765993},
  pmcid = {PMC11675211},
  url = {https://pubmed.ncbi.nlm.nih.gov/39765993/},
  keywords = {ME/CFS, cerebral blood flow, cardiac output, orthostatic intolerance, endothelial dysfunction},
  note = {91\% of ME/CFS patients (488/534) with normal HR/BP showed abnormal CO and CBF reduction. Absence of compensatory vasodilation suggests endothelial dysfunction}
}

@article{May1990,
  author = {May, James M and Qu, Zhi-chao and Nazarewicz, Rea and Dikalov, Sergey},
  title = {Ascorbic Acid Efficiently Enhances Neuronal Synthesis of Norepinephrine from Dopamine},
  journal = {Brain Research Bulletin},
  year = {2013},
  volume = {90},
  pages = {35--42},
  doi = {10.1016/j.brainresbull.2012.09.009},
  pmid = {23022576},
  pmcid = {PMC3527656},
  url = {https://pubmed.ncbi.nlm.nih.gov/23022576/},
  note = {More recent reference on vitamin C supporting catecholamine synthesis. Original citation was May 1990 which was not found}
}

@article{Afrin2016,
  author = {Afrin, Lawrence B and Butterfield, Joseph H and Raithel, Martin and Molderings, Gerhard J},
  title = {Often Seen, Rarely Recognized: Mast Cell Activation Disease---A Guide to Diagnosis and Therapeutic Options},
  journal = {Annals of Medicine},
  year = {2016},
  volume = {48},
  number = {3},
  pages = {190--201},
  doi = {10.3109/07853890.2016.1161231},
  pmid = {27012973},
  url = {https://pubmed.ncbi.nlm.nih.gov/27012973/}
}

@article{Seneviratne2017,
  author = {Seneviratne, Suranjith L and Maitland, Anne and Afrin, Lawrence},
  title = {Mast Cell Disorders in {Ehlers-Danlos} Syndrome},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  year = {2017},
  volume = {175},
  number = {1},
  pages = {226--236},
  doi = {10.1002/ajmg.c.31555},
  pmid = {28261938},
  url = {https://pubmed.ncbi.nlm.nih.gov/28261938/}
}

@article{Younger2013,
  author = {Younger, Jarred and Parkitny, Luke and McLain, David},
  title = {The Use of Low-Dose Naltrexone ({LDN}) as a Novel Anti-Inflammatory Treatment for Chronic Pain},
  journal = {Clinical Rheumatology},
  year = {2014},
  volume = {33},
  number = {4},
  pages = {451--459},
  doi = {10.1007/s10067-014-2517-2},
  pmid = {24526250},
  pmcid = {PMC3962576},
  url = {https://pubmed.ncbi.nlm.nih.gov/24526250/},
  note = {Review paper on LDN for chronic pain; specific ME/CFS trial with n=80 and 65\% response as cited in text not found. Published 2014, not 2013}
}

@article{Parkitny2014,
  author = {Younger, Jarred and Parkitny, Luke and McLain, David},
  title = {The Use of Low-Dose Naltrexone ({LDN}) as a Novel Anti-Inflammatory Treatment for Chronic Pain},
  journal = {Clinical Rheumatology},
  year = {2014},
  volume = {33},
  number = {4},
  pages = {451--459},
  doi = {10.1007/s10067-014-2517-2},
  pmid = {24526250},
  pmcid = {PMC3962576},
  url = {https://pubmed.ncbi.nlm.nih.gov/24526250/},
  note = {Same paper as Younger2013 (Parkitny is second author). Review paper, not a meta-analysis as cited in text}
}

@article{JasonEtAl2010,
  author = {Jason, Leonard and Benton, Mary and Torres-Harding, Susan and Muldowney, Kathleen},
  title = {The Impact of Energy Modulation on Physical Functioning and Fatigue Severity Among Patients with {ME/CFS}},
  journal = {Patient Education and Counseling},
  year = {2009},
  volume = {77},
  number = {2},
  pages = {237--241},
  doi = {10.1016/j.pec.2009.02.015},
  pmid = {19356884},
  pmcid = {PMC2767446},
  url = {https://pubmed.ncbi.nlm.nih.gov/19356884/},
  note = {Published 2009, may be cited as 2010 due to print publication date}
}

@article{Wilshire2018,
  author = {Wilshire, Carolyn E and Kindlon, Tom and Courtney, Robert and Matthees, Alem and Tuller, David and Geraghty, Keith and Levin, Bruce},
  title = {Rethinking the Treatment of Chronic Fatigue Syndrome---A Reanalysis and Evaluation of Findings from a Recent Major Trial of Graded Exercise and {CBT}},
  journal = {BMC Psychology},
  year = {2018},
  volume = {6},
  number = {1},
  pages = {6},
  doi = {10.1186/s40359-018-0218-3},
  pmid = {29562932},
  pmcid = {PMC5863477},
  url = {https://pubmed.ncbi.nlm.nih.gov/29562932/}
}

% ============================================================================
% CHAPTER 1 & 2 REFERENCES - Added for missing sections
% ============================================================================

% Historical Context References
@article{Gilliam1938,
  author = {Gilliam, Alexander G},
  title = {Epidemiological Study of an Epidemic, Diagnosed as Poliomyelitis, Occurring Among the Personnel of the {Los Angeles County General Hospital} During the Summer of 1934},
  journal = {Public Health Bulletin},
  volume = {240},
  pages = {1--90},
  year = {1938},
  publisher = {U.S. Public Health Service},
  note = {First documented ME/CFS outbreak}
}

@article{Sigurdsson1950,
  author = {Sigurdsson, Björn and Sigurjónsson, Jóhann and Sigurdsson, J H and Thorkelsson, J and Gudmundsson, K R},
  title = {A Disease Epidemic in {Iceland} Simulating Poliomyelitis},
  journal = {American Journal of Hygiene},
  volume = {52},
  number = {2},
  pages = {222--238},
  year = {1950},
  doi = {10.1093/oxfordjournals.aje.a119549},
  note = {Description of the 1948-49 Akureyri outbreak}
}

@article{RoyalFree1957,
  author = {{Medical Staff of the Royal Free Hospital}},
  title = {An Outbreak of Encephalomyelitis in the {Royal Free Hospital Group, London}, in 1955},
  journal = {British Medical Journal},
  volume = {2},
  number = {5050},
  pages = {895--904},
  year = {1957},
  month = {October},
  pmcid = {PMC1962472},
  doi = {10.1136/bmj.2.5050.895}
}

@book{Ramsay1986,
  author = {Ramsay, A Melvin},
  title = {Myalgic Encephalomyelitis and Postviral Fatigue States: The Saga of {Royal Free} Disease},
  publisher = {Gower Medical Publishing for the ME Association},
  address = {London},
  year = {1986},
  edition = {2nd},
  isbn = {0906923999}
}

@article{Buchwald1992,
  author = {Buchwald, Dedra and Cheney, Paul R and Peterson, Daniel L and Henry, Berch and Wormsley, Susan B and Geiger, Ann and Ablashi, Dharam V and Salahuddin, S Zaki and Saxinger, Carl and Biddle, Robert and Kikinis, Ron and Jolesz, Ferenc A and Folks, Thomas and Balachandran, Narayanasamy and Peter, John B and Gallo, Robert C and Komaroff, Anthony L},
  title = {A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection},
  journal = {Annals of Internal Medicine},
  volume = {116},
  number = {2},
  pages = {103--113},
  year = {1992},
  doi = {10.7326/0003-4819-116-2-103},
  pmid = {1309285}
}

@article{Holmes1988,
  author = {Holmes, Gary P and Kaplan, Jonathan E and Gantz, Nelson M and Komaroff, Anthony L and Schonberger, Lawrence B and Straus, Stephen E and Jones, James F and Dubois, Richard E and Cunningham-Rundles, Charlotte and Pahwa, Savita and Tosato, Giovanna and Zegans, Leonard S and Purtilo, David T and Brown, Nathaniel and Schooley, Robert T and Brus, Irena},
  title = {Chronic Fatigue Syndrome: A Working Case Definition},
  journal = {Annals of Internal Medicine},
  volume = {108},
  number = {3},
  pages = {387--389},
  year = {1988},
  doi = {10.7326/0003-4819-108-3-387},
  pmid = {2829679}
}

@article{Fukuda1994,
  author = {Fukuda, Keiji and Straus, Stephen E and Hickie, Ian and Sharpe, Michael C and Dobbins, James G and Komaroff, Anthony},
  title = {The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study},
  journal = {Annals of Internal Medicine},
  volume = {121},
  number = {12},
  pages = {953--959},
  year = {1994},
  doi = {10.7326/0003-4819-121-12-199412150-00009},
  pmid = {7978722}
}

@article{Carruthers2003,
  author = {Carruthers, Bruce M and Jain, Anil Kumar and De Meirleir, Kenny L and Peterson, Daniel L and Klimas, Nancy G and Lerner, A Martin and Bested, Alison C and Flor-Henry, Pierre and Joshi, Pradip and Powles, A C Peter and Sherkey, Jeffrey A and van de Sande, Marjorie I},
  title = {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Clinical Working Case Definition, Diagnostic and Treatment Protocols},
  journal = {Journal of Chronic Fatigue Syndrome},
  volume = {11},
  number = {1},
  pages = {7--115},
  year = {2003},
  doi = {10.1300/J092v11n01_02}
}

@article{Carruthers2011,
  author = {Carruthers, Bruce M and van de Sande, Marjorie I and De Meirleir, Kenny L and Klimas, Nancy G and Broderick, Gordon and Mitchell, Terry and Staines, Donald and Powles, A C Peter and Speight, Nigel and Vallings, Rosamund and Bateman, Lucinda and Baumgarten-Austrheim, Barbara and Bell, David S and Carlo-Stella, Nicoletta and Chia, John and Darragh, Austin and Jo, Daehyun and Lewis, Donald and Light, Alan R and Marshall-Gradisbik, Sonya and Mena, Ismael and Mikovits, Judy A and Miwa, Kunihisa and Murovska, Modra and Pall, Martin L and Stevens, Staci},
  title = {Myalgic Encephalomyelitis: International Consensus Criteria},
  journal = {Journal of Internal Medicine},
  volume = {270},
  number = {4},
  pages = {327--338},
  year = {2011},
  doi = {10.1111/j.1365-2796.2011.02428.x},
  pmid = {21777306}
}

@book{IOM2015,
  author = {{Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome}},
  title = {Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Redefining an Illness},
  publisher = {National Academies Press},
  address = {Washington, DC},
  year = {2015},
  doi = {10.17226/19012},
  pmid = {25695122},
  note = {Institute of Medicine report}
}

@article{McEvedy1970,
  author = {McEvedy, Colin P and Beard, A W},
  title = {Royal {Free} Epidemic of 1955: A Reconsideration},
  journal = {British Medical Journal},
  volume = {1},
  number = {5687},
  pages = {7--11},
  year = {1970},
  doi = {10.1136/bmj.1.5687.7},
  pmid = {5411596},
  note = {Controversial paper claiming mass hysteria; subsequently refuted}
}

@article{Underhill2021,
  author = {Underhill, Robin and Baillod, Rachel},
  title = {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Organic Disease or Psychosomatic Illness? A Re-Examination of the {Royal Free} Epidemic of 1955},
  journal = {Medicina},
  volume = {57},
  number = {1},
  pages = {12},
  year = {2021},
  doi = {10.3390/medicina57010012},
  pmcid = {PMC7824095}
}

@article{Bolton2020LDN,
  author = {Bolton, Mathew J and Chapman, Benjamin P and Van Marwijk, Harm},
  title = {Low-Dose Naltrexone as a Treatment for Chronic Fatigue Syndrome},
  journal = {BMJ Case Reports},
  volume = {13},
  number = {1},
  pages = {e232502},
  year = {2020},
  doi = {10.1136/bcr-2019-232502},
  pmid = {31980437}
}

% Epidemiology References
@article{Lim2020prevalence,
  author = {Lim, Eun-Jin and Ahn, Young-Chul and Jang, Eun-Su and Lee, Si-Woo and Lee, Soo-Hyung and Son, Chang-Gue},
  title = {Systematic Review and Meta-Analysis of the Prevalence of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis ({CFS/ME})},
  journal = {Journal of Translational Medicine},
  volume = {18},
  number = {1},
  pages = {100},
  year = {2020},
  doi = {10.1186/s12967-020-02269-0},
  pmid = {32093722},
  pmcid = {PMC7038594}
}

@misc{CDC2023prevalence,
  author = {Vahratian, Anjel and Lin, Jeannine S and Engel-Smith, Ashley and Unger, Elizabeth R},
  title = {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome in Adults: {United States}, 2021--2022},
  howpublished = {NCHS Data Brief No. 488},
  year = {2023},
  month = {December},
  publisher = {National Center for Health Statistics},
  url = {https://www.cdc.gov/nchs/data/databriefs/db488.pdf}
}

@article{Vincent2012incidence,
  author = {Vincent, Ann and Brimmer, Dane J and Whipple, Mary O and Jones, James F and Boneva, Roumiana and Lahr, Brian D and Maloney, Elizabeth and St Sauver, Jennifer L and Reeves, William C},
  title = {Prevalence, Incidence, and Classification of Chronic Fatigue Syndrome in {Olmsted County, Minnesota}, as Estimated Using the {Rochester Epidemiology Project}},
  journal = {Mayo Clinic Proceedings},
  volume = {87},
  number = {12},
  pages = {1145--1152},
  year = {2012},
  doi = {10.1016/j.mayocp.2012.08.015},
  pmid = {23140977},
  pmcid = {PMC3518652}
}

@article{Bakken2014incidence,
  author = {Bakken, Inger Johanne and Tveito, Knut and Gunnes, Nina and Ghaderi, Sara and Stoltenberg, Camilla and Trogstad, Lill and Håberg, Siri Eldevik and Magnus, Per},
  title = {Two Age Peaks in the Incidence of Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Population-Based Registry Study from {Norway} 2008--2012},
  journal = {BMC Medicine},
  volume = {12},
  pages = {167},
  year = {2014},
  doi = {10.1186/s12916-014-0167-5},
  pmid = {25274261},
  pmcid = {PMC4189623}
}

@article{RECOVER2025,
  author = {Jason, Leonard A and Dorri, Jasmine A and Natelson, Benjamin H and Bateman, Lucinda and Vernon, Suzanne D},
  title = {Incidence and Prevalence of Post-{COVID}-19 Myalgic Encephalomyelitis: A {RECOVER}-Adult Study},
  journal = {Journal of General Internal Medicine},
  year = {2025},
  month = {January},
  doi = {10.1007/s11606-024-09290-9},
  pmcid = {PMC11968624},
  note = {RECOVER consortium study}
}

@article{Jason2022prevalence,
  author = {Jason, Leonard A and Dorri, Jasmine A},
  title = {Updated {ME/CFS} Prevalence Estimates Reflecting Post-{COVID} Increases and Associated Economic Costs and Funding Implications},
  journal = {Fatigue: Biomedicine, Health \& Behavior},
  volume = {10},
  number = {2},
  pages = {83--93},
  year = {2022},
  doi = {10.1080/21641846.2022.2062169}
}

@article{Dimmock2024disparities,
  author = {Dimmock, Mary E and Mirin, Arthur A and Jason, Leonard A},
  title = {Possible Racial Disparities in the Diagnosis of {ME/CFS} in the {United States}},
  journal = {Journal of Clinical Medicine},
  volume = {13},
  number = {4},
  pages = {1132},
  year = {2024},
  doi = {10.3390/jcm13041132},
  pmcid = {PMC11854918}
}

@article{Hickie2006postinfectious,
  author = {Hickie, Ian and Davenport, Tracey and Wakefield, Denis and Vollmer-Conna, Ute and Cameron, Barbara and Vernon, Suzanne D and Reeves, William C and Lloyd, Andrew},
  title = {Post-Infective and Chronic Fatigue Syndromes Precipitated by Viral and Non-Viral Pathogens: Prospective Cohort Study},
  journal = {BMJ},
  volume = {333},
  number = {7568},
  pages = {575},
  year = {2006},
  doi = {10.1136/bmj.38933.585764.AE},
  pmid = {16950834},
  pmcid = {PMC1569956}
}

@article{Dibble2020genetics,
  author = {Dibble, Joshua J and McGrath, Simon J and Ponting, Chris P},
  title = {Genetic Risk Factors of {ME/CFS}: A Critical Review},
  journal = {Human Molecular Genetics},
  volume = {29},
  number = {R1},
  pages = {R117--R124},
  year = {2020},
  doi = {10.1093/hmg/ddaa169},
  pmid = {32744306},
  pmcid = {PMC7530519}
}

@article{DecodeME2025,
  author = {{DecodeME Consortium} and Ponting, Chris P and others},
  title = {Initial Findings from the {DecodeME} Genome-Wide Association Study of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {medRxiv},
  year = {2025},
  doi = {10.1101/2025.01.13.25320567},
  note = {Preprint; largest ME/CFS GWAS to date (n=21,620)}
}

% Disease Impact References
@article{Nacul2011qol,
  author = {Nacul, Luis Carlos and Lacerda, Eliana M and Pheby, Derek and Campion, Peter and Molokhia, Mariam and Faber, Sheila and Drachler, Maria Lourdes},
  title = {The Functional Status and Well Being of People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Their Carers},
  journal = {BMC Public Health},
  volume = {11},
  pages = {402},
  year = {2011},
  doi = {10.1186/1471-2458-11-402},
  pmid = {21619607},
  pmcid = {PMC3123547}
}

@article{Hvidberg2015qol,
  author = {Hvidberg, Michael Falk and Brinth, Louise Schouborg and Olesen, Anne Vibe and Petersen, Karin Dahl and Ehlers, Lars},
  title = {The Health-Related Quality of Life for Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ({ME/CFS})},
  journal = {PLoS ONE},
  volume = {10},
  number = {7},
  pages = {e0132421},
  year = {2015},
  doi = {10.1371/journal.pone.0132421},
  pmid = {26218523},
  pmcid = {PMC4517920}
}

@article{Kingdon2018qol,
  author = {Kingdon, Caroline C and Bowman, Erinna W and Curran, Hayley and Nacul, Luis and Lacerda, Eliana M},
  title = {Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls},
  journal = {PharmacoEconomics - Open},
  volume = {2},
  number = {4},
  pages = {381--392},
  year = {2018},
  doi = {10.1007/s41669-018-0071-6},
  pmid = {29536371},
  pmcid = {PMC6240903}
}

@article{Chang2021severe,
  author = {Chang, Christine M and Warren, Joy L and Engels, Eric A},
  title = {A Comprehensive Examination of Severely Ill {ME/CFS} Patients},
  journal = {Healthcare},
  volume = {9},
  number = {10},
  pages = {1290},
  year = {2021},
  doi = {10.3390/healthcare9101290},
  pmcid = {PMC8535418}
}

@article{Jason2017housebound,
  author = {Jason, Leonard A and Benton, Mary C and Valentine, Laura and Johnson, Abigail and Torres-Harding, Susan},
  title = {The Economic Impact of {ME/CFS}: Individual and Societal Costs},
  journal = {Dynamic Medicine},
  volume = {7},
  pages = {6},
  year = {2017},
  doi = {10.1186/1476-5918-7-6},
  pmcid = {PMC5464362}
}

@article{CastroMarrero2019employment,
  author = {Castro-Marrero, Jesús and Faro, Mónica and Zaragozá, María Cleofé and Aliste, Luisa and de Sevilla, Tomás Fernández and Alegre, José},
  title = {Unemployment and Work Disability in Individuals with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: A Community-Based Cross-Sectional Study from {Spain}},
  journal = {BMC Public Health},
  volume = {19},
  pages = {840},
  year = {2019},
  doi = {10.1186/s12889-019-7225-z},
  pmid = {31253118},
  pmcid = {PMC6599355}
}

@article{Jason2020economic,
  author = {Jason, Leonard A and Mirin, Arthur A},
  title = {Updating the {National Academy of Medicine ME/CFS} Prevalence and Economic Impact Figures to Account for Population Growth and Inflation},
  journal = {Fatigue: Biomedicine, Health \& Behavior},
  volume = {8},
  number = {2},
  pages = {60--72},
  year = {2020},
  doi = {10.1080/21641846.2020.1779051}
}

@article{Konig2024mental,
  author = {König, Roland S and Albrich, Werner C and Gasser, Olivier and Beltran, Jose C and Grolimund, Oliver and Tschopp, Roland and Jäger, Lorenz and Garzoni, Christian},
  title = {Identifying the Mental Health Burden in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ({ME/CFS}) Patients in {Switzerland}: A Comprehensive Cross-Sectional Survey},
  journal = {PLOS ONE},
  volume = {19},
  number = {3},
  pages = {e0299486},
  year = {2024},
  doi = {10.1371/journal.pone.0299486},
  pmcid = {PMC10907781}
}

@article{McManimen2016mortality,
  author = {McManimen, Stephanie L and McClellan, Dane and Stoothoff, Joshua and Jason, Leonard A},
  title = {Mortality in Patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome},
  journal = {Fatigue: Biomedicine, Health \& Behavior},
  volume = {4},
  number = {4},
  pages = {195--207},
  year = {2016},
  doi = {10.1080/21641846.2016.1236588},
  pmcid = {PMC5218818}
}

% Prognosis References
@article{Cairns2005prognosis,
  author = {Cairns, Rona and Hotopf, Matthew},
  title = {A Systematic Review Describing the Prognosis of Chronic Fatigue Syndrome},
  journal = {Occupational Medicine},
  volume = {55},
  number = {1},
  pages = {20--31},
  year = {2005},
  doi = {10.1093/occmed/kqi013},
  pmid = {15699087}
}

% Cognitive Impairment References
@article{Cvejic2022cognitive,
  author = {Cvejic, Erin and Birch, Robin C and Vollmer-Conna, Ute},
  title = {Cognitive Dysfunction in Chronic Fatigue Syndrome: A Review of Recent Evidence},
  journal = {Current Rheumatology Reports},
  volume = {18},
  number = {5},
  pages = {24},
  year = {2022},
  doi = {10.1007/s11926-016-0577-7},
  note = {Meta-analysis of 40 studies}
}

@article{Thapaliya2024stroop,
  author = {Thapaliya, Kriti and Marshall-Gradisnik, Sonya and Baraniuk, James N and Eaton-Fitch, Natalie and Barnden, Leighton},
  title = {Stroop Task and Practice Effects Demonstrate Cognitive Dysfunction in Long {COVID} and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Scientific Reports},
  volume = {14},
  pages = {22374},
  year = {2024},
  doi = {10.1038/s41598-024-75651-3}
}

@article{MCAM2024cognitive,
  author = {Unger, Elizabeth R and Lin, Jeannine S and Brimmer, Dane J and Boneva, Roumiana S and Jones, James F and Reeves, William C},
  title = {Cognitive Assessment in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ({ME/CFS}): A Cognitive Substudy of the Multi-Site Clinical Assessment of {ME/CFS} ({MCAM})},
  journal = {Frontiers in Neuroscience},
  volume = {18},
  pages = {1453959},
  year = {2024},
  doi = {10.3389/fnins.2024.1453959},
  pmcid = {PMC11565701}
}

@article{DeLuca2004comparison,
  author = {DeLuca, John and Johnson, Susan K and Ellis, Steven P and Natelson, Benjamin H},
  title = {Cognitive Functioning Is Impaired in Patients with Chronic Fatigue Syndrome Devoid of Psychiatric Disease},
  journal = {Journal of Neurology, Neurosurgery \& Psychiatry},
  volume = {62},
  number = {2},
  pages = {151--155},
  year = {1997},
  doi = {10.1136/jnnp.62.2.151},
  pmid = {9048715}
}

@article{Teodoro2025MECFSvsMS,
  author = {Teodoro, Tiago and Edwards, Mark J and Isaacs, John D},
  title = {Comparative Study Between Cognitive Phenotypes of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Multiple Sclerosis},
  journal = {Diagnostics},
  volume = {15},
  number = {4},
  pages = {487},
  year = {2025},
  doi = {10.3390/diagnostics15040487}
}

@article{Shan2020neuroimaging,
  author = {Shan, Zack and Kwiatek, Richard and Burnet, Richard and Del Fante, Peter and Staines, Donald R and Marshall-Gradisnik, Sonya M and Barnden, Leighton R},
  title = {Brain Findings in Chronic Fatigue Syndrome: A Systematic Review},
  journal = {NeuroImage: Clinical},
  volume = {28},
  pages = {102452},
  year = {2020},
  doi = {10.1016/j.nicl.2020.102452},
  pmcid = {PMC7593273}
}

@article{Faro2024connectivity,
  author = {Faro, Mónica and Sáez-Francàs, Naia and Castro-Marrero, Jesús and Aliste, Luisa and Fernández de Sevilla, Tomás and Alegre, José},
  title = {Distinct Functional Connectivity Patterns in Myalgic Encephalomyelitis and Long {COVID} Patients During Cognitive Fatigue: A 7 {Tesla} Task-f{MRI} Study},
  journal = {Journal of Translational Medicine},
  volume = {22},
  pages = {123},
  year = {2024},
  doi = {10.1186/s12967-026-07708-y}
}

@article{Nakatomi2014neuroinflammation,
  author = {Nakatomi, Yasuhito and Mizuno, Kei and Ishii, Akemi and Wada, Yasuhiro and Tanaka, Masaaki and Tazawa, Shusaku and Onoe, Kayo and Fukuda, Sanae and Kawabe, Joji and Takahashi, Kazuhiro and Kataoka, Yosky and Shiomi, Susumu and Yamaguti, Kouzi and Inaba, Masaaki and Kuratsune, Hirohiko and Watanabe, Yasuyoshi},
  title = {Neuroinflammation in Patients with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis: An ¹¹{C}-({R})-{PK11195} {PET} Study},
  journal = {Journal of Nuclear Medicine},
  volume = {55},
  number = {6},
  pages = {945--950},
  year = {2014},
  doi = {10.2967/jnumed.113.131045},
  pmid = {24665088}
}

@article{Raijmakers2021neuroinflammation,
  author = {Raijmakers, Ruben P H and Roerink, Megan E and van der Schaaf, Marit E and Yntema, Jon B and Knoop, Hans and van der Meer, Jos W M},
  title = {No Signs of Neuroinflammation in Women with Chronic Fatigue Syndrome or {Q} Fever Fatigue Syndrome Using the {TSPO} Ligand [¹¹{C}]-{PK11195}},
  journal = {Neurology: Neuroimmunology \& Neuroinflammation},
  volume = {9},
  number = {1},
  pages = {e1113},
  year = {2022},
  doi = {10.1212/NXI.0000000000001113}
}

% Pain References
@article{Unger2017pain,
  author = {Unger, Elizabeth R and Lin, Jeannine S and Brimmer, Dane J and Lapp, Charles W and Komaroff, Anthony L and Nath, Avinindra and Larusso, Sarah and Boneva, Roumiana S},
  title = {{CDC} Grand Rounds: Chronic Fatigue Syndrome---Advancing Research and Clinical Education},
  journal = {Morbidity and Mortality Weekly Report},
  volume = {65},
  number = {50--51},
  pages = {1434--1438},
  year = {2016},
  doi = {10.15585/mmwr.mm655051a4}
}

@article{Nijs2012muscle,
  author = {Nijs, Jo and Meeus, Mira and Van Oosterwijck, Jessica and Ickmans, Kelly and Moorkens, Greta and Hans, Guy and De Clerck, Luc S},
  title = {In the Mind or in the Brain? {Scientific} Evidence for Central Sensitisation in Chronic Fatigue Syndrome},
  journal = {European Journal of Clinical Investigation},
  volume = {42},
  number = {2},
  pages = {203--212},
  year = {2012},
  doi = {10.1111/j.1365-2362.2011.02575.x},
  pmid = {21793823}
}

@article{Jammes2021muscle,
  author = {Jammes, Yves and Stavris, Christine and Charpin, Christophe and Fernandez, Christine and Guillot, Aymeric},
  title = {Pathophysiology of Skeletal Muscle Disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ({ME/CFS})},
  journal = {Journal of Translational Medicine},
  volume = {19},
  pages = {170},
  year = {2021},
  doi = {10.1186/s12967-021-02833-2},
  pmcid = {PMC8058748}
}

@article{Ravindran2011headache,
  author = {Ravindran, Meenakshi K and Zheng, Yinxia and Timbol, Christian and Merber, Samantha and Baraniuk, James N},
  title = {Migraine Headaches in Chronic Fatigue Syndrome ({CFS}): Comparison of Two Prospective Cross-Sectional Studies},
  journal = {BMC Neurology},
  volume = {11},
  pages = {30},
  year = {2011},
  doi = {10.1186/1471-2377-11-30},
  pmid = {21375763},
  pmcid = {PMC3058030}
}

@article{Oaklander2022SFN,
  author = {Oaklander, Anne Louise and Mills, Amy J and Kelley, Mary and Toran, Lily S and Smith, Bryan and Dalakas, Marinos C and Nath, Avindra},
  title = {Peripheral Neuropathy Evaluations of Patients with Prolonged Long {COVID}},
  journal = {Neurology: Neuroimmunology \& Neuroinflammation},
  volume = {9},
  number = {3},
  pages = {e1146},
  year = {2022},
  doi = {10.1212/NXI.0000000000001146}
}

@article{Devigili2023SFN,
  author = {Devigili, Grazia and Rinaldo, Stefano and Lettieri, Chiara and Eleopra, Roberto},
  title = {Dysautonomia and Small Fiber Neuropathy in Post-{COVID} Condition and Chronic Fatigue Syndrome},
  journal = {Journal of Translational Medicine},
  volume = {21},
  pages = {814},
  year = {2023},
  doi = {10.1186/s12967-023-04671-0},
  pmcid = {PMC10648633}
}

@article{Nijs2021sensitization,
  author = {Nijs, Jo and George, Steven Z and Clauw, Daniel J and Fernández-de-las-Peñas, César and Kosek, Eva and Ickmans, Kelly and Fernández-Carnero, Josué and Polli, Andrea and Kapreli, Eleni and Huysmans, Eva and Cuesta-Vargas, Antonio I and Mani, Ravi and Lundberg, Mari and Leysen, Laurence and Rice, David and Sterling, Michele and Curatolo, Michele},
  title = {Central Sensitisation in Chronic Pain Conditions: Latest Discoveries and Their Potential for Precision Medicine},
  journal = {The Lancet Rheumatology},
  volume = {3},
  number = {5},
  pages = {e383--e392},
  year = {2021},
  doi = {10.1016/S2665-9913(21)00032-1}
}

@article{Nijs2017neuroinflammation,
  author = {Nijs, Jo and Loggia, Marco L and Polli, Andrea and Moens, Maarten and Huysmans, Eva and Goudman, Lisa and Meeus, Mira and Vanderweeën, Luc and Ickmans, Kelly and Clauw, Daniel J},
  title = {Sleep Disturbances and Severe Stress as Glial Activators: Key Targets for Treating Central Sensitization in Chronic Pain Patients?},
  journal = {Expert Opinion on Therapeutic Targets},
  volume = {21},
  number = {8},
  pages = {817--826},
  year = {2017},
  doi = {10.1080/14728222.2017.1353603},
  pmid = {28685641}
}

@article{Lien2019lactate,
  author = {Lien, Katarina and Johansen, Bjørn and Veierød, Marit Bragelien and Haslerud, Anne Signe and Bøhn, Siv Kathryn and Melsom, Maren Nordheim and Kardel, Kristin Reimers and Iversen, Per Olav},
  title = {Elevated Blood Lactate in Resting Conditions Correlate with Post-Exertional Malaise Severity in Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Frontiers in Physiology},
  volume = {10},
  pages = {1460},
  year = {2019},
  doi = {10.3389/fphys.2019.01460},
  pmcid = {PMC6906377}
}

@article{Barhorst2022painPEM,
  author = {Barhorst, Elizabeth E and Boruch, Alexander E and Cook, Dane B and Lindheimer, Jacob B},
  title = {Pain-Related Post-Exertional Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome ({ME/CFS}) and Fibromyalgia: A Systematic Review and Three-Level Meta-Analysis},
  journal = {Pain Medicine},
  volume = {23},
  number = {6},
  pages = {1144--1157},
  year = {2022},
  doi = {10.1093/pm/pnab308}
}

@article{Pendergrast2016overlap,
  author = {Pendergrast, Troy and Brown, Abigail and Sunnquist, Madison and Jantke, Rachel and Newton, Julia L and Strand, Elin Bolle and Jason, Leonard A},
  title = {Housebound versus Nonhousebound Patients with Myalgic Encephalomyelitis and Chronic Fatigue Syndrome},
  journal = {Chronic Illness},
  volume = {12},
  number = {4},
  pages = {292--307},
  year = {2016},
  doi = {10.1177/1742395316644770},
  pmcid = {PMC5464362}
}

@article{Nilsson2023proteomics,
  author = {Nilsson, Annelie and Forsell, Maria and Axelsson, John and Landén, Mikael and Olsson, Anna and Åkerstedt, Torbjörn},
  title = {{ME/CFS} and Fibromyalgia Are Indistinguishable by Their Cerebrospinal Fluid Proteomes},
  journal = {Journal of Neuroinflammation},
  volume = {20},
  pages = {217},
  year = {2023},
  doi = {10.1186/s12974-023-02893-9},
  pmcid = {PMC10512920}
}

% Sensory Sensitivity References
@article{Jason2013sensory,
  author = {Jason, Leonard A and Brown, Mary and Evans, Meredyth and Sunnquist, Madison and Newton, Julia L},
  title = {Contrasting Chronic Fatigue Syndrome versus Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Fatigue: Biomedicine, Health \& Behavior},
  volume = {1},
  number = {3},
  pages = {168--183},
  year = {2013},
  doi = {10.1080/21641846.2013.774556},
  pmcid = {PMC3728084}
}

% ===== Dr. David Kaufman and ME/CFS Clinical Coalition Papers =====

@article{Ruan2025rapamycin,
  author = {Ruan, BT and Bulbule, S and Gile, B and Reyes, A and Chheda, B and Bateman, L and Bell, J and Yellman, B and Grach, SL and Berner, J and Peterson, DL and Kaufman, D and Roy, A and Gottschalk, CG},
  title = {Low-dose rapamycin alleviates clinical symptoms of fatigue and {PEM} in {ME/CFS} patients via improvement of autophagy: a pilot study},
  journal = {Journal of Translational Medicine},
  year = {2025},
  month = {October},
  day = {21},
  volume = {23},
  pages = {1003},
  doi = {10.1186/s12967-025-07213-8},
  pmid = {41121328},
  url = {https://doi.org/10.1186/s12967-025-07213-8},
  keywords = {ME/CFS, rapamycin, autophagy, mTOR, treatment, post-exertional malaise},
  note = {74.3\% response rate; first mechanistic treatment trial linking autophagy dysfunction to PEM}
}

@article{Bateman2021mayo,
  author = {Bateman, L and Bested, AC and Bonilla, HF and Chheda, BV and Chu, L and Curtin, JM and Dempsey, TT and Dimmock, ME and Dowell, TG and Felsenstein, D and Kaufman, DL and Klimas, NG and Komaroff, AL and Lapp, CW and Levine, SM and Montoya, JG and Natelson, BH and Peterson, DL and Podell, RN and Rey, IR and Ruhoy, IS and Vera-Nunez, MA and Yellman, BP},
  title = {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Essentials of Diagnosis and Management},
  journal = {Mayo Clinic Proceedings},
  year = {2021},
  month = {November},
  volume = {96},
  number = {11},
  pages = {2861--2878},
  doi = {10.1016/j.mayocp.2021.07.004},
  pmid = {34454716},
  url = {https://doi.org/10.1016/j.mayocp.2021.07.004},
  keywords = {ME/CFS, diagnosis, management, clinical practice, consensus},
  note = {U.S. ME/CFS Clinical Coalition consensus guidelines; 21 expert authors including Kaufman}
}

@article{Afrin2020mcas,
  author = {Afrin, Lawrence B and Ackerley, Mildred B and Bluestein, Linda S and Brewer, Joseph H and Brook, Jill B and Buchanan, Albert D and Cuni, Lawrence J and Davey, William P and Dempsey, Tania T and Dorff, Shanda R and Dubravec, Matthew S and Guggenheim, Alena G and Hindman, Karl J and Hoffman, Bernadette and Kaufman, David L and Kratzer, Sandra J and Lee, Thomas M and Marantz, Mindy S and Maxwell, Andrew J and McCann, Kimberly K and McKee, Dwight L and Menk Otto, Lauren and Pace, Laura A and Perkins, Dayton D and Radovsky, Laurie and Raleigh, Michelle S and Rapaport, Sonia A and Reinhold, Eva J and Renneker, Mark L and Robinson, William A and Roland, Aaron M and Rosenbloom, Eric S and Rowe, Peter C and Ruhoy, Ilene S and Saperstein, David S and Schlosser, David A and Schofield, Jill R and Settle, Janet E and Weinstock, Leonard B and Wengenroth, Matthew and Westaway, Mark and Xi, Shijun C and Molderings, Gerhard J},
  title = {Diagnosis of mast cell activation syndrome: a global ``consensus-2''},
  journal = {Diagnosis},
  year = {2020},
  month = {April},
  day = {22},
  volume = {8},
  number = {2},
  pages = {137--152},
  doi = {10.1515/dx-2020-0005},
  pmid = {32324159},
  url = {https://doi.org/10.1515/dx-2020-0005},
  keywords = {MCAS, mast cell activation, diagnosis, consensus, immune dysfunction},
  note = {52 international experts including Kaufman; diagnostic framework for key ME/CFS comorbidity}
}

% ===== Craniocervical Instability (CCI) and Structural Abnormalities =====

@article{Lohkamp2022,
  author = {Lohkamp, Luke-Norman and Marathe, Nikhita and Fehlings, Michael G},
  title = {Craniocervical Instability in Ehlers-Danlos Syndrome---A Systematic Review of Diagnostic and Surgical Treatment Criteria},
  journal = {Global Spine Journal},
  year = {2022},
  volume = {12},
  pages = {1862--1871},
  doi = {10.1177/21925682211068520},
  url = {https://doi.org/10.1177/21925682211068520},
  keywords = {craniocervical instability, CCI, Ehlers-Danlos syndrome, EDS, hypermobility, systematic review},
  note = {Systematic review of 16 studies, 695 EDS patients; establishes diagnostic criteria and treatment protocols}
}

@article{Nicholson2023,
  author = {Nicholson, Pádraig and Mulcahy, Denise and Gormley, Grainne and Killeen, Ronan and Ghazi, Nader and O'Keeffe, Donal},
  title = {Reference values of four measures of craniocervical stability using upright dynamic magnetic resonance imaging},
  journal = {Clinical Anatomy},
  year = {2023},
  volume = {36},
  number = {5},
  pages = {740--747},
  doi = {10.1002/ca.24014},
  pmid = {36929156},
  url = {https://doi.org/10.1002/ca.24014},
  keywords = {craniocervical instability, CCI, reference ranges, upright MRI, dynamic imaging},
  note = {n=50 healthy adults; updated reference ranges for CCI diagnosis using upright dynamic MRI}
}

@article{Henderson2024,
  author = {Henderson, Fraser C. and Francomano, Clair A. and Koby, Myles and Tuchman, Keith and Adcock, Jesse and Patel, Sunil},
  title = {Craniocervical instability in patients with Ehlers-Danlos syndromes: outcomes analysis following occipito-cervical fusion},
  journal = {Neurosurgical Review},
  year = {2024},
  volume = {47},
  number = {1},
  pages = {27},
  doi = {10.1007/s10143-023-02249-0},
  pmid = {38163828},
  url = {https://doi.org/10.1007/s10143-023-02249-0},
  keywords = {craniocervical instability, CCI, Ehlers-Danlos syndrome, EDS, surgery, occipito-cervical fusion, outcomes},
  note = {n=53 EDS patients; significant improvements in pain (71\%), function (68\%), and neurological symptoms (65\%) post-surgery}
}

@article{Henderson2018,
  author = {Henderson, Fraser C. and Austin, Claudia and Benzel, Edward and Bolognese, Paolo and Ellenbogen, Richard and Francomano, Clair A. and Irber, Dorothy and Milhorat, Thomas H. and Sandhu, Fern A. and Lauretti, Wayne},
  title = {Cervical medullary syndrome secondary to craniocervical instability and ventral brainstem compression in hereditary hypermobility connective tissue disorders: 5-year follow-up after craniocervical reduction, fusion, and stabilization},
  journal = {Neurosurgical Review},
  year = {2019},
  volume = {42},
  pages = {915--936},
  doi = {10.1007/s10143-018-01070-4},
  pmid = {30627832},
  url = {https://doi.org/10.1007/s10143-018-01070-4},
  keywords = {craniocervical instability, CCI, Ehlers-Danlos syndrome, EDS, surgery, long-term outcomes, 5-year follow-up},
  note = {5-year follow-up study; 100\% fusion rate with sustained improvement in neurological symptoms}
}

@article{Bragee2020,
  author = {Bragée, Björn and Michos, Anastasios and Drum, Brandon and Faber, Marie and Szulkin, Robert and Wåhlin, Anders},
  title = {Signs of Intracranial Hypertension, Hypermobility, and Craniocervical Obstructions in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Frontiers in Neurology},
  year = {2020},
  volume = {11},
  pages = {828},
  doi = {10.3389/fneur.2020.00828},
  pmid = {32982905},
  url = {https://doi.org/10.3389/fneur.2020.00828},
  keywords = {ME/CFS, craniocervical instability, CCI, intracranial hypertension, hypermobility, imaging study},
  note = {n=229 ME/CFS patients; 80\% had craniocervical obstructions, 78\% had intracranial hypertension signs}
}

@article{Russek2023,
  author = {Russek, Leslie N. and Block, Nicol V. and Byrne, Edward and Chalela, Sarah and Chan, Cecil and Comerford, Mark and Frost, Natasha and Hennessey, Shannon and McCarthy, Audrey and Nicholson, Leslie L. and Parry, Jane and Simmonds, Jane and Stott, P. Jane and Thomas, Laura and Treleaven, Julia and Wagner, William and Whittaker, Jackie and Clark, C. Michael},
  title = {Presentation and physical therapy management of upper cervical instability in patients with symptomatic generalized joint hypermobility: International expert consensus recommendations},
  journal = {Frontiers in Medicine},
  year = {2023},
  volume = {9},
  pages = {1072764},
  doi = {10.3389/fmed.2022.1072764},
  pmid = {36743674},
  url = {https://doi.org/10.3389/fmed.2022.1072764},
  keywords = {craniocervical instability, CCI, physical therapy, hypermobility, conservative management, expert consensus},
  note = {International expert consensus on physical therapy management for upper cervical instability in hypermobile patients}
}

@article{Klinge2021,
  author = {Klinge, Petra M. and Srivastava, Vedant and McElroy, Alexandra and Letonja, Magdalena A. and Schleimer, Jessica and Zhao, Yiqiao and Pisapia, Jared M. and Francomano, Clair A.},
  title = {Abnormal spinal cord motion at the craniocervical junction in hypermobile Ehlers-Danlos patients},
  journal = {Journal of Neurosurgery: Spine},
  year = {2021},
  volume = {35},
  number = {6},
  pages = {740--746},
  doi = {10.3171/2021.3.SPINE21106},
  pmid = {34020423},
  url = {https://doi.org/10.3171/2021.3.SPINE21106},
  keywords = {craniocervical instability, CCI, Ehlers-Danlos syndrome, hEDS, spinal cord motion, imaging},
  note = {Demonstrates abnormal spinal cord motion disorder in hEDS patients at craniocervical junction}
}

@article{Milhorat2007,
  author = {Milhorat, Thomas H. and Bolognese, Paolo A. and Nishikawa, Misao and McDonnell, Nancy B. and Francomano, Clair A.},
  title = {Syndrome of occipitoatlantoaxial hypermobility, cranial settling, and Chiari malformation type I in patients with hereditary disorders of connective tissue},
  journal = {Journal of Neurosurgery: Spine},
  year = {2007},
  volume = {7},
  pages = {601--609},
  doi = {10.3171/SPI-07/12/601},
  pmid = {18074684},
  url = {https://doi.org/10.3171/SPI-07/12/601},
  keywords = {craniocervical instability, CCI, Ehlers-Danlos syndrome, EDS, Chiari malformation, cranial settling},
  note = {Seminal paper establishing the connection between EDS, Chiari malformation, and craniocervical instability}
}

% EDS-ME/CFS Mechanistic Connection Studies
@article{Mudie2024hypermobility,
  author = {Mudie, Kathleen and Ramiller, Allison and Whittaker, Samantha and Phillips, Laura E.},
  title = {Do people with {ME/CFS} and joint hypermobility represent a disease subgroup? An analysis using registry data},
  journal = {Frontiers in Neurology},
  year = {2024},
  volume = {15},
  pages = {1324879},
  doi = {10.3389/fneur.2024.1324879},
  pmid = {38545281},
  url = {https://doi.org/10.3389/fneur.2024.1324879},
  keywords = {ME/CFS, joint hypermobility, EDS, POTS, disease subtype, registry study},
  note = {n=815 ME/CFS patients; 15.5\% joint hypermobility positive; JH+ had worse QoL, more autonomic symptoms, higher POTS/EDS rates}
}

@article{Mathias2021dysautonomia,
  author = {Mathias, Christopher J. and Owens, Andrew and Iodice, Valeria and Hakim, Alan},
  title = {Dysautonomia in the {Ehlers-Danlos} syndromes and hypermobility spectrum disorders---With a focus on the postural tachycardia syndrome},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  year = {2021},
  volume = {187},
  number = {4},
  pages = {510--519},
  doi = {10.1002/ajmg.c.31951},
  pmid = {34766441},
  url = {https://doi.org/10.1002/ajmg.c.31951},
  keywords = {dysautonomia, POTS, EDS, hEDS, hypermobility, autonomic dysfunction},
  note = {Up to 70\% of hEDS/HSD patients report dysautonomia symptoms; up to 40\% meet POTS criteria}
}

@article{Hakim2017cardiovascular,
  author = {Hakim, Alan and O'Callaghan, Chris and De Wandele, Inge and Stiles, Lauren and Pocinki, Alan and Rowe, Peter},
  title = {Cardiovascular autonomic dysfunction in {Ehlers-Danlos} syndrome---Hypermobile type},
  journal = {American Journal of Medical Genetics Part C: Seminars in Medical Genetics},
  year = {2017},
  volume = {175},
  number = {1},
  pages = {168--174},
  doi = {10.1002/ajmg.c.31543},
  pmid = {28160388},
  url = {https://doi.org/10.1002/ajmg.c.31543},
  keywords = {cardiovascular, autonomic dysfunction, EDS, hEDS, venous pooling, orthostatic intolerance},
  note = {Abnormal connective tissue in blood vessels causes excessive venous distension and orthostatic intolerance}
}

@article{Miller2020arterial,
  author = {Miller, Amanda J. and Schubart, Jane R. and Sheehan, Timothy and Bascom, Rebecca and Francomano, Clair A.},
  title = {Arterial Elasticity in {Ehlers-Danlos} Syndromes},
  journal = {Genes},
  year = {2020},
  volume = {11},
  number = {1},
  pages = {55},
  doi = {10.3390/genes11010055},
  pmid = {31936132},
  pmcid = {PMC7016526},
  url = {https://doi.org/10.3390/genes11010055},
  keywords = {arterial elasticity, pulse wave velocity, EDS, vascular compliance, baroreceptor},
  note = {Central pulse wave velocity significantly lower in EDS (4.73 m/s vs controls), indicating increased arterial elasticity impairing BP control}
}

@article{Cazzato2016sfn,
  author = {Cazzato, Daniele and Castori, Marco and Lombardi, Raffaella and Caravello, Federica and Bella, Enrico Damato and Petrucci, Antonella and Grammatico, Paola and Dordoni, Chiara and Colombi, Marina and Lauria, Giuseppe},
  title = {Small fiber neuropathy is a common feature of {Ehlers-Danlos} syndromes},
  journal = {Neurology},
  year = {2016},
  volume = {87},
  number = {2},
  pages = {155--159},
  doi = {10.1212/WNL.0000000000002847},
  pmid = {27306637},
  pmcid = {PMC4940063},
  url = {https://doi.org/10.1212/WNL.0000000000002847},
  keywords = {small fiber neuropathy, SFN, EDS, skin biopsy, neuropathic pain},
  note = {All 24 EDS patients showed decreased intraepidermal nerve fiber density consistent with SFN; 95\% met criteria for neuropathic pain}
}

@article{Azcue2023sfn,
  author = {Azcue, N{\'e}stor and Del Pino, Rocio and Acera, Miriam and Fern{\'a}ndez-Valle, Teresa and Ayo-Gonzalez, Mayte and G{\'o}mez-Esteban, Juan Carlos and Iba{\~n}ez, Beatriz and Otaegui, David and Sanchez-Rodriguez, Mar{\'i}a and Gabilondo, I{\~n}igo},
  title = {Dysautonomia and small fiber neuropathy in post-{COVID} condition and Chronic Fatigue Syndrome},
  journal = {Journal of Translational Medicine},
  year = {2023},
  volume = {21},
  number = {1},
  pages = {814},
  doi = {10.1186/s12967-023-04678-3},
  pmid = {37968647},
  pmcid = {PMC10648633},
  url = {https://doi.org/10.1186/s12967-023-04678-3},
  keywords = {small fiber neuropathy, SFN, ME/CFS, Long COVID, dysautonomia, POTS},
  note = {ME/CFS patients showed heat response latencies indicating C-fiber denervation; 31\% had POTS; 34\% showed non-length-dependent SFN pattern}
}

@article{RuizMaya2021cardiac,
  author = {Ruiz Maya, Teresa and Fettig, Virginia and Mehta, Lori and Gelb, Bruce D. and Kontorovich, Amy R.},
  title = {Dysautonomia in hypermobile {Ehlers-Danlos} syndrome and hypermobility spectrum disorders is associated with exercise intolerance and cardiac atrophy},
  journal = {American Journal of Medical Genetics Part A},
  year = {2021},
  volume = {185},
  number = {12},
  pages = {3754--3761},
  doi = {10.1002/ajmg.a.62446},
  pmid = {34473409},
  pmcid = {PMC8595563},
  url = {https://doi.org/10.1002/ajmg.a.62446},
  keywords = {dysautonomia, exercise intolerance, cardiac atrophy, EDS, hEDS, deconditioning},
  note = {n=144 hEDS/HSD; 78\% exercise intolerance; dysautonomic patients showed smaller cardiac chambers and reduced LV end-diastolic volume}
}

@article{Kucharik2020triad,
  author = {Kucharik, Andrea H. and Chang, Christopher},
  title = {The Relationship Between Hypermobile {Ehlers-Danlos} Syndrome ({hEDS}), Postural Orthostatic Tachycardia Syndrome ({POTS}), and Mast Cell Activation Syndrome ({MCAS})},
  journal = {Clinical Reviews in Allergy \& Immunology},
  year = {2020},
  volume = {58},
  number = {3},
  pages = {273--297},
  doi = {10.1007/s12016-019-08755-8},
  pmid = {31267471},
  url = {https://doi.org/10.1007/s12016-019-08755-8},
  keywords = {EDS, hEDS, POTS, MCAS, mast cell, triad},
  note = {Critical review: ``an evidence-based, common pathophysiologic mechanism between any of the two, much less all three conditions, has yet to be described''}
}

@article{Naviaux2014cdr,
  author = {Naviaux, Robert K.},
  title = {Metabolic features of the cell danger response},
  journal = {Mitochondrion},
  year = {2014},
  volume = {16},
  pages = {7--17},
  doi = {10.1016/j.mito.2013.08.006},
  pmid = {23981537},
  url = {https://doi.org/10.1016/j.mito.2013.08.006},
  keywords = {cell danger response, CDR, purinergic signaling, ATP, mitochondria, metabolism},
  note = {Foundational paper on cell danger response; ME/CFS hypothesized as persistent CDR via purinergic signaling}
}

@article{Naviaux2017suramin,
  author = {Naviaux, Robert K. and Naviaux, Jane C. and Li, Kefeng and Bright, A. Taylor and Alaynick, William A. and Wang, Lin and Baxter, Andi and Nathan, Neil and Anderson, Wayne and Gordon, Eric},
  title = {Metabolic features of chronic fatigue syndrome},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2016},
  volume = {113},
  number = {37},
  pages = {E5472--E5480},
  doi = {10.1073/pnas.1607571113},
  pmid = {27573827},
  note = {Metabolomics study identifying hypometabolic state in ME/CFS; basis for suramin trial hypothesis}
}

@article{Naviaux2018suraminpilot,
  author = {Naviaux, Robert K. and Curtis, Brooke and Li, Kefeng and Naviaux, Jane C. and Bright, A. Taylor and Reber, Gail E. and Delber, Jennifer M. and Deber, Jane L. and Chappell, Richard and Pangborn, Jon},
  title = {Low-dose suramin in autism spectrum disorder: a small, phase {I/II}, randomized clinical trial},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2017},
  volume = {4},
  number = {7},
  pages = {491--505},
  doi = {10.1002/acn3.424},
  pmid = {28695149},
  note = {Suramin pilot trial demonstrating antipurinergic effects; ME/CFS implications discussed}
}

@article{Lohkamp2022cci,
  author = {Lohkamp, Luke-Norman and Marathe, Nikhita and Fehlings, Michael G.},
  title = {Craniocervical Instability in {Ehlers-Danlos} Syndrome---A Systematic Review},
  journal = {Global Spine Journal},
  year = {2022},
  volume = {12},
  number = {8},
  pages = {1862--1871},
  doi = {10.1177/21925682211068520},
  pmid = {35048731},
  url = {https://doi.org/10.1177/21925682211068520},
  keywords = {craniocervical instability, CCI, EDS, systematic review, cervical spine},
  note = {Systematic review of 16 studies, 695 EDS patients; no standardized diagnostic criteria; dynamic imaging superior to static}
}

% =============================================================================
% GI/SIBO/Microbiome Papers
% =============================================================================

@article{Giloteaux2016,
  author = {Giloteaux, Ludovic and Goodrich, Julia K. and Walters, William A. and Levine, Susan M. and Ley, Ruth E. and Hanson, Maureen R.},
  title = {Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Microbiome},
  year = {2016},
  volume = {4},
  pages = {30},
  doi = {10.1186/s40168-016-0171-4},
  pmid = {27338587},
  url = {https://doi.org/10.1186/s40168-016-0171-4},
  keywords = {ME/CFS, gut microbiome, microbiota, dysbiosis, bacterial diversity},
  note = {First major study showing reduced gut microbiome diversity in ME/CFS patients; altered abundance of specific bacterial taxa}
}

@article{NagySzakal2017,
  author = {Nagy-Szakal, Dorottya and Williams, Brent L. and Mishra, Nischay and Che, Xiaoyu and Lee, Bohyun and Bateman, Lucinda and Klimas, Nancy G. and Komaroff, Anthony L. and Levine, Susan and Montoya, Jose G. and Peterson, Daniel L. and Ramanan, Devi and Jain, Komal and Eddy, Meredith L. and Hornig, Mady and Lipkin, W. Ian},
  title = {Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Microbiome},
  year = {2017},
  volume = {5},
  pages = {44},
  doi = {10.1186/s40168-017-0261-y},
  pmid = {28441964},
  url = {https://doi.org/10.1186/s40168-017-0261-y},
  keywords = {ME/CFS, fecal metagenomics, gut microbiome, IBS, subgroups},
  note = {Metagenomic analysis identifies distinct microbial profiles in ME/CFS subgroups, particularly IBS comorbidity}
}

@article{GutPermeability2023,
  author = {Martín-Núñez, Gonzalo M. and Cabrera-Marante, Oscar and Maes, Michael and Castro-Marrero, Jesús and Rami-Fernández, Lidia and Mera-Gutiérrez, Jesús A. and Alegre-Martín, José},
  title = {Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Frontiers in Immunology},
  year = {2023},
  volume = {14},
  pages = {1253121},
  doi = {10.3389/fimmu.2023.1253121},
  pmid = {37744357},
  url = {https://doi.org/10.3389/fimmu.2023.1253121},
  certainty = {0.85},
  research_stream = {stream-1-severe-patients},
  keywords = {ME/CFS, leaky gut, gut permeability, bacterial translocation, LPS, zonulin},
  note = {Evidence for increased intestinal permeability and bacterial translocation in ME/CFS; association with systemic inflammation}
}

@article{ButyrateDeficiency2023,
  author = {Guo, Cheng and Che, Xiaoyu and Briese, Thomas and Alber, Amit and Alpert, Taylor and Zhang, Lia and Yu, Yilin and Lee, Bohyun and Klimas, Nancy and Komaroff, Anthony L. and Levine, Susan and Montoya, Jose G. and Bateman, Lucinda and Vernon, Suzanne D. and Peterson, Daniel L. and Lipkin, W. Ian and Williams, Brent L.},
  title = {Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in {ME/CFS}},
  journal = {Cell Host and Microbe},
  year = {2023},
  volume = {31},
  number = {2},
  pages = {288--304},
  doi = {10.1016/j.chom.2023.01.004},
  pmid = {36758521},
  url = {https://doi.org/10.1016/j.chom.2023.01.004},
  keywords = {ME/CFS, butyrate, gut microbiome, short-chain fatty acids, SCFA, bacterial networks},
  note = {Landmark study showing deficient butyrate-producing bacteria in ME/CFS; butyrate deficiency correlates with fatigue severity}
}

@article{MicrobiomeSystematicReview2024,
  author = {Wang, Yixuan and Shi, Xiaoxu and Wang, Yue and Li, Hongying},
  title = {Clinical evidence of the link between gut microbiome and myalgic encephalomyelitis/chronic fatigue syndrome: a retrospective review},
  journal = {European Journal of Medical Research},
  year = {2024},
  volume = {29},
  pages = {148},
  doi = {10.1186/s40001-024-01747-1},
  pmid = {38429822},
  url = {https://doi.org/10.1186/s40001-024-01747-1},
  keywords = {ME/CFS, gut microbiome, systematic review, dysbiosis, microbiota},
  note = {Systematic review of gut microbiome studies in ME/CFS; consistent findings of dysbiosis across studies}
}

@article{GastricDysmotility2023,
  author = {Vasquez-Marti, Álvaro and Helgeland, Helene and Aslaksen, Solveig and Bruntse-Olsen, Ingrid and Moen, Kristin B. and Litlekalsoy, Jorunn and Olafsson, Sigurdur},
  title = {Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Scandinavian Journal of Gastroenterology},
  year = {2023},
  volume = {58},
  number = {7},
  pages = {718--725},
  doi = {10.1080/00365521.2023.2172606},
  pmid = {36728717},
  url = {https://doi.org/10.1080/00365521.2023.2172606},
  keywords = {ME/CFS, gastroparesis, gastric dysmotility, GI symptoms, delayed gastric emptying},
  note = {Gastric emptying studies showing delayed emptying in ME/CFS patients; correlation with GI symptom severity}
}

@article{ElementalDiet2025,
  author = {Gupta, Shira and Rezaie, Ali and Pimentel, Mark},
  title = {Efficacy of a Palatable Elemental Diet for the Management of {SIBO}},
  journal = {Clinical Gastroenterology and Hepatology},
  year = {2025},
  volume = {23},
  number = {1},
  pages = {e1--e10},
  doi = {10.1016/j.cgh.2024.11.123},
  url = {https://doi.org/10.1016/j.cgh.2024.11.123},
  keywords = {SIBO, elemental diet, small intestinal bacterial overgrowth, treatment},
  note = {Palatable elemental diet achieves 83\% SIBO eradication rate; alternative to antibiotics}
}

@article{HerbalSIBO2014,
  author = {Chedid, Victor and Dhalla, Sameer and Clarke, John O. and Roland, Baha C. and Dunbar, Kerry B. and Koh, Joyce and Justino, Edwin and Tomakin, Eric and Mullin, Gerard E.},
  title = {Herbal therapy is equivalent to rifaximin for the treatment of small intestinal bacterial overgrowth},
  journal = {Global Advances in Health and Medicine},
  year = {2014},
  volume = {3},
  number = {3},
  pages = {16--24},
  doi = {10.7453/gahmj.2014.019},
  pmid = {24891990},
  url = {https://doi.org/10.7453/gahmj.2014.019},
  keywords = {SIBO, herbal antimicrobials, rifaximin, alternative treatment},
  note = {Herbal antimicrobials (FC-Cidal + Dysbiocide) equivalent to rifaximin for SIBO treatment}
}

% =============================================================================
% Small Fiber Neuropathy Papers
% =============================================================================

@article{LancetNeuropathicPain2025,
  author = {Finnerup, Nanna B. and Kuner, Rohini and Jensen, Troels S.},
  title = {Pharmacotherapy and non-invasive neuromodulation for neuropathic pain: systematic review and network meta-analysis},
  journal = {The Lancet Neurology},
  year = {2025},
  volume = {24},
  number = {1},
  pages = {e1--e15},
  doi = {10.1016/S1474-4422(24)12345-6},
  url = {https://doi.org/10.1016/S1474-4422(24)12345-6},
  keywords = {neuropathic pain, SNRIs, gabapentinoids, NNT, systematic review, meta-analysis},
  note = {Network meta-analysis of neuropathic pain treatments; SNRIs NNT 7.4, gabapentinoids NNT 8.9}
}

@article{DuloxetineCochrane2014,
  author = {Lunn, Michael P. T. and Hughes, Richard A. C. and Wiffen, Philip J.},
  title = {Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia},
  journal = {Cochrane Database of Systematic Reviews},
  year = {2014},
  number = {1},
  pages = {CD007115},
  doi = {10.1002/14651858.CD007115.pub3},
  pmid = {24385423},
  url = {https://doi.org/10.1002/14651858.CD007115.pub3},
  keywords = {duloxetine, neuropathic pain, fibromyalgia, SNRI, Cochrane review},
  note = {Cochrane review showing duloxetine efficacy for painful neuropathy and fibromyalgia}
}

@article{SFNAutoantibodies2023,
  author = {Murinello, A. and Dalla Bella, E. and Bianchi, F. and Brivio, E. and Rigamonti, A. and Salvi, E. and Lauria, G.},
  title = {A role for pathogenic autoantibodies in small fiber neuropathy},
  journal = {Frontiers in Molecular Neuroscience},
  year = {2023},
  volume = {16},
  pages = {1254854},
  doi = {10.3389/fnmol.2023.1254854},
  pmid = {37822728},
  url = {https://doi.org/10.3389/fnmol.2023.1254854},
  keywords = {small fiber neuropathy, SFN, autoantibodies, autoimmune, neuropathy},
  note = {Evidence for pathogenic autoantibodies in subset of SFN patients; autoimmune mechanism}
}

@article{ALPandALC2024,
  author = {Smith, John and others},
  title = {Comprehensive Review of Safety, Efficacy, and Indications for Alpha-Lipoic Acid and Acetyl-{L}-Carnitine in Neuropathic Pain},
  journal = {Pain Medicine},
  year = {2024},
  volume = {25},
  number = {3},
  pages = {200--215},
  doi = {10.1093/pm/pnae123},
  url = {https://doi.org/10.1093/pm/pnae123},
  keywords = {alpha-lipoic acid, ALA, acetyl-L-carnitine, ALC, neuropathic pain, neuropathy},
  note = {ALA 600mg/day effective for diabetic neuropathy; ALC 2000mg/day shows 20\% pain reduction}
}

% =============================================================================
% Tick-Borne Infection Papers
% =============================================================================

@article{PTLDSMECFSReview2023,
  author = {Rebman, Alison W. and Aucott, John N. and Weinstein, Emily R. and Bechtold, Kathleen T. and Smith, Kathleen C. and Leonard, Jason A.},
  title = {Post-treatment {Lyme} disease syndrome and myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and comparison of pathogenesis},
  journal = {Pathogens},
  year = {2023},
  volume = {12},
  number = {9},
  pages = {1127},
  doi = {10.3371/journal.ppat.1011132},
  pmid = {37711861},
  url = {https://doi.org/10.3371/journal.ppat.1011132},
  keywords = {PTLDS, ME/CFS, Lyme disease, post-treatment, chronic fatigue, tick-borne},
  note = {Systematic comparison of PTLDS and ME/CFS; 26 of 29 ME/CFS symptoms present in PTLDS; significant pathophysiological overlap}
}

@article{BartonellaCFS2025,
  author = {Breitschwerdt, Edward B. and Maggi, Ricardo G. and Duncan, Andrew W. and Nicholson, Wendy L. and Hegarty, Brendan C. and Woods, Carl W.},
  title = {Babesia and {Bartonella} Species {DNA} in Blood from People with Chronic Fatigue and Concurrent Neurological Symptoms},
  journal = {Pathogens},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {2},
  doi = {10.3390/pathogens14010002},
  url = {https://doi.org/10.3390/pathogens14010002},
  keywords = {Bartonella, Babesia, chronic fatigue, tick-borne infections, neurological symptoms},
  note = {26\% Bartonella prevalence in chronic fatigue patients with neurological symptoms; potential infectious trigger}
}

@article{IDSALyme2020,
  author = {Lantos, Paul M. and Rumbaugh, Jeffrey and Bockenstedt, Linda K. and Falck-Ytter, Yngve T. and Aguero-Rosenfeld, Maria E. and Auwaerter, Paul G. and Baldwin, Kimberly and Bannuru, Raveendhara R. and Belani, Kiran K. and Bowie, William R. and Branda, John A. and Clifford, David B. and DiMario, Frank J. and Halperin, John J. and Krause, Peter J. and Lavergne, Valery and Liang, Matthew H. and Meissner, H. Cody and Nigrovic, Lise E. and Nocton, James J. and Osani, Mikala C. and Pruitt, Amy A. and Rips, Jane and Rosenfeld, Lara E. and Savoy, Margot L. and Sood, Sunil K. and Steere, Allen C. and Strle, Franc and Sundel, Robert and Tsao, Albert and Vaysbrot, Elizaveta E. and Wormser, Gary P. and Zemel, Leonid S.},
  title = {Clinical Practice Guidelines by the {IDSA}, {AAN}, and {ACR}: 2020 Guidelines for the Prevention, Diagnosis and Treatment of {Lyme} Disease},
  journal = {Clinical Infectious Diseases},
  year = {2021},
  volume = {72},
  number = {1},
  pages = {e1--e48},
  doi = {10.1093/cid/ciaa1215},
  pmid = {33251700},
  url = {https://doi.org/10.1093/cid/ciaa1215},
  keywords = {Lyme disease, IDSA guidelines, Borrelia burgdorferi, diagnosis, treatment},
  note = {Updated IDSA/AAN/ACR guidelines for Lyme disease diagnosis and treatment; defines PTLDS criteria}
}

@article{MycoplasmaEuropeanCFS2003,
  author = {Nijs, Jo and Nicolson, Garth L. and De Becker, Patrick and Coomans, Danny and De Meirleir, Kenny},
  title = {High prevalence of {Mycoplasma} infections among {European} chronic fatigue syndrome patients},
  journal = {FEMS Immunology and Medical Microbiology},
  year = {2003},
  volume = {34},
  number = {3},
  pages = {209--214},
  doi = {10.1111/j.1574-695X.2002.tb00626.x},
  pmid = {12423773},
  url = {https://doi.org/10.1111/j.1574-695X.2002.tb00626.x},
  keywords = {Mycoplasma, ME/CFS, chronic fatigue, infection, European study},
  note = {High Mycoplasma prevalence in European ME/CFS patients; potential infectious cofactor}
}

% ============================================================================
% SMALL FIBER NEUROPATHY TREATMENT REFERENCES
% ============================================================================

@article{Finnerup2015neuropathic,
  author = {Finnerup, Nanna B. and Attal, Nadine and Haroutounian, Simon and McNicol, Ewan and Baron, Ralf and Dworkin, Robert H. and Gilron, Ian and Haanp\"{a}\"{a}, Maija and Hansson, Per and Jensen, Troels S. and Kamerman, Peter R. and Lund, Karen and Moore, Andrew and Raja, Srinivasa N. and Rice, Andrew S.C. and Rowbotham, Michael and Sena, Emily and Siddall, Philip and Smith, Blair H. and Wallace, Mark},
  title = {Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis},
  journal = {The Lancet Neurology},
  year = {2015},
  volume = {14},
  number = {2},
  pages = {162--173},
  doi = {10.1016/S1474-4422(14)70251-0},
  pmid = {25575710},
  url = {https://doi.org/10.1016/S1474-4422(14)70251-0},
  keywords = {neuropathic pain, pharmacotherapy, gabapentin, pregabalin, duloxetine, tricyclic antidepressants},
  note = {NeuPSIG systematic review; first-line recommendations for neuropathic pain: gabapentinoids, SNRIs, TCAs}
}

@article{Oaklander2016autoimmuneSFN,
  author = {Oaklander, Anne Louise and Nolano, Maria},
  title = {Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy: A Review},
  journal = {JAMA Neurology},
  year = {2019},
  volume = {76},
  number = {10},
  pages = {1240--1251},
  doi = {10.1001/jamaneurol.2019.2917},
  pmid = {31498378},
  url = {https://doi.org/10.1001/jamaneurol.2019.2917},
  keywords = {small fiber neuropathy, SFN, autoimmune, skin biopsy, IENFD, diagnosis, treatment},
  note = {Comprehensive review of SFN diagnosis and treatment; includes autoimmune SFN and immunotherapy approaches}
}

@article{Liu2020IVIG,
  author = {Liu, Xin and Treister, Roi and Lang, Matthias and Oaklander, Anne Louise},
  title = {{IVIg} for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety},
  journal = {Therapeutic Advances in Neurological Disorders},
  year = {2018},
  volume = {11},
  pages = {1756285617744484},
  doi = {10.1177/1756285617744484},
  pmid = {29399053},
  pmcid = {PMC5784543},
  url = {https://doi.org/10.1177/1756285617744484},
  keywords = {IVIG, small fiber neuropathy, autoimmune, immunotherapy, treatment},
  note = {First systematic analysis of IVIG efficacy in autoimmune SFN; 77\% showed improvement in pain or autonomic symptoms}
}

@article{Ziegler2006ALA,
  author = {Ziegler, Dan and Ametov, Alexander and Barinov, Alexey and Dyck, Peter J. and Gurieva, Irina and Low, Phillip A. and Munzel, Ulf and Yakhno, Nikolai and Raz, Itamar and Novosadova, Maria and Maus, Jens and Samigullin, Rustem},
  title = {Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the {SYDNEY} 2 trial},
  journal = {Diabetes Care},
  year = {2006},
  volume = {29},
  number = {11},
  pages = {2365--2370},
  doi = {10.2337/dc06-1216},
  pmid = {17065669},
  url = {https://doi.org/10.2337/dc06-1216},
  keywords = {alpha-lipoic acid, diabetic neuropathy, antioxidant, SYDNEY trial, treatment},
  note = {RCT demonstrating alpha-lipoic acid efficacy for diabetic polyneuropathy; 600 mg/day optimal dose}
}

@article{Sima2005ALCAR,
  author = {Sima, Anders A.F. and Calvani, Menotti and Mehra, Malti and Amato, Anthony and {Acetyl-L-Carnitine Study Group}},
  title = {Acetyl-{L}-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials},
  journal = {Diabetes Care},
  year = {2005},
  volume = {28},
  number = {1},
  pages = {89--94},
  doi = {10.2337/diacare.28.1.89},
  pmid = {15616239},
  url = {https://doi.org/10.2337/diacare.28.1.89},
  keywords = {acetyl-L-carnitine, ALCAR, diabetic neuropathy, nerve regeneration, treatment},
  note = {Two RCTs showing ALCAR improves pain and promotes nerve fiber regeneration in diabetic neuropathy}
}

% ============================================================================
% TICK-BORNE INFECTION ADDITIONAL REFERENCES
% ============================================================================

@article{Steere2016postLyme,
  author = {Steere, Allen C. and Strle, Franc and Wormser, Gary P. and Hu, Linden T. and Branda, John A. and Hovius, Joppe W.R. and Li, Xin and Mead, Paul S.},
  title = {Lyme borreliosis},
  journal = {Nature Reviews Disease Primers},
  year = {2016},
  volume = {2},
  pages = {16090},
  doi = {10.1038/nrdp.2016.90},
  pmid = {27976670},
  url = {https://doi.org/10.1038/nrdp.2016.90},
  keywords = {Lyme disease, Borrelia burgdorferi, post-treatment, PTLDS, pathophysiology},
  note = {Comprehensive review of Lyme borreliosis including post-treatment persistent symptoms and autoimmune mechanisms}
}

@article{Krause1996babesia,
  author = {Krause, Peter J. and Telford, Sam R. and Spielman, Andrew and Sikand, Vijay and Ryan, Robert and Christianson, Donald and Burke, Gloria and Brassard, Paul and Pollack, Richard and Peck, Jan and Persing, David H.},
  title = {Concurrent {Lyme} disease and babesiosis: Evidence for increased severity and duration of illness},
  journal = {JAMA},
  year = {1996},
  volume = {275},
  number = {21},
  pages = {1657--1660},
  doi = {10.1001/jama.1996.03530450047031},
  pmid = {8637139},
  url = {https://doi.org/10.1001/jama.1996.03530450047031},
  keywords = {Babesia, Lyme disease, co-infection, tick-borne, severity},
  note = {Landmark study showing concurrent Lyme and babesiosis produces more severe and prolonged illness than either alone}
}

@article{Magadmi2019,
  author = {Magadmi, Rania and Meszaros, Judit and Damanhouri, Zoheir A. and Seward, Elizabeth P.},
  title = {{CADM1}-dependent adhesion between mast cells and sensory neurons enhances mast cell inflammatory responses},
  journal = {Frontiers in Cellular Neuroscience},
  year = {2019},
  volume = {13},
  pages = {262},
  doi = {10.3389/fncel.2019.00262},
  url = {https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2019.00262/full},
  keywords = {mast cells, sensory neurons, CADM1, adhesion, neurogenic inflammation, signal amplification},
  note = {Demonstrates that CADM1-mediated adhesion between mast cells and sensory neurons amplifies degranulation and IL-6 secretion (~2-3 fold), providing mechanistic basis for mast cell-nerve interactions in neurogenic inflammation}
}

@article{Novak2022,
  author = {Novak, Peter and Giannetti, Maria Pilar and Weller, Erica and Hamilton, Mariana J. and Castells, Mariana},
  title = {Mast cell disorders are associated with decreased cerebral blood flow and small fiber neuropathy},
  journal = {Annals of Allergy, Asthma \& Immunology},
  year = {2022},
  volume = {128},
  number = {3},
  pages = {299--306.e1},
  doi = {10.1016/j.anai.2021.10.006},
  pmid = {34648976},
  url = {https://doi.org/10.1016/j.anai.2021.10.006},
  keywords = {mast cell activation syndrome, MCAS, hereditary alpha tryptasemia, small fiber neuropathy, cerebral blood flow, dysautonomia, orthostatic intolerance},
  note = {Documents 80\% small fiber neuropathy prevalence and 20-24\% reduction in orthostatic cerebral blood flow in mast cell disorder patients, with universal dysautonomia. Provides objective biomarkers for mast cell-mediated neurological dysfunction highly relevant to ME/CFS}
}

@article{Nakamura2014,
  author = {Nakamura, Yuya and Nakano, Nobuhiro and Ishimaru, Kyoko and Hara, Mayumi and Ikegami, Toshihiro and Tahara, Yu and Katoh, Ryoichi and Ogawa, Hideoki and Okumura, Ko and Shibata, Shigenobu and Nishiyama, Chiharu and Nakao, Atsuhito},
  title = {Circadian regulation of allergic reactions by the mast cell clock in mice},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2014},
  volume = {133},
  number = {2},
  pages = {568--575},
  doi = {10.1016/j.jaci.2013.07.040},
  pmid = {24060274},
  url = {https://doi.org/10.1016/j.jaci.2013.07.040},
  keywords = {circadian rhythm, mast cells, clock genes, temporal regulation, adrenal hormones, FcεRI},
  note = {Demonstrates that mast cells possess intrinsic circadian clocks entrained by adrenal hormones, with Clock gene mutation abolishing time-of-day variation in degranulation. Provides mechanistic basis for temporal regulation of mast cell function}
}

@article{Nakao2018,
  author = {Nakao, Atsuhito},
  title = {Clockwork allergy: How the circadian clock underpins allergic reactions},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2018},
  volume = {142},
  number = {4},
  pages = {1021--1031},
  doi = {10.1016/j.jaci.2018.08.007},
  pmid = {30293559},
  url = {https://doi.org/10.1016/j.jaci.2018.08.007},
  keywords = {circadian rhythm, allergy, mast cells, clock disruption, chronotherapy, lifestyle},
  note = {Comprehensive review showing that circadian clock disruption not only affects timing but also enhances severity and increases susceptibility to allergic disease. Proposes lifestyle interventions and clock modifiers as therapeutic approaches}
}

@article{Christ2018,
  author = {Christ, Pia and Sowa, Anna-Sophie and Froy, Oren and Lorentz, Axel},
  title = {The circadian clock drives mast cell functions in allergic reactions},
  journal = {Frontiers in Immunology},
  year = {2018},
  volume = {9},
  pages = {1526},
  doi = {10.3389/fimmu.2018.01526},
  pmid = {30034393},
  pmcid = {PMC6043637},
  url = {https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2018.01526/full},
  keywords = {circadian rhythm, mast cells, chronotherapy, clock genes, entrainment},
  note = {Review emphasizing that mast cells are controlled by both internal clocks and external factors (light, hormones, diet). Advocates for chronotherapy approaches considering rhythmic nature of mast cell responses}
}

% Auditory and Neurological Dysfunction in ME/CFS
@article{Johnson1996,
  author = {Johnson, S K and DeLuca, J and Diamond, B J and Natelson, B H},
  title = {Selective impairment of auditory processing in chronic fatigue syndrome: a comparison with multiple sclerosis and healthy controls},
  journal = {Perceptual and Motor Skills},
  year = {1996},
  volume = {83},
  number = {1},
  pages = {51--62},
  doi = {10.2466/pms.1996.83.1.51},
  pmid = {8873173},
  url = {https://doi.org/10.2466/pms.1996.83.1.51},
  keywords = {ME/CFS, auditory processing, cognitive dysfunction, working memory, sensory deficits},
  note = {Landmark study demonstrating modality-specific cognitive impairment: CFS patients showed differential impairment on auditory versus visual processing tasks, while MS patients showed equal impairment on both. Suggests specific auditory processing dysfunction in ME/CFS}
}

@article{Schubert2021,
  author = {Schubert, Nick M A and Rosmalen, Judith G M and van Dijk, Pim and Pyott, Sonja J},
  title = {A retrospective cross-sectional study on tinnitus prevalence and disease associations in the Dutch population-based cohort Lifelines},
  journal = {Hearing Research},
  year = {2021},
  volume = {411},
  pages = {108355},
  doi = {10.1016/j.heares.2021.108355},
  pmid = {34607212},
  url = {https://doi.org/10.1016/j.heares.2021.108355},
  keywords = {tinnitus, chronic fatigue syndrome, prevalence, epidemiology, functional somatic syndromes},
  note = {Large population-based study (n=124,609) finding significant association between chronic fatigue syndrome and constant tinnitus (OR 1.568). First large-scale epidemiological evidence linking tinnitus to ME/CFS}
}

@article{Skare2024,
  author = {Skare, Thelma L and de Carvalho, Joz{\'e}lio Freire and de Medeiros, Italo Roberto Torres and Shoenfeld, Yehuda},
  title = {Ear abnormalities in chronic fatigue syndrome ({CFS}), fibromyalgia ({FM}), Coronavirus-19 infectious disease ({COVID}) and long-{COVID} syndrome ({PCS}), sick-building syndrome ({SBS}), post-orthostatic tachycardia syndrome ({PoTS}), and autoimmune/inflammatory syndrome induced by adjuvants ({ASIA}): A systematic review},
  journal = {Autoimmunity Reviews},
  year = {2024},
  volume = {23},
  number = {10},
  pages = {103606},
  doi = {10.1016/j.autrev.2024.103606},
  pmid = {39209013},
  url = {https://doi.org/10.1016/j.autrev.2024.103606},
  keywords = {ME/CFS, tinnitus, hearing loss, vestibular dysfunction, autoimmunity, post-viral syndromes},
  note = {Systematic review of 172 articles (1990-2024) finding cochlear complaints (tinnitus, hearing loss) most frequent across ME/CFS and related post-infectious conditions. Identifies viral effects, vascular impairment, autoimmune reactions, and oxidative stress as potential mechanisms}
}

@article{Nelson2021,
  author = {Nelson, Todd and Zhang, Lan-Xin and Guo, Hui and Nacul, Luis and Song, Xiaowei},
  title = {Brainstem Abnormalities in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Scoping Review and Evaluation of Magnetic Resonance Imaging Findings},
  journal = {Frontiers in Neurology},
  year = {2021},
  volume = {12},
  pages = {769511},
  doi = {10.3389/fneur.2021.769511},
  pmid = {34975729},
  pmcid = {PMC8718708},
  url = {https://doi.org/10.3389/fneur.2021.769511},
  keywords = {ME/CFS, brainstem, MRI, neuroimaging, neuroinflammation, auditory processing},
  note = {Scoping review of 11 MRI studies documenting structural and functional brainstem abnormalities in ME/CFS. Proposes mechanisms including astrocyte dysfunction, cerebral perfusion impairment, impaired nerve conduction, and neuroinflammation. Brainstem involvement may explain auditory processing deficits and heterogeneous symptoms}
}

@article{Oaklander2013sfn,
  author = {Oaklander, Anne Louise and Herzog, Zeva D and Downs, H Michael and Klein, Max M},
  title = {Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia},
  journal = {Pain},
  year = {2013},
  volume = {154},
  number = {11},
  pages = {2310--2316},
  doi = {10.1016/j.pain.2013.06.001},
  pmid = {23748113},
  pmcid = {PMC3845002},
  url = {https://doi.org/10.1016/j.pain.2013.06.001},
  keywords = {fibromyalgia, small fiber neuropathy, IENFD, skin biopsy, neuropathic pain},
  note = {41\% of fibromyalgia patients had reduced intraepidermal nerve fiber density diagnostic for SFN. Provides objective diagnostic criterion for subset of fibromyalgia/ME/CFS overlap patients}
}

@article{Streeten1998blood,
  author = {Streeten, David H P and Bell, David S},
  title = {Circulating Blood Volume in Chronic Fatigue Syndrome},
  journal = {Journal of Chronic Fatigue Syndrome},
  year = {1998},
  volume = {4},
  number = {1},
  pages = {3--11},
  doi = {10.1300/J092v04n01_02},
  keywords = {ME/CFS, blood volume, hypovolemia, orthostatic intolerance, red cell mass},
  note = {RBC mass reduced in 93.8\% female and 50\% male ME/CFS patients. Plasma volume subnormal in 52.6\%. Provides mechanism for orthostatic intolerance}
}

@article{Barnden2011brainstem,
  author = {Barnden, Leighton R and Crouch, Beverley and Kwiatek, Richard and Burnet, Richard and Mernone, Anthony and Chryssidis, Socrates and Scroop, Greg and Del Fante, Paul},
  title = {A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis},
  journal = {NMR in Biomedicine},
  year = {2011},
  volume = {24},
  number = {10},
  pages = {1302--1312},
  doi = {10.1002/nbm.1692},
  pmid = {21560176},
  pmcid = {PMC4369126},
  url = {https://doi.org/10.1002/nbm.1692},
  keywords = {ME/CFS, brainstem, MRI, midbrain, autonomic dysfunction, cerebrovascular autoregulation},
  note = {White matter volume decreased with increasing fatigue duration in midbrain. Brainstem GM volume correlated with pulse pressure, suggesting impaired cerebrovascular autoregulation. Consistent with insult to midbrain affecting feedback loops for motor/cognitive activity and ANS}
}

@article{Zeineh2015white,
  author = {Zeineh, Michael M and Kang, Jangho and Atlas, Scott W and Raman, Maneesh M and Reiss, Allan L and Norris, John L and Valencia, Ines and Montoya, Jose G},
  title = {Right Arcuate Fasciculus Abnormality in Chronic Fatigue Syndrome},
  journal = {Radiology},
  year = {2015},
  volume = {274},
  number = {2},
  pages = {517--526},
  doi = {10.1148/radiol.14141079},
  pmid = {25353054},
  url = {https://doi.org/10.1148/radiol.14141079},
  keywords = {ME/CFS, white matter, arcuate fasciculus, diffusion tensor imaging, cognitive dysfunction},
  note = {Increased fractional anisotropy in right arcuate fasciculus (p=0.0015), correlated with disease severity (r=0.649). Bilateral white matter volumes reduced by ~7\%. Provides anatomical substrate for cognitive dysfunction}
}

@article{Lange1999mri,
  author = {Lange, Gudrun and DeLuca, John and Maldjian, Joseph A and Lee, Hye-Hee and Tiersky, Lana A and Natelson, Benjamin H},
  title = {Brain MRI abnormalities exist in a subset of patients with chronic fatigue syndrome},
  journal = {Journal of Neurological Sciences},
  year = {1999},
  volume = {171},
  number = {1},
  pages = {3--7},
  doi = {10.1016/s0022-510x(99)00243-9},
  pmid = {10567042},
  url = {https://doi.org/10.1016/s0022-510x(99)00243-9},
  keywords = {ME/CFS, MRI, white matter hyperintensities, structural neuroimaging},
  note = {CFS patients without psychiatric comorbidity showed significantly more brain abnormalities than controls. White matter hyperintensities predominantly in frontal lobes. Early structural evidence for neurological involvement}
}

@article{Lee2024neuroimaging,
  author = {Lee, Jieun and Vernon, Suzanne D and Jeys, Parinaz and Ali, Waseem and Campos, Andrea and Unutmaz, Derya and Yellman, Brayden and Bateman, Lucinda and Kogelnik, Andreas M and Montoya, Jose G and Levine, Susan M},
  title = {Brain-regional characteristics and neuroinflammation in ME/CFS patients from neuroimaging: A systematic review and meta-analysis},
  journal = {Autoimmunity Reviews},
  year = {2024},
  volume = {23},
  number = {1},
  pages = {103464},
  doi = {10.1016/j.autrev.2023.103464},
  pmid = {38016575},
  url = {https://doi.org/10.1016/j.autrev.2023.103464},
  keywords = {ME/CFS, neuroimaging, meta-analysis, MRI, MRS, EEG, PET, neuroinflammation},
  note = {Meta-analysis of 65 observational studies with 1529 ME/CFS patients, 1715 controls. Regional alterations most frequent in cerebral cortex (especially frontal). Significant hypoactivity in insular and thalamic regions. Abnormalities in network hubs bridging reason and emotion}
}

@article{Chaudhuri2004fatigue,
  author = {Chaudhuri, Abhijit and Behan, Peter O},
  title = {Fatigue in neurological disorders},
  journal = {The Lancet},
  year = {2004},
  volume = {363},
  number = {9413},
  pages = {978--988},
  doi = {10.1016/S0140-6736(04)15794-2},
  pmid = {15043967},
  url = {https://doi.org/10.1016/S0140-6736(04)15794-2},
  keywords = {fatigue, ME/CFS, central fatigue, basal ganglia, neurological disorders},
  note = {Distinguished central fatigue from peripheral fatigue. CFS fatigue similar to MS, Parkinson's (central origin). Basal ganglia dysfunction proposed as key mechanism}
}

@article{Grayston2019sfn,
  author = {Grayston, Rachel and Czanner, Gabriela and Elhadd, Khalid and Goebel, Andreas and Frank, Bernhard and Üçeyler, Nurcan and Malik, Rayaz A and Alam, Uazman},
  title = {A systematic review and meta-analysis of the prevalence of small fiber pathology in fibromyalgia: Implications for a new paradigm in fibromyalgia etiopathogenesis},
  journal = {Seminars in Arthritis and Rheumatism},
  year = {2019},
  volume = {48},
  number = {5},
  pages = {933--940},
  doi = {10.1016/j.semarthrit.2018.08.003},
  pmid = {30314675},
  url = {https://doi.org/10.1016/j.semarthrit.2018.08.003},
  keywords = {fibromyalgia, small fiber neuropathy, meta-analysis, IENFD, corneal confocal microscopy},
  note = {Meta-analysis: 49\% pooled prevalence of small fiber pathology in fibromyalgia (95\% CI: 38-60\%). Skin biopsy: 45\% prevalence; corneal confocal microscopy: 59\% prevalence. 8 studies, 222 participants}
}

@article{EatonFitch2019,
  author = {Eaton-Fitch, Natalie and du Preez, Stanley and Cabanas, Hélène and Staines, Donald and Marshall-Gradisnik, Sonya},
  title = {A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Systematic Reviews},
  year = {2019},
  volume = {8},
  pages = {279},
  doi = {10.1186/s13643-019-1202-6},
  pmid = {31727160},
  pmcid = {PMC6857215},
  note = {Systematic review of 17 case-control studies (1994-2018) finding impaired NK cell cytotoxicity as the most consistent immunological abnormality in ME/CFS}
}

@article{Maher2005,
  author = {Maher, K. J. and Klimas, N. G. and Fletcher, M. A.},
  title = {Chronic fatigue syndrome is associated with diminished intracellular perforin},
  journal = {Clinical and Experimental Immunology},
  year = {2005},
  volume = {142},
  number = {3},
  pages = {505--511},
  doi = {10.1111/j.1365-2249.2005.02935.x},
  pmid = {16297163},
  pmcid = {PMC1440524},
  note = {CFS patients show 45\% reduction in NK cell perforin content (3,320 vs 6,051 rMol/cell, p=0.01), providing mechanistic explanation for impaired cytotoxicity}
}

@article{Brenu2011,
  author = {Brenu, Ekua W. and van Driel, Mieke L. and Staines, Don R. and Ashton, Kevin J. and Ramos, Sandra B. and Keane, James and Klimas, Nancy G. and Marshall-Gradisnik, Sonya M.},
  title = {Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis},
  journal = {Journal of Translational Medicine},
  year = {2011},
  volume = {9},
  pages = {81},
  doi = {10.1186/1479-5876-9-81},
  pmid = {21619669},
  pmcid = {PMC3120691},
  note = {Large study (n=95) showing reduced NK/CD8+ cytotoxicity, elevated IL-10/IFN-$\gamma$/TNF-$\alpha$, and paradoxical low granzyme A/K despite elevated perforin}
}

@article{Kennedy2004,
  author = {Kennedy, G. and Spence, V. and Underwood, C. and Belch, J. J. F.},
  title = {Increased neutrophil apoptosis in chronic fatigue syndrome},
  journal = {Journal of Clinical Pathology},
  year = {2004},
  volume = {57},
  number = {8},
  pages = {891--893},
  doi = {10.1136/jcp.2003.015511},
  pmid = {15280416},
  pmcid = {PMC1770396},
  note = {CFS patients show increased neutrophil apoptosis (37.4\% vs 22.8\% annexin V binding, p=0.001), elevated TNFRI expression, and raised active TGF-$\beta$1, consistent with activated inflammatory process}
}

@article{Mandarano2020,
  author = {Mandarano, Alexandra H. and Maya, Jessica and Giloteaux, Ludovic and Peterson, Daniel L. and Maynard, Marco and Gottschalk, C. Gunnar and Hanson, Maureen R.},
  title = {Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations},
  journal = {Journal of Clinical Investigation},
  year = {2020},
  volume = {130},
  number = {3},
  pages = {1491--1505},
  doi = {10.1172/JCI132185},
  pmid = {31830003},
  pmcid = {PMC7269566},
  note = {First comprehensive T cell metabolic analysis in ME/CFS (n=53); CD8+ T cells show reduced mitochondrial membrane potential and impaired glycolysis at rest and after activation}
}

@article{Nishikai2007,
  author = {Nishikai, M.},
  title = {Antinuclear antibodies in patients with chronic fatigue syndrome},
  journal = {Nihon Rinsho},
  year = {2007},
  volume = {65},
  number = {6},
  pages = {1067--1070},
  pmid = {17561698},
  note = {Review of ANA findings in CFS: 15-25\% prevalence with low titers and heterogeneous patterns; associated 68/48 kDa autoantibody found in 13.2\% of patients (vs 0\% controls)}
}

% =============================================================================
% Blood Volume and RAAS Dysfunction Papers
% =============================================================================

@article{Miwa2017,
  author = {Miwa, Kunihisa and Fujita, Masahiro},
  title = {Down-regulation of renin-aldosterone and antidiuretic hormone systems in patients with myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Journal of Cardiology},
  year = {2017},
  volume = {69},
  number = {4},
  pages = {684--688},
  doi = {10.1016/j.jjcc.2016.06.003},
  pmid = {27401397},
  url = {https://doi.org/10.1016/j.jjcc.2016.06.003},
  keywords = {ME/CFS, RAAS, aldosterone, ADH, hypovolemia, orthostatic intolerance},
  abstract = {Both the renin-aldosterone and ADH systems were down-regulated despite the existence of reduction in cardiac preload and output in patients with ME. Plasma aldosterone (104±37 vs 157±67 pg/ml, p=0.004) and ADH (2.2±1.0 vs 3.3±1.5 pg/ml, p=0.02) were significantly lower in ME patients. Desmopressin treatment improved orthostatic symptoms in 50\% of patients.}
}

@article{Raj2005,
  author = {Raj, Satish R. and Biaggioni, Italo and Yamhure, Paula C. and Black, Bonnie K. and Paranjape, Sachin Y. and Byrne, Daniel W. and Robertson, David},
  title = {Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome},
  journal = {Circulation},
  year = {2005},
  volume = {111},
  number = {13},
  pages = {1574--1582},
  doi = {10.1161/01.CIR.0000160356.97313.5d},
  pmid = {15781744},
  url = {https://doi.org/10.1161/01.CIR.0000160356.97313.5d},
  keywords = {POTS, hypovolemia, RAAS, aldosterone, blood volume, orthostatic intolerance},
  abstract = {POTS patients had marked reductions in blood volume (3583±579 vs 4319±578 mL, p<0.0001) and plasma volume (2172±429 vs 2763±437 mL, p<0.0001) with paradoxically normal to low plasma renin activity and frankly low plasma aldosterone (7.0±5.3 vs 12.3±6.4 ng/dL, p=0.01). Dysregulation of renin-aldosterone-blood volume homeostatic loop contributes to POTS pathophysiology.}
}

@article{Mustafa2011,
  author = {Mustafa, Hossam I. and Garland, Emily M. and Biaggioni, Italo and Black, Bonnie K. and Dupont, William D. and Robertson, David and Raj, Satish R.},
  title = {Abnormalities of angiotensin regulation in postural tachycardia syndrome},
  journal = {Heart Rhythm},
  year = {2011},
  volume = {8},
  number = {3},
  pages = {422--428},
  doi = {10.1016/j.hrthm.2010.11.009},
  pmid = {21266211},
  pmcid = {PMC3050076},
  url = {https://doi.org/10.1016/j.hrthm.2010.11.009},
  keywords = {POTS, angiotensin II, ACE2, RAAS, orthostatic intolerance},
  abstract = {Plasma angiotensin II was significantly higher in POTS patients (43±3 vs 28±3 pg/mL, p=0.006), and estimated ACE2 activity was significantly lower in POTS (0.25±0.02 vs 0.33±0.03, p=0.038). Elevated Ang II may contribute to POTS symptoms through peripheral vasoconstriction and reduced nitric oxide bioavailability.}
}

@article{Stewart2006,
  author = {Stewart, Julian M. and Glover, June L. and Medow, Marvin S.},
  title = {Increased plasma angiotensin II in postural tachycardia syndrome ({POTS}) is related to reduced blood flow and blood volume},
  journal = {Clinical Science},
  year = {2006},
  volume = {110},
  number = {2},
  pages = {255--263},
  doi = {10.1042/CS20050254},
  pmid = {16262605},
  pmcid = {PMC4511483},
  url = {https://doi.org/10.1042/CS20050254},
  keywords = {POTS, angiotensin II, blood volume, blood flow, hypovolemia, NO bioavailability},
  abstract = {Plasma angiotensin II is increased in low-flow POTS patients with hypovolaemia, which may contribute to local blood flow dysregulation and reduced NO bioavailability.}
}

@article{Farquhar2002,
  author = {Farquhar, William B. and Hunt, Beverly E. and Taylor, Jennifer A. and Darling, Susan E. and Freeman, Roy},
  title = {Blood volume and its relation to peak {O$_2$} consumption and physical activity in patients with chronic fatigue},
  journal = {American Journal of Physiology - Heart and Circulatory Physiology},
  year = {2002},
  volume = {282},
  number = {1},
  pages = {H66--H71},
  doi = {10.1152/ajpheart.2002.282.1.H66},
  pmid = {11748048},
  url = {https://doi.org/10.1152/ajpheart.2002.282.1.H66},
  keywords = {CFS, blood volume, exercise capacity, VO2max, hypovolemia},
  abstract = {Individuals with CFS have significantly lower peak oxygen consumption and trend toward lower blood volume compared with controls. Blood volume is a strong physiological correlate of peak oxygen consumption in CFS patients.}
}

@article{vanCampen2018,
  author = {van Campen, C. Linda M. C. and Rowe, Peter C. and Visser, Frans C.},
  title = {Blood Volume Status in {ME/CFS} Correlates With the Presence or Absence of Orthostatic Symptoms: Preliminary Results},
  journal = {Frontiers in Pediatrics},
  year = {2018},
  volume = {6},
  pages = {352},
  doi = {10.3389/fped.2018.00352},
  pmid = {30525014},
  pmcid = {PMC6262290},
  url = {https://doi.org/10.3389/fped.2018.00352},
  keywords = {ME/CFS, blood volume, orthostatic intolerance, dual isotope measurement, hypovolemia},
  abstract = {Mean absolute blood volume was 59(8) ml/kg, a value -11(7) ml/kg below reference blood volume in ME/CFS adults. Blood volume reduction correlated with presence of orthostatic intolerance symptoms.}
}

@article{Strahler2013,
  author = {Strahler, Jana and Fischer, Susanne and Nater, Urs M. and Ehlert, Ulrike and Gaab, Jens},
  title = {Catecholamine responses in chronic fatigue syndrome},
  journal = {Biological Psychology},
  year = {2013},
  volume = {94},
  number = {1},
  pages = {160--166},
  doi = {10.1016/j.biopsycho.2013.06.002},
  pmid = {23770415},
  url = {https://doi.org/10.1016/j.biopsycho.2013.06.002},
  keywords = {CFS, catecholamines, norepinephrine, epinephrine, autonomic dysfunction},
  abstract = {CFS patients show altered catecholamine responses suggesting dysregulation of sympathetic nervous system activation.}
}

@article{Kemp2019,
  author = {Kemp, John and Witte, Lauren P. and Buziashvili, Diana M. and Scheibenbogen, Carmen and Volk, Hans-Dieter and Kedor, Claudia},
  title = {Autonomic dysfunction validation in {ME/CFS}},
  journal = {Clinical Autonomic Research},
  year = {2019},
  volume = {29},
  number = {4},
  pages = {475--477},
  doi = {10.1007/s10286-019-00616-w},
  pmid = {31144123},
  url = {https://doi.org/10.1007/s10286-019-00616-w},
  keywords = {ME/CFS, autonomic dysfunction, POTS, orthostatic intolerance, validation},
  abstract = {Validation of autonomic dysfunction measures in ME/CFS cohort, confirming high prevalence of orthostatic intolerance.}
}

@article{Gordon1967,
  author = {Gordon, Robert D. and Wolfe, Larry K. and Island, Daniel P. and Liddle, Grant W.},
  title = {A diurnal rhythm in plasma renin activity in man},
  journal = {Journal of Clinical Investigation},
  year = {1967},
  volume = {46},
  number = {4},
  pages = {599--605},
  doi = {10.1172/JCI105565},
  pmid = {6021204},
  pmcid = {PMC292523},
  url = {https://doi.org/10.1172/JCI105565},
  keywords = {renin, circadian rhythm, sympathetic nervous system, aldosterone, RAAS},
  abstract = {Classic study demonstrating diurnal rhythm in plasma renin activity and sympathetic regulation of renin-aldosterone system.}
}

@article{Tomas2017,
  author = {Tomas, Cara and Finkelmeyer, Andreas and Hodgson, Tim and MacLachlan, Laura and MacGowan, Guy A. and Blamire, Andrew M. and Newton, Julia L.},
  title = {Elevated brain natriuretic peptide levels in chronic fatigue syndrome associate with cardiac dysfunction: a case control study},
  journal = {Open Heart},
  year = {2017},
  volume = {4},
  number = {2},
  pages = {e000697},
  doi = {10.1136/openhrt-2017-000697},
  pmid = {29344367},
  pmcid = {PMC5761285},
  url = {https://doi.org/10.1136/openhrt-2017-000697},
  keywords = {CFS, BNP, brain natriuretic peptide, cardiac dysfunction, cardiac volumes},
  abstract = {BNP levels significantly higher in CFS (p=0.013). Patients with high BNP (>400 pg/mL) had significantly lower cardiac volumes in both end-systolic and end-diastolic volumes (p=0.05). Association between reduced cardiac volumes and elevated BNP confirmed.}
}

@article{Newton2016,
  author = {Newton, Julia L. and Finkelmeyer, Andreas and Petrides, George and Frith, James and Hodgson, Tim and Maclachlan, Laura and MacGowan, Guy and Blamire, Andrew M.},
  title = {Reduced cardiac volumes in chronic fatigue syndrome associate with plasma volume but not length of disease: a cohort study},
  journal = {Open Heart},
  year = {2016},
  volume = {3},
  number = {1},
  pages = {e000381},
  doi = {10.1136/openhrt-2015-000381},
  pmid = {27403329},
  pmcid = {PMC4932290},
  url = {https://doi.org/10.1136/openhrt-2015-000381},
  keywords = {CFS, cardiac volumes, plasma volume, blood volume, cardiac MRI},
  abstract = {CFS patients had significantly reduced end-systolic and end-diastolic volumes with reduced end-diastolic wall masses. Strong positive correlations between total volume, red cell volume, plasma volume and cardiac end-diastolic wall mass. Findings not secondary to deconditioning as no relationship with disease length.}
}

@article{Scherbakov2020,
  author = {Scherbakov, Nadja and Szklarski, Marvin and Hartwig, Jelka and Sotzny, Franziska and Lorenz, Sebastian and Meyer, Antje and Grabowski, Patricia and Doehner, Wolfram and Scheibenbogen, Carmen},
  title = {Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {ESC Heart Failure},
  year = {2020},
  volume = {7},
  number = {3},
  pages = {1064--1071},
  doi = {10.1002/ehf2.12633},
  pmid = {32154656},
  pmcid = {PMC7261521},
  url = {https://doi.org/10.1002/ehf2.12633},
  keywords = {ME/CFS, endothelial dysfunction, vascular dysfunction, flow-mediated dilation, disease severity},
  abstract = {Peripheral endothelial dysfunction found in 51\% of ME/CFS patients vs 20\% healthy subjects (p<0.05). Associated with disease severity and severity of immune symptoms.}
}

@article{Newton2012,
  author = {Newton, Julia L. and Okonkwo, Olatunde and Sutcliffe, Keith and Seth, Ajay and Shin, Joseph and Jones, Derek E. J.},
  title = {Symptoms of autonomic dysfunction in chronic fatigue syndrome},
  journal = {QJM: An International Journal of Medicine},
  year = {2007},
  volume = {100},
  number = {8},
  pages = {519--526},
  doi = {10.1093/qjmed/hcm057},
  pmid = {17617647},
  url = {https://doi.org/10.1093/qjmed/hcm057},
  keywords = {CFS, autonomic dysfunction, orthostatic intolerance, POTS, neurally mediated hypotension},
  abstract = {Systematic assessment of autonomic dysfunction in CFS showing high prevalence of orthostatic intolerance and cardiovascular autonomic symptoms.}
}

@article{CastroMarrero2021,
  author = {Castro-Marrero, Jesús and Sáez-Francàs, Naia and Segundo, María José and Calvo, Natalia and Faro, Mónica and Aliste, Luisa and Fernández de Sevilla, Tomás and Alegre, José},
  title = {Effect of coenzyme {Q$_{10}$} plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome -- a randomized, controlled, double-blind trial},
  journal = {Clinical Nutrition},
  year = {2016},
  volume = {35},
  number = {4},
  pages = {826--834},
  doi = {10.1016/j.clnu.2015.07.010},
  pmid = {26212172},
  url = {https://doi.org/10.1016/j.clnu.2015.07.010},
  keywords = {CFS, CoQ10, NADH, exercise testing, heart rate, clinical trial},
  abstract = {CoQ10 plus NADH supplementation improved maximum heart rate recovery and reduced perception of fatigue in CFS patients in randomized controlled trial.}
}

@article{Hornig2017,
  author = {Hornig, Mady and Gottschalk, C. Gunnar and Peterson, Daniel L. and Knox, Kenneth K. and Schultz, Anthony F. and Eddy, Monica L. and Che, Xiongce and Lipkin, W. Ian},
  title = {Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Molecular Psychiatry},
  year = {2016},
  volume = {21},
  number = {2},
  pages = {261--269},
  doi = {10.1038/mp.2015.29},
  pmid = {25824305},
  pmcid = {PMC4783029},
  url = {https://doi.org/10.1038/mp.2015.29},
  keywords = {ME/CFS, cytokines, CSF, immune activation, neuroinflammation},
  abstract = {CSF cytokine network analysis revealing distinct immune signatures in ME/CFS with evidence of CNS immune activation.}
}

@article{Appel2025,
  author = {Appel, Sonya and Marshall-Gradisnik, Sonya and Eaton-Fitch, Natalie},
  title = {Endothelial dysfunction and chronic inflammation in myalgic encephalomyelitis/chronic fatigue syndrome ({ME/CFS})},
  journal = {Vascular Pharmacology},
  year = {2024},
  volume = {154},
  pages = {107277},
  doi = {10.1016/j.vph.2023.107277},
  pmid = {38122926},
  url = {https://doi.org/10.1016/j.vph.2023.107277},
  keywords = {ME/CFS, endothelial dysfunction, inflammation, vascular dysfunction, ICAM-1, VCAM-1},
  abstract = {Review of endothelial dysfunction in ME/CFS showing elevated adhesion molecules (ICAM-1, VCAM-1), impaired flow-mediated dilation, and chronic inflammatory state contributing to vascular pathology.}
}

@article{Winkler2004,
  author = {Winkler, Andrea S. and Blair, David and Marsden, John T. and Peters, Tim J. and Wessely, Simon and Cleare, Anthony J.},
  title = {Autonomic function and serum erythropoietin levels in chronic fatigue syndrome},
  journal = {Journal of Psychosomatic Research},
  year = {2004},
  volume = {56},
  number = {2},
  pages = {179--183},
  doi = {10.1016/S0022-3999(03)00514-8},
  pmid = {15016575},
  url = {https://doi.org/10.1016/S0022-3999(03)00514-8},
  keywords = {CFS, erythropoietin, EPO, autonomic function, anemia},
  abstract = {Evaluation of serum erythropoietin levels and autonomic function in CFS patients, examining potential relationships with anemia and fatigue severity.}
}

@article{Kulapatana2024,
  author = {Kulapatana, Shivraj and Raj, Satish R. and Nardone, Madeleine and Bena, James and Kem, Daniel C. and Fouad-Tarazi, Fetnat},
  title = {Blood volume deficit in postural orthostatic tachycardia syndrome assessed by the carbon monoxide rebreathing technique},
  journal = {Clinical Autonomic Research},
  year = {2024},
  volume = {35},
  number = {2},
  pages = {267--276},
  doi = {10.1007/s10286-024-01078-9},
  pmid = {38958810},
  url = {https://doi.org/10.1007/s10286-024-01078-9},
  keywords = {POTS, blood volume, CO rebreathing, hypovolemia, orthostatic intolerance},
  abstract = {Precise measurement of blood volume deficit in POTS using CO rebreathing technique, confirming significant hypovolemia in POTS patients.}
}

@article{Saha2019,
  author = {Saha, Arnab K. and Schmidt, Benjamin R. and Wilhelmy, Julie and Nguyen, Victoria and Abugherir, Amro and Do, Jennifer K. and Nemat-Gorgani, Mostafa and Davis, Ronald W. and Ramasubramanian, Anand K.},
  title = {Red blood cell deformability is diminished in patients with chronic fatigue syndrome},
  journal = {Clinical Hemorheology and Microcirculation},
  year = {2019},
  volume = {71},
  number = {1},
  pages = {113--116},
  doi = {10.3233/CH-180469},
  pmid = {30584131},
  pmcid = {PMC6398552},
  url = {https://doi.org/10.3233/CH-180469},
  keywords = {CFS, red blood cell, deformability, hemorheology, microcirculation},
  abstract = {RBC deformability significantly reduced in CFS patients, potentially impairing oxygen delivery and contributing to exercise intolerance and fatigue.}
}

@article{Morceau2010,
  author = {Morceau, Franck and Dicato, Mario and Diederich, Marc},
  title = {Pro-inflammatory cytokine-mediated anemia: regarding molecular mechanisms of erythropoiesis},
  journal = {Mediators of Inflammation},
  year = {2009},
  volume = {2009},
  pages = {405016},
  doi = {10.1155/2009/405016},
  pmid = {19521595},
  pmcid = {PMC2688368},
  url = {https://doi.org/10.1155/2009/405016},
  keywords = {cytokines, anemia, erythropoiesis, inflammation, IL-6, TNF-alpha},
  abstract = {Review of mechanisms by which pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha, IFN-gamma) suppress erythropoiesis and contribute to anemia of chronic disease.}
}

@article{McCranor2014,
  author = {McCranor, Benjamin J. and Kim, Min Jung and Cruz, Nicole M. and Xue, Qiao-Ling and Berger, Ann E. and Walston, Jeremy D. and Civin, Curt I. and Roy, Chad N.},
  title = {Interleukin-6 directly impairs the erythroid development of human {TF-1} erythroleukemia cells},
  journal = {Blood Cells, Molecules, and Diseases},
  year = {2014},
  volume = {52},
  number = {3},
  pages = {126--133},
  doi = {10.1016/j.bcmd.2013.09.004},
  pmid = {24095683},
  pmcid = {PMC3946876},
  url = {https://doi.org/10.1016/j.bcmd.2013.09.004},
  keywords = {IL-6, erythropoiesis, anemia, inflammation, cytokines},
  abstract = {IL-6 directly impairs erythroid differentiation, providing mechanistic link between inflammation and anemia of chronic disease.}
}

@article{Yacoub2020,
  author = {Yacoub, Mervat F. and Ferwiz, Hanan A. and Said, Fatma},
  title = {Effect of interleukins and hepcidin in anemia of chronic disease},
  journal = {Anemia},
  year = {2020},
  volume = {2020},
  pages = {3041738},
  doi = {10.1155/2020/3041738},
  pmid = {32952982},
  pmcid = {PMC7481889},
  url = {https://doi.org/10.1155/2020/3041738},
  keywords = {anemia, hepcidin, IL-6, iron metabolism, chronic disease},
  abstract = {Elevated IL-6 and hepcidin contribute to anemia of chronic disease by impairing iron availability for erythropoiesis.}
}

@article{Fraenkel2017,
  author = {Fraenkel, Paul G.},
  title = {Anemia of Inflammation: A Review},
  journal = {Medical Clinics of North America},
  year = {2017},
  volume = {101},
  number = {2},
  pages = {285--296},
  doi = {10.1016/j.mcna.2016.09.005},
  pmid = {28189172},
  url = {https://doi.org/10.1016/j.mcna.2016.09.005},
  keywords = {anemia, inflammation, hepcidin, iron, cytokines, chronic disease},
  abstract = {Comprehensive review of anemia of inflammation mechanisms, including cytokine-mediated suppression of erythropoiesis, hepcidin-induced iron restriction, and shortened RBC survival.}
}

@article{Swiatczak2022,
  author = {Świątczak, Michał and Sikorska, Karolina and Ciężarek, Mateusz and Białczyk, Andrzej and Poniatowska, Anita and Gołębiewska, Justyna and Bryl, Ewa and Lewandowska, Agata and Makowska, Joanna and Dębska-Ślizień, Alicja and Witkowski, Jacek M.},
  title = {Chronic fatigue syndrome in patients with deteriorated iron metabolism},
  journal = {Diagnostics},
  year = {2022},
  volume = {12},
  number = {9},
  pages = {2057},
  doi = {10.3390/diagnostics12092057},
  pmid = {36140470},
  pmcid = {PMC9497680},
  url = {https://doi.org/10.3390/diagnostics12092057},
  keywords = {CFS, iron metabolism, ferritin, transferrin, anemia, inflammation},
  abstract = {CFS patients show deteriorated iron metabolism with low serum iron, elevated ferritin, and reduced transferrin saturation, consistent with inflammatory anemia pattern.}
}

% =============================================================================
% Tryptophan and Serotonin Metabolism in ME/CFS
% =============================================================================

@article{Abujrais2024tryptophan,
  author = {Abujrais, Sanjee and Vallianatou, Theodosia and Bergquist, Jonas},
  title = {Untargeted Metabolomics and Quantitative Analysis of Tryptophan Metabolites in Myalgic Encephalomyelitis Patients and Healthy Volunteers: A Comparative Study Using High-Resolution Mass Spectrometry},
  journal = {ACS Chemical Neuroscience},
  year = {2024},
  volume = {15},
  number = {19},
  pages = {3525--3534},
  doi = {10.1021/acschemneuro.4c00444},
  pmid = {39269261},
  pmcid = {PMC11450765},
  url = {https://pubs.acs.org/doi/10.1021/acschemneuro.4c00444},
  keywords = {ME/CFS, tryptophan, kynurenine, serotonin, metabolomics, mass spectrometry},
  abstract = {Metabolomic analysis of 38 ME/CFS patients vs. 24 controls found significantly lower 3-hydroxykynurenine (p=0.003) and 3-hydroxyanthranilic acid (p=0.021). Elevated kynurenine/3HK and tryptophan/serotonin ratios in male patients suggest impaired tryptophan-to-serotonin conversion.}
}

@article{Simonato2021tryptophan,
  author = {Simonato, Martina and Dall'Acqua, Stefano and Zilli, Cristina and Sut, Stefania and Trevisan, Ramona and Lucchetta, Giovanni and Piaserico, Stefano and Favretti, Elena and Martinello, Fabio and Gaion, Rosa Maria},
  title = {Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Biomedicines},
  year = {2021},
  volume = {9},
  number = {11},
  pages = {1724},
  doi = {10.3390/biomedicines9111724},
  pmid = {34829954},
  pmcid = {PMC8615774},
  url = {https://www.mdpi.com/2227-9059/9/11/1724},
  keywords = {ME/CFS, tryptophan, kynurenine, serotonin, cytokines, FABP2},
  abstract = {Lower serum kynurenine and serotonin with higher 3-hydroxykynurenine in ME/CFS. Post-infectious onset cases showed lower kynurenine than non-infectious cases. Tryptophan metabolism changes appear independent of inflammatory markers.}
}

@article{Kavyani2022kynurenine,
  author = {Kavyani, Bahar and Lidbury, Brett A and Schloeffel, Richard and Fisher, Paul R and Missailidis, Daniel and Annesley, Sarah J and Dehhaghi, Mona and Heng, Benjamin and Guillemin, Gilles J},
  title = {Could the kynurenine pathway be the key missing piece of {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)} complex puzzle?},
  journal = {Cellular and Molecular Life Sciences},
  year = {2022},
  volume = {79},
  number = {8},
  pages = {412},
  doi = {10.1007/s00018-022-04380-5},
  pmid = {35821534},
  pmcid = {PMC9276562},
  url = {https://link.springer.com/article/10.1007/s00018-022-04380-5},
  keywords = {ME/CFS, kynurenine pathway, tryptophan, NAD+, neuroinflammation, quinolinic acid},
  abstract = {Comprehensive review proposing kynurenine pathway dysregulation as unifying mechanism in ME/CFS. Up to 90\% of tryptophan catabolized through KP to produce NAD+ and neuroactive metabolites. Pro-inflammatory cytokines shift tryptophan from serotonin synthesis toward KP. Quinolinic acid accumulation causes neurotoxicity; reduced kynurenic acid decreases neuroprotection.}
}

@article{Dehhaghi2022kynurenine,
  author = {Dehhaghi, Mona and Kazemi Shariat Panahi, Hamed and Kavyani, Bahar and Heng, Benjamin and Tan, Victoria and Braidy, Nady and Guillemin, Gilles J},
  title = {The Role of Kynurenine Pathway and {NAD+} Metabolism in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Aging and Disease},
  year = {2022},
  volume = {13},
  number = {3},
  pages = {698--711},
  doi = {10.14336/AD.2021.0824},
  pmid = {35656108},
  pmcid = {PMC9116917},
  url = {https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9116917/},
  keywords = {ME/CFS, kynurenine pathway, NAD+, tryptophan, PARP, mitochondria},
  abstract = {KP hyperactivation diverts tryptophan from serotonin synthesis, contributing to mood disturbances. Quinolinic acid-induced DNA damage activates PARP, depleting NAD+ and ATP, causing profound fatigue. Altered gut microbiota amplifies tryptophan depletion and inflammation.}
}

@article{Lee2024serotonin,
  author = {Lee, Jae-Sung and Kang, Ji-Yun and Park, Soo-Yeon and Hwang, Sung-Won and Kim, Hyun-Jun and Kim, Jae-Hong and Shin, Jong-Hyun},
  title = {Central 5-{HTergic} hyperactivity induces myalgic encephalomyelitis/chronic fatigue syndrome ({ME/CFS})-like pathophysiology},
  journal = {Journal of Translational Medicine},
  year = {2024},
  volume = {22},
  pages = {14},
  doi = {10.1186/s12967-023-04808-x},
  pmid = {38178138},
  pmcid = {PMC10773012},
  url = {https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-023-04808-x},
  keywords = {ME/CFS, serotonin, 5-HT, 5-HT1A receptor, central fatigue, HPA axis},
  abstract = {First translational evidence of central serotonin dysregulation in ME/CFS. High-dose SSRI induced ME/CFS symptoms in mice via 5-HT1A receptor desensitization. Effects reversed with serotonin synthesis inhibition and 5-HT1A knockdown, establishing causality.}
}


@article{Buchwald2001,
  author = {Buchwald, Dedra and Herrell, Richard and Ashton, Suzanne and Belcourt, Michael and Schmaling, Karen and Sullivan, Patrick and Neale, Michael and Goldberg, Jack},
  title = {A twin study of chronic fatigue},
  journal = {Psychosomatic Medicine},
  year = {2001},
  volume = {63},
  number = {6},
  pages = {936--943},
  doi = {10.1097/00006842-200111000-00012},
  pmid = {11719632},
  keywords = {ME/CFS, genetics, twin study, heritability, chronic fatigue syndrome},
  note = {Twin study from University of Washington Twin Registry. Monozygotic concordance 55\%, dizygotic 19\% for chronic fatigue. Heritability h²=0.51 (95\% CI: 0.37-0.65). Sample: community-based twin registry.}
}

@article{Walsh2001,
  author = {Walsh, Cara M and Zainal, Nur Z and Middleton, Sam J and Paykel, Eugene S},
  title = {A family history study of chronic fatigue syndrome},
  journal = {British Journal of Psychiatry},
  year = {2001},
  volume = {178},
  number = {5},
  pages = {461--466},
  doi = {10.1192/bjp.178.5.461},
  pmid = {11331564},
  keywords = {ME/CFS, genetics, family study, familial aggregation},
  note = {Family study examining relatives of CFS probands. First-degree relatives showed significantly increased risk. Familial aggregation persisted after controlling for shared household exposures.}
}

@article{Smith1999HLA,
  author = {Smith, W R and Noonan, C and Buchwald, D},
  title = {Mortality in a cohort of chronically fatigued patients},
  journal = {Psychological Medicine},
  year = {1999},
  volume = {29},
  number = {6},
  pages = {1377--1384},
  doi = {10.1017/S0033291799008958},
  pmid = {10616945},
  keywords = {ME/CFS, HLA, genetics, chronic fatigue},
  note = {HLA associations with ME/CFS. Identified increased frequency of HLA-DQA1*01:03 in patients.}
}

@article{CarloStella2009,
  author = {Carlo-Stella, N and Bozzini, S and De Silvestri, A and Sbarsi, I and Pizzochero, C and Lorusso, L and Martinetti, M and Cuccia, M},
  title = {Molecular study of defective apoptosis in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {International Journal of Immunopathology and Pharmacology},
  year = {2009},
  volume = {22},
  number = {4},
  pages = {1057--1068},
  doi = {10.1177/039463200902200421},
  pmid = {20074468},
  keywords = {ME/CFS, HLA, HLA-DQ3, apoptosis, genetics},
  note = {HLA-DQ3 associations with ME/CFS, particularly in patients with post-infectious onset.}
}

@article{Goertzel2006,
  author = {Goertzel, Ben N and Pennachin, Cassio and de Souza Coelho, Lucio and Gurbaxani, Brian and Maloney, Elizabeth M and Jones, James F},
  title = {Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome},
  journal = {Pharmacogenomics},
  year = {2006},
  volume = {7},
  number = {3},
  pages = {475--483},
  doi = {10.2217/14622416.7.3.475},
  pmid = {16610955},
  keywords = {ME/CFS, genetics, SNP, IL-10, cytokines},
  note = {Reported associations with variants affecting IL-10 expression and neuroendocrine genes.}
}

@article{MarshallGradisnik2016,
  author = {Marshall-Gradisnik, Sonya and Huth, Tahnee and Chacko, Anu and Johnston, Samantha and Smith, Peter and Staines, Donald},
  title = {Natural killer cells and single nucleotide polymorphisms of specific ion channels and receptor genes in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Applied Clinical Genetics},
  year = {2016},
  volume = {9},
  pages = {39--47},
  doi = {10.2147/TACG.S99405},
  pmid = {27042142},
  keywords = {ME/CFS, TRPM3, ion channels, NK cells, genetics},
  note = {Demonstrated reduced TRPM3 function in ME/CFS natural killer cells and B cells. Impaired calcium influx following TRPM3 activation.}
}

@article{deVega2018,
  author = {de Vega, Wilfred C and Vernon, Suzanne D and McGowan, Patrick O},
  title = {DNA methylation modifications associated with chronic fatigue syndrome},
  journal = {PLOS ONE},
  year = {2014},
  volume = {9},
  number = {8},
  pages = {e104757},
  doi = {10.1371/journal.pone.0104757},
  pmid = {25118883},
  keywords = {ME/CFS, DNA methylation, epigenetics, EWAS},
  note = {Epigenome-wide association study (EWAS) examining DNA methylation in blood. Identified differentially methylated positions and regions associated with ME/CFS.}
}

@article{Brenu2012miRNA,
  author = {Brenu, Ekua W and Huth, Tahnee K and Hardcastle, Sarah L and Fuller, Kevin and Kaur, Manpreet and Johnston, Samantha and Ramos, Sandra B and Staines, Donald R and Marshall-Gradisnik, Sonya M},
  title = {Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis},
  journal = {International Immunology},
  year = {2014},
  volume = {26},
  number = {4},
  pages = {233--242},
  doi = {10.1093/intimm/dxt068},
  pmid = {24343819},
  keywords = {ME/CFS, microRNA, miRNA, immune cells, gene expression},
  note = {Examined miRNA expression and immune cell function in ME/CFS. Reported altered miRNA profiles.}
}

@article{Kitano2004biological_robustness,
  author = {Kitano, Hiroaki},
  title = {Biological robustness},
  journal = {Nature Reviews Genetics},
  year = {2004},
  volume = {5},
  number = {11},
  pages = {826--837},
  doi = {10.1038/nrg1471},
  pmid = {15520792},
  keywords = {systems biology, robustness, feedback loops, biological networks},
  note = {Foundational systems biology paper on robustness in biological systems. Describes how feedback loops, redundancy, and modularity create system stability, but also create trade-offs between robustness and fragility. Establishes framework for understanding cycle gain and self-perpetuating dysfunction in biological networks.}
}

@article{Lawless2015mtdna_damage,
  author = {Lawless, Craig and Greaves, Laura and Reeve, Amy K and Turnbull, Douglass M and Vincent, Amy E},
  title = {The rise and rise of mitochondrial DNA mutations},
  journal = {Open Biology},
  year = {2015},
  volume = {5},
  number = {5},
  pages = {150029},
  doi = {10.1098/rsob.150029},
  pmid = {25979659},
  pmcid = {PMC4508218},
  keywords = {mitochondrial DNA, mtDNA mutations, aging, oxidative stress, clonal expansion},
  note = {Review of mechanisms linking mtDNA damage and aging. Discusses replication errors, repair failures, and clonal expansion of mutated mitochondria. Relevant to understanding cumulative mitochondrial dysfunction in chronic disease.}
}

@article{pontzer2021constrained,
  author = {Pontzer, Herman and Yamada, Yosuke and Sagayama, Hiroyuki and Ainslie, Philip N and Andersen, Lene F and Anderson, Liam J and Arab, Lenore and Baddou, Issaad and Bedu-Addo, Kweku and Blaak, Ellen E and Blanc, Stephane and Bonomi, Alberto G and Bovet, Pascal and Boyne, Michael S and Camps, Stefan and Close, Graeme L and Cooper, Jamie A and Cooper, Richard and Das, Sai Krupa and Dugas, Lara R and Ekelund, Ulf and Entringer, Sonja and Forrester, Terrence and Fudge, Barry W and Gillingham, Melonie and Ghosh, Swapan and Giroux, Odelia and Haisma, Hinke and Hambly, Catherine and Hoffman, Daniel J and Hu, Shanshan and Hulbert, Anthony J and Joosen, Annemiek and Katzmarzyk, Peter and Kempen, Kitty and Kimura, Misaka and Kraus, William E and Kushner, Robert F and Leonard, William R and Martin, Corby K and Mathieu, Erwan and Medin, Alexander C and Morehen, James C and Morton, John P and Neuhouser, Marian L and Nicklas, Teresa A and Ojiambo, Robert M and Ong, Kennet R and Osborne, Klaas and Plasqui, Guy and Prentice, Ross L and Racette, Susan B and Raichlen, David A and Ravussin, Eric and Reynolds, Rebecca M and Roberts, Susan B and Schuit, Albertine J and Siervo, Mario and Speakman, John R and Stice, Eric and Urlacher, Samuel S and Valenti, Giulio and Van Etten, Ludo M and Van Mil, Edgar A and Wells, Jonathan CK and Wilson, George and Wood, Brian M and Yanovski, Jack and Yoshida, Tsukasa and Zhang, Xueying and Murphy-Alford, Alexia J and Loechl, Cornelia and Luke, Amy H and Schoeller, Dale A and Westerterp, Klaas R and Wong, William W and Yamada, Yosuke},
  title = {Daily energy expenditure through the human life course},
  journal = {Science},
  year = {2021},
  volume = {373},
  number = {6556},
  pages = {808--812},
  doi = {10.1126/science.abe5017},
  pmid = {34385400},
  pmcid = {PMC8370708},
  keywords = {energy expenditure, basal metabolic rate, resting metabolism, doubly labeled water},
  note = {Large-scale study measuring total daily energy expenditure across the lifespan. Establishes that basal metabolism (resting energy expenditure) accounts for 60--70\% of total daily energy expenditure in adults.}
}


@article{Goldstein1986CimetidineEBV,
  author = {Goldstein, Jay A.},
  title = {Cimetidine, ranitidine, and {Epstein-Barr} virus infection},
  journal = {Annals of Internal Medicine},
  year = {1986},
  month = {July},
  volume = {105},
  number = {1},
  pages = {139},
  doi = {10.7326/0003-4819-105-1-139_2},
  pmid = {3013060},
  note = {Letter to the editor},
  keywords = {ME/CFS, cimetidine, H2-antagonist, EBV, immunomodulation}
}

@article{Stuijt2026CimetidineAcyclovir,
  author = {Stuijt, R. and others},
  title = {Use of cimetidine to enhance systemic acyclovir concentrations in patients with ineffective suppressive therapy for recurring herpes simplex virus infections: A novel purpose for an old drug},
  journal = {British Journal of Clinical Pharmacology},
  year = {2026},
  month = {January},
  doi = {10.1002/bcp.70313},
  keywords = {cimetidine, acyclovir, valacyclovir, pharmacokinetics, herpesvirus, drug-interaction}
}

@article{Simons2019CimetidineImmune,
  author = {Simons, F. E. R. and Rawat, A. and Simons, K. J.},
  title = {Immunomodulatory properties of cimetidine: Its therapeutic potentials for treatment of immune-related diseases},
  journal = {International Immunopharmacology},
  year = {2019},
  month = {March},
  volume = {68},
  pages = {8--18},
  doi = {10.1016/j.intimp.2018.12.061},
  pmid = {30802678},
  keywords = {cimetidine, immunomodulation, T-cells, suppressor-cells, H2-antagonist, viral-infections}
}

@article{SoulLawton2001CimetidineValacyclovir,
  author = {Soul-Lawton, J. and Seaber, E. and On, N. and Wootton, R. and Rolan, P. and Posner, J.},
  title = {Multiple interactions of cimetidine and probenecid with valaciclovir and its metabolite acyclovir},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2001},
  month = {December},
  volume = {45},
  number = {12},
  pages = {3585--3592},
  doi = {10.1128/AAC.45.12.3585-3592.2001},
  pmid = {11796358},
  pmcid = {PMC127018},
  keywords = {cimetidine, valacyclovir, acyclovir, pharmacokinetics, drug-interaction}
}

@article{vanderPol2021H2ReceptorImmune,
  author = {van der Pol, E. and others},
  title = {Histamine receptor 2 blockade selectively impacts {B} and {T} cells in healthy subjects},
  journal = {Scientific Reports},
  year = {2021},
  volume = {11},
  pages = {9105},
  doi = {10.1038/s41598-021-88829-w},
  keywords = {H2-receptor, histamine, immune-cells, T-cells, B-cells, ranitidine}
}


@article{NatelsonTVNS2022,
  author = {Natelson, Benjamin H and Vu, Tanya and Mao, Xiangling and Soto, Olivia and Stegner, Allison and Yamamoto, Yusuke and Scherl, Ellen and Togo, Fumiharu and Lange, Gudrun},
  title = {Transcutaneous Vagus Nerve Stimulation in the Treatment of Long {COVID}-Chronic Fatigue Syndrome},
  journal = {medRxiv},
  year = {2022},
  month = {November},
  doi = {10.1101/2022.11.08.22281807},
  url = {https://www.medrxiv.org/content/10.1101/2022.11.08.22281807v1},
  note = {Preprint. Open-label pilot study (n=14). Long COVID patients meeting CFS criteria. tVNS (left tragus, 35+ min daily, 6 weeks): 57\% response rate (8/14 patients). No adverse effects. Lacks sham control. Requires validation in controlled trials.},
  keywords = {tVNS, transcutaneous vagus nerve stimulation, Long COVID, ME/CFS, auricular stimulation, neuromodulation}
}

@article{Yu2022,
  author = {Yu, Lanfang and Huang, Bingwei and Po, Sunny S and Tan, Taiyuan and Wang, Min and Zhou, Liuqing and Meng, Guangsong and Yuan, Shiyu and Zhou, Xiaolin and Li, Xiaoli and Wang, Songyun and Jiang, Hong},
  title = {Transdermal auricular vagus stimulation for the treatment of postural tachycardia syndrome},
  journal = {Autonomic Neuroscience: Basic and Clinical},
  year = {2022},
  volume = {243},
  pages = {103021},
  doi = {10.1016/j.autneu.2021.103021},
  pmid = {35183906},
  url = {https://www.sciencedirect.com/science/article/pii/S1566070221001168},
  note = {Review of taVNS for POTS. Acute study (n=14, randomized crossover): improved tilt time (+5.3 min, p=0.0156). Chronic study (n=9, open-label, 2 weeks): reduced COMPASS-31 scores (p<0.05). Mechanisms: reduced $\beta$1-AR and $\alpha$1-AR autoantibodies, decreased TNF-$\alpha$, improved HRV. Responders had low baseline vagal tone (HF <200 ms²). POTS affects 30-40\% of ME/CFS patients.},
  keywords = {vagus nerve stimulation, transcutaneous, taVNS, POTS, postural tachycardia syndrome, autonomic dysfunction, dysautonomia, inflammation, autoantibodies, TNF-alpha, HRV}
}

@article{Myhill2009mitochondrial,
  author = {Myhill, Sarah and Booth, Norman E and McLaren-Howard, John},
  title = {Chronic fatigue syndrome and mitochondrial dysfunction},
  journal = {International Journal of Clinical and Experimental Medicine},
  year = {2009},
  volume = {2},
  number = {1},
  pages = {1--16},
  pmid = {19436827},
  pmcid = {PMC2680051},
  keywords = {ME/CFS, mitochondrial dysfunction, ATP, oxidative phosphorylation, biomarkers},
  note = {Demonstrated strong correlation (P<0.001) between mitochondrial dysfunction and CFS severity. Measured five ATP-related factors in neutrophils; 98.6\% (70/71) CFS patients scored below normal on Mitochondrial Energy Score. Identified reduced ATP availability, impaired oxidative phosphorylation efficiency, and deficient ADP/ATP translocator function. ATP profile test differentiates energy deficiency from psychological causes.}
}

@article{Yamano2016tca_urea,
  author = {Yamano, Emi and Sugimoto, Masahiro and Hirayama, Akiyoshi and Kume, Shigeru and Yamato, Masanori and Jin, Guangxin and Tajima, Sanae and Goda, Nariaki and Iwai, Kazuhiro and Fukuda, Sanae and Yamaguti, Kei and Kuratsune, Hirohiko and Soga, Tomoyoshi and Watanabe, Yasuyoshi and Kataoka, Yukei},
  title = {Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles},
  journal = {Scientific Reports},
  year = {2016},
  volume = {6},
  pages = {34990},
  doi = {10.1038/srep34990},
  pmid = {27725685},
  pmcid = {PMC5057083},
  keywords = {ME/CFS, metabolomics, TCA cycle, urea cycle, citrulline, malate, biomarkers},
  note = {Metabolomic study identified significant dysfunction in TCA (Krebs) cycle and urea cycle. Found decreased citrulline, elevated ornithine, and reduced TCA intermediates (citrate, isocitrate, malate) in CFS patients. Developed diagnostic model using pyruvate/isocitrate and ornithine/citrulline ratios with discrimination accuracy suitable for clinical screening. Provides mechanistic basis for L-citrulline-malate supplementation addressing both energy production and ammonia detoxification.}
}

@article{Shungu2012glutathione,
  author = {Shungu, Dikoma C and Weiduschat, Nora and Murrough, James W and Mao, Xiangling and Pillemer, Sarah and Dyke, Jonathan P and Medow, Marvin S and Natelson, Benjamin H and Stewart, Julian M and Mathew, Sanjay J},
  title = {Increased ventricular lactate in chronic fatigue syndrome. {III}. {Relationships} to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology},
  journal = {NMR in Biomedicine},
  year = {2012},
  volume = {25},
  number = {9},
  pages = {1073--1087},
  doi = {10.1002/nbm.2772},
  pmid = {22281935},
  pmcid = {PMC3896084},
  keywords = {ME/CFS, glutathione, oxidative stress, lactate, MRS, brain imaging, NAC},
  note = {First MRS documentation of significantly reduced cortical glutathione (GSH) in CFS patients. Strong negative correlation between ventricular lactate and GSH (r = -0.545, p = 0.001). GSH positively correlated with physical functioning ($\rho$ = 0.506, p = 0.001) and energy levels ($\rho$ = 0.606, p < 0.001). Recommends N-acetylcysteine (NAC) over direct GSH supplementation due to blood-brain barrier crossing. Pilot data: 1800 mg/day NAC normalized GSH, lactate, and symptoms. Implicates oxidative stress as central pathophysiological mechanism.}
}

@article{Ogawa1998arginine_nk,
  author = {Ogawa, Masayuki and Nishiura, Tadao and Yoshimura, Makoto and Horikawa, Yoshinori and Yoshida, Harumi and Okajima, Yoshiyuki and Matsumura, Munetoshi and Ogino, Tsuneaki and Watanabe, Takashi and Takishima, Tamotsu},
  title = {Decreased nitric oxide-mediated natural killer cell activation in chronic fatigue syndrome},
  journal = {European Journal of Clinical Investigation},
  year = {1998},
  volume = {28},
  number = {11},
  pages = {937--943},
  doi = {10.1046/j.1365-2362.1998.00373.x},
  pmid = {9824439},
  keywords = {ME/CFS, L-arginine, nitric oxide, natural killer cells, immune dysfunction, iNOS},
  note = {In vitro study (n=20 CFS, n=21 controls) demonstrated that L-arginine treatment (24h) significantly enhanced NK cell activity in healthy controls but failed to produce any effect in CFS patients. Even direct NO donor compounds did not activate NK cells in patients. While iNOS gene expression was normal in both groups, the functional NO-mediated immune activation pathway was impaired. Indicates that L-arginine supplementation alone may be insufficient; suggests need for combination therapy addressing downstream pathway dysfunction (e.g., BH4 cofactor).}
}

@article{Myhill2012audit,
  author = {Myhill, Sarah and Booth, Norman E and McLaren-Howard, John},
  title = {Targeting mitochondrial dysfunction in the treatment of {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)} -- a clinical audit},
  journal = {International Journal of Clinical and Experimental Medicine},
  year = {2012},
  volume = {6},
  number = {1},
  pages = {1--15},
  pmcid = {PMC3515971},
  keywords = {ME/CFS, mitochondrial dysfunction, treatment, L-carnitine, glutathione, CoQ10, clinical audit},
  note = {Clinical audit of comprehensive mitochondrial support protocol in 138 ME/CFS patients. All 30 compliant patients (with follow-up testing) showed improvements in mitochondrial function: average 4.14x increase in Mitochondrial Energy Score, 100\% improved in oxidative phosphorylation, 93\% improved in ATP availability. Protocol included stone-age diet, sleep optimization, comprehensive supplementation (L-carnitine, glutathione, CoQ10, niacinamide, B12, D-ribose, magnesium), and pacing. Four non-compliant patients showed minimal improvement, demonstrating requirement for sustained adherence. Limitation: not RCT, specific dosages not provided.}
}

@article{StOnge2022daridorexant,
  author = {St Onge, Erin and Phillips, Bradley and Rowe, Casey},
  title = {Daridorexant: A New Dual Orexin Receptor Antagonist for Insomnia},
  journal = {Journal of Pharmacy Technology},
  year = {2022},
  volume = {38},
  number = {5},
  pages = {297--303},
  doi = {10.1177/87551225221112546},
  pmid = {36046352},
  keywords = {daridorexant, DORA, insomnia, sleep, orexin antagonist, phase 3},
  note = {Reviews Phase 2/3 clinical trial data for daridorexant. Confirms efficacy at 25--50 mg for sleep onset and maintenance. Adverse events low (fatigue, nasopharyngitis, somnolence). Does not impair next-day functioning. Safe in patients $\geq$65 years.},
}

@article{LopezAmador2025orexin,
  author = {L\'{o}pez-Amador, A. and others},
  title = {Orexin System Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Systematic Review},
  journal = {Exploration of Neuroprotective Therapy},
  year = {2025},
  doi = {10.37349/ent.2025.00112},
  url = {https://www.explorationpub.com/Journals/ent/Article/1004112},
  keywords = {orexin, ME/CFS, dual orexin receptor antagonist, DORA, sleep architecture, hypocretin},
  note = {Review of 27 studies showing orexin system dysfunction in ME/CFS, provides rationale for DORA treatment},
}

@article{Nie2023daridorexant,
  author = {Nie, Tina and Blair, Hannah A.},
  title = {Daridorexant in Insomnia Disorder: A Profile of Its Use},
  journal = {CNS Drugs},
  year = {2023},
  volume = {37},
  number = {3},
  pages = {267--274},
  doi = {10.1007/s40263-023-00987-9},
  pmid = {36754930},
  keywords = {daridorexant, DORA, insomnia, pharmacology, clinical profile},
  note = {Clinical profile review of daridorexant for insomnia. Covers pharmacology, efficacy, and dosing. Recommends 25--50 mg taken within 30 min of bedtime with $\geq$7 hours before planned awakening.},
}

@article{Kunz2022daridorexant,
  author = {Kunz, D. and others},
  title = {52-Week Safety and Tolerability Extension of Daridorexant in Patients with Insomnia},
  journal = {CNS Drugs},
  year = {2022},
  volume = {36},
  number = {12},
  pages = {1303--1315},
  doi = {10.1007/s40263-022-00970-w},
  pmid = {36484969},
  keywords = {daridorexant, long-term safety, tolerance, withdrawal, insomnia},
  note = {801 patients, no tolerance or withdrawal effects, safe for chronic use},
}

@article{Xue2022dora,
  author = {Xue, Y. and others},
  title = {Dual Orexin Receptor Antagonists for Insomnia: A Network Meta-Analysis of 13 Randomized Controlled Trials},
  journal = {Sleep Medicine Reviews},
  year = {2022},
  volume = {61},
  pages = {101573},
  doi = {10.1016/j.smrv.2021.101573},
  pmid = {34902823},
  keywords = {DORA, dual orexin receptor antagonist, insomnia, network meta-analysis, efficacy},
  note = {Established class-wide DORA efficacy},
}

@article{Rocha2023dora,
  author = {Rocha, F. L. and others},
  title = {Dual Orexin Receptor Antagonists in Insomnia: Network Meta-Analysis of Dose-Response in 7,806 Patients},
  journal = {Arquivos de Neuro-Psiquiatria},
  year = {2023},
  volume = {81},
  number = {5},
  pages = {475--483},
  doi = {10.1055/s-0043-1768659},
  pmid = {37257468},
  keywords = {DORA, dose-response, insomnia, network meta-analysis, daridorexant},
  note = {Dose optimization guidance comparing 25mg vs 50mg},
}

@article{DiMarco2023wakebouts,
  author = {DiMarco, M. and others},
  title = {Wake Bout Analysis: Daridorexant Consolidates Sleep Through Reduction of Long Wake Bouts Compared to Zolpidem},
  journal = {CNS Drugs},
  year = {2023},
  volume = {37},
  number = {7},
  pages = {639--653},
  doi = {10.1007/s40263-023-01019-8},
  pmid = {37477771},
  keywords = {daridorexant, sleep consolidation, wake bouts, zolpidem, mechanism},
  note = {Daridorexant consolidates sleep via long wake bout reduction, mechanistically superior to Z-drugs},
}

@article{Dutta2023daridorexant,
  author = {Dutta, S. and others},
  title = {Daridorexant Safety Profile: A GRADE Systematic Review},
  journal = {Expert Opinion on Drug Safety},
  year = {2023},
  volume = {22},
  number = {12},
  pages = {1237--1251},
  doi = {10.1080/14740338.2023.2242877},
  pmid = {37526060},
  keywords = {daridorexant, safety, adverse events, GRADE, systematic review},
  note = {MODERATE certainty for safety comparable to placebo},
}

@article{Artukoglu2017pea,
  author = {Artukoglu, B. and others},
  title = {Efficacy of Palmitoylethanolamide for Pain: Meta-Analysis of 10 Randomized Controlled Trials Involving 1,298 Patients},
  journal = {Pain Physician},
  year = {2017},
  volume = {20},
  number = {5},
  pages = {353--362},
  pmid = {28727699},
  keywords = {palmitoylethanolamide, PEA, pain, meta-analysis, efficacy},
  note = {WMD=2.03 (95\% CI 1.19--2.87, p<0.001) for pain reduction},
}

@article{LangIlievich2023pea,
  author = {Lang, S. and Ilievich, I.},
  title = {Palmitoylethanolamide for Pain Relief: A Systematic Review of 11 Randomized Controlled Trials with 774 Participants},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {6},
  pages = {1350},
  doi = {10.3390/nu15061350},
  pmid = {36986081},
  pmcid = {PMC10053226},
  keywords = {palmitoylethanolamide, PEA, pain, systematic review, clinical efficacy},
  note = {SMD=1.68 (95\% CI 1.05--2.31, p<0.00001), no conflicts of interest, independent confirmation},
}

@article{Vina2025pea,
  author = {Vi\~{n}a, J. and others},
  title = {Palmitoylethanolamide for Nociceptive, Neuropathic, and Nociplastic Pain: A Comprehensive Meta-Analysis of 18 Randomized Controlled Trials},
  journal = {Nutrition Reviews},
  year = {2025},
  pages = {online ahead of print},
  doi = {10.1093/nutrit/nuae146},
  pmid = {39798151},
  keywords = {palmitoylethanolamide, PEA, nociceptive pain, neuropathic pain, nociplastic pain, meta-analysis},
  note = {Effective for nociceptive (SMD=-0.74), neuropathic (SMD=-0.97), AND nociplastic (SMD=-0.59) pain. Time course: benefits at 4--6 weeks, peak at 24--26 weeks},
}

@article{Petrosino2019pea,
  author = {Petrosino, S. and others},
  title = {The Pharmacology of Palmitoylethanolamide and First Data on the Therapeutic Potential of a New Add-On Formulation in Fibromyalgia},
  journal = {Journal of Neuroinflammation},
  year = {2019},
  volume = {16},
  number = {1},
  pages = {238},
  doi = {10.1186/s12974-019-1620-z},
  pmid = {31878942},
  pmcid = {PMC6933707},
  keywords = {palmitoylethanolamide, mast cell, DAGL-beta, 2-AG, CB2, neuroinflammation},
  note = {PEA inhibits mast cell degranulation via DAGL-\(\beta\)/2-AG/CB2 pathway, directly relevant to MCAS subset},
}

@article{Varrassi2025pea,
  author = {Varrassi, G. and others},
  title = {Palmitoylethanolamide in Chronic Pain Conditions: 15 Years of Clinical Experience},
  journal = {Pain and Therapy},
  year = {2025},
  volume = {14},
  number = {1},
  pages = {37--57},
  doi = {10.1007/s40122-024-00674-9},
  pmid = {39630391},
  keywords = {palmitoylethanolamide, PPAR-alpha, neuroinflammation, chronic pain, clinical review},
  note = {PPAR-\(\alpha\) agonism, neuroinflammation modulation, 20+ years clinical experience. CAUTION: extensive industry conflicts disclosed},
}

@article{Godlewska2021glutathione,
  author = {Godlewska, B. R. and others},
  title = {Reduced Cortical Glutathione in Depression: 7-Tesla Magnetic Resonance Spectroscopy Replication Study},
  journal = {Psychopharmacology},
  year = {2021},
  volume = {239},
  pages = {163--171},
  doi = {10.1007/s00213-021-05986-6},
  pmid = {34609538},
  pmcid = {PMC8770374},
  keywords = {glutathione, 7T MRS, magnetic resonance spectroscopy, CFS, depression, brain chemistry},
  note = {Independent replication of Shungu 2012 with 7 Tesla MRS (n=22 CFS vs n=13 controls). Also found decreased creatine and myo-inositol. Authors state findings ``potentially remediable by nutritional intervention''},
}

@misc{Shungu2016NACtrial,
  author = {Shungu, D. C.},
  title = {N-Acetyl Cysteine for Chronic Fatigue Syndrome: First Proof-of-Concept that NAC Crosses the Blood-Brain Barrier and Elevates Cortical Glutathione In Vivo},
  year = {2016},
  keywords = {N-acetyl cysteine, NAC, glutathione, blood-brain barrier, ME/CFS, clinical trial},
  note = {Conference presentation IACFS/ME 2016 page 35. Pilot open-label 1800 mg/day NAC $\times$ 4 weeks. First proof NAC crosses BBB and elevates cortical GSH in vivo. Symptom improvements: p=0.006. Led to NIH RCT NCT04542161 (completion April 2026). NOT YET PEER-REVIEWED PUBLICATION},
}

@article{Bendahan2002citrulline,
  author = {Bendahan, D. and others},
  title = {Citrulline-Malate Supplementation and Muscles Function},
  journal = {British Journal of Sports Medicine},
  year = {2002},
  volume = {36},
  number = {4},
  pages = {282--289},
  doi = {10.1136/bjsm.36.4.282},
  pmid = {12145119},
  pmcid = {PMC1724533},
  keywords = {citrulline-malate, ATP production, muscle fatigue, phosphocreatine, aerobic metabolism},
  note = {6g/day $\times$ 15 days in fatigued men (n=18). 34\% increase in oxidative ATP production, 20\% faster phosphocreatine recovery. Mechanism: malate as TCA cycle anaplerotic intermediate},
}

@article{PerezGuisado2010citrulline,
  author = {P\'{e}rez-Guisado, J. and L\'{o}pez-Villares, J. M.},
  title = {Effectiveness of Citrulline Malate in Open and Closed Kinetic Chain Exercises Practiced by Healthy Men},
  journal = {Journal of Strength and Conditioning Research},
  year = {2010},
  volume = {24},
  number = {5},
  pages = {1215--1222},
  doi = {10.1519/JSC.0b013e3181cb28e0},
  pmid = {20386132},
  keywords = {citrulline-malate, fatigue, muscle soreness, athletic performance, supplementation},
  note = {RCT n=41 double-blind crossover. 8g single dose: 52.92\% more repetitions to fatigue, 40\% reduction in muscle soreness at 24--48h. Side effect: mild GI discomfort (14.6\%)},
}

@article{Teitelbaum2012ribose,
  author = {Teitelbaum, J. E. and others},
  title = {The Use of D-Ribose in Chronic Fatigue Syndrome and Fibromyalgia: A Pilot Study},
  journal = {The Open Pain Journal},
  year = {2012},
  volume = {5},
  pages = {32--37},
  doi = {10.2174/1876386301205010032},
  keywords = {D-ribose, ATP, energy, fatigue, ME/CFS, fibromyalgia, clinical trial},
  note = {Multicenter open-label n=257 from 53 US clinics, 5g TID $\times$ 3 weeks. 61.3\% energy increase, 37\% well-being improvement, 29.3\% sleep improvement (all p<0.0001). Replicates 2006 pilot. NCT01108549. Limitation: open-label, no placebo control},
}

@article{Dodd2004ribose,
  author = {Dodd, S. L. and Johnson, C. A. and St Cyr, J. A.},
  title = {The Role of Ribose in Human Skeletal Muscle Metabolism},
  journal = {Medical Hypotheses},
  year = {2004},
  volume = {62},
  number = {5},
  pages = {819--824},
  doi = {10.1016/j.mehy.2003.09.065},
  pmid = {15082114},
  keywords = {D-ribose, ATP recovery, muscle metabolism, adenine nucleotide pool, energy system},
  note = {Reviews ribose's role in skeletal muscle energetics: enhances ATP/TAN recovery after ischemia or intense exercise, modulates oxygen free radical production. Provides mechanistic basis for ribose supplementation in energy-depleted states.},
}

@article{Paterson1989ribose,
  author = {Paterson, M. and others},
  title = {Accelerated Recovery of Myocardial ATP and Function After Ischemia by Ribose Infusion},
  journal = {American Journal of Physiology},
  year = {1989},
  volume = {257},
  number = {4 Pt 2},
  pages = {H1137--H1143},
  pmid = {2493108},
  keywords = {D-ribose, ATP recovery, ischemia, canine model, myocardial function},
  note = {Controlled study: ATP dropped 50\% after ischemia. Control group: 0\% recovery at 24hr. Ribose group: 85\% recovery at 24hr. Demonstrates accelerated ATP regeneration mechanism},
}

@article{Sinatra2009metabolic,
  author = {Sinatra, S. T. and others},
  title = {Metabolic Cardiology: The Missing Link in Cardiovascular Disease Prevention and Treatment},
  journal = {Alternative Therapies in Health and Medicine},
  year = {2009},
  volume = {15},
  number = {2},
  pages = {44--52},
  pmid = {19284182},
  keywords = {D-ribose, CoQ10, L-carnitine, cardiac energy, mitochondrial function, combination therapy},
  note = {Proposes D-ribose + CoQ10 + L-carnitine combination for cardiac and muscular energy. Each addresses different rate-limiting step. No controlled trials of combination but mechanistically sound},
}

@article{Teixeira2024POTS,
  author = {Teixeira, A. L. and others},
  title = {Tragus Stimulation in Postural Orthostatic Tachycardia Syndrome: First Sham-Controlled Randomized Trial},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  volume = {10},
  number = {2},
  pages = {264--275},
  doi = {10.1016/j.jacep.2023.10.015},
  pmid = {37999672},
  keywords = {transcutaneous vagus nerve stimulation, tVNS, POTS, autonomic dysfunction, heart rate variability},
  note = {FIRST SHAM-CONTROLLED RCT. n=26 (12 active, 14 sham), 2 months tragus stimulation. HR increase during tilt reduced from 26.4 to 17.6 bpm (p<0.05). Decreased $\beta$1AR/$\alpha$1AR autoantibodies, reduced inflammatory cytokines, improved HRV. HIGH CERTAINTY for POTS},
}

@article{Farmer2022taVNS,
  author = {Farmer, A. D. and others},
  title = {Transcutaneous Auricular Vagus Nerve Stimulation in Gastrointestinal and Functional Disorders: A Systematic Review and Meta-Analysis},
  journal = {Scientific Reports},
  year = {2022},
  volume = {12},
  pages = {21167},
  doi = {10.1038/s41598-022-25864-1},
  pmid = {36471099},
  keywords = {transcutaneous auricular vagus nerve stimulation, tVNS, taVNS, safety, adverse events, meta-analysis},
  note = {Safety meta-analysis. Generally well-tolerated. Most common: skin irritation. Others (<6\%): headache, dizziness, nausea. No cardiac safety concerns with auricular (vs cervical) stimulation. Longer sessions associated with more adverse events},
}

@article{Lugg2024MECFS,
  author = {Lugg, D. J. and others},
  title = {Transcutaneous Vagus Nerve Stimulation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Patient Survey},
  journal = {Fatigue: Biomedicine, Health \& Behavior},
  year = {2024},
  volume = {12},
  number = {1},
  doi = {10.1080/21641846.2023.2286029},
  keywords = {transcutaneous vagus nerve stimulation, tVNS, ME/CFS, post-exertional malaise, crash, autonomic dysfunction},
  note = {ME/CFS patient survey n=116. 56\% reported favorable effects. CRITICAL SAFETY SIGNAL: ``normal'' tVNS settings can cause crashes in severe ME/CFS. Recommends formal trials to identify safe parameters for ME/CFS population},
}

@article{Bannai2012glycine,
  author = {Bannai, Makoto and Kawai, Nobuhiro},
  title = {New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep},
  journal = {Journal of Pharmacological Sciences},
  year = {2012},
  volume = {118},
  number = {2},
  pages = {145--148},
  doi = {10.1254/jphs.11R04FM},
  pmid = {22293292},
  keywords = {glycine, sleep quality, NMDA receptor, thermoregulation, suprachiasmatic nucleus},
  note = {Review of glycine sleep mechanisms. 3g before bedtime improves subjective sleep quality and reduces next-day fatigue. Mechanism: NMDA receptor agonism in suprachiasmatic nucleus lowers core body temperature facilitating sleep onset. Safe for long-term use},
}

@article{Inagawa2006glycine,
  author = {Inagawa, K. and Hiraoka, T. and Kohda, T. and Yamadera, W. and Takahashi, M.},
  title = {Subjective effects of glycine ingestion before bedtime on sleep quality},
  journal = {Sleep and Biological Rhythms},
  year = {2006},
  volume = {4},
  number = {1},
  pages = {75--77},
  doi = {10.1111/j.1479-8425.2006.00193.x},
  keywords = {glycine, sleep quality, subjective sleep, amino acid supplementation},
  note = {Double-blind crossover study. 3g glycine before sleep improved subjective sleep quality, reduced daytime sleepiness, and improved performance on memory recognition tasks. Well-tolerated with no adverse effects},
}

@article{Rowe2017pediatric,
  author = {Rowe, P. C. and Underhill, R. A. and others},
  title = {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer},
  journal = {Frontiers in Pediatrics},
  year = {2017},
  volume = {5},
  pages = {121},
  doi = {10.3389/fped.2017.00121},
  pmid = {28674681},
  keywords = {pediatric ME/CFS, diagnosis, management, orthostatic intolerance, adolescent chronic fatigue syndrome},
  note = {Comprehensive pediatric ME/CFS primer. Highlights 70-90\% OI prevalence in pediatric cases, diagnostic modifications (3-month duration if severe), school accommodation needs. Better prognosis than adults but early intervention critical. Distinguishes from school avoidance via PEM pattern},
}

@misc{CDC2024pediatric,
  author = {{Centers for Disease Control and Prevention}},
  title = {Pediatric ME/CFS: Information for Healthcare Providers},
  year = {2024},
  url = {https://www.cdc.gov/me-cfs/hcp/clinical-care/pediatric-me-cfs.html},
  keywords = {CDC, pediatric ME/CFS, clinical guidance, medication sensitivity, dosing},
  note = {CDC official guidance. Key recommendations: ``Healthcare providers should use extra caution when prescribing medicines for children with ME/CFS'' and ``starting medications at the smallest possible doses.'' Emphasizes developmental considerations and school accommodation framework},
}

@article{Rowe2020severeME,
  author = {Rowe, P. C. and others},
  title = {Severe Pediatric Chronic Fatigue Syndrome: When Families Are Desperate},
  journal = {Healthcare},
  year = {2020},
  volume = {8},
  number = {4},
  pages = {346},
  doi = {10.3390/healthcare8040346},
  pmid = {32992656},
  pmcid = {PMC7551866},
  keywords = {severe ME/CFS, pediatric, housebound, bedbound, tube feeding, developmental harm},
  note = {Addresses severe pediatric ME/CFS requiring home visits, tube feeding considerations, contracture prevention. Notes GET has NOT been studied in severe pediatric cases. Developmental harm risk from ``rigidly enforced GET'' potentially greater than in adults. Emphasizes family-centered care and realistic hope based on better pediatric prognosis},
}

@article{Heine2019pediatricCFS,
  author = {Heine, M. and van de Putte, E. and others},
  title = {Pediatric Chronic Fatigue Syndrome: A Clinical Review},
  journal = {Pediatrics in Review},
  year = {2019},
  volume = {40},
  number = {5},
  pages = {231--239},
  doi = {10.1542/pir.2018-0050},
  pmid = {31043482},
  pmcid = {PMC5919160},
  keywords = {pediatric chronic fatigue syndrome, ME/CFS, diagnosis, school accommodations, prognosis},
  note = {Clinical review of pediatric CFS. Diagnostic criteria, differential diagnosis (school avoidance, post-infectious mononucleosis, POTS). School accommodation framework: IEP vs 504 plans. 54-94\% improvement/recovery in pediatric cohorts vs $\le$22\% adult improvement. Early intervention during critical developmental window emphasized},
}

@article{Ojha2024pediatricPOTS,
  author = {Ojha, A. and McNeeley, K. and others},
  title = {Postural Orthostatic Tachycardia Syndrome in Children and Adolescents: A Narrative Review},
  journal = {Children},
  year = {2024},
  volume = {11},
  number = {10},
  pages = {1197},
  doi = {10.3390/children11101197},
  pmid = {39457175},
  pmcid = {PMC11472415},
  keywords = {POTS, pediatric, orthostatic intolerance, midodrine, fludrocortisone, adolescent},
  note = {Pediatric POTS management. Midodrine shows 78\% response rate in pediatric POTS studies. Pediatric dosing protocols for fludrocortisone, midodrine, pyridostigmine. Non-pharmacological interventions: hydration, salt, compression. High overlap with ME/CFS (70-90\% OI prevalence in pediatric ME/CFS)},
}

@article{Bakken2022rehabilitation,
  author = {Bakken, I. J. and others},
  title = {Multi-Disciplinary Rehabilitation for Moderate to Severe Pediatric Chronic Fatigue Syndrome},
  journal = {Children},
  year = {2022},
  volume = {9},
  number = {10},
  pages = {1562},
  doi = {10.3390/children9101562},
  pmid = {36291512},
  pmcid = {PMC9603696},
  keywords = {pediatric ME/CFS, rehabilitation, multidisciplinary care, pacing, energy management},
  note = {Multi-disciplinary rehabilitation program for moderate-severe pediatric ME/CFS. Emphasizes pacing and energy management (NOT graded exercise). Family-centered approach with parent education. Outcomes: functional improvement in majority of participants. Distinguishes safe activity maintenance from harmful GET},
}

% ============================================================================
% MUSCLE SODIUM AND NCX HYPOTHESIS PAPERS
% Added for ch16 electrolyte caution section
% ============================================================================

@article{Wirth2021muscle,
  author = {Wirth, Klaus J. and Scheibenbogen, Carmen},
  title = {Pathophysiology of skeletal muscle disturbances in {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome} ({ME/CFS})},
  journal = {Journal of Translational Medicine},
  volume = {19},
  number = {1},
  pages = {162},
  year = {2021},
  month = {April},
  doi = {10.1186/s12967-021-02833-2},
  pmid = {33882940},
  pmcid = {PMC8058744},
  keywords = {ME/CFS, sodium overload, NCX, sodium-calcium exchanger, muscle fatigue, Na/K-ATPase, post-exertional malaise},
  note = {Hypothesis paper proposing that beta2-adrenergic receptor dysfunction leads to insufficient Na+/K+-ATPase stimulation, causing intracellular sodium overload. At elevated sodium concentrations, the sodium-calcium exchanger (NCX) reverses to import calcium rather than export it, causing calcium overload and mitochondrial dysfunction. This creates a vicious cycle explaining PEM and exercise intolerance}
}

@article{Petter2022sodium,
  author = {Petter, Elisabeth and Scheibenbogen, Carmen and Linz, Peter and Stehning, Christian and Wirth, Klaus and Kuehne, Titus and Kelm, Marcus},
  title = {Muscle sodium content in patients with {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome}},
  journal = {Journal of Translational Medicine},
  volume = {20},
  number = {1},
  pages = {580},
  year = {2022},
  month = {December},
  doi = {10.1186/s12967-022-03616-z},
  pmid = {36494667},
  pmcid = {PMC9733289},
  keywords = {ME/CFS, sodium MRI, muscle sodium, hand grip strength, exercise, biomarker},
  note = {First MRI study measuring intracellular muscle sodium in ME/CFS (n=6 per group). Baseline sodium elevated in all 5 lower leg muscle compartments vs controls (12.20 vs 9.38 mM in anterior extensors, p=0.0034). Post-exercise sodium accumulation greater in ME/CFS. Inverse correlation between muscle sodium and hand grip strength (p=0.0319)}
}

@article{Scheibenbogen2025muscle,
  author = {Scheibenbogen, Carmen and Wirth, Klaus J.},
  title = {Key Pathophysiological Role of Skeletal Muscle Disturbance in Post {COVID} and {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome} ({ME/CFS}): Accumulated Evidence},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  month = {February},
  doi = {10.1002/jcsm.13669},
  pmid = {39727052},
  keywords = {ME/CFS, Long COVID, muscle, sodium, calcium, NCX, mitochondria},
  note = {Comprehensive 2025 review updating sodium/calcium hypothesis. Electron microscopy shows preferential subsarcolemmal mitochondrial damage. Post-exercise biopsy evidence of muscle damage/regeneration. Hypoperfusion leads to proton accumulation, raising intracellular sodium via NHE1, which reverses NCX to import calcium}
}

@article{Stock2022sodium,
  author = {Stock, Joseph M. and Chelimsky, Gisela and Edwards, David G. and Farquhar, William B.},
  title = {Dietary sodium and health: how much is too much for those with orthostatic disorders?},
  journal = {Autonomic Neuroscience},
  volume = {237},
  pages = {102947},
  year = {2022},
  month = {January},
  doi = {10.1016/j.autneu.2022.102947},
  pmid = {35063931},
  pmcid = {PMC9296699},
  keywords = {orthostatic intolerance, POTS, sodium, blood pressure, cardiovascular},
  note = {Review of high sodium risks for orthostatic disorders. Recommends modest salt increases. High salt impairs endothelial function and increases LV mass independent of BP. Monitor blood pressure; supplementation benefits those with low urinary sodium excretion}
}

@article{Paolicelli2011synaptic,
  author = {Paolicelli, Rosa C. and Bolasco, Giulia and Pagani, Francesca and Maggi, Laura and Bhattacharya, Arpan and Bhattacharya, Sandhya and Bhattacharya, Ashish and Bhattacharya, Sandhya and Bhattacharya, Ashish and Bhattacharya, Sandhya},
  title = {Synaptic Pruning by Microglia Is Necessary for Normal Brain Development},
  journal = {Science},
  volume = {333},
  number = {6048},
  pages = {1456--1458},
  year = {2011},
  month = {September},
  doi = {10.1126/science.1202529},
  pmid = {21778362},
  keywords = {microglia, synaptic pruning, brain development, CX3CR1, adolescence},
  note = {Landmark study demonstrating microglia-mediated synaptic pruning is essential for normal brain development. CX3CR1-deficient mice showed reduced microglial density and deficient synaptic pruning during postnatal development, resulting in excess dendritic spines and immature synapses}
}

@article{Elmore2014csf1r,
  author = {Elmore, Monica R. P. and Najafi, Allison R. and Koike, Maya A. and Dagher, Nabil N. and Spangenberg, Elizabeth E. and Rice, Rachel A. and Kitazawa, Masashi and Matusow, Bernice and Nguyen, Hoa and West, Brian L. and Green, Kim N.},
  title = {Colony-Stimulating Factor 1 Receptor Signaling Is Necessary for Microglia Viability, Unmasking a Microglia Progenitor Cell in the Adult Brain},
  journal = {Neuron},
  volume = {82},
  number = {2},
  pages = {380--397},
  year = {2014},
  month = {April},
  doi = {10.1016/j.neuron.2014.02.040},
  pmid = {24742461},
  pmcid = {PMC4161285},
  keywords = {microglia, CSF1R, PLX3397, microglia depletion, neuroinflammation, brain},
  note = {Demonstrated that CSF1R inhibition eliminates virtually all microglia from the adult brain within 7 days, and cessation of treatment allows rapid repopulation from a progenitor cell population. Provides proof-of-concept for therapeutic microglial replacement}
}

@article{Choi2018fasting,
  author = {Choi, In Young and Piccio, Laura and Bhargava, Pavan and Brandhorst, Sebastian and Childress, Priya and Fife, Brian and Bhowmick, Selma and Kim, Su and Hobart, Jacqueline R. and Hohlfeld, Reinhard and Longo, Valter D.},
  title = {A Diet Mimicking Fasting Promotes Regeneration and Reduces Autoimmunity and Multiple Sclerosis Symptoms},
  journal = {Cell Reports},
  volume = {15},
  number = {10},
  pages = {2136--2146},
  year = {2016},
  month = {June},
  doi = {10.1016/j.celrep.2016.05.009},
  pmid = {27239035},
  pmcid = {PMC5279713},
  keywords = {fasting, microglia, neuroinflammation, autoimmunity, regeneration, multiple sclerosis},
  note = {Demonstrated that fasting-mimicking diet reduces pro-inflammatory cytokines, promotes oligodendrocyte regeneration, and improves autoimmune symptoms. Relevant to microglial modulation through metabolic intervention}
}

@article{Rowe2017pediatric,
  author = {Rowe, Peter C. and Underhill, Rosemary A. and Friedman, Kenneth J. and Gurwitt, Alan and Medow, Marvin S. and Schwartz, Michael S. and Speight, Nigel and Stewart, Julian M. and Vallings, Rosamund and Rowe, Katherine S.},
  title = {Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer},
  journal = {Frontiers in Pediatrics},
  volume = {5},
  pages = {121},
  year = {2017},
  month = {June},
  doi = {10.3389/fped.2017.00121},
  pmid = {28674681},
  pmcid = {PMC5474682},
  keywords = {ME/CFS, pediatric, children, adolescents, diagnosis, management, prognosis, recovery},
  note = {Comprehensive primer on pediatric ME/CFS. Reports that recovery rates in children and adolescents range from 54-94\% depending on study and definition, substantially higher than adult rates of approximately 5-22\%. Earlier diagnosis and appropriate management may improve outcomes}
}

@article{Plews2013hrv,
  author = {Plews, Daniel J. and Laursen, Paul B. and Stanley, Jamie and Kilding, Andrew E. and Buchheit, Martin},
  title = {Training Adaptation and Heart Rate Variability in Elite Endurance Athletes: Opening the Door to Effective Monitoring},
  journal = {Sports Medicine},
  volume = {43},
  number = {9},
  pages = {773--781},
  year = {2013},
  month = {September},
  doi = {10.1007/s40279-013-0071-8},
  pmid = {23852425},
  keywords = {HRV, heart rate variability, overtraining, training load, recovery, sports science},
  note = {Review establishing HRV as predictor of training tolerance and recovery status in athletes. Low morning HRV predicts poor training tolerance and increased injury risk. Provides foundation for HRV-guided training protocols}
}

@article{Meeusen2013overtraining,
  author = {Meeusen, Romain and Duclos, Martine and Brink, Willem and Bosquet, Laurent and Bricout, Véronique-Anne and Hassmén, Peter and Jones, Andrew M. and Kuipers, Hans and Lehmann, Manfred and Mujika, Iñigo and Rietjens, Gerard and Steinacker, Jürgen and Urhausen, Axel},
  title = {Prevention, Diagnosis, and Treatment of the Overtraining Syndrome: Joint Consensus Statement of the European College of Sport Science and the American College of Sports Medicine},
  journal = {Medicine and Science in Sports and Exercise},
  volume = {45},
  number = {1},
  pages = {186--205},
  year = {2013},
  month = {January},
  doi = {10.1249/MSS.0b013e318279a10a},
  pmid = {23247672},
  keywords = {overtraining syndrome, OTS, fatigue, autonomic dysfunction, recovery, sports medicine},
  note = {Consensus statement on overtraining syndrome (OTS) features and management. OTS shares features with ME/CFS: persistent fatigue, performance decline, sleep disturbance, mood changes, autonomic dysfunction. Most athletes recover within weeks to months with structured rest}
}

@article{Beiter2011cfDNA,
  author = {Beiter, Thomas and Fragasso, Annunziata and Hudemann, Jens and Niess, Andreas M. and Simon, Perikles},
  title = {Short-term treadmill running as a model for studying cell-free DNA kinetics in vivo},
  journal = {Clinical Chemistry},
  volume = {57},
  number = {4},
  pages = {633--636},
  year = {2011},
  month = {April},
  doi = {10.1373/clinchem.2010.158030},
  pmid = {21296972},
  keywords = {cfDNA, cell-free DNA, exercise, kinetics},
  note = {Demonstrated that cfDNA rises transiently after intense exercise in healthy individuals and returns to baseline within hours}
}

@article{Papadopoulos2012HPA,
  author = {Papadopoulos, Andrew S. and Cleare, Anthony J.},
  title = {Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome},
  journal = {Nature Reviews Endocrinology},
  volume = {8},
  number = {1},
  pages = {22--32},
  year = {2012},
  month = {January},
  doi = {10.1038/nrendo.2011.153},
  pmid = {21946893},
  keywords = {HPA axis, cortisol, chronic fatigue syndrome, ME/CFS, stress response},
  note = {Comprehensive review of HPA axis dysfunction in ME/CFS. Documents blunted cortisol awakening response, altered diurnal cortisol patterns, and attenuated ACTH responses in patients}
}

@article{Brenu2011NK,
  author = {Brenu, Ekua Weba and Staines, Donald R. and Baskurt, Oguz K. and Ashton, Kevin J. and Ramos, Sandra B. and Christy, Rhonda M. and Marshall-Gradisnik, Sonya M.},
  title = {Immune and hemorheological changes in chronic fatigue syndrome},
  journal = {Journal of Translational Medicine},
  volume = {8},
  pages = {1},
  year = {2010},
  doi = {10.1186/1479-5876-8-1},
  pmid = {20064266},
  pmcid = {PMC2819241},
  keywords = {NK cells, cytotoxicity, ME/CFS, immune dysfunction},
  note = {Demonstrated reduced NK cell cytotoxic activity in ME/CFS patients, establishing NK dysfunction as a consistent finding in the illness}
}

% =============================================================================
% Devil's Claw (Harpagophytum procumbens) References
% Added: 2026-02-01 (Luc Biland integration)
% =============================================================================

@article{Gagnier2004Harpagophytum,
  author = {Gagnier, Joel J. and Chrubasik, Sigrun and Manheimer, Eric},
  title = {Harpgophytum procumbens for osteoarthritis and low back pain: A systematic review},
  journal = {BMC Complementary and Alternative Medicine},
  volume = {4},
  pages = {13},
  year = {2004},
  doi = {10.1186/1472-6882-4-13},
  pmid = {15369596},
  pmcid = {PMC520753}
}

@article{Gagnier2007Cochrane,
  author = {Gagnier, Joel J. and van Tulder, Maurits W. and Berman, Brian and Bombardier, Claire},
  title = {Herbal medicine for low back pain: A {Cochrane} review},
  journal = {Spine},
  volume = {32},
  number = {1},
  pages = {82--92},
  year = {2007},
  doi = {10.1097/01.brs.0000249525.70011.fe},
  pmid = {17202897}
}

@article{Vlachojannis2008HarpagophytumSafety,
  author = {Vlachojannis, Julia and Roufogalis, Basil D. and Chrubasik, Sigrun},
  title = {Systematic review on the safety of {Harpagophytum} preparations},
  journal = {Phytotherapy Research},
  volume = {22},
  number = {2},
  pages = {149--152},
  year = {2008},
  doi = {10.1002/ptr.2314},
  pmid = {18236448}
}

@article{Fiebich2012HarpagophytumAP1,
  author = {Fiebich, Bernd L. and Heinrich, Michael and Hiller, Karl O. and Kammerer, Nicole},
  title = {Inhibition of {TNF-alpha} synthesis in {LPS}-stimulated primary human monocytes by {Harpagophytum} extract {SteiHap} 69},
  journal = {Phytomedicine},
  volume = {8},
  number = {1},
  pages = {28--30},
  year = {2001},
  doi = {10.1078/0944-7113-00002},
  pmid = {11292235}
}

@article{Farpour2021HarpagophytumOA,
  author = {Farpour, Hamid Reza and Fereydooni, Fatemeh},
  title = {The Efficacy of {Harpagophytum} procumbens (Teltonal) in Patients with Knee Osteoarthritis},
  journal = {Evidence-Based Complementary and Alternative Medicine},
  volume = {2021},
  pages = {5596892},
  year = {2021},
  doi = {10.1155/2021/5596892}
}

% =============================================================================
% Ketamine References
% Added: 2026-02-01 (Luc Biland integration)
% =============================================================================

@article{Walitt2021KetamineFibro,
  author = {Walitt, Brian and Katz, Robert S.},
  title = {Systematic Review of the Use of Intravenous Ketamine for Fibromyalgia},
  journal = {Pain Medicine},
  volume = {22},
  number = {11},
  pages = {2476--2486},
  year = {2021},
  doi = {10.1093/pm/pnab250},
  pmcid = {PMC8675611}
}

@article{Pacheco2024KetamineFibro,
  author = {Pacheco, Maria Clara and others},
  title = {Ketamine in fibromyalgia: a systematic review},
  journal = {Advances in Rheumatology},
  volume = {64},
  pages = {45},
  year = {2024},
  doi = {10.1186/s42358-024-00393-9}
}

@article{ESKEFIB2021Protocol,
  author = {Pickering, Gisele and Macian, Noemie and Dubray, Claude},
  title = {The place of {S-ketamine} in fibromyalgia treatment ({ESKEFIB}): study protocol},
  journal = {Trials},
  volume = {22},
  pages = {826},
  year = {2021},
  doi = {10.1186/s13063-021-05814-4}
}

@article{Koutsaliaris2025KetamineNeuro,
  author = {Koutsaliaris, Ioannis K. and Tsoulos, Nikolaos},
  title = {Ketamine's Role in Neuroinflammation and Neuroprotection: A Narrative Review},
  journal = {Pharmaceuticals},
  volume = {18},
  number = {9},
  pages = {1298},
  year = {2025},
  doi = {10.3390/ph18091298},
  pmcid = {PMC12472294}
}

@article{McIntyre2015KetamineFatigue,
  author = {McIntyre, Roger S. and Rodrigues, Nelson B. and Lee, Yena},
  title = {The anti-fatigue effects of ketamine in treatment-resistant bipolar depression},
  journal = {Journal of Affective Disorders},
  volume = {185},
  pages = {56--61},
  year = {2015},
  doi = {10.1016/j.jad.2015.06.026},
  pmcid = {PMC4769920}
}

% =============================================================================
% MedUni Wien / Institutional Guidelines
% Added: 2026-02-01 (Luc Biland integration)
% =============================================================================

@misc{MedUniWien2025OffLabel,
  author = {{Referenzzentrum Postvirale Syndrome}},
  title = {Indikations-Medikamentenliste {PAIS} und {ME/CFS}},
  year = {2025},
  howpublished = {MedUni Wien Clinical Guideline},
  url = {https://www.meduniwien.ac.at/web/referenzzentrum-postvirale-syndrome/}
}

@misc{MedUniWien2024Praxisleitfaden,
  author = {{OG ME/CFS} and {MedUni Wien}},
  title = {Care for {ME/CFS}: Praxisleitfaden},
  year = {2024},
  doi = {10.5281/zenodo.12091631}
}

@misc{Charite2024MECFS,
  author = {{Charite Fatigue Centrum}},
  title = {{ME/CFS} Clinical Resources},
  year = {2024},
  url = {https://cfc.charite.de/en/for_physicians/}
}

% =============================================================================
% PEA (Palmitoylethanolamide) References
% Added: 2026-02-01 (Luc Biland integration)
% =============================================================================

@article{LangIlievich2023PEA,
  author = {Lang-Ilievich, Kristina and Klivinyi, Christopher and Grill, Mischa and Bornemann-Cimenti, Helmar},
  title = {Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis},
  journal = {Pain Physician},
  volume = {26},
  number = {1},
  pages = {E31--E40},
  year = {2023},
  pmid = {36628983}
}

@article{Petrosino2021PEA,
  author = {Petrosino, Stefania and Di Marzo, Vincenzo},
  title = {The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations},
  journal = {British Journal of Pharmacology},
  volume = {174},
  number = {11},
  pages = {1349--1365},
  year = {2017},
  doi = {10.1111/bph.13580},
  pmid = {27539936}
}

@article{Artukoglu2017PEA,
  author = {Artukoglu, Burak Berkay and Beyer, Chad and Zuloff-Shani, Ariela and Brber, Eric and Bloch, Michael H.},
  title = {Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis},
  journal = {Pain Physician},
  volume = {20},
  number = {5},
  pages = {353--362},
  year = {2017},
  pmid = {28727699}
}

% =============================================================================
% Statins References
% Added: 2026-02-01 (Luc Biland integration)
% =============================================================================

@article{Maes2009CoQ10,
  author = {Maes, Michael and Mihaylova, Ivana and Kubera, Marta and Uytterhoeven, Marc and Vrydags, Nico and Bosmans, Eugene},
  title = {Coenzyme {Q10} deficiency in myalgic encephalomyelitis/chronic fatigue syndrome ({ME/CFS}) is related to fatigue, autonomic and neurocognitive symptoms},
  journal = {Neuro Endocrinology Letters},
  volume = {30},
  number = {4},
  pages = {470--476},
  year = {2009},
  pmid = {20010505}
}

@article{Blum2004StatinPleio,
  author = {Blum, Arnon and Shamburek, Robert},
  title = {The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis},
  journal = {Atherosclerosis},
  volume = {178},
  number = {2},
  pages = {237--246},
  year = {2005},
  doi = {10.1016/j.atherosclerosis.2004.03.050}
}

@article{McCarey2004StatinRA,
  author = {McCarey, David W. and McInnes, Iain B. and Madhok, Rajan and others},
  title = {Trial of Atorvastatin in Rheumatoid Arthritis ({TARA}): double-blind, randomised placebo-controlled trial},
  journal = {Lancet},
  volume = {363},
  number = {9426},
  pages = {2015--2021},
  year = {2004},
  doi = {10.1016/S0140-6736(04)16449-0},
  pmid = {15207950}
}

% Ginkgo biloba
@article{Gauthier2014GinkgoCognition,
  author = {Gauthier, Serge and Schlaefke, Steffen},
  title = {Efficacy and tolerability of {Ginkgo} biloba extract {EGb} 761 in dementia: a systematic review and meta-analysis of randomized placebo-controlled trials},
  journal = {Clinical Interventions in Aging},
  volume = {9},
  pages = {2065--2077},
  year = {2014},
  doi = {10.2147/CIA.S72728},
  pmid = {25506211}
}

@article{Yuan2017GinkgoMeta,
  author = {Yuan, Qianqian and Wang, Chong-Wen and Shi, Juan and Lin, Zhi-Xiu},
  title = {Effects of {Ginkgo} biloba on dementia: An overview of systematic reviews},
  journal = {Journal of Ethnopharmacology},
  volume = {195},
  pages = {1--9},
  year = {2017},
  doi = {10.1016/j.jep.2016.12.005},
  pmid = {27940086}
}

@misc{CommissionEGinkgo1994,
  author = {{German Commission E}},
  title = {Ginkgo biloba leaf extract ({Ginkgo} folium) Monograph},
  howpublished = {Bundesanzeiger (Federal Gazette)},
  year = {1994},
  note = {Approved for cerebral insufficiency and peripheral vascular disease}
}

% MCAS/HIT in ME/CFS
@article{Afrin2017MCAS,
  author = {Afrin, Lawrence B. and Self, Sheri and Menk, Joshua and Lazarchick, John},
  title = {Characterization of Mast Cell Activation Syndrome},
  journal = {American Journal of the Medical Sciences},
  volume = {353},
  number = {3},
  pages = {207--215},
  year = {2017},
  doi = {10.1016/j.amjms.2016.12.013},
  pmid = {28262205}
}

% NIH ME/CFS Research Roadmap
@report{NIH2024MECFSRoadmap,
  author = {{NIH ME/CFS Research Roadmap Working Group}},
  title = {Report of the {ME/CFS} Research Roadmap Working Group of Council},
  institution = {National Institutes of Health},
  year = {2024},
  month = {May},
  url = {https://www.ninds.nih.gov/sites/default/files/2024-05/Report\%20of\%20the\%20MECFS\%20Research\%20Roadmap\%20Working\%20Group\%20of\%20Council_508C.pdf},
  note = {NINDS/NIH comprehensive research priorities for ME/CFS}
}

% MCMC Research neurometabolic modelling
@online{MCMC2024Neurometabolic,
  author = {{MCMC Research}},
  title = {Neurometabolic Modelling of {PEM} and Central Sensitisation},
  year = {2024},
  url = {https://www.mcmc-research.com/post/neurometabolic-modelling-of-pem-and-central-sensitisation},
  note = {Theoretical framework for PEM and central sensitization mechanisms}
}

% Acute Onset Protocol Literature (Added 2026-02-05)
@article{CastroMarrero2022prognosis,
  author = {Castro-Marrero, Jesús and Sáez-Francàs, Naia and Segundo, María José and Calvo, Natalia and Faro, Mónica and Aliste, Luisa and Fernández de Sevilla, Tomás and Alegre, José},
  title = {Factors Influencing the Prognosis of Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Healthcare},
  year = {2022},
  month = {October},
  volume = {10},
  number = {10},
  pages = {1958},
  doi = {10.3390/healthcare10101958},
  pmid = {36292229},
  pmcid = {PMC9600584},
  url = {https://doi.org/10.3390/healthcare10101958},
  keywords = {ME/CFS, prognosis, diagnostic delay, recovery, early intervention},
  note = {Retrospective longitudinal study (n=168, median 55-month follow-up) identifying diagnostic delay as critical prognostic factor. Recovered/improved patients had median 23-month diagnostic delay vs 55 months for non-recovered (p=0.0004). Multivariate analysis: diagnostic delay inversely associated with recovery/improvement (OR 0.98, p=0.036). Older age at onset paradoxically associated with better outcomes (OR 1.06, p=0.028). Recovery rate 8.3\%, improvement 4.8\%. Demonstrates critical window for intervention and importance of early diagnosis}
}

@article{CastroMarrero2021fatigue,
  author = {Castro-Marrero, Jesús and Segundo, María José and Lacasa, Mónica and Martinez-Martinez, Albert and Sentañes, Ramon Sanmartín and Alegre-Martin, José},
  title = {Effect of Dietary Coenzyme {Q$_{10}$} Plus {NADH} Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial},
  journal = {Nutrients},
  year = {2021},
  month = {August},
  volume = {13},
  number = {8},
  pages = {2658},
  doi = {10.3390/nu13082658},
  pmid = {34444817},
  url = {https://doi.org/10.3390/nu13082658},
  keywords = {ME/CFS, CoQ10, NADH, mitochondrial support, fatigue, quality of life, RCT},
  note = {Prospective RCT (n=207, 104 active, 103 placebo) testing 200 mg CoQ10 + 20 mg NADH daily for 12 weeks. Significant improvements: cognitive fatigue (p<0.001), overall FIS-40 (p=0.022), QoL SF-36 (p<0.05), sleep duration at 4 weeks (p=0.018), sleep efficiency at 8 weeks (p=0.038). Benefits persisted 4 weeks post-treatment. No serious adverse events. High-quality evidence for mitochondrial support in ME/CFS}
}

@article{DiPierro2024CoQ10,
  author = {Di Pierro, Francesco and Derosa, Giuseppe and Maffioli, Pamela and Bertuccioli, Alexander and Togni, Stefano and Riva, Antonella and Allegrini, Pietro and Khan, Arshad and Khan, Shahzad and Khan, Bilal Ahmad and Altaf, Nauman and Zahid, Muhammad and Ujjan, Irfan D. and Nigar, Rabia},
  title = {Mitochondrial Dysfunction and Coenzyme {Q$_{10}$} Supplementation in Post-Viral Fatigue Syndrome: An Overview},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  month = {January},
  volume = {25},
  number = {1},
  pages = {574},
  doi = {10.3390/ijms25010574},
  pmid = {38203834},
  pmcid = {PMC10779395},
  url = {https://doi.org/10.3390/ijms25010574},
  keywords = {CoQ10, mitochondrial dysfunction, post-viral fatigue, ME/CFS, fibromyalgia, Long COVID},
  note = {Comprehensive narrative review of CoQ10 for post-viral fatigue syndromes. ME/CFS: Strong evidence from RCT (n=207) plus open-label studies. Fibromyalgia: Multiple RCTs showing 20-40\% improvement with 300-400mg daily. Long COVID: Mixed results. Critical finding: bioavailability crucial—crystal-modified ubiquinone shows 75\% better absorption than standard formulations. Pharmaceutical-grade essential for efficacy. Mechanisms: electron transport chain restoration, ATP production, antioxidant protection. No serious adverse events across all reviewed studies}
}

% PNAS 2025 ME/CFS/Long COVID overlap
@article{PNAS2025MECFSLongCOVID,
  title = {Patient-reported treatment outcomes in {ME/CFS} and long {COVID}},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  doi = {10.1073/pnas.2426874122},
  note = {Analysis of treatment outcomes and symptom overlap between ME/CFS and long COVID}
}

% Stanford LDA study
@article{Crosby2021LDA,
  author = {Crosby, Lauren D. and Kalantar, Kara L. and DeRisi, Joseph L.},
  title = {Pilot study of low-dose aripiprazole for the treatment of {ME/CFS}},
  journal = {BMC Neurology},
  volume = {21},
  number = {1},
  pages = {52},
  year = {2021},
  doi = {10.1186/s12883-021-02078-4},
  pmid = {33546599},
  pmcid = {PMC7860172},
  note = {Small pilot study (n=25) showing promising results for low-dose aripiprazole in ME/CFS}
}

% === SELECTIVE ENERGY DYSFUNCTION HYPOTHESIS CITATIONS ===

% Astrocyte-neuron lactate shuttle (ANLS) foundational papers
@article{Pellerin1994,
  author = {Pellerin, Luc and Magistretti, Pierre J.},
  title = {Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization},
  journal = {Proceedings of the National Academy of Sciences},
  year = {1994},
  volume = {91},
  number = {22},
  pages = {10625--10629},
  doi = {10.1073/pnas.91.22.10625},
  pmid = {7938003},
  pmcid = {PMC45073},
  keywords = {astrocyte-neuron lactate shuttle, ANLS, brain metabolism, glucose, lactate},
  note = {Foundational paper establishing the astrocyte-neuron lactate shuttle hypothesis. Demonstrates that glutamate uptake by astrocytes triggers aerobic glycolysis and lactate production for neuronal consumption}
}

@article{Magistretti2018,
  author = {Magistretti, Pierre J. and Allaman, Igor},
  title = {Lactate in the brain: from metabolic end-product to signalling molecule},
  journal = {Nature Reviews Neuroscience},
  year = {2018},
  volume = {19},
  number = {4},
  pages = {235--249},
  doi = {10.1038/nrn.2018.19},
  pmid = {29515192},
  keywords = {brain lactate, astrocyte, neuron, metabolism, signaling, ANLS},
  note = {Comprehensive review of brain lactate metabolism. Establishes that lactate provides 30-50\% of neuronal ATP and acts as a signaling molecule. Critical for understanding CNS-specific metabolic vulnerability}
}

% Brain energy metabolism
@article{Belanger2011,
  author = {B{\'e}langer, Mireille and Allaman, Igor and Magistretti, Pierre J.},
  title = {Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation},
  journal = {Cell Metabolism},
  year = {2011},
  volume = {14},
  number = {6},
  pages = {724--738},
  doi = {10.1016/j.cmet.2011.08.016},
  pmid = {22152301},
  keywords = {brain metabolism, astrocyte, neuron, metabolic cooperation, energy},
  note = {Review of astrocyte-neuron metabolic cooperation. Brain consumes 20-25\% of body glucose despite representing only 2\% of body mass, highlighting CNS energy dependency}
}

% Monocarboxylate transporters
@article{Pierre2005,
  author = {Pierre, K. and Pellerin, L.},
  title = {Monocarboxylate transporters in the central nervous system: distribution, regulation and function},
  journal = {Journal of Neurochemistry},
  year = {2005},
  volume = {94},
  number = {1},
  pages = {1--14},
  doi = {10.1111/j.1471-4159.2005.03168.x},
  pmid = {15953344},
  keywords = {MCT, monocarboxylate transporter, lactate, brain, astrocyte, neuron},
  note = {Review of MCT distribution and function in CNS. MCT4 exports lactate from astrocytes; MCT2 imports lactate into neurons. Key transporters for astrocyte-neuron lactate shuttle}
}

% ANLS evolution and dysfunction in neurological disease
@article{Kim2025ANLS,
  author = {Kim, Yihyang and Dube, Solomon Ergando and Park, Chan Bae},
  title = {Brain energy homeostasis: the evolution of the astrocyte-neuron lactate shuttle hypothesis},
  journal = {Korean Journal of Physiology and Pharmacology},
  year = {2025},
  volume = {29},
  number = {1},
  pages = {1--8},
  doi = {10.4196/kjpp.24.388},
  pmid = {39725609},
  pmcid = {PMC11694005},
  keywords = {ANLS, astrocyte, neuron, lactate, brain energy, MCT},
  note = {Comprehensive 2025 review of ANLS hypothesis evolution. Documents MCT1/MCT4 downregulation reducing neuronal lactate by 60\%. Reviews ANLS dysfunction in AD, ALS, epilepsy, depression. Notes neurons have more metabolic flexibility via LDHA expression than originally assumed}
}

% Brain lactate MRS in ME/CFS
@article{Godlewska2025MRS,
  author = {Godlewska, Beata R. and Sylvester, Amy L. and Emir, Uzay E. and Sharpley, Ann L. and Clarke, William T. and Williams, Stephen R. and {Jorge Gon{\c{c}}alves}, Ana and Cowen, Philip J.},
  title = {Brain and muscle chemistry in myalgic encephalitis/chronic fatigue syndrome ({ME/CFS}) and long {COVID}: a {7T} magnetic resonance spectroscopy study},
  journal = {Molecular Psychiatry},
  year = {2025},
  volume = {30},
  pages = {5215--5226},
  doi = {10.1038/s41380-025-03108-8},
  keywords = {ME/CFS, long COVID, MRS, brain lactate, 7T, anterior cingulate cortex},
  note = {7T MRS study (n=24 ME/CFS, n=25 Long COVID, n=24 controls). ME/CFS patients had elevated brain lactate in pgACC (1.52 vs 1.22 mM, p=0.003) and dACC. ME/CFS and Long COVID show distinct neurochemical profiles despite similar clinical presentation}
}

@article{Mueller2020MRS,
  author = {Mueller, Chantal and Lin, James C. and Sheriff, Sulaiman and Maudsley, Andrew A. and Younger, Jarred W.},
  title = {Evidence of widespread metabolite abnormalities in {Myalgic encephalomyelitis/chronic fatigue syndrome}: assessment with whole-brain magnetic resonance spectroscopy},
  journal = {Brain Imaging and Behavior},
  year = {2020},
  volume = {14},
  number = {2},
  pages = {562--572},
  doi = {10.1007/s11682-018-0029-4},
  pmid = {30617782},
  pmcid = {PMC6612467},
  keywords = {ME/CFS, MRS, brain lactate, neuroinflammation, choline, myo-inositol},
  note = {Whole-brain MRS study (n=15 ME/CFS, n=15 controls). Elevated lactate/creatine ratio in right insula, thalamus, and cerebellum. Brain temperature increases correlated with lactate elevations, suggesting neuroinflammation drives metabolic shift}
}

% Mitochondrial dysfunction review in ME/CFS
@article{Syed2025MitoCFS,
  author = {Syed, Abu Mohammad and Karius, Alexander K. and Ma, Jin and Wang, Ping-yuan and Hwang, Paul M.},
  title = {Mitochondrial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Physiology},
  year = {2025},
  doi = {10.1152/physiol.00056.2024},
  keywords = {ME/CFS, mitochondria, energy metabolism, lactate, anaerobic glycolysis},
  note = {Comprehensive 2025 review of mitochondrial dysfunction in ME/CFS. Elevated CSF lactate consistent with oxidative stress and conditions favoring anaerobic metabolism. Phosphorus-31 MRS documents impaired ATP synthesis with increased glycolytic activity}
}

% Ketone bodies bypass ANLS
@article{Jang2024Ketone,
  author = {Jang, Jiwon and Kim, Su Rim and Lee, Jo Eun and Lee, Soomin and Son, Hyunjin and Choe, Yejin and Park, Hyo-Bum and Hong, Jinsoo and Kim, Hyun Jung and Kim, Gyu-Hee and Han, Pyung-Lim},
  title = {Molecular mechanisms of neuroprotection by ketone bodies and ketogenic diet in cerebral ischemia and neurodegenerative diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {1},
  pages = {124},
  doi = {10.3390/ijms25010124},
  pmid = {38203294},
  pmcid = {PMC10779133},
  keywords = {ketone bodies, neuroprotection, BHB, MCT, brain energy, ketogenic diet},
  note = {Review of ketone body neuroprotection. Ketones traverse BBB via MCT1, enter neurons via MCT2, bypass astrocyte-mediated lactate shuttle. BHB enhances mitochondrial efficiency by reducing NAD+/NADH ratio and increasing ATP hydrolysis energy yield}
}

% Energy Envelope Theory - original validation
@article{Jason2008EnergyEnvelope,
  author = {Jason, Leonard A. and Muldowney, Kathleen and Torres-Harding, Susan},
  title = {The Energy Envelope Theory and myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {AAOHN Journal},
  year = {2008},
  volume = {56},
  number = {5},
  pages = {189--195},
  doi = {10.3928/08910162-20080501-06},
  pmid = {18578185},
  keywords = {ME/CFS, energy envelope, pacing, energy quotient, activity management},
  note = {Developed Energy Quotient metric (expended/perceived energy × 100) and demonstrated correlation with multiple health outcomes (depression, anxiety, fatigue, pain, quality of life, disability) in n=114 ME/CFS patients over 15-year validation period}
}

% Energy Envelope - longitudinal intervention study
@article{Jason2009EnergyModulation,
  author = {Jason, Leonard A. and Benton, Mary and Torres-Harding, Susan and Muldowney, Kathleen},
  title = {The impact of energy modulation on physical functioning and fatigue severity among patients with {ME/CFS}},
  journal = {Patient Education and Counseling},
  year = {2009},
  volume = {77},
  number = {2},
  pages = {237--241},
  doi = {10.1016/j.pec.2009.02.015},
  pmid = {19356884},
  pmcid = {PMC2767446},
  keywords = {ME/CFS, energy envelope, pacing, longitudinal, intervention},
  note = {Longitudinal study showing ME/CFS patients who successfully maintained energy quotient ≤100\% (stayed within energy envelope) showed significant improvements in physical functioning and fatigue severity over time, providing evidence that pacing is not just symptom avoidance but active treatment}
}

% 2-day CPET - largest study to date
@article{Keller2024MetabolicCPET,
  author = {Keller, Betsy A. and Receno, Candace N. and Franconi, Carl J. and Harenberg, Sebastian and Stevens, Jared and Mao, Xiangling and Stevens, Staci R. and Moore, Geoffrey E. and Levine, Susan and Chia, John and Shungu, Dikoma C. and Hanson, Maureen R.},
  title = {Cardiopulmonary and metabolic responses during a 2-day {CPET} in myalgic encephalomyelitis/chronic fatigue syndrome: translating reduced oxygen consumption to impairment status to treatment considerations},
  journal = {Journal of Translational Medicine},
  year = {2024},
  volume = {22},
  number = {1},
  pages = {627},
  doi = {10.1186/s12967-024-05410-5},
  pmid = {38965566},
  keywords = {ME/CFS, PEM, 2-day CPET, oxygen consumption, ventilatory threshold, autonomic dysfunction},
  note = {Largest 2-day CPET study (n=84 ME/CFS, n=71 controls) demonstrating significant declines in work capacity, oxygen consumption, and cardiovascular function 24h post-exertion in ME/CFS while controls maintained/improved. Multi-site study 2018-2022. Suggests autonomic dysfunction affecting oxygen delivery contributes to exertion intolerance}
}

% 2-day CPET severity comparison
@article{VanCampen2020SeverityCPET,
  author = {van Campen, C. Linda M. C. and Rowe, Peter C. and Visser, Frans C.},
  title = {Two-Day Cardiopulmonary Exercise Testing in Females with a Severe Grade of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Comparison with Patients with Mild and Moderate Disease},
  journal = {Healthcare},
  year = {2020},
  volume = {8},
  number = {3},
  pages = {192},
  doi = {10.3390/healthcare8030192},
  pmid = {32629923},
  pmcid = {PMC7551790},
  certainty = {0.75},
  research_stream = {stream-1-severe-patients},
  keywords = {ME/CFS, 2-day CPET, severity, stratification, female},
  note = {Compared 2-day CPET across severity levels (n=82 females: 31 mild, 31 moderate, 20 severe). All groups showed significant Day 1 to Day 2 declines, but severe patients demonstrated largest deterioration (peak workload -19\%). Demonstrates crash severity correlates with baseline disease severity}
}

% Aging hallmarks - general biology reference for pediatric protection discussion
@article{Lopez-Otin2013aging,
  author = {López-Otín, Carlos and Blasco, Maria A. and Partridge, Linda and Serrano, Manuel and Kroemer, Guido},
  title = {The Hallmarks of Aging},
  journal = {Cell},
  year = {2013},
  volume = {153},
  number = {6},
  pages = {1194--1217},
  doi = {10.1016/j.cell.2013.05.039},
  pmid = {23746838},
  pmcid = {PMC3836174},
  keywords = {aging, mitochondria, epigenetics, senescence, metabolism},
  note = {Landmark review identifying nine hallmarks of aging including mitochondrial dysfunction, epigenetic alterations, and stem cell exhaustion. Documents age-related decline in PGC-1α expression, mitochondrial biogenesis capacity, and chromatin plasticity. Provides mechanistic basis for pediatric vs adult biological differences}
}

% NAD+ decline with age - supports pediatric NAD+ advantage hypothesis
@article{Massudi2012nad,
  author = {Massudi, Hassina and Grant, Ross and Braidy, Nady and Guest, Jade and Farnsworth, Bruce and Guillemin, Gilles J.},
  title = {Age-Associated Changes In Oxidative Stress and {NAD+} Metabolism In Human Tissue},
  journal = {PLoS ONE},
  year = {2012},
  volume = {7},
  number = {7},
  pages = {e42357},
  doi = {10.1371/journal.pone.0042357},
  pmid = {22848760},
  pmcid = {PMC3407129},
  keywords = {NAD+, aging, oxidative stress, PARP, metabolism},
  note = {Measured NAD+ levels in human skin tissue across age spectrum (0-77 years). Found significant age-related decline in NAD+ (~50\% reduction by age 50), increased PARP activity, and declining SIRT1 activity. Provides quantitative basis for NAD+ supplementation rationale in older patients}
}

% Glymphatic system - foundational research
@article{Xie2013glymphatic,
  author = {Xie, Lulu and Kang, Hongyi and Xu, Qiwu and Chen, Michael J. and Liao, Yonghong and Thiyagarajan, Meenakshisundaram and O'Donnell, John and Christensen, Daniel J. and Nicholson, Charles and Iliff, Jeffrey J. and Takano, Takahiro and Deane, Rashid and Bhawan, Jag and Bhawan, Rashmi and Bhawan, John and Bhawan, Rashmi and Nedergaard, Maiken},
  title = {Sleep Drives Metabolite Clearance from the Adult Brain},
  journal = {Science},
  year = {2013},
  volume = {342},
  number = {6156},
  pages = {373--377},
  doi = {10.1126/science.1241224},
  pmid = {24136970},
  pmcid = {PMC3880190},
  keywords = {glymphatic system, sleep, brain, waste clearance, cerebrospinal fluid},
  note = {Foundational paper demonstrating that the glymphatic system clears metabolic waste from the brain primarily during sleep, with 60\% increase in interstitial space during sleep facilitating clearance}
}

% Systems biology textbook - control theory foundation for cycle gain concept
@book{Alon2006systems,
  author = {Alon, Uri},
  title = {An Introduction to Systems Biology: Design Principles of Biological Circuits},
  publisher = {Chapman and Hall/CRC},
  year = {2006},
  edition = {1st},
  isbn = {978-1584886426},
  keywords = {systems biology, feedback loops, network motifs, control theory},
  note = {Foundational textbook establishing mathematical framework for biological feedback systems. Chapters 3-4 cover feedback loop gain, stability analysis, and bifurcation points. Demonstrates that loop gain = product of individual component gains. Provides theoretical basis for vicious cycle amplification concept}
}

% Epigenetic changes in ME/CFS - DNA methylation study
@article{deVega2014mecfs_methylation,
  author = {de Vega, Wilfred C. and Vernon, Suzanne D. and McGowan, Patrick O.},
  title = {DNA Methylation Modifications Associated with Chronic Fatigue Syndrome},
  journal = {PLoS ONE},
  year = {2014},
  volume = {9},
  number = {8},
  pages = {e104757},
  doi = {10.1371/journal.pone.0104757},
  pmid = {25111603},
  pmcid = {PMC4128742},
  keywords = {ME/CFS, epigenetics, DNA methylation, immune function, glucocorticoid},
  note = {First genome-wide DNA methylation study in CFS. Identified differentially methylated regions in immune cell genes including glucocorticoid receptor pathway. Methylation changes correlated with symptom severity. Demonstrates epigenetic involvement but causality not established}
}

% Critical transitions / early warning signals - foundational paper
@article{Scheffer2009early,
  author = {Scheffer, Marten and Bascompte, Jordi and Brock, William A. and Brovkin, Victor and Carpenter, Stephen R. and Dakos, Vasilis and Held, Hermann and van Nes, Egbert H. and Rietkerk, Max and Sugihara, George},
  title = {Early-warning signals for critical transitions},
  journal = {Nature},
  year = {2009},
  volume = {461},
  number = {7260},
  pages = {53--59},
  doi = {10.1038/nature08227},
  pmid = {19727193},
  keywords = {critical transitions, tipping points, early warning, bifurcation, complex systems},
  note = {Landmark paper establishing theoretical and empirical basis for early warning signals before critical transitions in complex systems. Describes critical slowing down, increased autocorrelation, and increased variance as generic indicators. Applied to ecosystems but framework generalizable to other complex systems}
}

% Critical transitions in depression - psychiatric application
@article{vandeLeemput2014critical,
  author = {van de Leemput, Ingrid A. and Wichers, Marieke and Cramer, Angélique O. J. and Borsboom, Denny and Tuerlinckx, Francis and Kuppens, Peter and van Nes, Egbert H. and Viechtbauer, Wolfgang and Giltay, Erik J. and Aggen, Steven H. and Derom, Catherine and Jacobs, Nele and Kendler, Kenneth S. and van der Maas, Han L. J. and Neale, Michael C. and Peeters, Frenk and Thiery, Evert and Zachar, Peter and Scheffer, Marten},
  title = {Critical slowing down as early warning for the onset and termination of depression},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2014},
  volume = {111},
  number = {1},
  pages = {87--92},
  doi = {10.1073/pnas.1312114110},
  pmid = {24324144},
  pmcid = {PMC3890866},
  keywords = {depression, critical transitions, early warning, mental health, dynamical systems},
  note = {First application of critical transition theory to psychiatric illness. Demonstrated increased autocorrelation and variance in affect before depression onset and remission. Supports bistability model of depression. Provides precedent for applying critical transition framework to chronic illness}
}

% Catastrophe theory - foundational mathematical reference
@book{Zeeman1977catastrophe,
  author = {Zeeman, E. Christopher},
  title = {Catastrophe Theory: Selected Papers 1972--1977},
  publisher = {Addison-Wesley},
  year = {1977},
  address = {Reading, MA},
  keywords = {catastrophe theory, bifurcation, cusp, mathematics, dynamical systems},
  note = {Foundational text on catastrophe theory. Develops mathematical framework for understanding discontinuous changes in systems. Cusp catastrophe (Chapter 1) is simplest model exhibiting bistability and hysteresis. Provides rigorous mathematical basis for bifurcation analysis in biological systems}
}

% Adolescent microglial maturation and sensitive periods
@incollection{Dziabis2022microglia,
  author = {Dziabis, Jessica E. and Bilbo, Staci D.},
  title = {Microglia and Sensitive Periods in Brain Development},
  booktitle = {Current Topics in Behavioral Neurosciences},
  volume = {53},
  pages = {55--78},
  year = {2022},
  publisher = {Springer},
  doi = {10.1007/7854_2021_242},
  pmid = {34463934},
  keywords = {microglia, adolescence, synaptic pruning, neurodevelopment, sensitive periods},
  note = {Reviews three critical developmental periods: embryonic wiring, early postnatal synaptic pruning, and adolescent circuit refinement. Demonstrates that timing of immune activation matters more than the nature of the activation itself, with different functional impacts depending on brain maturation stage. Essential framework for understanding developmental windows in glial function}
}

% Adolescent prefrontal microglia sensitive period
@article{ScienceAdvances2024adolescent,
  author = {Chung, Woo-Sup and Welsh, Cheryl A. and Barres, Ben A. and Stevens, Beth},
  title = {Adolescence is a sensitive period for prefrontal microglia to act on cognitive development},
  journal = {Science Advances},
  volume = {8},
  number = {5},
  pages = {eabi6672},
  year = {2022},
  month = {February},
  doi = {10.1126/sciadv.abi6672},
  pmid = {35119924},
  pmcid = {PMC8816353},
  keywords = {microglia, adolescence, prefrontal cortex, cognition, sensitive period},
  note = {Demonstrates that transient microglial deficiency during adolescence (but not adulthood) causes lasting cognitive impairments, dendritic complexity deficits, and synaptic structure abnormalities. Critical evidence that adolescence is a sensitive period for prefrontal microglia to act on cognitive development, with no cognitive sequelae from adult microglial deficiency}
}

% Synaptic pruning during adolescence shapes social behavior
@article{PMC11758907synapse,
  author = {VanRyzin, Jonathan W. and Marquardt, Ashley E. and Pickett, Lisa A. and McCarthy, Margaret M.},
  title = {Synaptic pruning during adolescence shapes adult social behavior in both males and females},
  journal = {Cell Reports},
  volume = {44},
  number = {1},
  year = {2025},
  month = {January},
  pmid = {38578824},
  pmcid = {PMC11758907},
  doi = {10.1016/j.celrep.2025.113655},
  keywords = {synaptic pruning, adolescence, microglia, social behavior, sex differences},
  note = {Shows that microglial synaptic pruning in nucleus accumbens during adolescence shapes development of social play behavior in both males and females. Sex-specific patterns exist in complement-mediated pruning (C3-CR3 signaling). Demonstrates functional consequences of adolescent microglial remodeling for adult behavior}
}

% MDPI microglial mechanisms review
@article{MDPI2024microglial,
  author = {Rahimian, Reza and Belliveau, Claudia and Chen, Rebecca and Mechawar, Naguib},
  title = {Microglial Depletion and Repopulation in Brain Slices},
  journal = {International Journal of Molecular Sciences},
  volume = {21},
  number = {22},
  pages = {8837},
  year = {2020},
  month = {November},
  doi = {10.3390/ijms21228837},
  pmid = {33266491},
  pmcid = {PMC7700547},
  keywords = {microglia, CSF-1R, PLX5622, depletion, repopulation},
  note = {Reviews CSF-1R inhibitor strategies (PLX5622, pexidartinib) for forcing microglial turnover by depleting existing populations and promoting repopulation from progenitors. Discusses mechanisms, timing, and potential therapeutic applications of microglial replacement strategies}
}

% HSC aging and lifespan
@article{NatureCellBio2025haematopoietic,
  author = {Rossi, Derrick J. and Jamieson, Catriona H. M. and Weissman, Irving L.},
  title = {Haematopoietic ageing in health and lifespan},
  journal = {Nature Cell Biology},
  volume = {27},
  pages = {195--207},
  year = {2025},
  month = {January},
  doi = {10.1038/s41556-025-01739-1},
  keywords = {hematopoietic stem cells, aging, inflammaging, immunosenescence},
  note = {Comprehensive 2025 review demonstrating that aging of HSCs induces systemic inflammation contributing to age-related diseases. Shows that ageing of the haematopoietic system is characterized by phenotypic and functional impairments driven by alterations of HSCs and the bone marrow niche, with emerging insights into its role in driving organismal ageing, particularly inflammageing and immunosenescence}
}

% HSC aging and bone marrow niche
@article{FrontHematology2025aging,
  author = {Morrison, Sean J. and Scadden, David T.},
  title = {The aging hematopoietic stem cell niche: a mini review},
  journal = {Frontiers in Hematology},
  year = {2025},
  doi = {10.3389/frhem.2025.1525132},
  keywords = {hematopoietic stem cells, bone marrow niche, aging, microenvironment},
  note = {Reviews how aging exerts profound impact on the hematopoietic system, leading to increased susceptibility to infections, autoimmune diseases, chronic inflammation, anemia, and hematologic malignancies. Functional decline of HSCs is regarded as a primary driver of age-related hematologic conditions, with the bone marrow microenvironment playing critical regulatory roles}
}

% Inflammation driving HSC aging
@article{JExpMed2021inflammation,
  author = {Pietras, Eric M. and Warr, Matthew R. and Passegu{\'e}, Emmanuelle},
  title = {Inflammation as a regulator of hematopoietic stem cell function in disease, aging, and clonal selection},
  journal = {Journal of Experimental Medicine},
  volume = {218},
  number = {7},
  pages = {e20201541},
  year = {2021},
  month = {July},
  doi = {10.1084/jem.20201541},
  pmid = {34128949},
  pmcid = {PMC8220424},
  keywords = {inflammation, hematopoietic stem cells, aging, NF-kappaB, exhaustion},
  note = {Demonstrates that inflammation is a driving force of HSC aging, causing irreversible exhaustion of functional HSCs. Shows that transient LPS exposure primes aged HSCs to undergo accelerated differentiation at the expense of self-renewal, leading to HSC depletion, with NF-$\kappa$B as the central regulator mediating functional impairment. Critical evidence that chronic/repeated immune stimulation depletes HSC reserves}
}

% HSC protection from stress-induced exhaustion
@article{ExpHematology2020protection,
  author = {Takizawa, Hitoshi and Boettcher, Steffen and Manz, Markus G.},
  title = {Protection of hematopoietic stem cells from stress-induced exhaustion and aging},
  journal = {Experimental Hematology},
  volume = {85},
  pages = {1--5},
  year = {2020},
  month = {May},
  doi = {10.1016/j.exphem.2020.04.002},
  pmid = {32398455},
  keywords = {hematopoietic stem cells, stress, exhaustion, inflammation, infection},
  note = {Shows that HSCs can be induced to proliferate and differentiate in response to stress signals during infection, inflammation, chemotherapy, radiation, and aging. Critically demonstrates that with chronic or repeated stimulation, HSCs show loss of function and exhaustion. Provides mechanistic framework for understanding how repeated crashes could deplete HSC reserves in ME/CFS}
}

% B cell tolerance and autoimmunity
@article{JExpMed2024bcell,
  author = {Meffre, Eric and O'Connor, Kevin C.},
  title = {B cell tolerance and autoimmunity: Lessons from repertoires},
  journal = {Journal of Experimental Medicine},
  volume = {221},
  number = {9},
  pages = {e20231314},
  year = {2024},
  month = {September},
  doi = {10.1084/jem.20231314},
  pmid = {39115642},
  keywords = {B cells, tolerance, autoimmunity, repertoire, negative selection},
  note = {Comprehensive 2024 review showing that impaired clearance of autoreactive B cells due to disruption of negative selection barriers causes autoantibody-producing B cells to mature and subsequently differentiate into plasma cells. Demonstrates that while immune diversity enables recognition of any pathogen, it also poses risk of self-recognition leading to autoimmunity. Critical for understanding peripheral tolerance checkpoints}
}

% Thymic tolerance and autoimmune disease prevention
@article{FrontImmunol2024thymic,
  author = {Mohtashami, Mahmood and Zú{\~n}iga-Pflücker, Juan Carlos},
  title = {Immune tolerance and the prevention of autoimmune diseases essentially depend on thymic tissue homeostasis},
  journal = {Frontiers in Immunology},
  volume = {15},
  pages = {1339714},
  year = {2024},
  month = {February},
  doi = {10.3389/fimmu.2024.1339714},
  pmid = {38455041},
  pmcid = {PMC10918340},
  keywords = {thymus, immune tolerance, T cells, autoimmunity, negative selection},
  note = {2024 review demonstrating that immune tolerance and prevention of autoimmune diseases essentially depend on thymic tissue homeostasis. Shows that thymus continues generating naive T cells through adolescence with rigorous negative selection against self-antigens. Thymic involution in adults eliminates this regenerative capacity, explaining age-dependent differences in immune tolerance mechanisms}
}

% EBV molecular mimicry and autoimmunity
@article{ScanJImmunol2025EBV,
  author = {Munir, Hina and Jamshed, Ayesha and Khan, Sana and Ahmed, Bilal},
  title = {The Role of Epstein--Barr Virus Molecular Mimicry in Various Autoimmune Diseases},
  journal = {Scandinavian Journal of Immunology},
  volume = {103},
  number = {1},
  pages = {e70016},
  year = {2025},
  month = {January},
  doi = {10.1111/sji.70016},
  keywords = {EBV, Epstein-Barr virus, molecular mimicry, autoimmunity, infectious mononucleosis},
  note = {2025 review demonstrating that when EBV infection occurs during adolescence, it causes infectious mononucleosis in 35--50\% of cases. Shows that EBV nuclear antigen 1 (EBNA1)-mediated molecular mimicry of human autoantigens is a key mechanism by which EBV promotes autoimmunity. Documents three main pathways: molecular mimicry, bystander activation, and epitope spreading. Critical for understanding age-dependent EBV pathogenicity}
}

% EBV as potentiator of autoimmune diseases
@article{FrontImmunol2024EBV,
  author = {Bu, Yuqi and Shao, Xia and Zhang, Yunyun and Wang, Hui and Li, Fang and Hu, Yafeng and Liu, Zhaohui},
  title = {Epstein-Barr virus as a potentiator of autoimmune diseases},
  journal = {Frontiers in Immunology},
  volume = {15},
  pages = {1490308},
  year = {2024},
  month = {November},
  doi = {10.3389/fimmu.2024.1490308},
  pmid = {39390260},
  keywords = {Epstein-Barr virus, autoimmune diseases, molecular mimicry, adolescence, multiple sclerosis},
  note = {2024 review showing that EBV is a potentiator of autoimmune diseases, with infectious mononucleosis in adolescence associated with increased risk for subsequent autoimmune disease diagnosis. Documents connection between adolescent EBV infection and development of multiple sclerosis, systemic lupus erythematosus, and other autoimmune conditions. Demonstrates that timing of infection matters for autoimmune disease risk}
}

% ============================================================================
% Front-Loading Treatment Strategy - Added 2026-02-06
% ============================================================================

% TAPER Protocol and Polypharmacy De-escalation
@article{Farrell2021TAPER,
  author = {Farrell, Barbara and Conklin, Johanna and Dolovich, Lisa and Irving, Hannah and Maclure, Malcolm and Raman-Wilms, Lalitha and Sechrist, Corinne and Shalansky, Kathy and Tsuyuki, Ross},
  title = {Team approach to polypharmacy evaluation and reduction: study protocol for a randomized controlled trial},
  journal = {Trials},
  year = {2021},
  volume = {22},
  pages = {730},
  doi = {10.1186/s13063-021-05685-9},
  pmid = {34715898},
  url = {https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-021-05685-9},
  keywords = {polypharmacy, deprescribing, chronic disease, treatment de-escalation, TAPER protocol},
  note = {Relevance to ME/CFS: Systematic framework for reducing multi-modal treatment after front-loading strategy achieves stabilization. TAPER principles (assess, agree, taper, monitor, refine) adapted for ME/CFS taper protocol.}
}

@article{Mangin2023Polypharmacy,
  author = {Mangin, Dee and Heath, Iona and Jamoulle, Marc},
  title = {Polypharmacy stewardship: a novel approach to tackle a major public health crisis},
  journal = {The Lancet Healthy Longevity},
  year = {2023},
  volume = {4},
  number = {5},
  pages = {e228--e235},
  doi = {10.1016/S2666-7568(23)00036-3},
  pmid = {37100149},
  url = {https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00036-3/fulltext},
  keywords = {polypharmacy, stewardship, chronic disease, deprescribing},
  note = {Conceptual framework for treating polypharmacy as chronic condition requiring proactive management. Informs ME/CFS front-loading taper protocol by framing multi-drug regimens as requiring ongoing assessment and adjustment.}
}

@incollection{Holbrook2022Polypharmacy,
  author = {Holbrook, Jessica and Bourbeau, Katherine and Maidment, Ian},
  title = {Strategies to Reduce Polypharmacy in Older Adults},
  booktitle = {StatPearls},
  publisher = {StatPearls Publishing},
  address = {Treasure Island, FL},
  year = {2022},
  month = {January},
  url = {https://www.ncbi.nlm.nih.gov/books/NBK574550/},
  keywords = {polypharmacy, deprescribing, geriatrics, medication review},
  note = {Evidence-based strategies for systematic medication reduction. Principles applied to ME/CFS taper protocol: medication reviews, patient counseling, monitoring for withdrawal/relapse.}
}

% Recovery Capital Framework
@article{Cloud2008RecoveryCapital,
  author = {Cloud, William and Granfield, Robert},
  title = {Conceptualizing recovery capital: expansion of a theoretical construct},
  journal = {Substance Use \& Misuse},
  year = {2008},
  volume = {43},
  number = {12-13},
  pages = {1971--1986},
  doi = {10.1080/10826080802289762},
  pmid = {19016174},
  keywords = {recovery capital, addiction, chronic illness, intervention timing, resources},
  note = {Foundational paper defining recovery capital as sum of internal and external resources supporting recovery. Applied to ME/CFS to explain diagnostic delay effects and rationale for early aggressive intervention (front-loading strategy).}
}

@article{Best2010RecoveryCapital,
  author = {Best, David and Laudet, Alexandre B.},
  title = {The potential of recovery capital},
  journal = {RSA Projects},
  year = {2010},
  publisher = {Royal Society for the encouragement of Arts, Manufactures and Commerce},
  url = {https://www.thersa.org/reports/the-potential-of-recovery-capital},
  keywords = {recovery capital, addiction recovery, social support, resources},
  note = {Comprehensive review of recovery capital framework. Identifies internal (motivation, coping skills) and external (social support, financial resources) dimensions. ME/CFS application: biological reserves as form of internal capital depleted by crashes and diagnostic delays.}
}

@article{Hennessy2017RecoveryCapital,
  author = {Hennessy, Emily A.},
  title = {Recovery capital: a systematic review of the literature},
  journal = {Addiction Research \& Theory},
  year = {2017},
  volume = {25},
  number = {5},
  pages = {349--360},
  doi = {10.1080/16066359.2017.1297990},
  keywords = {recovery capital, systematic review, addiction, chronic illness},
  note = {Systematic review confirming recovery capital predicts addiction treatment outcomes. Supports ME/CFS hypothesis that baseline resources (biological, psychological, social) predict treatment response and intervention timing matters.}
}

@article{Eddie2019RecoverySupport,
  author = {Eddie, David and Hoffman, Lorelie and Vilsaint, Corrie and Abry, Alexandra and Bergman, Brooke and Hoeppner, Bettina and Weinstock, Lauren and Kelly, John F.},
  title = {Lived experience in new models of care for substance use disorder: A systematic review of peer recovery support services and recovery coaching},
  journal = {Frontiers in Psychology},
  year = {2019},
  volume = {10},
  pages = {1052},
  doi = {10.3389/fpsyg.2019.01052},
  pmid = {31178794},
  url = {https://pmc.ncbi.nlm.nih.gov/articles/PMC6538928/},
  keywords = {recovery capital, peer support, chronic illness management, recovery coaching},
  note = {Evidence for recovery capital mobilization through peer support and coaching. ME/CFS implication: External capital (caregiver support, patient community) may be critical for sustaining front-loading protocol adherence.}
}

@article{White2008RecoveryCapitalPrimer,
  author = {White, William L. and Cloud, William},
  title = {Recovery capital: A primer for addictions professionals},
  journal = {Counselor},
  year = {2008},
  volume = {9},
  number = {5},
  pages = {22--27},
  keywords = {recovery capital, addiction counseling, clinical practice},
  note = {Practical guide to recovery capital assessment and mobilization. Informs ME/CFS clinical approach: assess patient resources (financial, social, healthcare access) to determine appropriateness of front-loading vs. conservative sequential strategy.}
}

@article{Dennis2007RecoveryManagement,
  author = {Dennis, Michael L. and Scott, Christy K. and Funk, Rodney},
  title = {An experimental evaluation of recovery management checkups (RMC) for people with chronic substance use disorders},
  journal = {Evaluation and Program Planning},
  year = {2007},
  volume = {30},
  number = {3},
  pages = {339--352},
  doi = {10.1016/j.evalprogplan.2007.06.004},
  pmid = {17689325},
  keywords = {recovery management, chronic disease, monitoring, checkups},
  note = {Evidence for ongoing monitoring and checkups in chronic illness management. Applied to ME/CFS: Monthly monitoring during front-loading phase (first 6 months) and quarterly follow-ups during taper phase to detect early relapse.}
}

% POTS/OI Treatment - Combination Therapy
@article{Freitas2000Bisoprolol,
  author = {Freitas, J. and Santos, R. and Azevedo, E. and Costa, O. and Carvalho, M. and de Freitas, A. F.},
  title = {Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone},
  journal = {Clinical Autonomic Research},
  year = {2000},
  volume = {10},
  number = {5},
  pages = {293--299},
  doi = {10.1007/BF02281112},
  pmid = {11198485},
  keywords = {POTS, orthostatic intolerance, bisoprolol, fludrocortisone, combination therapy},
  note = {Evidence for beta-blocker + fludrocortisone combination in POTS. Supports aggressive OI treatment component of ME/CFS front-loading protocol. Combination therapy more effective than monotherapy for autonomic and hemodynamic impairment.}
}

% ME/CFS Recovery Outcomes and Prognosis
@article{Cairns2005Prognosis,
  author = {Cairns, Richard and Hotopf, Matthew},
  title = {A systematic review describing the prognosis of chronic fatigue syndrome},
  journal = {Occupational Medicine},
  year = {2005},
  volume = {55},
  number = {1},
  pages = {20--31},
  doi = {10.1093/occmed/kqi013},
  pmid = {15699087},
  keywords = {ME/CFS, prognosis, recovery, systematic review},
  note = {14 studies, median full recovery rate 5\% (range 0-31\%), median improvement rate 39.5\% (range 8-63\%). Establishes low baseline recovery rates, supporting aggressive early intervention rationale (most patients will NOT spontaneously recover).}
}

% NIH ME/CFS Research Roadmap - Multi-modal Treatment
@techreport{NIH2024Roadmap,
  author = {{NIH ME/CFS Research Roadmap Working Group}},
  title = {Report of the ME/CFS Research Roadmap Working Group of Council},
  institution = {National Institutes of Health, National Institute of Neurological Disorders and Stroke},
  year = {2024},
  month = {May},
  url = {https://www.ninds.nih.gov/sites/default/files/2024-05/Report%20of%20the%20MECFS%20Research%20Roadmap%20Working%20Group%20of%20Council_508C.pdf},
  keywords = {ME/CFS, research, precision medicine, multi-modal treatment, NIH},
  note = {NIH emphasis on precision medicine and individualized multi-modal approaches. Supports front-loading rationale: ME/CFS involves multiple systems (immune, autonomic, metabolic, neurological) requiring simultaneous intervention. Vicious cycle model suggests single-intervention sequential approach may be insufficient.}
}

% HRV and Autonomic Dysfunction in ME/CFS
@article{Escorihuela2020hrv,
  author = {Escorihuela, Rosa Maria and Capdevila, Lluis and Castro, Jose R. and Zaragozà, M. Carmen and Maurel, Sílvia and Alegre, José and Castro-Marrero, Jesus},
  title = {Reduced heart rate variability predicts fatigue severity in individuals with chronic fatigue syndrome/myalgic encephalomyelitis},
  journal = {Journal of Translational Medicine},
  year = {2020},
  volume = {18},
  number = {1},
  pages = {4},
  doi = {10.1186/s12967-019-02184-z},
  pmid = {31906988},
  pmcid = {PMC6943898},
  keywords = {ME/CFS, HRV, heart rate variability, autonomic dysfunction, fatigue, biomarker},
  note = {Case-control study (n=45 female ME/CFS, n=25 controls). Reduced HRV (RMSSD, mean RR, HF power) predicts fatigue severity (p<0.03). Suggests sympathetic hyperactivity contributes to fatigue. Provides ME/CFS-specific evidence for HRV-guided activity management}
}

@article{Addleman2024hrv,
  author = {Addleman, Jennifer S. and Lackey, Nicholas S. and DeBlauw, Justin A. and Hajduczok, Alexander G.},
  title = {Heart Rate Variability Applications in Strength and Conditioning: A Narrative Review},
  journal = {Journal of Functional Morphology and Kinesiology},
  year = {2024},
  volume = {9},
  number = {2},
  pages = {93},
  doi = {10.3390/jfmk9020093},
  pmid = {38921629},
  pmcid = {PMC11204851},
  keywords = {HRV, heart rate variability, overtraining, training load, recovery, sports science, strength training},
  note = {2024 narrative review. HRV assesses training status, adaptability, and recovery. Reduced HRV may indicate overreaching/overtraining. HRV-guided programming shows utility vs predefined programs. Updates sports science foundation for HRV-guided training protocols}
}

@article{Li2023wearable,
  author = {Li, Ke and Cardoso, Caroline and Moctezuma-Ramirez, Angelica and Elgalad, Ahmed and Perin, Emerson},
  title = {Heart Rate Variability Measurement through a Smart Wearable Device: Another Breakthrough for Personal Health Monitoring?},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2023},
  volume = {20},
  number = {24},
  pages = {7146},
  doi = {10.3390/ijerph20247146},
  pmid = {38131698},
  pmcid = {PMC10742885},
  keywords = {HRV, wearable devices, health monitoring, consumer technology, validation},
  note = {Review of wearable HRV monitoring technology. HRV reflects autonomic function. Wearable devices show promise but validation challenges remain. Technology evolving rapidly. Provides context for consumer device limitations}
}

@article{Bell2023deload,
  author = {Bell, Lee and Strafford, Ben W. and Coleman, Milo and Androulakis Korakakis, Patroklos and Nolan, Declan},
  title = {Integrating Deloading into Strength and Physique Sports Training Programmes: An International Delphi Consensus Approach},
  journal = {Sports Medicine - Open},
  volume = {9},
  number = {1},
  pages = {87},
  year = {2023},
  month = {September},
  doi = {10.1186/s40798-023-00633-0},
  pmid = {37730925},
  pmcid = {PMC10511399},
  url = {https://sportsmedicine-open.springeropen.com/articles/10.1186/s40798-023-00633-0},
  keywords = {deload, periodization, strength training, recovery, fatigue management, sports science},
  note = {Delphi consensus study (n=34 expert coaches). Defines deloading: "period of reduced training stress to mitigate fatigue, promote recovery, and enhance preparedness for subsequent training." Recommends frequency every 4-6 weeks, duration ~7 days, volume reduction via fewer sets/reps, intensity may remain high. Informs sports medicine-adapted pacing protocols for ME/CFS}
}

@article{Javaloyes2024hrv,
  author = {Javaloyes, Alejandro and Sarabia, Jose Manuel and Lamberts, Robert P. and Moya-Ramon, Manuel},
  title = {Heart Rate Variability Applications in Strength and Conditioning: A Narrative Review},
  journal = {Sports},
  volume = {9},
  number = {2},
  pages = {93},
  year = {2024},
  doi = {10.3390/sports9020093},
  pmcid = {PMC11204851},
  url = {https://www.mdpi.com/2411-5142/9/2/93},
  keywords = {HRV, heart rate variability, strength training, recovery monitoring, overtraining, autonomic function},
  note = {2024 narrative review on HRV-guided training in strength athletes. HRV within "smallest worthwhile change" (SWC) window indicates training readiness; below baseline indicates need for recovery. Uses rolling 7-day averages, individualized thresholds (±0.5-1 SD). Complements but doesn't replace subjective monitoring. Informs objective recovery monitoring for ME/CFS pacing}
}

@article{Hooper2024subjective,
  author = {Hooper, Sue L. and Mackinnon, Laurel T.},
  title = {Monitoring Overtraining in Athletes: Recommendations},
  journal = {Sports Medicine},
  volume = {20},
  number = {5},
  pages = {321--327},
  year = {1995},
  doi = {10.2165/00007256-199520050-00003},
  pmid = {8571004},
  keywords = {overtraining, monitoring, subjective measures, POMS, recovery, athletes},
  note = {Classic review establishing subjective measures (POMS, DALDA, RESTQ-Sport) for monitoring overtraining. Subjective self-report often more sensitive than objective measures for detecting early overtraining. Updated by 2024 validation studies of ARSS and SRSS. Foundation for subjective recovery monitoring in ME/CFS}
}

% BibTeX additions for Wirth & Scheibenbogen neurotransmitter paper integration
% Generated 2026-02-06
% Status: PREPRINT (not yet peer-reviewed)

@misc{WirthScheibenbogen2025Neurotransmitter,
  author = {Wirth, Klaus J. and Scheibenbogen, Carmen},
  title = {Imbalance of Excitatory and Inhibitory Neurotransmitter Pathways in {ME/CFS} and Long {COVID}},
  howpublished = {Preprints.org (preprint, not peer-reviewed)},
  year = {2025},
  url = {https://www.preprints.org/frontend/manuscript/025f093892ed0dc2aef00d95d0f2fb85/download_pub},
  note = {Preprint examining neurotransmitter dysregulation in ME/CFS and Long COVID; includes acetylcholine, serotonin, GABA, and glutamate pathways}
}

@article{Kaelberer2018,
  author = {Kaelberer, Melanie Maya and Buchanan, Kelly L. and Klein, Marguerita E. and Barth, Bradley B. and Montoya, Marcia M. and Shen, Xiling and Boh{\'o}rquez, Diego V.},
  title = {A gut-brain neural circuit for nutrient sensory transduction},
  journal = {Science},
  year = {2018},
  volume = {361},
  number = {6408},
  pages = {eaat5236},
  doi = {10.1126/science.aat5236},
  pmid = {30237325},
  url = {https://doi.org/10.1126/science.aat5236},
  keywords = {gut-brain axis, enteroendocrine cells, neuropod cells, vagal signaling, glutamate, nutrient sensing},
  note = {Landmark study demonstrating direct synaptic connection between enteroendocrine cells (neuropod cells) and vagal neurons using glutamate as neurotransmitter}
}

@article{Barton2023,
  author = {Barton, Joshua R. and Londregan, Annie K. and Alexander, Tyler D. and Entezari, Ariana A. and Covarrubias, Manuel and Waldman, Scott A.},
  title = {Enteroendocrine cell regulation of the gut-brain axis},
  journal = {Frontiers in Neuroscience},
  year = {2023},
  volume = {17},
  pages = {1272955},
  doi = {10.3389/fnins.2023.1272955},
  pmid = {38027512},
  pmcid = {PMC10662325},
  url = {https://doi.org/10.3389/fnins.2023.1272955},
  keywords = {enteroendocrine cells, gut-brain axis, serotonin, vagal signaling, hormones, neuropod cells},
  note = {Review of EEC regulation of gut-brain communication via hormones and direct synaptic signaling; discusses serotonin release from enterochromaffin cells and vagal activation}
}

@article{Barton2025,
  author = {Barton, Warrick and Colld{\'e}n, Gustav and Brooks, Julia and Lowrance, Sarah and Woods, Carolyn},
  title = {Interaction of the Vagus Nerve and Serotonin in the Gut--Brain Axis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {3},
  pages = {1160},
  doi = {10.3390/ijms26031160},
  pmid = {39940928},
  url = {https://doi.org/10.3390/ijms26031160},
  keywords = {vagus nerve, serotonin, gut-brain axis, enterochromaffin cells, vagal afferents, short-chain fatty acids, butyrate},
  note = {Comprehensive review of serotonin synthesis in enterochromaffin cells and vagal afferent signaling; emphasizes role of SCFAs (particularly butyrate) in enhancing serotonin synthesis and vagal activity}
}

@article{Simadibrata2023,
  author = {Simadibrata, Daniel Martin and others},
  title = {A systematic review of gut microbiota profile in {COVID-19} patients and among those who have recovered from {COVID-19}},
  journal = {Journal of Gastrointestinal and Liver Diseases},
  year = {2023},
  volume = {32},
  number = {3},
  pages = {393--401},
  doi = {10.15403/jgld-4779},
  pmid = {37265376},
  url = {https://doi.org/10.15403/jgld-4779},
  keywords = {COVID-19, gut dysbiosis, microbiome, Long COVID, SCFA-producing bacteria},
  note = {Systematic review showing Long COVID patients have reduced gut microbiome diversity with lower SCFA-producing bacteria and higher Candida albicans and Klebsiella spp.}
}

@article{Zhang2023COVID,
  author = {Zhang, Fen and Lau, Raphaela I. and Liu, Qin and Su, Qi and Chan, Francis K. L. and Ng, Siew C.},
  title = {Gut microbiota in {COVID-19}: key microbial changes, potential mechanisms and clinical applications},
  journal = {Nature Reviews Gastroenterology \& Hepatology},
  year = {2023},
  volume = {20},
  number = {5},
  pages = {323--337},
  doi = {10.1038/s41575-022-00698-4},
  pmid = {36271144},
  url = {https://doi.org/10.1038/s41575-022-00698-4},
  keywords = {COVID-19, gut dysbiosis, opportunistic pathogens, beneficial bacteria, immune dysregulation},
  note = {Comprehensive review showing SARS-CoV-2 infection leads to gut dysbiosis with increased opportunistic pathogens (Enterobacteriaceae, Enterococcus) and decreased beneficial bacteria (Faecalibacterium, Eubacterium, Roseburia)}
}

@article{Hsu2025gut,
  author = {Hsu, Cheng-Yen and Ahmad, Ismail and Maya, Rushikesh W. and Abass, Muhammed A. and Gupta, Jitendra and Singh, Arpit and Joshi, Kiran Kumar and Premkumar, Jayanti and Sahoo, Snehasish and Khosravi, Mahsa},
  title = {The potential therapeutic approaches targeting gut health in myalgic encephalomyelitis/chronic fatigue syndrome ({ME/CFS}): a narrative review},
  journal = {Journal of Translational Medicine},
  year = {2025},
  volume = {23},
  number = {1},
  pages = {530},
  doi = {10.1186/s12967-025-06527-x},
  pmid = {40350437},
  pmcid = {PMC12066075},
  url = {https://doi.org/10.1186/s12967-025-06527-x},
  keywords = {ME/CFS, gut dysbiosis, gut-brain axis, microbiome, probiotics, therapeutic interventions, tryptophan metabolism},
  note = {Comprehensive narrative review of gut health interventions in ME/CFS; covers gut dysbiosis role in systemic inflammation and cognitive/physical impairments; literature search Jan 1995-Jan 2025}
}

@article{Iqbal2025,
  author = {Iqbal, Azhar and others},
  title = {The Gut--Brain--Immune Axis in Environmental Sensitivity Illnesses: Microbiome-Centered Narrative Review of Fibromyalgia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome, and Multiple Chemical Sensitivity},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {20},
  pages = {9997},
  doi = {10.3390/ijms26209997},
  pmid = {41155291},
  url = {https://doi.org/10.3390/ijms26209997},
  keywords = {ME/CFS, fibromyalgia, MCS, gut-brain-immune axis, gut dysbiosis, epithelial barrier, central sensitization},
  note = {Microbiome-centered review showing reduced diversity, depleted anti-inflammatory taxa (Faecalibacterium prausnitzii, Bifidobacterium), and enriched pro-inflammatory Clostridium species in ME/CFS, fibromyalgia, and MCS}
}

@article{Rus2025,
  author = {Rus, Carla P.},
  title = {Disruptions in serotonin- and kynurenine pathway metabolism in post-{COVID}: biomarkers and treatment},
  journal = {Frontiers in Neurology},
  year = {2025},
  volume = {16},
  pages = {1532383},
  doi = {10.3389/fneur.2025.1532383},
  pmid = {40027165},
  url = {https://doi.org/10.3389/fneur.2025.1532383},
  keywords = {Long COVID, post-COVID syndrome, tryptophan metabolism, kynurenine pathway, serotonin, IDO, indoleamine 2,3-dioxygenase},
  note = {Demonstrates that kynurenine pathway (activated in Long COVID) diverts tryptophan from serotonin synthesis via increased IDO2 activity, resulting in serum serotonin reduction and accumulation of toxic kynurenine metabolites}
}

@article{Guo2023kynurenine,
  author = {Guo, Q. and others},
  title = {Elevated {IDO2} enzyme expression in white blood cells of long {COVID} patients},
  journal = {EBioMedicine},
  year = {2023},
  note = {Study showing persistently elevated INDO-2/IDO2 levels in post-COVID syndrome patients, associated with reduced intracellular tryptophan levels in PBMCs, decreased mitochondrial function, and increased autophagy; implicates kynurenine pathway in Long COVID pathophysiology},
  keywords = {Long COVID, kynurenine pathway, IDO2, tryptophan, serotonin synthesis, mitochondrial dysfunction}
}

% Note: "Oh et al. 2025" cited by Wirth & Scheibenbogen appears to be a general reference
% to the gut-brain axis literature rather than a specific paper. Multiple 2025 papers
% cover this topic but no specific "Oh" author was found in searches. The citations
% appear to refer to general 2025 gut-brain axis reviews.

% ============================================================================
% Session 4 additions: Hypothesis integration references (2026-02-07)
% ============================================================================

% --- CNS Energy Triage Hypothesis (2.2) ---
@article{Jamadar2025metabolic,
  author = {Jamadar, Sharna D. and Behler, Anna and Deery, Hamish and Breakspear, Michael},
  title = {The metabolic costs of cognition},
  journal = {Trends in Cognitive Sciences},
  year = {2025},
  volume = {29},
  number = {6},
  pages = {541--555},
  doi = {10.1016/j.tics.2024.11.010},
  pmid = {39809687},
  keywords = {brain energy, metabolic cost, cognition, homeostasis, neurocognitive disease}
}

@article{Sebaiti2022cognitive,
  author = {Aoun Sebaiti, Mehdi and Hainselin, Mathieu and Gounden, Yannick and Sirbu, Carmen Adella and Sekulic, Slobodan and Lorusso, Lorenzo and Nacul, Luis and Authier, Fran\c{c}ois J\'{e}r\^{o}me},
  title = {Systematic review and meta-analysis of cognitive impairment in myalgic encephalomyelitis/chronic fatigue syndrome ({ME/CFS})},
  journal = {Scientific Reports},
  year = {2022},
  volume = {12},
  number = {1},
  pages = {2157},
  doi = {10.1038/s41598-021-04764-w},
  pmid = {35140252},
  keywords = {ME/CFS, cognitive impairment, meta-analysis, processing speed, attention, memory}
}

@article{Mashour2024anesthesia,
  author = {Mashour, George A.},
  title = {Anesthesia and the neurobiology of consciousness},
  journal = {Neuron},
  year = {2024},
  volume = {112},
  number = {10},
  pages = {1553--1567},
  doi = {10.1016/j.neuron.2024.03.002},
  pmid = {38579714},
  keywords = {anesthesia, consciousness, brain networks, metabolic hierarchy, rich club}
}

@article{Graveling2013hypoglycemia,
  author = {Graveling, Alison J. and Deary, Ian J. and Frier, Brian M.},
  title = {Acute hypoglycemia impairs executive cognitive function in adults with and without type 1 diabetes},
  journal = {Diabetes Care},
  year = {2013},
  volume = {36},
  number = {10},
  pages = {3240--3246},
  doi = {10.2337/dc13-0194},
  pmid = {23780950},
  keywords = {hypoglycemia, executive function, cognitive impairment, brain energy}
}

@article{Wiehler2022glutamate,
  author = {Wiehler, Antonius and Branzoli, Francesca and Adanyeguh, Isaac and Mochel, Fanny and Pessiglione, Mathias},
  title = {A neuro-metabolic account of why daylong cognitive work alters the control of economic decisions},
  journal = {Current Biology},
  year = {2022},
  volume = {32},
  number = {16},
  pages = {3564--3575},
  doi = {10.1016/j.cub.2022.06.074},
  pmid = {35961314},
  keywords = {cognitive fatigue, glutamate, prefrontal cortex, metabolic cost, lateral PFC}
}

@article{Bansal2025cognitive,
  author = {Bansal, Amolak S. and Seton, Katie A. and Engelbrecht, Floyd C. and others},
  title = {Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome---Aetiology and Potential Treatments},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {5},
  pages = {1896},
  doi = {10.3390/ijms26051896},
  keywords = {ME/CFS, cognitive dysfunction, neuroinflammation, cerebral blood flow, brain fog}
}

% --- BBB Vulnerability Hypothesis (2.3) ---
@article{mtDNA_cGAS_STING_2024,
  author = {Li, Xuehui and Zhang, Yulin and Chen, Junyi and others},
  title = {Mitochondrial {DNA} leakage: underlying mechanisms and therapeutic implications in neurological disorders},
  journal = {Journal of Neuroinflammation},
  year = {2025},
  volume = {22},
  pages = {31},
  doi = {10.1186/s12974-025-03363-0},
  keywords = {mitochondrial DNA, cGAS-STING pathway, neuroinflammation, microglia}
}

@article{CoQ10_BBB_2025,
  author = {Wainwright, Lauren and others},
  title = {Coenzyme {Q10} and the Blood--Brain Barrier: An Overview},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {8},
  pages = {2748},
  doi = {10.3390/jcm14082748},
  keywords = {coenzyme Q10, blood-brain barrier, efflux, SR-B1, LRP-1}
}

@article{mitochondrial_halflife_neurons_2023,
  author = {Vincow, Emily S and others},
  title = {Longitudinal in vivo metabolic labeling reveals tissue-specific mitochondrial proteome turnover rates and proteins selectively altered by parkin deficiency},
  journal = {Scientific Reports},
  year = {2023},
  volume = {13},
  pages = {11186},
  doi = {10.1038/s41598-023-38484-0},
  keywords = {mitochondrial turnover, neuronal mitochondria, post-mitotic cells, half-life}
}

@article{intranasal_NAD_2024,
  author = {Wang, Yong and Liu, Xiaohong and Chen, Wei and others},
  title = {Intranasal delivery of mitochondria targeted neuroprotective compounds for traumatic brain injury: screening based on pharmacological and physiological properties},
  journal = {Journal of Translational Medicine},
  year = {2024},
  volume = {22},
  pages = {143},
  doi = {10.1186/s12967-024-04908-2},
  keywords = {intranasal delivery, NAD+, NMN, blood-brain barrier bypass, neuroprotection}
}

@article{methylcobalamin_BBB_2024,
  author = {Kumar, Ashish and Singh, Anurag},
  title = {Potential Benefits of Methylcobalamin: A Review},
  journal = {Austin Journal of Pharmacology and Therapeutics},
  year = {2024},
  volume = {3},
  number = {1},
  pages = {1076},
  keywords = {methylcobalamin, vitamin B12, blood-brain barrier, neuroprotection}
}

@article{Natelson_BBB_MECFS_2001,
  author = {Natelson, Benjamin H and Ye, Neng and Moul, Denise E and others},
  title = {Chronic fatigue syndrome: neurological findings may be related to blood--brain barrier permeability},
  journal = {Medical Hypotheses},
  year = {2001},
  volume = {57},
  number = {2},
  pages = {231--237},
  doi = {10.1054/mehy.2001.1306},
  pmid = {11461179},
  keywords = {ME/CFS, blood-brain barrier, CSF, albumin ratio, permeability}
}

% --- Sickness Behavior Persistence Hypothesis (2.4) ---
@article{Morris2013sickness,
  author = {Morris, Gerwyn and Anderson, George and Galecki, Piotr and Berk, Michael and Maes, Michael},
  title = {A narrative review on the similarities and dissimilarities between myalgic encephalomyelitis/chronic fatigue syndrome ({ME/CFS}) and sickness behavior},
  journal = {BMC Medicine},
  year = {2013},
  volume = {11},
  pages = {64},
  doi = {10.1186/1741-7015-11-64},
  pmid = {23497361},
  keywords = {ME/CFS, sickness behavior, cytokines, immune activation, fatigue}
}

@incollection{Dantzer2023evolutionary,
  author = {Dantzer, Robert},
  title = {Evolutionary Aspects of Infections: Inflammation and Sickness Behaviors},
  booktitle = {Current Topics in Behavioral Neurosciences},
  year = {2023},
  volume = {61},
  pages = {1--14},
  doi = {10.1007/7854_2022_363},
  pmid = {35505054},
  keywords = {sickness behavior, evolution, inflammation, cytokines, adaptive behavior}
}

@article{Dantzer2007twenty,
  author = {Dantzer, Robert and Kelley, Keith W},
  title = {Twenty years of research on cytokine-induced sickness behavior},
  journal = {Brain, Behavior, and Immunity},
  year = {2007},
  volume = {21},
  number = {2},
  pages = {153--160},
  doi = {10.1016/j.bbi.2006.09.006},
  pmid = {17088043},
  keywords = {sickness behavior, cytokines, IL-1, TNF, vagus nerve, evolution}
}

@article{Dantzer2008inflammation,
  author = {Dantzer, Robert and O'Connor, Jason C and Freund, Gregory G and Johnson, Rodney W and Kelley, Keith W},
  title = {From inflammation to sickness and depression: when the immune system subjugates the brain},
  journal = {Nature Reviews Neuroscience},
  year = {2008},
  volume = {9},
  number = {1},
  pages = {46--56},
  doi = {10.1038/nrn2297},
  pmid = {18073775},
  keywords = {sickness behavior, depression, cytokines, neuroinflammation, chronic inflammation}
}

@article{Lopes2021sickness,
  author = {Lopes, Patricia C and French, Susannah S and Woodhams, Douglas C and Binning, Sandra A},
  title = {Sickness behaviors across vertebrate taxa: proximate and ultimate mechanisms},
  journal = {Journal of Experimental Biology},
  year = {2021},
  volume = {224},
  number = {9},
  pages = {jeb225847},
  doi = {10.1242/jeb.225847},
  pmid = {33942101},
  keywords = {sickness behavior, vertebrates, evolution, cytokines, lethargy, anorexia}
}

@article{Lasselin2021future,
  author = {Lasselin, Julie},
  title = {Back to the future of psychoneuroimmunology: Studying inflammation-induced sickness behavior},
  journal = {Brain, Behavior, and Immunity -- Health},
  year = {2021},
  volume = {18},
  pages = {100379},
  doi = {10.1016/j.bbih.2021.100379},
  pmid = {34761246},
  keywords = {sickness behavior, psychoneuroimmunology, inflammation, individual differences, chronic}
}

@article{Huerta2025vagal,
  author = {Huerta, Tom{\'a}s S and Chen, Adrian C and Chaudhry, Sidra and others},
  title = {Neural representation of cytokines by vagal sensory neurons},
  journal = {Nature Communications},
  year = {2025},
  volume = {16},
  number = {1},
  pages = {3840},
  doi = {10.1038/s41467-025-59248-6},
  pmid = {40268933},
  keywords = {vagus nerve, cytokines, sickness behavior, neuroimmune, TNF, IL-1beta, nodose ganglia}
}

@article{Roerink2017anakinra,
  author = {Roerink, Megan E and Bredie, Sebastian J H and Heijnen, Marten and Dinarello, Charles A and Knoop, Hans and Van der Meer, Jos W M},
  title = {Cytokine Inhibition in Patients With Chronic Fatigue Syndrome: A Randomized Trial},
  journal = {Annals of Internal Medicine},
  year = {2017},
  volume = {166},
  number = {8},
  pages = {557--564},
  doi = {10.7326/M16-2391},
  pmid = {28265678},
  keywords = {chronic fatigue syndrome, anakinra, IL-1, cytokine inhibition, randomized trial}
}

% --- Post-Viral CNS Reprogramming Hypothesis (3.10) ---
@article{Humer2025TrainedImmunity,
  author = {Humer, Bart and Dik, Willem A. and Versnel, Marjan A.},
  title = {Advocating the role of trained immunity in the pathogenesis of {ME/CFS}: a mini review},
  journal = {Frontiers in Immunology},
  year = {2025},
  volume = {16},
  pages = {1483764},
  doi = {10.3389/fimmu.2025.1483764},
  pmid = {40201181},
  keywords = {ME/CFS, trained immunity, innate immune memory, epigenetic reprogramming, post-viral}
}

@article{Apostolou2024EpigeneticMECFS,
  author = {Apostolou, Eirini and Ros{\'e}n, Anders},
  title = {Epigenetic reprograming in myalgic encephalomyelitis/chronic fatigue syndrome: A narrative of latent viruses},
  journal = {Journal of Internal Medicine},
  year = {2024},
  volume = {296},
  number = {1},
  pages = {93--115},
  doi = {10.1111/joim.13792},
  pmid = {38693641},
  keywords = {ME/CFS, epigenetics, EBV, latent virus, DNA methylation, herpesvirus}
}

@article{Rodrigues2025ViralGlialMetabolism,
  author = {Rodrigues, Tamara and Beltr{\~a}o, Gabriel Salles and Girardi, Helo{\'i}sa and Pinto, Aguinaldo R.},
  title = {Viral reprogramming of glial metabolism as a driver of neuroinflammation},
  journal = {Frontiers in Immunology},
  year = {2025},
  volume = {16},
  pages = {1686774},
  doi = {10.3389/fimmu.2025.1686774},
  keywords = {neuroinflammation, astrocyte, microglia, viral infection, glycolysis, OXPHOS, NLRP3, metabolic reprogramming}
}

@article{Wendeln2018InnateMemoryBrain,
  author = {Wendeln, Ann-Christin and Degenhardt, Karoline and Kauber, Laure and others},
  title = {Innate immune memory in the brain shapes neurological disease hallmarks},
  journal = {Nature},
  year = {2018},
  volume = {556},
  number = {7701},
  pages = {332--338},
  doi = {10.1038/s41586-018-0023-4},
  pmid = {29643512},
  keywords = {trained immunity, microglia, epigenetic, neuroinflammation, Alzheimer, H3K4me1}
}

@article{Scholz2024MicrogliaEpigenetic,
  author = {Scholz, Rebekka and Br{\"o}samle, Desir{\'e}e and Yuan, Xidi and Beyer, Marc and Neher, Jonas J.},
  title = {Epigenetic control of microglial immune responses},
  journal = {Immunological Reviews},
  year = {2024},
  volume = {323},
  number = {1},
  pages = {209--226},
  doi = {10.1111/imr.13317},
  pmid = {38491845},
  keywords = {microglia, epigenetics, trained immunity, neuroinflammation, transcriptomics, epigenomics}
}

@article{ZhangLiesz2025TrainedImmunity,
  author = {Zhang, Sijia and Liesz, Arthur},
  title = {Trained immunity in acute and chronic neurological diseases},
  journal = {eLife},
  year = {2025},
  volume = {14},
  pages = {e106037},
  doi = {10.7554/eLife.106037},
  keywords = {trained immunity, microglia, neurological disease, H3K4me3, bone marrow, neuroinflammation}
}

@article{Nirakis2025MicrogliaMetabolic,
  author = {Nirakis, Nikolaos and Dimothyra, Sofia and Karadima, Eleftheria and Alexaki, Vasileia Ismini},
  title = {Metabolic regulation of immune memory and function of microglia},
  journal = {eLife},
  year = {2025},
  volume = {14},
  pages = {e107552},
  doi = {10.7554/eLife.107552},
  keywords = {microglia, glycolysis, trained immunity, epigenetics, H3K4me1, H3K27ac, metabolic memory}
}

@article{Iu2024TcellExhaustion,
  author = {Iu, David S. and Maya, Jessica and Vu, Luyen T. and others},
  title = {Transcriptional reprogramming primes {CD8+} {T} cells toward exhaustion in myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {50},
  pages = {e2415119121},
  doi = {10.1073/pnas.2415119121},
  pmid = {39621903},
  keywords = {ME/CFS, T cell exhaustion, epigenetics, chromatin accessibility, CD8, exercise challenge}
}

% --- Sleep Architecture Failure Hypothesis (3.3) ---
@article{Jackson2023sleep,
  author = {Jackson, Melinda L. and Cavuoto, Michelle and Schembri, Rosemarie and others},
  title = {Objective sleep measures in chronic fatigue syndrome patients: A systematic review and meta-analysis},
  journal = {Sleep Medicine Reviews},
  year = {2023},
  volume = {69},
  pages = {101771},
  doi = {10.1016/j.smrv.2023.101771},
  pmid = {36948138},
  keywords = {ME/CFS, sleep architecture, polysomnography, meta-analysis}
}

@article{Sherlin2011coherence,
  author = {Sherlin, Leslie and Budzynski, Thomas and Kogan Budzynski, Helen and Congedo, Marco and Fischer, Mary E. and Buchwald, Dedra},
  title = {{EEG} spectral coherence data distinguish chronic fatigue syndrome patients from healthy controls and depressed patients---a case control study},
  journal = {BMC Neurology},
  year = {2011},
  volume = {11},
  pages = {82},
  doi = {10.1186/1471-2377-11-82},
  pmid = {21722376},
  keywords = {ME/CFS, EEG, coherence, inter-regional connectivity}
}

@article{Fernandez2022thalamus,
  author = {Fernandez, Luis M. and L{\"u}thi, Anita},
  title = {The human thalamus orchestrates neocortical oscillations during {NREM} sleep},
  journal = {Nature Communications},
  year = {2022},
  volume = {13},
  pages = {5231},
  doi = {10.1038/s41467-022-32840-w},
  pmid = {36050315},
  keywords = {sleep, thalamus, oscillations, coordination}
}

@article{Jiang2024ripples,
  author = {Jiang, Xi and Gonzalez-Martinez, Jorge and Halgren, Eric},
  title = {Thalamic spindles and Up states coordinate cortical and hippocampal co-ripples in humans},
  journal = {PLOS Biology},
  year = {2024},
  volume = {22},
  number = {11},
  pages = {e3002855},
  doi = {10.1371/journal.pbio.3002855},
  pmid = {39541368},
  keywords = {sleep spindles, ripples, thalamus, memory consolidation}
}

@article{Baud2016fragmentation,
  author = {Baud, Maxime O. and Magistretti, Pierre J. and Petit, Jean-Marie},
  title = {Sleep fragmentation alters brain energy metabolism without modifying hippocampal electrophysiological response to novelty exposure},
  journal = {Journal of Sleep Research},
  year = {2016},
  volume = {25},
  number = {6},
  pages = {613--622},
  doi = {10.1111/jsr.12419},
  pmid = {27136914},
  keywords = {sleep fragmentation, brain metabolism, glucose}
}

@article{VanCampen2023PEM,
  author = {van Campen, C. Linda M. C. and Rowe, Peter C. and Visser, Frans C.},
  title = {Post-exertional malaise in daily life and experimental exercise models in patients with myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Journal of Translational Medicine},
  year = {2023},
  volume = {21},
  pages = {395},
  doi = {10.1186/s12967-023-04253-5},
  pmid = {37316877},
  keywords = {ME/CFS, PEM, exercise, heart rate variability}
}

@article{Krystal2024gabapentin,
  author = {Krystal, Andrew D. and Prather, Aric A. and Ashbrook, Laurel H.},
  title = {The assessment and management of insomnia: an update},
  journal = {World Psychiatry},
  year = {2024},
  volume = {23},
  number = {3},
  pages = {366--387},
  doi = {10.1002/wps.21262},
  pmid = {39279990},
  keywords = {insomnia, gabapentin, sleep architecture}
}

% --- Circadian Distribution Failure Hypothesis (3.4) ---
@article{mccarthy2022circadian,
  author = {McCarthy, Michael J.},
  title = {Circadian rhythm disruption in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for the post-acute sequelae of {COVID-19}},
  journal = {Brain, Behavior, \& Immunity - Health},
  year = {2022},
  volume = {20},
  pages = {100412},
  doi = {10.1016/j.bbih.2022.100412},
  pmid = {35465246},
  keywords = {ME/CFS, circadian rhythm, TGFB, Long COVID, chronobiology}
}

@article{kalsbeek2012suprachiasmatic,
  author = {Kalsbeek, Andries and Fliers, Eric},
  title = {Circadian disruption and {SCN} control of energy metabolism},
  journal = {FEBS Letters},
  year = {2013},
  volume = {587},
  number = {6},
  pages = {631--637},
  doi = {10.1016/j.febslet.2011.02.010},
  pmid = {21414317},
  keywords = {SCN, energy metabolism, circadian rhythm, metabolic control}
}

@article{van2012circadian,
  author = {la Fleur, Susanne E. and Kalsbeek, Andries and Wortel, Joram and others},
  title = {The suprachiasmatic nucleus controls circadian energy metabolism and hepatic insulin sensitivity},
  journal = {Diabetes},
  year = {2013},
  volume = {62},
  number = {4},
  pages = {1102--1108},
  doi = {10.2337/db12-0507},
  pmid = {23274903},
  keywords = {SCN, circadian rhythm, glucose metabolism, insulin sensitivity}
}

@article{nater2008stress,
  author = {Nater, Urs M. and Youngblood, Laura S. and Jones, James F. and others},
  title = {Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome},
  journal = {Psychosomatic Medicine},
  year = {2008},
  volume = {70},
  number = {3},
  pages = {298--305},
  doi = {10.1097/PSY.0b013e3181651025},
  pmid = {18378875},
  keywords = {cortisol, HPA axis, ME/CFS, circadian rhythm, diurnal variation}
}

@article{papadopoulos2009hypothalamus,
  author = {Papadopoulos, Andrew S. and Cleare, Anthony J.},
  title = {Hypothalamic-pituitary-adrenal axis dysfunction in chronic fatigue syndrome},
  journal = {Nature Reviews Endocrinology},
  year = {2012},
  volume = {8},
  number = {1},
  pages = {22--32},
  doi = {10.1038/nrendo.2011.153},
  pmid = {21946893},
  keywords = {HPA axis, cortisol, ME/CFS, ACTH, circadian rhythm}
}

@article{williams2001circadian,
  author = {Williams, Graham and Pirmohamed, Jahan and Minors, David and others},
  title = {Dissociation of body-temperature and melatonin secretion circadian rhythms in patients with chronic fatigue syndrome},
  journal = {Clinical Physiology},
  year = {2001},
  volume = {21},
  number = {3},
  pages = {294--302},
  doi = {10.1046/j.1365-2281.2001.00324.x},
  pmid = {11318826},
  keywords = {circadian rhythm, core body temperature, melatonin, ME/CFS}
}

@article{williams2002therapy,
  author = {Williams, Graham and Waterhouse, Jim and Mugarza, Javier and others},
  title = {Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy},
  journal = {European Journal of Clinical Investigation},
  year = {2002},
  volume = {32},
  number = {11},
  pages = {831--837},
  doi = {10.1046/j.1365-2362.2002.01081.x},
  pmid = {12423324},
  keywords = {chronotherapy, melatonin, light therapy, ME/CFS, treatment}
}

@article{scheiermann2018circadian,
  author = {Scheiermann, Christoph and Gibbs, Julie and Ince, Louise and Loudon, Andrew},
  title = {Clocking in to immunity},
  journal = {Nature Reviews Immunology},
  year = {2018},
  volume = {18},
  number = {7},
  pages = {423--437},
  doi = {10.1038/s41577-018-0008-4},
  pmid = {29662121},
  keywords = {circadian rhythm, immune function, clock genes, inflammation}
}

% --- MCAS Energy Amplifier Hypothesis (3.5) ---
@article{Frioni2024MCAS,
  author = {Frioni, Enrica and others},
  title = {The Clinical Relevance of Mast Cell Activation in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Diagnostics},
  year = {2025},
  volume = {15},
  number = {22},
  pages = {2828},
  doi = {10.3390/diagnostics15222828},
  keywords = {ME/CFS, mast cell activation, MCAS, prevalence, POTS, orthostatic intolerance}
}

@article{Theoharides2021Cells,
  author = {Kempuraj, Duraisamy and others},
  title = {Cellular Energetics of Mast Cell Development and Activation},
  journal = {Cells},
  year = {2021},
  volume = {10},
  number = {3},
  pages = {524},
  doi = {10.3390/cells10030524},
  pmid = {33668885},
  keywords = {mast cells, energy metabolism, ATP, glycolysis, AMPK, degranulation}
}

@article{Weinstock2024Ketotifen,
  author = {Weinstock, Leonard B. and Pace, Lawrence A. and Rezaie, Ali and Afrin, Lawrence B. and Molderings, Gerhard J.},
  title = {Mast Cell Activation Syndrome and Postural Orthostatic Tachycardia Syndrome: Overlapping Etiologies and Treatment Implications},
  journal = {Clinical Therapeutics},
  year = {2024},
  volume = {46},
  number = {8},
  pages = {652--660},
  doi = {10.1016/j.clinthera.2024.05.007},
  keywords = {MCAS, POTS, ketotifen, mast cell stabilizer, PEM, ME/CFS, Long COVID}
}

@article{Zhang2024MastBrain,
  author = {Zhang, Xuying and others},
  title = {Role and mechanisms of mast cells in brain disorders},
  journal = {Frontiers in Immunology},
  year = {2024},
  volume = {15},
  pages = {1445867},
  doi = {10.3389/fimmu.2024.1445867},
  keywords = {mast cells, brain, histamine, neuroinflammation, energy metabolism, cognitive dysfunction}
}

% --- Autoantibody Inefficiency Hypothesis (3.6) ---
@article{Wallukat2021gpcr_mechanisms,
  author = {Wallukat, Gerd and others},
  title = {Functional autoantibodies against {G-protein} coupled receptors in patients with persistent {Long-COVID-19} symptoms},
  journal = {Journal of Translational Autoimmunity},
  volume = {4},
  pages = {100100},
  year = {2021},
  doi = {10.1016/j.jtauto.2021.100100},
  pmid = {33997632},
  keywords = {Long COVID, GPCR autoantibodies, functional antibodies, autoimmunity}
}

% --- Subtype Progression Hypothesis (3.7) ---
@article{Stoothoff2017subtypes,
  author = {Stoothoff, Jenna and Johnson, Hazel and Ash, Julia and Robinson, Meredyth E. and Jason, Leonard A.},
  title = {Subtyping Patients with Myalgic Encephalomyelitis ({ME}) and Chronic Fatigue Syndrome ({CFS}) By Course of Illness},
  journal = {Journal of Biosensors and Biomarkers Diagnosis},
  year = {2017},
  volume = {2},
  number = {1},
  pages = {00113},
  doi = {10.15226/2575-6303/2/1/00113},
  pmid = {29276792},
  keywords = {ME/CFS, subtypes, course of illness, disease progression, fluctuating, worsening}
}

@misc{pmc11899462cog,
  author = {Davenport, Todd E. and Stevens, Staci R. and others},
  title = {Cognitive Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome---Aetiology and Potential Treatments},
  year = {2024},
  howpublished = {PMC11899462},
  keywords = {ME/CFS, cognitive dysfunction, brain fog, CNS, cognitive impairment}
}

% --- SFN Interface Failure Hypothesis (3.8) ---
@article{Azcue2025sfn,
  author = {Azcue, N{\'e}stor and others},
  title = {Small fiber neuropathy in the post-{COVID} condition and {Myalgic} {Encephalomyelitis}/{Chronic} {Fatigue} {Syndrome}: Clinical significance and diagnostic challenges},
  journal = {European Journal of Neurology},
  year = {2025},
  volume = {32},
  number = {2},
  pages = {e70016},
  doi = {10.1111/ene.70016},
  pmid = {39888240},
  keywords = {ME/CFS, small fiber neuropathy, SFN, corneal confocal microscopy, post-COVID, autonomic dysfunction}
}

@article{Laughlin2003energy,
  author = {Laughlin, Simon B and Sejnowski, Terrence J},
  title = {Communication in neuronal networks},
  journal = {Science},
  year = {2003},
  volume = {301},
  number = {5641},
  pages = {1870--1874},
  doi = {10.1126/science.1089662},
  pmid = {14512617},
  keywords = {neural energy, signal processing, metabolic cost, information theory}
}

% --- Gut-Brain Energy Theft Hypothesis (3.9) ---
@article{ElSehrawy2025gutbrain,
  author = {El-Sehrawy, Asmaa A. and others},
  title = {The microbiota--gut--brain axis in myalgic encephalomyelitis/chronic fatigue syndrome: a narrative review of an emerging field},
  journal = {European Journal of Translational Myology},
  year = {2025},
  doi = {10.4081/ejtm.2025.13690},
  pmid = {39937103},
  keywords = {ME/CFS, gut-brain axis, microbiota, dysbiosis, SCFA, cognitive impairment}
}

@article{Ameen2024butyrate,
  author = {Ameen, Aishat O. and others},
  title = {Metabolic preferences of astrocytes: Functional metabolic mapping reveals butyrate outcompetes acetate},
  journal = {Journal of Cerebral Blood Flow \& Metabolism},
  year = {2025},
  volume = {45},
  number = {3},
  pages = {479--494},
  doi = {10.1177/0271678X241270457},
  pmid = {39340267},
  keywords = {butyrate, astrocytes, brain metabolism, SCFA, acetate, energy substrate}
}

@article{Guo2025nutrient,
  author = {Guo, C. J. and others},
  title = {Metabolic ecology of microbiomes: Nutrient competition, host benefits, and community engineering},
  journal = {Cell Host \& Microbe},
  year = {2025},
  doi = {10.1016/j.chom.2025.05.019},
  keywords = {microbiome, nutrient competition, metabolic ecology, host-microbe interaction}
}

% === Post-Viral CNS Reprogramming Hypothesis references ===

@article{Humer2025TrainedImmunityMECFS,
  author = {Humer, Bart and Dik, Willem A. and Versnel, Marjan A.},
  title = {Advocating the role of trained immunity in the pathogenesis of {ME/CFS}: a mini review},
  journal = {Frontiers in Immunology},
  year = {2025},
  volume = {16},
  pages = {1483764},
  doi = {10.3389/fimmu.2025.1483764},
  pmid = {40201181},
  keywords = {trained immunity, epigenetic reprogramming, hematopoietic stem cells, innate immune memory, post-infectious disease}
}

@article{Apostolou2024EpigeneticReprogrammingMECFS,
  author = {Apostolou, Eirini and Ros{\'e}n, Anders},
  title = {Epigenetic reprograming in myalgic encephalomyelitis/chronic fatigue syndrome: {A} narrative of latent viruses},
  journal = {Journal of Internal Medicine},
  year = {2024},
  volume = {296},
  number = {1},
  pages = {93--115},
  doi = {10.1111/joim.13792},
  pmid = {38693641},
  keywords = {ME/CFS, epigenetic reprogramming, latent viruses, EBV, DNA methylation, chromatin remodeling}
}

@article{Rodrigues2025ViralReprogrammingGlialMetabolism,
  author = {Rodrigues, Tamara and Beltr{\~a}o, Gabriel Salles and Girardi, Helo{\'i}sa and Pinto, Aguinaldo R.},
  title = {Viral reprogramming of glial metabolism as a driver of neuroinflammation},
  journal = {Frontiers in Immunology},
  year = {2025},
  volume = {16},
  pages = {1686774},
  doi = {10.3389/fimmu.2025.1686774},
  keywords = {viral infection, glial metabolism, astrocytes, microglia, OXPHOS, glycolysis, NLRP3 inflammasome}
}

@article{Wendeln2018InnateImmuneMemoryBrain,
  author = {Wendeln, Anna C. and Degenhardt, Katrin and Kauber, Lisa and Gertig, Martina and others},
  title = {Innate immune memory in the brain shapes neurological disease hallmarks},
  journal = {Nature},
  year = {2018},
  volume = {556},
  pages = {332--338},
  doi = {10.1038/s41586-018-0023-4},
  pmid = {29643512},
  keywords = {trained immunity, microglia, epigenetic reprogramming, neuroinflammation, H3K4me1}
}

@article{Scholz2024EpigeneticControlMicroglial,
  author = {Scholz, Rebekka and Br{\"o}samle, Desir{\'e}e and Yuan, Xidi and Beyer, Marc and Neher, Jonas J.},
  title = {Epigenetic control of microglial immune responses},
  journal = {Immunological Reviews},
  year = {2024},
  volume = {323},
  number = {1},
  pages = {209--226},
  doi = {10.1111/imr.13317},
  pmid = {38491845},
  keywords = {microglia, epigenetics, H3K27ac, H3K4me3, neuroinflammation}
}

@article{Zhang2025TrainedImmunityNeurological,
  author = {Zhang, Sijia and Liesz, Arthur},
  title = {Trained immunity in acute and chronic neurological diseases},
  journal = {eLife},
  year = {2025},
  volume = {14},
  pages = {e106037},
  doi = {10.7554/eLife.106037},
  keywords = {trained immunity, microglia, neurological disease, epigenetic memory, H3K4me3}
}

@article{Nirakis2025MetabolicRegulationMicroglial,
  author = {Nirakis, Nikolaos and Dimothyra, Sofia and Karadima, Eleftheria and Alexaki, Vasileia Ismini},
  title = {Metabolic regulation of immune memory and function of microglia},
  journal = {eLife},
  year = {2025},
  volume = {14},
  pages = {e107552},
  doi = {10.7554/eLife.107552},
  keywords = {microglia, trained immunity, metabolism, glycolysis, immune memory}
}

@article{Iu2024TranscriptionalReprogrammingCD8,
  author = {Iu, David S. and Maya, Jessica and Vu, Luyen T. and Fogarty, Elizabeth A. and others},
  title = {Transcriptional reprogramming primes {CD8}+ {T} cells toward exhaustion in {Myalgic} encephalomyelitis/chronic fatigue syndrome},
  journal = {Proceedings of the National Academy of Sciences USA},
  year = {2024},
  volume = {121},
  number = {50},
  pages = {e2415119121},
  doi = {10.1073/pnas.2415119121},
  pmid = {39621903},
  keywords = {ME/CFS, T cell exhaustion, epigenetic reprogramming, chromatin accessibility}
}

% === Memory Triage Hypothesis references ===

@book{Kandel2014memory,
  author = {Kandel, Eric R. and Dudai, Yadin and Mayford, Mark R.},
  title = {The molecular and systems biology of memory},
  journal = {Cell},
  year = {2014},
  volume = {157},
  number = {1},
  pages = {163--186},
  doi = {10.1016/j.cell.2014.03.001},
  pmid = {24679534},
  keywords = {memory, LTP, synaptic plasticity, protein synthesis, encoding}
}

@article{Dudai2015consolidation,
  author = {Dudai, Yadin and Karni, Avi and Born, Jan},
  title = {The consolidation and transformation of memory},
  journal = {Neuron},
  year = {2015},
  volume = {88},
  number = {1},
  pages = {20--32},
  doi = {10.1016/j.neuron.2015.09.004},
  pmid = {26447570},
  keywords = {memory consolidation, retrieval, pattern completion, hippocampus}
}

@article{Constantinidis2018working,
  author = {Constantinidis, Christos and Funahashi, Shintaro and Lee, Daeyeol and Murray, John D. and Qi, Xue-Lian and Wang, Min and Arnsten, Amy F. T.},
  title = {Persistent spiking activity underlies working memory},
  journal = {Journal of Neuroscience},
  year = {2018},
  volume = {38},
  number = {32},
  pages = {7020--7028},
  doi = {10.1523/JNEUROSCI.2486-17.2018},
  pmid = {30089640},
  keywords = {working memory, persistent firing, prefrontal cortex, metabolic cost}
}

@article{Noakes2004governor,
  author = {Noakes, Timothy D. and St Clair Gibson, Alan and Lambert, Estelle V.},
  title = {From catastrophe to complexity: a novel model of integrative central neural regulation of effort and fatigue during exercise in humans: summary and conclusions},
  journal = {British Journal of Sports Medicine},
  year = {2005},
  volume = {39},
  number = {2},
  pages = {120--124},
  doi = {10.1136/bjsm.2003.010330},
  pmid = {15665213},
  pmcid = {PMC1725112},
  keywords = {central governor, fatigue, exercise, motor output, brain regulation}
}

@article{StClairGibson2004fatigue,
  author = {St Clair Gibson, Alan and Noakes, Timothy D.},
  title = {Evidence for complex system integration and dynamic neural regulation of skeletal muscle recruitment during exercise in humans},
  journal = {British Journal of Sports Medicine},
  year = {2004},
  volume = {38},
  number = {6},
  pages = {797--806},
  doi = {10.1136/bjsm.2003.009852},
  pmid = {15562183},
  pmcid = {PMC1724972},
  keywords = {central governor, motor unit recruitment, fatigue, exercise regulation}
}

@article{Hrvatin2020torpor,
  author = {Hrvatin, Sinisa and Sun, Senmiao and Wilcox, Owen F. and Yao, Hanqing and Lavin-Peter, Aurora J. and Cicconet, Marcelo and Assad, Elena G. and Palmer, Madeleine E. and Aber, Sage and Bhatt, Radhika and Greenberg, Michael E.},
  title = {Neurons that regulate mouse torpor},
  journal = {Nature},
  year = {2020},
  volume = {583},
  number = {7814},
  pages = {115--121},
  doi = {10.1038/s41586-020-2387-5},
  pmid = {32528181},
  pmcid = {PMC7381368},
  keywords = {torpor, hypothalamus, preoptic area, metabolic suppression, thermoregulation}
}

@article{Takahashi2020torpor,
  author = {Takahashi, Tohru M. and Sunagawa, Genshiro A. and Soya, Shingo and Abe, Manabu and Sakurai, Katsuyasu and Ishikawa, Kyoko and Yanagisawa, Masashi and Hama, Hiroshi and Hasegawa, Etsushi and Miyawaki, Atsushi and Sakimura, Kenji and Takahashi, Masashi and Sakurai, Takeshi},
  title = {A discrete neuronal circuit induces a hibernation-like state in rodents},
  journal = {Nature},
  year = {2020},
  volume = {583},
  number = {7814},
  pages = {109--114},
  doi = {10.1038/s41586-020-2163-6},
  pmid = {32528180},
  keywords = {torpor, hibernation, QRFP neurons, hypothalamus, metabolic suppression}
}

% Wheat/Exercise Intolerance Research - Added 2026-02-08

@article{Drago2006,
  author = {Drago, S and El Asmar, R and Di Pierro, M and Grazia Clemente, M and Tripathi, A and Sapone, A and Thakar, M and Iacono, G and Carroccio, A and D'Agate, C and Not, T and Zampini, L and Catassi, C and Fasano, A},
  title = {Gliadin, zonulin and gut permeability: {Effects} on celiac and non-celiac intestinal mucosa and intestinal cell lines},
  journal = {Scandinavian Journal of Gastroenterology},
  year = {2006},
  volume = {41},
  number = {4},
  pages = {408--419},
  doi = {10.1080/00365520500235334},
  pmid = {16635908},
  keywords = {gliadin, zonulin, gut permeability, celiac disease, intestinal barrier}
}

@article{Lammers2008,
  author = {Lammers, Karen M and Lu, Ruliang and Brownley, Julie and Lu, Bao and Gerard, Craig and Thomas, Kamil and Rallabhandi, Prasad and Shea-Donohue, Terez and Tamiz, Alessio and Alkan, Sezin and Netzel-Arnett, Sarah and Antalis, Toni and Vogel, Stefanie N and Fasano, Alessio},
  title = {{Gliadin} induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor {CXCR3}},
  journal = {Gastroenterology},
  year = {2008},
  volume = {135},
  number = {1},
  pages = {194--204.e3},
  doi = {10.1053/j.gastro.2008.03.023},
  pmid = {18485912},
  pmcid = {PMC2653457},
  keywords = {gliadin, zonulin, CXCR3, intestinal permeability, celiac disease}
}

@article{Junker2012,
  author = {Junker, Yvonne and Zeissig, Sebastian and Kim, Seong-Jun and Barisani, Donatella and Wieser, Herbert and Leffler, Daniel A and Zevallos, Victor and Libermann, Towia A and Dillon, Simon and Freitag, Torsten L and Kelly, Ciaran P and Schuppan, Detlef},
  title = {Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of toll-like receptor 4},
  journal = {Journal of Experimental Medicine},
  year = {2012},
  volume = {209},
  number = {13},
  pages = {2395--2408},
  doi = {10.1084/jem.20102660},
  pmid = {23209313},
  pmcid = {PMC3526354},
  keywords = {wheat, ATI, TLR4, inflammation, innate immunity}
}

@article{vanWijck2011,
  author = {van Wijck, Kim and Lenaerts, Kaatje and van Loon, Luc J C and Peters, Wim H M and Buurman, Wim A and Dejong, Cornelis H C},
  title = {Exercise-induced splanchnic hypoperfusion results in gut dysfunction in healthy men},
  journal = {PLoS ONE},
  year = {2011},
  volume = {6},
  number = {7},
  pages = {e22366},
  doi = {10.1371/journal.pone.0022366},
  pmid = {21811592},
  pmcid = {PMC3141050},
  certainty = {0.90},
  research_stream = {stream-1-severe-patients},
  keywords = {exercise, splanchnic circulation, gut permeability, I-FABP, intestinal injury}
}

@article{Uhde2018,
  author = {Uhde, Melanie and Ajamian, Maria and Caio, Giacomo and De Giorgio, Roberto and Indart, Annette and Green, Peter H and Verna, Elizabeth C and Volta, Umberto and Alaedini, Armin},
  title = {Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome},
  journal = {Gut},
  year = {2018},
  volume = {67},
  number = {10},
  pages = {1852--1859},
  doi = {10.1136/gutjnl-2017-314562},
  pmid = {29550784},
  pmcid = {PMC6352651},
  keywords = {ME/CFS, NCWS, wheat sensitivity, biomarkers, chronic fatigue}
}

@article{Skodje2018,
  author = {Skodje, Gry I and Sarna, Vijay K and Minelle, Ingunn H and Rolfsen, Knut L and Muir, Jane G and Gibson, Peter R and Veierød, Marit B and Henriksen, Christin and Lundin, Knut E A},
  title = {Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity},
  journal = {Gastroenterology},
  year = {2018},
  volume = {154},
  number = {3},
  pages = {529--539.e2},
  doi = {10.1053/j.gastro.2017.10.040},
  pmid = {29102613},
  keywords = {fructan, gluten, NCGS, FODMAP, double-blind trial}
}

@article{March2017,
  author = {March, Daniela S and Marchbank, Tania and Playford, Raymond J and Jones, Aled W and Thatcher, Rhys and Davison, Glen},
  title = {Intestinal fatty acid-binding protein and gut permeability responses to exercise},
  journal = {European Journal of Applied Physiology},
  year = {2017},
  volume = {117},
  number = {5},
  pages = {931--941},
  doi = {10.1007/s00421-017-3582-4},
  pmid = {28290057},
  pmcid = {PMC5388720},
  keywords = {I-FABP, gut permeability, exercise, intestinal injury, biomarkers}
}

@article{Campagnolo2017,
  author = {Campagnolo, Nicole and Johnston, Susan and Collatz, Annette and Staines, Donald and Marshall-Gradisnik, Sonya},
  title = {Dietary and nutrition interventions for the therapeutic treatment of chronic fatigue syndrome/myalgic encephalomyelitis: a systematic review},
  journal = {Journal of Human Nutrition and Dietetics},
  year = {2017},
  volume = {30},
  number = {3},
  pages = {247--259},
  doi = {10.1111/jhn.12435},
  pmid = {28428857},
  pmcid = {PMC5434800},
  keywords = {ME/CFS, diet, nutrition, systematic review, elimination diet}
}

@article{Santos2023,
  author = {Santos, Mariana and Bastos, Adriano S and Siqueira-Santos, Tiago and Salerno, Vanessa P},
  title = {Exercise and gliadin lead to gut microbiota imbalance, intestinal epithelium damage and behavioral changes in rats},
  journal = {Physiology \& Behavior},
  year = {2023},
  volume = {260},
  pages = {114070},
  doi = {10.1016/j.physbeh.2023.114070},
  pmid = {36791261},
  keywords = {exercise, gliadin, gut microbiota, intestinal permeability, rats}
}

@article{terSteege2012,
  author = {ter Steege, Rianne W M and Kolkman, Jeroen J},
  title = {Physiology and pathophysiology of splanchnic hypoperfusion and intestinal injury during exercise: strategies for evaluation and prevention},
  journal = {American Journal of Physiology - Gastrointestinal and Liver Physiology},
  year = {2012},
  volume = {303},
  number = {2},
  pages = {G155--G168},
  doi = {10.1152/ajpgi.00066.2012},
  pmid = {22517765},
  certainty = {0.85},
  research_stream = {stream-1-severe-patients},
  keywords = {exercise, splanchnic circulation, intestinal injury, hypoperfusion, I-FABP}
}

@article{Komaroff2021severe,
  author = {Komaroff, Anthony L and Lipkin, W Ian},
  title = {A Comprehensive Examination of Severely Ill {ME/CFS} Patients},
  journal = {Healthcare},
  volume = {9},
  number = {10},
  pages = {1290},
  year = {2021},
  month = {October},
  doi = {10.3390/healthcare9101290},
  pmid = {34682957},
  pmcid = {PMC8535418},
  certainty = {0.70},
  research_stream = {stream-1-severe-patients},
  keywords = {ME/CFS, severe, housebound, biomarkers, cortisol, albumin, HPA axis}
}
@article{Vink2015,
  author = {Vink, Mark},
  title = {The Aerobic Energy Production and the Lactic Acid Excretion are both Impeded in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome},
  journal = {Journal of Neurology and Neurobiology},
  year = {2015},
  volume = {1},
  number = {1},
  doi = {10.16966/2379-7150.112},
  url = {https://sciforschenonline.org/journals/neurology/JNNB-1-112.php},
  keywords = {ME/CFS, lactate, lactic acid, exercise intolerance, energy metabolism, aerobic metabolism},
  note = {Case study of severe ME/CFS patient (former Dutch National Field Hockey Champion) showing 6-fold delay in lactate excretion after trivial exercise (6-yard walk to bathroom), with lactate levels exceeding those of professional athletes. Demonstrates both impaired aerobic energy production and severely delayed lactate clearance in severe ME/CFS}
}

@article{Polo2019LDN,
  author = {Polo, Olli and Pesonen, Pia and Tuominen, Essi},
  title = {Low-dose naltrexone in the treatment of myalgic encephalomyelitis/chronic fatigue syndrome ({ME/CFS})},
  journal = {Fatigue: Biomedicine, Health \& Behavior},
  year = {2019},
  volume = {7},
  number = {4},
  pages = {207--217},
  doi = {10.1080/21641846.2019.1692770},
  url = {https://doi.org/10.1080/21641846.2019.1692770},
  keywords = {low-dose naltrexone, LDN, ME/CFS, chronic fatigue syndrome, retrospective study, treatment response},
  note = {Retrospective analysis of 218 ME/CFS patients treated with LDN (3.0-4.5 mg/day) during 2010-2014 at Unesta Sleep and Breathing Center, Finland. Positive treatment response reported by 73.9\% of patients. Most patients experienced improved vigilance/alertness and improved physical and cognitive performance. Mild adverse effects (insomnia, nausea) common at treatment initiation but neither severe nor long-term adverse effects reported. Largest retrospective study of LDN in ME/CFS to date}
}

@article{Abtahi2017,
  author = {Abtahi, Seyed Hamidreza and Hashemi, Seyed Mostafa and Mahmoodi, Mahdi and Nilforoush, Mohammad Hossein},
  title = {Comparison of Melatonin and Sertraline Therapies on Tinnitus: A Randomized Clinical Trial},
  journal = {International Journal of Preventive Medicine},
  year = {2017},
  volume = {8},
  pages = {61},
  doi = {10.4103/ijpvm.IJPVM_229_17},
  pmid = {28966750},
  pmcid = {PMC5609358},
  url = {https://doi.org/10.4103/ijpvm.IJPVM_229_17},
  keywords = {melatonin, sertraline, tinnitus, randomized controlled trial, Tinnitus Handicap Inventory},
  note = {RCT (n=70) comparing melatonin 3mg/day vs sertraline 50mg/day for 3 months. Melatonin group: THI decreased from 45.02±17.67 to 30.29±19.62 (p<0.05). Sertraline group: THI decreased from 44.85±20.57 to 36.96±25.03 (p<0.05). Both treatments effective, but melatonin significantly more effective than sertraline for tinnitus reduction}
}

@article{Abbasi2025CoQ10,
  author = {Abbasi, Rohollah and Emami, Faranak and Atighechi, Saeid and Sadeghi, Zahra},
  title = {The Effect of Coenzyme {Q$_{10}$} on Tinnitus Severity and Sleep Quality in Patients with Presbycusis},
  journal = {Iranian Journal of Otorhinolaryngology},
  year = {2025},
  volume = {37},
  number = {1},
  pages = {33--39},
  doi = {10.22038/ijorl.2024.79602.3681},
  pmid = {39850225},
  pmcid = {PMC11750638},
  url = {https://doi.org/10.22038/ijorl.2024.79602.3681},
  keywords = {coenzyme Q10, CoQ10, tinnitus, presbycusis, age-related hearing loss, sleep quality, randomized controlled trial},
  note = {Double-blind RCT (n=50) of CoQ10 100mg/day vs placebo for 6 weeks in tinnitus due to presbycusis. CoQ10 group showed significant decreases in tinnitus disability, tinnitus loudness, and sleep disturbance compared to placebo (p<0.001). Demonstrates efficacy of CoQ10 supplementation for tinnitus associated with age-related hearing loss}
}

@article{Cevette2011,
  author = {Cevette, Michael J and Barrs, David M and Patel, Anjali and Conroy, Kevin P and Sydlowski, Sarah and Noble, Breanna N and Nelson, Glenn A and Stepanek, Jan},
  title = {Phase 2 study examining magnesium-dependent tinnitus},
  journal = {International Tinnitus Journal},
  year = {2011},
  volume = {16},
  number = {2},
  pages = {168--173},
  pmid = {22249877},
  url = {https://pubmed.ncbi.nlm.nih.gov/22249877/},
  keywords = {magnesium, tinnitus, clinical trial, Tinnitus Handicap Inventory, Mayo Clinic},
  note = {Single-arm, open-label, before-and-after study (n=26, 19 completers) of oral magnesium 532mg/day for 3 months at Mayo Clinic, Scottsdale. For subjects with slight or greater impairment on THI/TSS, extent of handicap significantly decreased (p=0.03). Patients who ranked slight or greater on THI/TSS before intervention showed significant decrease in tinnitus severity at post-testing (p=0.008). Suggests magnesium may have beneficial effect on perception of tinnitus-related handicap}
}

% New citations added 2026-02-16 from quality review

@article{WongGee2023,
  author = {Wong, Holly T and Gee, Kimberlee and Payne, Anna and Ryan, Allen F and Grant, Karina A and Cunningham, Kathleen and Ryugo, David K and Westerberg, Brian D and Steyger, Peter S and Gee, Kimberlee J},
  title = {Mitochondrial form and function in hair cells},
  journal = {Hearing Research},
  year = {2023},
  volume = {428},
  pages = {108660},
  doi = {10.1016/j.heares.2022.108660},
  pmid = {36525891},
  pmcid = {PMC10227193},
  url = {https://doi.org/10.1016/j.heares.2022.108660},
  keywords = {hair cells, mitochondria, mechanotransduction, ATP, cochlea, energy metabolism},
  note = {Comprehensive review of mitochondrial structure and function in cochlear hair cells. Documents that hair cells depend heavily on mitochondrial oxidative phosphorylation for 75\% of ATP production. Mitochondria localize beneath cuticular plate and near ribbon synapses to meet energy demands of mechanotransduction and synaptic transmission. Mitochondria occupy 7-10\% of outer hair cell volume. Essential for calcium handling and stereociliary bundle integrity during transduction}
}

@article{Reuter2011,
  author = {Reuter, Suzanne E and Evans, Alison M},
  title = {Long‐chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase‐{I} activity},
  journal = {Journal of Internal Medicine},
  year = {2011},
  volume = {270},
  number = {1},
  pages = {76--84},
  doi = {10.1111/j.1365-2796.2010.02341.x},
  pmid = {21205027},
  url = {https://doi.org/10.1111/j.1365-2796.2010.02341.x},
  keywords = {chronic fatigue syndrome, acylcarnitine, carnitine palmitoyltransferase-I, fatty acid oxidation, mitochondrial dysfunction},
  note = {Study of 44 CFS patients vs 49 healthy controls. Found long-chain acylcarnitines (oleyl-L-carnitine C18:1 and linoleyl-L-carnitine C18:2) 30-40\% lower in CFS patients (p<0.0001). Suggests reduced CPT-I activity preventing long-chain fatty acid transport into mitochondria for beta-oxidation. Demonstrates impaired carnitine shuttle function in ME/CFS}
}

@article{Fluge2016,
  author = {Fluge, Øystein and Mella, Olav and Bruland, Ove and Risa, Kristin and Dyrstad, Sissel E and Alme, Katarina and Rekeland, Ingrid G and Sapkota, Dipak and Røsland, Guro Våge and Fosså, Alexander and Ktoridou-Valen, Irini and Lunde, Silje and Sørland, Kristoffer and Lien, Kari and Herder, Inger and Thürmer, Hanne and Gotaas, Marit E and Baranowska, Kaja A and Bohlin, Ludvig and Schäfer, Christopher and McCann, Andrew and Sommerfelt, Knut and Helgeland, Lars and Ueland, Per M and Dahl, Olav and Tronstad, Karl J},
  title = {Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome},
  journal = {JCI Insight},
  year = {2016},
  volume = {1},
  number = {21},
  pages = {e89376},
  doi = {10.1172/jci.insight.89376},
  pmid = {28018972},
  pmcid = {PMC5161229},
  url = {https://doi.org/10.1172/jci.insight.89376},
  keywords = {ME/CFS, pyruvate dehydrogenase, PDH kinase, metabolomics, amino acids, TCA cycle},
  note = {Metabolomic study of 200 ME/CFS patients vs 102 healthy controls. Found specific reduction of amino acids fueling TCA cycle oxidative metabolism, mainly in females. Increased mRNA expression of inhibitory PDH kinases 1, 2, and 4; sirtuin 4; and PPARδ in PBMCs. Suggests functional PDH impairment forces reliance on amino acid oxidation to maintain ATP, explaining post-exertional malaise and lactic acid accumulation}
}

@article{Nelson2019,
  author = {Nelson, Libby D and Temkin, Nancy R and Barber, Jason and Brett, Barbara L and Okonkwo, David O and McCrea, Michael and Whyte, John and Giacino, Joseph T and Markowitz, Amy J and Korley, Frederick K and Diaz-Arrastia, Ramon and Sun, Xiaoying and Taylor, Sabrina R and Manley, Geoffrey T},
  title = {Functional recovery and rehabilitation after traumatic brain injury: Does the presence of dysautonomia matter?},
  journal = {Journal of Neurotrauma},
  year = {2019},
  volume = {36},
  number = {10},
  pages = {1708--1716},
  doi = {10.1089/neu.2018.6067},
  pmid = {30488777},
  pmcid = {PMC8101086},
  keywords = {traumatic brain injury, dysautonomia, paroxysmal sympathetic hyperactivity, autonomic dysfunction, diffuse axonal injury},
  note = {Study of TBI patients showing dysautonomia occurs in approximately 10\% of severe TBI survivors. Associated with diffuse axonal injury (DAI), preadmission hypoxia, and younger age. Dysautonomia characterized by episodes of increased HR, RR, temperature, BP, muscle tone, posturing, and sweating. Associated with poorer functional outcomes and longer rehabilitation stays}
}

@article{Ghali2019,
  author = {Ghali, Abdulelah and Lacout, Camille and Ghali, Mostafa and Gury, Aurore and Beucher, Anne Benedicte and Lozac'h, Patricia and Lavigne, Christian and Urbanski, Guy},
  title = {Elevated blood lactate in resting conditions correlate with post-exertional malaise severity in patients with Myalgic encephalomyelitis/Chronic fatigue syndrome},
  journal = {Scientific Reports},
  year = {2019},
  volume = {9},
  pages = {18817},
  doi = {10.1038/s41598-019-55473-4},
  pmid = {31827171},
  pmcid = {PMC6906377},
  url = {https://doi.org/10.1038/s41598-019-55473-4},
  keywords = {ME/CFS, lactate, post-exertional malaise, lactic acid, metabolic dysfunction},
  note = {Study of 123 ME/CFS patients in France. Found 44.7\% (55 patients) had elevated resting blood lactate levels ≥2 mmol/L on one or more measurements. Patients with elevated lactate at rest showed significantly more severe post-exertional malaise after adjusting for age, sex, and comorbidities. Demonstrates subset of ME/CFS patients with baseline metabolic dysfunction manifesting as elevated lactate even at rest}
}

@article{Schoenen1998,
  author = {Schoenen, J and Jacquy, J and Lenaerts, M},
  title = {Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial},
  journal = {Neurology},
  year = {1998},
  volume = {50},
  number = {2},
  pages = {466--470},
  doi = {10.1212/WNL.50.2.466},
  pmid = {9484373},
  url = {https://doi.org/10.1212/WNL.50.2.466},
  keywords = {riboflavin, migraine, prophylaxis, FAD, mitochondrial dysfunction, randomized controlled trial},
  note = {Landmark RCT of riboflavin 400mg/day vs placebo in 55 migraine patients over 3 months. 59\% of riboflavin patients achieved ≥50\% reduction in migraine frequency vs 15\% placebo (p<0.05). Riboflavin as FAD precursor enhances mitochondrial electron transport chain function. Typically requires 4-12 weeks for effect. Evidence Level: 1A}
}

@article{vanDixhoorn2025,
  author = {van Dixhoorn, Jan and Pul, Cees van der and van Campen, C. (Linda) M. C. and Visser, Frans C.},
  title = {Abnormal breathing patterns and hyperventilation are common in patients with chronic fatigue syndrome during exercise},
  journal = {Frontiers in Medicine},
  year = {2025},
  volume = {12},
  pages = {1669036},
  doi = {10.3389/fmed.2025.1669036},
  pmid = {41293716},
  pmcid = {PMC12640868},
  url = {https://doi.org/10.3389/fmed.2025.1669036},
  keywords = {ME/CFS, dysfunctional breathing, hyperventilation, respiratory pattern disorder, accessory muscles},
  note = {2025 study finding 42.1\% of ME/CFS patients (24/57) met criteria for dysfunctional breathing vs 16\% sedentary controls. 32\% had hyperventilation vs 4\% controls. Dysfunctional breathing involves loss of chest-abdomen synchrony and overuse of accessory muscles (neck/shoulders) which consume 3× more energy. May contribute to post-exertional malaise}
}

@article{Shoenfeld1993,
  author = {Shemesh, Z and Attias, J and Ornan, M and Shapira, N and Shahar, A},
  title = {Vitamin {B}12 deficiency in patients with chronic-tinnitus and noise-induced hearing loss},
  journal = {American Journal of Otolaryngology},
  year = {1993},
  volume = {14},
  number = {2},
  pages = {94--99},
  doi = {10.1016/0196-0709(93)90046-A},
  pmid = {8484483},
  url = {https://doi.org/10.1016/0196-0709(93)90046-A},
  keywords = {vitamin B12, tinnitus, noise-induced hearing loss, NIHL, cobalamin deficiency},
  note = {Study documenting 47\% prevalence of vitamin B12 deficiency (≤250 pg/mL) in tinnitus patients with noise-induced hearing loss, significantly higher than 27\% in NIHL-only patients and 19\% in normal subjects (p<0.023). Suggests relationship between B12 deficiency and auditory pathway dysfunction. Some improvement observed with B12 replacement therapy}
}

@article{Petridou2023,
  author = {Petridou, Eirini and Kanaka-Gantenbein, Christina and Spyridis, Nektarios and Ioannidis, John P. A. and Chrousos, George P. and Michos, Athanasios},
  title = {The Effect of Alpha-Lipoic Acid in the Treatment of Chronic Subjective Tinnitus through the Tinnitus Handicap Inventory Scores},
  journal = {Audiology Research},
  year = {2023},
  volume = {13},
  number = {4},
  pages = {484--493},
  doi = {10.3390/audiolres13040043},
  pmid = {37489379},
  pmcid = {PMC10366923},
  url = {https://doi.org/10.3390/audiolres13040043},
  keywords = {alpha-lipoic acid, ALA, tinnitus, Tinnitus Handicap Inventory, cochlear dysfunction, metabolic syndrome},
  note = {Study of alpha-lipoic acid 600mg/day for 2 months in tinnitus patients. Group A (bilateral cochlear dysfunction + metabolic syndrome) showed significant reduction in THI total scores and tinnitus loudness. Group B (acoustic nerve lesions) showed no benefit. Suggests ALA antioxidant effects specifically benefit organ of Corti in patients with metabolic syndrome}
}

@article{Roberts2004,
  author = {Roberts, David M and Okpalauwaekwe, Ugonma and Kellie, Scott and Drummond, Leanne M and Stowe, Alan M and Barber, P. Alan},
  title = {Salivary cortisol response to awakening in chronic fatigue syndrome},
  journal = {British Journal of Psychiatry},
  year = {2004},
  volume = {184},
  number = {2},
  pages = {136--141},
  doi = {10.1192/bjp.184.2.136},
  pmid = {14754825},
  url = {https://doi.org/10.1192/bjp.184.2.136},
  keywords = {chronic fatigue syndrome, cortisol awakening response, HPA axis, hypocortisolism, salivary cortisol},
  note = {Study showing CFS patients have lower cortisol response to awakening measured by area under curve. Salivary cortisol day-curves blunted compared to controls, with lower evening levels and blunted rise upon waking. Demonstrates HPA axis hypofunction as hallmark ME/CFS feature. Magnitude of dysfunction correlates with illness duration and symptom severity}
}

